<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP2007525148A - 
  Polyene polyketides, methods for their production and use as pharmaceuticals [Related Applications] This application is based on US Provisional Application No. 60 / 441,123, filed Jan. 21, 2003, and US Provisional Application No. 60 / 441,2003. Claims priority to 60 / 494,568, US provisional application 60 / 469,810 filed May 13, 2003 and US provisional application 60 / 491,516 filed August 1, 2003 Is.
 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP2007525148A/en">
    <meta name="description" content="
   
    The present invention relates to a new class of polyene polyketides, pharmaceutically acceptable salts and derivatives thereof and methods for obtaining the compounds. One way to obtain these compounds is by culturing a new strain of Streptomyces isonensis, and another method involves the expression of genes in the biosynthetic pathway in transformed host cells. The present invention further provides novel strains of Streptomyces isenensis used to produce these compounds and the use of these compounds and their pharmaceutically acceptable salts and derivatives as drugs, particularly fungal cell growth and And its use as an inhibitor of cancer cell growth. The invention also relates to pharmaceutical compositions comprising these novel polyketides or their pharmaceutically acceptable salts or derivatives. Finally, the present invention relates to novel polynucleotide sequences involved in the biosynthesis of these novel polyketides and their encoded proteins.   
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Polyene polyketides, methods for their production and use as pharmaceuticals [Related Applications] This application is based on US Provisional Application No. 60 / 441,123, filed Jan. 21, 2003, and US Provisional Application No. 60 / 441,2003. Claims priority to 60 / 494,568, US provisional application 60 / 469,810 filed May 13, 2003 and US provisional application 60 / 491,516 filed August 1, 2003 Is.
 
       ">
    <meta name="DC.date" content="2004-01-21" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    The present invention relates to a new class of polyene polyketides, pharmaceutically acceptable salts and derivatives thereof and methods for obtaining the compounds. One way to obtain these compounds is by culturing a new strain of Streptomyces isonensis, and another method involves the expression of genes in the biosynthetic pathway in transformed host cells. The present invention further provides novel strains of Streptomyces isenensis used to produce these compounds and the use of these compounds and their pharmaceutically acceptable salts and derivatives as drugs, particularly fungal cell growth and And its use as an inhibitor of cancer cell growth. The invention also relates to pharmaceutical compositions comprising these novel polyketides or their pharmaceutically acceptable salts or derivatives. Finally, the present invention relates to novel polynucleotide sequences involved in the biosynthesis of these novel polyketides and their encoded proteins.   
   
 
   ">
    <meta name="citation_patent_application_number" content="JP:2006500436A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/05/ae/fa/2fa8c3656d8519/JP2007525148A.pdf">
    <meta name="citation_patent_publication_number" content="JP:2007525148:A">
    <meta name="DC.date" content="2007-09-06">
    <meta name="DC.contributor" content="ブライアン  オー バックマン" scheme="inventor">
    <meta name="DC.contributor" content="ジェイムス  ビー ムカルピン" scheme="inventor">
    <meta name="DC.contributor" content="エマヌエル ザゾプロス" scheme="inventor">
    <meta name="DC.contributor" content="クリス  エム ファーネット" scheme="inventor">
    <meta name="DC.contributor" content="エコピア  バイオサイエンシーズ  インク" scheme="assignee">
    <meta name="DC.relation" content="WO:2003062458:A2" scheme="references">
    <meta name="DC.relation" content="JP:2006528664:A" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Polyene polyketides, methods for their production and use as pharmaceuticals [Related Applications] This application is based on US Provisional Application No. 60 / 441,123, filed Jan. 21, 2003, and US Provisional Application No. 60 / 441,2003. Claims priority to 60 / 494,568, US provisional application 60 / 469,810 filed May 13, 2003 and US provisional application 60 / 491,516 filed August 1, 2003 Is.
 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA56310237" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">本発明は、ポリエンポリケチドの新分類、その薬学的に許容される塩及び誘導体並びにその化合物を得るための方法に関する。これらの化合物を得る１つの方法は、ストレプトミセス・アイズネンシスの新規株の培養によるものであり、別の方法は、形質転換宿主細胞において、生合成経路の遺伝子の発現を伴う。本発明はさらに、これらの化合物を生成するのに用いられるストレプトミセス・アイズネンシスの新規株と、これらの化合物及びそれらの薬学的に許容される塩及び誘導体の薬剤としての使用、特に真菌細胞増殖及び癌細胞増殖の阻害薬としての使用とに関する。本発明はまた、これらの新規ポリケチド又はそれらの薬学的に許容される塩若しくは誘導体を含む医薬組成物に関する。最後に本発明は、これらの新規ポリケチドの生合成に関係する新規ポリヌクレオチド配列及びそれらのコードされたタンパク質に関する。<br class="style-scope patent-text"> </span>The present invention relates to a new class of polyene polyketides, pharmaceutically acceptable salts and derivatives thereof and methods for obtaining the compounds. One way to obtain these compounds is by culturing a new strain of Streptomyces isonensis, and another method involves the expression of genes in the biosynthetic pathway in transformed host cells. The present invention further provides novel strains of Streptomyces isenensis used to produce these compounds and the use of these compounds and their pharmaceutically acceptable salts and derivatives as drugs, particularly fungal cell growth and And its use as an inhibitor of cancer cell growth. The invention also relates to pharmaceutical compositions comprising these novel polyketides or their pharmaceutically acceptable salts or derivatives. Finally, the present invention relates to novel polynucleotide sequences involved in the biosynthesis of these novel polyketides and their encoded proteins. <br class="style-scope patent-text"> </span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">31</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/db/86/cb/0b83ced5d56e3f/2007525148-203.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ba/52/29/d7489d032f0b18/2007525148-204.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b8/bf/c5/32acdb8ae13c0b/2007525148-205.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a6/3a/2d/53e2adfd24aec9/2007525148-206.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/64/3b/a8/c1dfc9270b24b0/2007525148-207.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/64/31/a6/eb9db60036ea46/2007525148-208.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/54/53/83/18a91f71e38de1/2007525148-209.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/cd/e5/e3/9920cdcd642e27/2007525148-210.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/38/a7/a9/e2f934d7406320/2007525148-211.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e4/19/dc/3ca0df57137982/2007525148-212.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/45/d3/ce/54142fd6aa0f51/2007525148-213.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/7f/a5/01/2927f88a58ebc3/2007525148-214.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9b/f0/65/7a6ad8920527f7/2007525148-215.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/79/0c/ff/7e5a5f44f9c682/2007525148-216.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c0/67/53/298d4c37e84371/2007525148-217.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/50/56/f8/197166c3381b3e/2007525148-218.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9b/c5/d7/c8b20e16e1a046/2007525148-219.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/96/21/1c/99838752b8b2a3/2007525148-220.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/92/39/3d/c4b3a3c0e7a729/2007525148-221.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b5/e7/53/9a36593103c171/2007525148-222.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/82/48/4e/6a619094016dc2/2007525148-223.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e1/cb/cd/0247aa2bfe0f98/2007525148-224.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/58/2d/92/2eab0262cb7b9b/2007525148-225.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/80/5e/4e/dbbcfc9c9b521a/2007525148-226.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/79/46/ed/e9ada0f84004ff/2007525148-227.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/df/a7/8c/f0466e4f59e164/2007525148-228.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/77/de/8f/11698ae7839d4f/2007525148-229.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e2/43/71/ca9776079c8760/2007525148-230.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/82/64/c2/044403c19b1248/2007525148-231.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/09/1d/c1/a0179c0282224c/2007525148-232.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/95/18/38/3825b4cf06b94f/2007525148-233.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/20"><a id="link" href="#" class="style-scope state-modifier">C07H15/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Carbocyclic rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07H15/203"><a id="link" href="#" class="style-scope state-modifier">C07H15/203</a></state-modifier>
                  <span class="description style-scope classification-tree">Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/10"><a id="link" href="#" class="style-scope state-modifier">A61P31/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Antimycotics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/02"><a id="link" href="#" class="style-scope state-modifier">A61P35/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents specific for leukemia</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C215/00"><a id="link" href="#" class="style-scope state-modifier">C07C215/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino and hydroxy groups bound to the same carbon skeleton</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C215/02"><a id="link" href="#" class="style-scope state-modifier">C07C215/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C215/22"><a id="link" href="#" class="style-scope state-modifier">C07C215/22</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C215/24"><a id="link" href="#" class="style-scope state-modifier">C07C215/24</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C225/00"><a id="link" href="#" class="style-scope state-modifier">C07C225/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C225/02"><a id="link" href="#" class="style-scope state-modifier">C07C225/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C225/14"><a id="link" href="#" class="style-scope state-modifier">C07C225/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C235/00"><a id="link" href="#" class="style-scope state-modifier">C07C235/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C235/02"><a id="link" href="#" class="style-scope state-modifier">C07C235/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C235/28"><a id="link" href="#" class="style-scope state-modifier">C07C235/28</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C237/00"><a id="link" href="#" class="style-scope state-modifier">C07C237/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C237/02"><a id="link" href="#" class="style-scope state-modifier">C07C237/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C237/16"><a id="link" href="#" class="style-scope state-modifier">C07C237/16</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C279/00"><a id="link" href="#" class="style-scope state-modifier">C07C279/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C279/20"><a id="link" href="#" class="style-scope state-modifier">C07C279/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C279/22"><a id="link" href="#" class="style-scope state-modifier">C07C279/22</a></state-modifier>
                  <span class="description style-scope classification-tree">Y being a hydrogen or a carbon atom, e.g. benzoylguanidines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C305/00"><a id="link" href="#" class="style-scope state-modifier">C07C305/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Esters of sulfuric acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C305/02"><a id="link" href="#" class="style-scope state-modifier">C07C305/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C305/14"><a id="link" href="#" class="style-scope state-modifier">C07C305/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and unsaturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/02"><a id="link" href="#" class="style-scope state-modifier">C07H15/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Acyclic radicals, not substituted by cyclic structures</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/04"><a id="link" href="#" class="style-scope state-modifier">C07H15/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/10"><a id="link" href="#" class="style-scope state-modifier">C07H15/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/18"><a id="link" href="#" class="style-scope state-modifier">C07H15/18</a></state-modifier>
                  <span class="description style-scope classification-tree">Acyclic radicals, substituted by carbocyclic rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/26"><a id="link" href="#" class="style-scope state-modifier">C07H15/26</a></state-modifier>
                  <span class="description style-scope classification-tree">Acyclic or carbocyclic radicals, substituted by hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/00"><a id="link" href="#" class="style-scope state-modifier">C12N1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/20"><a id="link" href="#" class="style-scope state-modifier">C12N1/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/205"><a id="link" href="#" class="style-scope state-modifier">C12N1/205</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacterial isolates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P11/00"><a id="link" href="#" class="style-scope state-modifier">C12P11/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of sulfur-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P13/00"><a id="link" href="#" class="style-scope state-modifier">C12P13/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of nitrogen-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P13/001"><a id="link" href="#" class="style-scope state-modifier">C12P13/001</a></state-modifier>
                  <span class="description style-scope classification-tree">Amines; Imines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P13/00"><a id="link" href="#" class="style-scope state-modifier">C12P13/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of nitrogen-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P13/02"><a id="link" href="#" class="style-scope state-modifier">C12P13/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/00"><a id="link" href="#" class="style-scope state-modifier">C12P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of compounds containing saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/44"><a id="link" href="#" class="style-scope state-modifier">C12P19/44</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of O-glycosides, e.g. glucosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/00"><a id="link" href="#" class="style-scope state-modifier">C12P7/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of oxygen-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/40"><a id="link" href="#" class="style-scope state-modifier">C12P7/40</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/42"><a id="link" href="#" class="style-scope state-modifier">C12P7/42</a></state-modifier>
                  <span class="description style-scope classification-tree">Hydroxy-carboxylic acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C2601/00"><a id="link" href="#" class="style-scope state-modifier">C07C2601/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Systems containing only non-condensed rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C2601/06"><a id="link" href="#" class="style-scope state-modifier">C07C2601/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Systems containing only non-condensed rings with a five-membered ring</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07C2601/10"><a id="link" href="#" class="style-scope state-modifier">C07C2601/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C"><a id="link" href="#" class="style-scope state-modifier">C07C</a></state-modifier>
                  <span class="description style-scope classification-tree">ACYCLIC OR CARBOCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C2601/00"><a id="link" href="#" class="style-scope state-modifier">C07C2601/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Systems containing only non-condensed rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07C2601/12"><a id="link" href="#" class="style-scope state-modifier">C07C2601/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Systems containing only non-condensed rings with a six-membered ring</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07C2601/14"><a id="link" href="#" class="style-scope state-modifier">C07C2601/14</a></state-modifier>
                  <span class="description style-scope classification-tree">The ring being saturated</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R"><a id="link" href="#" class="style-scope state-modifier">C12R</a></state-modifier>
                  <span class="description style-scope classification-tree">INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R2001/00"><a id="link" href="#" class="style-scope state-modifier">C12R2001/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms ; Processes using microorganisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R2001/01"><a id="link" href="#" class="style-scope state-modifier">C12R2001/01</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria or Actinomycetales ; using bacteria or Actinomycetales</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12R2001/465"><a id="link" href="#" class="style-scope state-modifier">C12R2001/465</a></state-modifier>
                  <span class="description style-scope classification-tree">Streptomyces</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y"><a id="link" href="#" class="style-scope state-modifier">Y</a></state-modifier>
                  <span class="description style-scope classification-tree">GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10"><a id="link" href="#" class="style-scope state-modifier">Y10</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNICAL SUBJECTS COVERED BY FORMER USPC</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S"><a id="link" href="#" class="style-scope state-modifier">Y10S</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S435/00"><a id="link" href="#" class="style-scope state-modifier">Y10S435/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemistry: molecular biology and microbiology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S435/8215"><a id="link" href="#" class="style-scope state-modifier">Y10S435/8215</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y10S435/822"><a id="link" href="#" class="style-scope state-modifier">Y10S435/822</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms using bacteria or actinomycetales</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="Y10S435/886"><a id="link" href="#" class="style-scope state-modifier">Y10S435/886</a></state-modifier>
                  <span class="description style-scope classification-tree">Streptomyces</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 23 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Organic Chemistry"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Organic Chemistry
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP2007525148A</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published unexamined patent application (based on international application)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/05/ae/fa/2fa8c3656d8519/JP2007525148A.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;compound&quot;,&quot;seq&quot;,&quot;residues&quot;,&quot;group&quot;,&quot;nucleic acid&quot;]" data-before="20030121"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP2007525148A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2007525148A/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ブライアン  オー バックマン"><a id="link" href="#" class="style-scope state-modifier">ブライアン  オー バックマン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ジェイムス  ビー ムカルピン"><a id="link" href="#" class="style-scope state-modifier">ジェイムス  ビー ムカルピン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="エマヌエル ザゾプロス"><a id="link" href="#" class="style-scope state-modifier">エマヌエル ザゾプロス</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="クリス  エム ファーネット"><a id="link" href="#" class="style-scope state-modifier">クリス  エム ファーネット</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2004</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7416868B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US10/760,494</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1585752B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP04703730A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2004065401A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/CA2004/000068</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2453071A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002453071A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2453080C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002453080A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7375088B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US10/760,493</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2007525148A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2006500436A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE602004010229D1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE602004010229T</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2006500436A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2004-01-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="エコピア  バイオサイエンシーズ  インク"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by エコピア  バイオサイエンシーズ  インク</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2007-09-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2007525148A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2007525148A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Pending</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (11)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (16)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=2007525148A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/2007525148/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP2007525148A">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES20476534" lang="EN" load-source="google" class="style-scope patent-text">
  <technical-field class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、ポリエンポリケチドの新たな分類、それらの薬学的に許容される塩及び誘導体、及びそれらの生成方法に関連している。これらの新規のポリケチドを得る方法の一つに、ストレプトミセス・アイズネンシス（Streptomyces aizunensis）の新規株の培養によるものがある；別の方法は、形質転換した宿主細胞における、本発明の生合成の遺伝子クラスターの発現にかかわるものである。化合物は、一定のバクテリアの既知の株によっても生成される。本発明は、これらの化合物を生成するストレプトミセス・アイズネンシスの新規株及びこれらの化合物の生合成を導く遺伝子クラスターを包含している。本発明は、これらの新規ポリケチドの使用及びそれらの薬学的に許容される塩及び医薬品としての誘導体、特に真菌並びに細菌性細胞の増殖の阻害剤、癌細胞増殖の阻害剤として、並びに血清コレステロール及び他のステロイドを低下させるために使用されている。本発明は、これらの新規ポリケチド、又は薬学的に許容される塩若しくはその誘導体を含む、薬学的に許容される組成物を包含している。
</span>
&nbsp;&nbsp;The present invention relates to a new class of polyene polyketides, their pharmaceutically acceptable salts and derivatives, and methods for their production. One method for obtaining these novel polyketides is by culturing a new strain of Streptomyces aizunensis; another method is the biosynthetic gene of the invention in transformed host cells. It is related to the expression of clusters. Compounds are also produced by known strains of bacteria. The present invention encompasses novel strains of Streptomyces isuzunensis that produce these compounds and gene clusters that direct the biosynthesis of these compounds. The present invention relates to the use of these new polyketides and their pharmaceutically acceptable salts and pharmaceutical derivatives, in particular fungal and bacterial cell growth inhibitors, cancer cell growth inhibitors, and serum cholesterol and Has been used to lower other steroids. The present invention includes pharmaceutically acceptable compositions comprising these novel polyketides, or pharmaceutically acceptable salts or derivatives thereof.
</span>
    </p>
  </technical-field>
  <background-art class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  放線菌は、土壌中に豊富に存在する細菌の一つの科（family）を構成しており、治療上有用な多くの抗生物質、抗真菌薬、抗癌剤及びコレステロールを低下させる薬剤がこれらの細菌により二次代謝産物として生成された結果として、多大な商業及び科学的な利益をもたらしてきた。多くの放線菌、特にストレプトミセス属は、著しく多様な生物活性代謝物を生成する能力を有するため、広く研究されてきた。新しい天然産物の徹底的な探求は、新種の細菌の同定及び改良株の創出につながった。
</span>
&nbsp;&nbsp;Actinomycetes constitute a family of bacteria that are abundant in soil, and many of these therapeutically useful antibiotics, antifungals, anticancer agents and drugs that lower cholesterol are used by these bacteria. As a result of being produced as a secondary metabolite, it has provided tremendous commercial and scientific benefits. Many actinomycetes, especially the genus Streptomyces, have been extensively studied because they have the ability to produce a remarkably diverse bioactive metabolite. A thorough search for new natural products has led to the identification of new species and the creation of improved strains.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ポリエンポリケチドは、多大な商業用利益を生んだ放線菌によって生産された、一群の天然産物である。例えば、Sakuda et al., 1996 J. of Chem. Soc.、 Perkin trans. 1, 2315-19及びSakuda et al., Tetrahedron Letters, Vol 35, No. 16, 2777-2789 (1995) は、ステレプトマイシス種によって生成される線状のポリエン、リニアマイシンＡ（linearmycin A）を開示している。Sakuda et al.は、リニアマイシンＡが抗真菌活性及び抗細菌活性の両方を示したと報告している。Pawlak et al. J of Antibiotics, Vol. XXXIII No. 9, 989-997は、アクチノマイセス・ジアスタトクロモゲネス（Actinomyces diastatochromogenes）によって生成されたポリエンマクロライドリエノマイシン（polyene macrolide lienomycin）を開示している。Pawlak et al. は、リエノマイシンが抗真菌活性、抗細菌活性、抗腫瘍性活性を示したと報告している。ポリエンマクロライドの抗真菌活性は、高コレステロール血症の作用と相関している（C. P. Schaffner, Polyene Microlides in Clinical Practice, in Macrolide Antibiotics: Chemistry, biology and practice, S. Omura, ed. Academic Press (1984), p491; C. P. Schaffner and H. W. Gordon, Proc Natl. Acad. Sci. U. S. A. 61, 36 (1968)）。
</span>
&nbsp;&nbsp;Polyene polyketides are a group of natural products produced by actinomycetes that produced tremendous commercial benefits. For example, Sakuda et al., 1996 J. of Chem. Soc., Perkin trans. 1, 2315-19 and Sakuda et al., Tetrahedron Letters, <figure-callout id="35" label="Vol" filenames="2007525148-220.png,2007525148-222.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Vol</a></figure-callout> 35, No. 16, 2777-2789 (1995) A linear polyene produced by a Mysis species, linearmycin A, is disclosed. Sakuda et al. Report that linearomycin A exhibited both antifungal and antibacterial activity. Pawlak et al. J of Antibiotics, Vol. XXXIII No. 9, 989-997 discloses polyene macrolide lienomycin produced by Actinomyces diastatochromogenes. ing. Pawlak et al. Report that rienomycin showed antifungal, antibacterial and antitumor activity. The antifungal activity of polyene macrolides correlates with the action of hypercholesterolemia (CP Schaffner, Polyene Microlides in Clinical Practice, in Macrolide Antibiotics: Chemistry, biology and practice, S. Omura, ed. Academic Press (1984 ), p491; CP Schaffner and HW Gordon, Proc Natl. Acad. Sci. USA 61, 36 (1968)).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ポリケチドは、一連の縮合反応及びその後の修飾を通して形成された、二炭素単位からなる炭素鎖基幹を有している。Ｉ型ポリケチドは、炭素鎖の伸長及び修飾の各サイクルのために別々の触媒活性部位を持つモジュラーポリケチドシンターゼ（ＰＫＳ）酵素によって、事実上、合成されている。ＰＫＳタンパク質が、マルチモジュラーな性質を有するため、ポリケチド生合成の特異性及び機序については、よく知られている。
</span>
&nbsp;&nbsp;Polyketides have a carbon chain backbone consisting of two carbon units formed through a series of condensation reactions and subsequent modifications. Type I polyketides are effectively synthesized by a modular polyketide synthase (PKS) enzyme with separate catalytic active sites for each cycle of carbon chain elongation and modification. Because PKS proteins have multi-modular properties, the specificity and mechanism of polyketide biosynthesis is well known.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  多くの生物活性化合物が同定されたのにもかかわらず、増強された性質を持つ新規の天然化合物を得る必要性は依然として残っている。このような化合物を得る現在の方法は、コストも時間もかかる、自然分離株のスクリーニング及び既存の化合物の化学修飾を含むものでる。現在のスクリーニング方法は、化合物の一般的な生物学的性質に基づいており、分子構造の予備知識を要する。既知の活性化合物を化学修飾する方法は存在するが、得られる化合物の種類に関して実質的な限界がある。
</span>
&nbsp;&nbsp;Despite the identification of many bioactive compounds, there remains a need to obtain new natural compounds with enhanced properties. Current methods of obtaining such compounds include costly and time consuming screening of natural isolates and chemical modification of existing compounds. Current screening methods are based on the general biological properties of compounds and require prior knowledge of the molecular structure. Although there are methods for chemically modifying known active compounds, there are substantial limitations as to the type of compound obtained.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  従って、費用効果がよい方法で、かつ、高収率で、薬学的な活性を持つ化合物を得る必要性はかなり高い。本発明は、強力な新治療化合物を生産することの出来るストレプトミセス・アイズネンシスの改良株だけでなく、化学合成よりもむしろデノボ生合成によって新規化合物を生成するための試薬（例えば、ポリヌクレオチド、ポリヌクレオチドを含むベクター及びベクターを含む宿主細胞）及び方法によって、これらの問題を解決する。<br class="style-scope patent-text">
<nplcit num="1" class="style-scope patent-text"> <text class="style-scope patent-text">Sakuda et al, 1996 J. of Chem. Soc., Perkin trans. 1, 2315-19</text> </nplcit>
<nplcit num="2" class="style-scope patent-text"> <text class="style-scope patent-text">Sakuda et al., Tetrahedron Letters, Vol 35, No. 16, 2777-2789 (1995)</text> </nplcit>
<nplcit num="3" class="style-scope patent-text"> <text class="style-scope patent-text">Pawlak et al. J of Antibiotics、 Vol. XXXIII No. 9, 989-997</text> </nplcit>
<nplcit num="4" class="style-scope patent-text"> <text class="style-scope patent-text">C. P. Schaffner, Polyene Microlides in Clinical Practice, in Macrolide Antibiotics: Chemistry, biology and practice, S. Omura, ed. Academic Press (1984), p491</text> </nplcit>
<nplcit num="5" class="style-scope patent-text"> <text class="style-scope patent-text">C. P. Schaffner and H. W. Gordon, Proc Natl. Acad. Sci. U. S. A. 61, 36 (1968)）</text> </nplcit>
</span>Therefore, there is a considerable need to obtain pharmaceutically active compounds in a cost effective manner and in high yield. The present invention is not only an improved strain of Streptomyces isenensis capable of producing potent new therapeutic compounds, but also reagents for producing new compounds by de novo biosynthesis rather than chemical synthesis (eg, polynucleotides, polys Vectors containing nucleotides and host cells containing vectors) and methods solve these problems. <br class="style-scope patent-text"> <nplcit num="1" class="style-scope patent-text"> <text class="style-scope patent-text"> Sakuda et al, 1996 J. of Chem. Soc., Perkin trans. 1, 2315-19 </text> </nplcit> <nplcit num="2" class="style-scope patent-text"> <text class="style-scope patent-text"> Sakuda et al., Tetrahedron Letters, <figure-callout id="35" label="Vol" filenames="2007525148-220.png,2007525148-222.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Vol</a></figure-callout> 35, No. 16, 2777-2789 (1995) </text> </nplcit> <nplcit num="3" class="style-scope patent-text"> <text class="style-scope patent-text"> Pawlak et al. J of Antibiotics, Vol.XXXIII No. 9, 989-997 </text> </nplcit> <nplcit num="4" class="style-scope patent-text"> <text class="style-scope patent-text"> CP Schaffner, Polyene Microlides in Clinical Practice, in Macrolide Antibiotics: Chemistry, biology and practice, S. Omura, ed. Academic Press (1984), p491 </text> </nplcit> <nplcit num="5" class="style-scope patent-text"> <text class="style-scope patent-text"> CP Schaffner and HW Gordon, Proc Natl. Acad. Sci. USA 61, 36 (1968)) </text> </nplcit> </span>
    </p>
  </background-art>
  <disclosure class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、式Ｉの化合物、
</span>
&nbsp;&nbsp;The present invention relates to a compound of formula I,
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="1" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000002" he="63" wi="146" file="2007525148.tif" img-format="tif" img-content="drawing" width="584" height="252" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
                            式Ｉ<br class="style-scope patent-text"> <br class="style-scope patent-text">
  及びその薬学的に許容される塩を含むものである。<br class="style-scope patent-text">
  式中、Ａは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>、−Ｎ＝ＣＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>、
 <chemistry id="" num="1" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000002" he="63" wi="146" file="2007525148.tif" img-format="tif" img-content="drawing" width="584" height="252" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Formula I <br class="style-scope patent-text"> <br class="style-scope patent-text"> And pharmaceutically acceptable salts thereof. <br class="style-scope patent-text"> In the formula, A represents —NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> , —N═CR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> ,
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="2" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000003" he="26" wi="46" file="2007525148.tif" img-format="tif" img-content="drawing" width="184" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
及び                              <br class="style-scope patent-text"> <chemistry id="" num="3" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000004" he="26" wi="38" file="2007525148.tif" img-format="tif" img-content="drawing" width="152" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
からなる群から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>は、それぞれ独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、Ｃ<sub class="style-scope patent-text">３−６</sub>シクロアルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>ヘテロシクロアルキル、アリール、ヘテロアリール及びアミノ酸からなる群から選択され、該アルキル、アルケニル、アリール及びヘテロアリールは、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>、ＮＨ<sub class="style-scope patent-text">２</sub>又はアリールから選択される基で置換されていてもよく、該アリールは、さらにハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>又はＮＨ<sub class="style-scope patent-text">２</sub>から独立して選択される１又は２以上の基で置換されていてもよい。<br class="style-scope patent-text">
Ｂは、エテン−１，２−ジイル又は
 <chemistry id="" num="2" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000003" he="26" wi="46" file="2007525148.tif" img-format="tif" img-content="drawing" width="184" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> as well as <br class="style-scope patent-text"> <chemistry id="" num="3" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000004" he="26" wi="38" file="2007525148.tif" img-format="tif" img-content="drawing" width="152" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of <br class="style-scope patent-text"> R <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each independently H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, C <sub class="style-scope patent-text">3-6</sub> cycloalkyl, C <sub class="style-scope patent-text">2-6</sub> heterocycloalkyl, aryl, hetero Selected from the group consisting of aryl and amino acid, wherein the alkyl, alkenyl, aryl and heteroaryl may be substituted with a group selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> , NH <sub class="style-scope patent-text">2</sub> or aryl, It may be substituted with one or more groups independently selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> or NH <sub class="style-scope patent-text">2</sub> . <br class="style-scope patent-text"> B is ethene-1,2-diyl or
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="4" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000005" he="26" wi="34" file="2007525148.tif" img-format="tif" img-content="drawing" width="136" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
から選択され、<br class="style-scope patent-text">
式中、Ｒ<sup class="style-scope patent-text">１０</sup>はオキソ又はＯＲ<sup class="style-scope patent-text">１１</sup>であり、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１１</sup>は、Ｈ又はヘテロシクロアルキルであり、該ヘテロシクロアルキルは、ＯＸ、Ｃ<sub class="style-scope patent-text">１−３</sub>アルキル及び−Ｏ−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択される１〜４個の置換基で置換されていてもよく、ＸがＨであるか、又は、ＯＸである隣接する置換基が少なくとも２個ある場合には、Ｘは、該隣接する酸素基が式
 <chemistry id="" num="4" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000005" he="26" wi="34" file="2007525148.tif" img-format="tif" img-content="drawing" width="136" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from <br class="style-scope patent-text"> Wherein R <sup class="style-scope patent-text">10</sup> is oxo or OR <sup class="style-scope patent-text">11</sup> ; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">11</sup> is H or heterocycloalkyl, which is substituted with 1 to 4 substituents selected from OX, C <sub class="style-scope patent-text">1-3</sub> alkyl and —O—C (O) R <sup class="style-scope patent-text">1.</sup> And when X is H or there are at least two adjacent substituents that are OX, X is an oxygen group of the formula
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="5" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000006" he="27" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール５員環を形成するような結合であってもよい。<br class="style-scope patent-text">
式中、Ｒ<sup class="style-scope patent-text">５</sup>及びＲ<sup class="style-scope patent-text">６</sup>は、それぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル及びＣ<sub class="style-scope patent-text">２−７</sub>アルケニルからなる群より選択され、<br class="style-scope patent-text">
Ｄは、
 <chemistry id="" num="5" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000006" he="27" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> A bond that forms an acetal 5-membered ring may be used. <br class="style-scope patent-text"> Wherein R <sup class="style-scope patent-text">5</sup> and R <sup class="style-scope patent-text">6</sup> are each independently selected from the group consisting of H, C <sub class="style-scope patent-text">1-6</sub> alkyl and C <sub class="style-scope patent-text">2-7</sub> alkenyl, <br class="style-scope patent-text"> D is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="6" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000007" he="33" wi="36" file="2007525148.tif" img-format="tif" img-content="drawing" width="144" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
−ＮＲ<sup class="style-scope patent-text">１２ａ</sup>Ｒ<sup class="style-scope patent-text">１２ａ</sup>及びＯＲ<sup class="style-scope patent-text">１２  </sup>から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１２</sup>は、Ｈ、１〜２のフェニル基で置換されてもよいＣ<sub class="style-scope patent-text">１−６</sub>アルキルから選択され、該フェニル基は、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル又はハロで置換されていてもよい。<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１２ａ</sup>及びＲ<sup class="style-scope patent-text">１２ａ</sup>は、それぞれ独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、Ｃ<sub class="style-scope patent-text">３−６  </sub>シクロアルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>ヘテロシクロアルキル、アリール、ヘテロアリール及びアミノ酸から選択され、該アルキル、アルケニル、アリール及びヘテロアリールは、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>、ＮＨ<sub class="style-scope patent-text">２</sub>又はアリールから選択される基で置換されていてもよく、該アリールはさらに、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>又はＮＨ<sub class="style-scope patent-text">２</sub>から独立して選択される１又は２以上の基で置換されていてもよい。<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">１</sup>は、
 <chemistry id="" num="6" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000007" he="33" wi="36" file="2007525148.tif" img-format="tif" img-content="drawing" width="144" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from -NR <sup class="style-scope patent-text">12a</sup> R <sup class="style-scope patent-text">12a</sup> and OR <sup class="style-scope patent-text">12</sup> ; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">12</sup> is selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl optionally substituted with 1-2 phenyl groups, and the phenyl group may be substituted with C <sub class="style-scope patent-text">1-6</sub> alkyl or halo. <br class="style-scope patent-text"> R <sup class="style-scope patent-text">12a</sup> and <sup class="style-scope patent-text">R 12a</sup> are each independently, <sub class="style-scope patent-text">H, C 1-6</sub> <sub class="style-scope patent-text">alkyl, C 2-6</sub> <sub class="style-scope patent-text">alkenyl, C 3-6</sub> <sub class="style-scope patent-text">cycloalkyl, C 2-6</sub> heterocycloalkyl, aryl, heteroaryl and amino acid , The alkyl, alkenyl, aryl and heteroaryl may be substituted with a group selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> , NH <sub class="style-scope patent-text">2</sub> or aryl, wherein the aryl is further halogen, OH, NO <sub class="style-scope patent-text">2</sub> or NH <sub class="style-scope patent-text">2</sub> May be substituted with one or more groups independently selected from <br class="style-scope patent-text"> W <sup class="style-scope patent-text">1</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="7" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000008" he="14" wi="24" file="2007525148.tif" img-format="tif" img-content="drawing" width="96" height="56" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">２</sup>は、
 <chemistry id="" num="7" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000008" he="14" wi="24" file="2007525148.tif" img-format="tif" img-content="drawing" width="96" height="56" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">2</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="8" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000009" he="17" wi="36" file="2007525148.tif" img-format="tif" img-content="drawing" width="144" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">３</sup>は、
 <chemistry id="" num="8" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000009" he="17" wi="36" file="2007525148.tif" img-format="tif" img-content="drawing" width="144" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">3</sup> is,
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="9" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000010" he="15" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">５</sup>は、
 <chemistry id="" num="9" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000010" he="15" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">5</sup> is,
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="10" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000011" he="17" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text"> <br class="style-scope patent-text">
  Ｘ<sup class="style-scope patent-text">１</sup>、Ｘ<sup class="style-scope patent-text">２</sup>、Ｘ<sup class="style-scope patent-text">３</sup>、Ｘ<sup class="style-scope patent-text">４</sup>、Ｘ<sup class="style-scope patent-text">５</sup>、Ｘ<sup class="style-scope patent-text">６</sup>、Ｘ<sup class="style-scope patent-text">７</sup>、Ｘ<sup class="style-scope patent-text">８</sup>、Ｘ<sup class="style-scope patent-text">９</sup>、Ｘ<sup class="style-scope patent-text">１２</sup>及びＸ<sup class="style-scope patent-text">１３</sup>が結合である場合には、二つの該隣接酸素原子及びそれらに付着する炭素原子が一緒に、式
 <chemistry id="" num="10" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000011" he="17" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> <br class="style-scope patent-text"> If X <sup class="style-scope patent-text">1</sup> , X <sup class="style-scope patent-text">2</sup> , X <sup class="style-scope patent-text">3</sup> , X <sup class="style-scope patent-text">4</sup> , X <sup class="style-scope patent-text">5</sup> , X <sup class="style-scope patent-text">6</sup> , X <sup class="style-scope patent-text">7</sup> , X <sup class="style-scope patent-text">8</sup> , X <sup class="style-scope patent-text">9</sup> , X <sup class="style-scope patent-text">12</sup> and X <sup class="style-scope patent-text">13</sup> are a bond, then they are attached to the two adjacent oxygen atoms and to them Together with carbon atoms
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="11" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000012" he="23" wi="22" file="2007525148.tif" img-format="tif" img-content="drawing" width="88" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール６員環を形成するように、Ｘ<sup class="style-scope patent-text">１</sup>、Ｘ<sup class="style-scope patent-text">２</sup>、Ｘ<sup class="style-scope patent-text">３</sup>、Ｘ<sup class="style-scope patent-text">４</sup>、Ｘ<sup class="style-scope patent-text">５</sup>、Ｘ<sup class="style-scope patent-text">６</sup>、Ｘ<sup class="style-scope patent-text">７</sup>、Ｘ<sup class="style-scope patent-text">８</sup>、Ｘ<sup class="style-scope patent-text">９</sup>、Ｘ<sup class="style-scope patent-text">１２</sup>及びＸ<sup class="style-scope patent-text">１３</sup>は、それぞれ独立してＨ、−Ｃ（Ｏ）−Ｒ<sup class="style-scope patent-text">７</sup>及び結合から選択され、<br class="style-scope patent-text">
  Ｒ<sup class="style-scope patent-text">５</sup>、Ｒ<sup class="style-scope patent-text">６</sup>及びＲ<sup class="style-scope patent-text">７</sup>はそれぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルケニルから選択され、<br class="style-scope patent-text">
  Ｙ<sup class="style-scope patent-text">１</sup>、Ｙ<sup class="style-scope patent-text">２</sup>、Ｙ<sup class="style-scope patent-text">３</sup>、Ｙ<sup class="style-scope patent-text">４</sup>、Ｙ<sup class="style-scope patent-text">５</sup>、Ｙ<sup class="style-scope patent-text">６</sup>、Ｙ<sup class="style-scope patent-text">７</sup>、Ｙ<sup class="style-scope patent-text">８</sup>、Ｙ<sup class="style-scope patent-text">９</sup>、Ｙ<sup class="style-scope patent-text">１０</sup>、Ｙ<sup class="style-scope patent-text">１１</sup>、Ｙ<sup class="style-scope patent-text">１２</sup>、Ｙ<sup class="style-scope patent-text">１３</sup>及びＹ<sup class="style-scope patent-text">１５</sup>は、それぞれ独立してエテン−１，２−ジイル、エタン−１，２−ジイル及び
 <chemistry id="" num="11" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000012" he="23" wi="22" file="2007525148.tif" img-format="tif" img-content="drawing" width="88" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> So as to form a acetal 6-membered <sup class="style-scope patent-text"> <sup class="style-scope patent-text"> <sup class="style-scope patent-text"> <sup class="style-scope patent-text">ring, X 1, X 2, X</sup> </sup> </sup> </sup> 3, <figure-callout id="4" label="X" filenames="2007525148-214.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 4, <figure-callout id="5" label="X" filenames="2007525148-217.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 5, <figure-callout id="6" label="X" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 6, <figure-callout id="7" label="X" filenames="2007525148-216.png,2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 7, <figure-callout id="8" label="X" filenames="2007525148-232.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 8, <figure-callout id="9" label="X" filenames="2007525148-219.png,2007525148-223.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 9, X 12 and <sup class="style-scope patent-text">X 13</sup> are each independently H is selected from -C (O) -R <sup class="style-scope patent-text">7</sup> and bonds, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">5</sup> , R <sup class="style-scope patent-text">6</sup> and R <sup class="style-scope patent-text">7</sup> are each independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkenyl, <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">1</sup> , Y <sup class="style-scope patent-text">2</sup> , Y <sup class="style-scope patent-text">3</sup> , Y <sup class="style-scope patent-text">4</sup> , Y <sup class="style-scope patent-text">5</sup> , Y <sup class="style-scope patent-text">6</sup> , Y <sup class="style-scope patent-text">7</sup> , Y <sup class="style-scope patent-text">8</sup> , Y <sup class="style-scope patent-text">9</sup> , Y <sup class="style-scope patent-text">10</sup> , Y <sup class="style-scope patent-text">11</sup> , Y <sup class="style-scope patent-text">12</sup> , Y <sup class="style-scope patent-text">13</sup> and Y <sup class="style-scope patent-text">15</sup> are each independently ethene-1 , 2-diyl, ethane-1,2-diyl and
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="12" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000013" he="19" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
から選択され、式中、該エテン−１，２−ジイル基及びエタン−１，２−ジイル基は、メチル基で置換されていてもよい。<br class="style-scope patent-text">
ＺはＯＨ、ＮＨＲ<sup class="style-scope patent-text">８</sup>及び
 <chemistry id="" num="12" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000013" he="19" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Wherein the ethene-1,2-diyl group and ethane-1,2-diyl group may be substituted with a methyl group. <br class="style-scope patent-text"> Z is OH, NHR <sup class="style-scope patent-text">8</sup> and
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="13" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000014" he="26" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
から選択され、点線が結合のときには、Ｚはオキソ又はＮＲ<sup class="style-scope patent-text">９</sup>であり、<br class="style-scope patent-text">
  Ｒ<sup class="style-scope patent-text">８</sup>は、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニルから選択され、<br class="style-scope patent-text">
  Ｒ<sup class="style-scope patent-text">９</sup>は、アリールで置換されていてもよいＣ<sub class="style-scope patent-text">１−６</sub>アルキルである。
 <chemistry id="" num="13" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000014" he="26" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Z is oxo or NR <sup class="style-scope patent-text">9</sup> when the dotted line is a bond, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">8</sup> is selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">9</sup> is C <sub class="style-scope patent-text">1-6</sub> alkyl <sub class="style-scope patent-text">optionally</sub> substituted with aryl.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は線状のグリコシル化ポリケチドであり、アミドヒドロキシシクロペンテノン（amidohydroxycyclopentenone）成分を有する化合物２（ａ）、及び薬学的に許容されるその塩をも対象にしている。
</span>
&nbsp;&nbsp;The present invention is also a linear glycosylated polyketide, which is also directed to compound 2 (a) having an amidohydroxycyclopentenone component and pharmaceutically acceptable salts thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="14" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000015" he="24" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
  化合物２（ａ）
 <chemistry id="" num="14" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000015" he="24" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (a)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の系統名は、以下のように決定された。<br class="style-scope patent-text">
５６−アミノ−１５，１７，３３，３５，３７，４１，４３，４５，４７，５１，５３−ウンデカヒドロキシ−１４，１６，３０−トリメチル−３１−オキソ−２９−（３，４，５−トリヒドロキシ−６−メチル−テトラヒドロ−ピラン−２−イロルオキシ）−ヘキサペンタコンタ−２，４，６，８，１２，１８，２０，２２，２４，２６，３８，４８−ドデカン酸（２−ヒドロキシ−５−オキソ−シクロペント−１−エニル）−アミド。
</span>The systematic name of compound 2 (a) was determined as follows. <br class="style-scope patent-text"> 56-amino-15,17,33,35,37,41,43,45,47,51,53-undecahydroxy-14,16,30-trimethyl-31-oxo-29- (3,4,5 -Trihydroxy-6-methyl-tetrahydro-pyran-2-yloloxy) -hexapentaconta-2,4,6,8,12,18,20,22,24,26,38,48-dodecanoic acid (2- Hydroxy-5-oxo-cyclopent-1-enyl) -amide.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、治療上有効な量の式Ｉの化合物又は薬学的に許容されるその塩、及び薬学的に許容される担体を含む、式Ｉの化合物の薬学的組成物を包含している。特に、本発明は、治療上有効な量の化合物２（ａ）又は薬学的に許容される塩、及び薬学的に許容される担体を含む、化合物２（ａ）の薬学的組成物を対象にしている。
</span>
&nbsp;&nbsp;The present invention includes a pharmaceutical composition of a compound of formula I comprising a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. In particular, the present invention is directed to a pharmaceutical composition of Compound 2 (a) comprising a therapeutically effective amount of Compound 2 (a) or a pharmaceutically acceptable salt and a pharmaceutically acceptable carrier. ing.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、化合物２（ａ）及びここで定義されている式Ｉ及び式IIを含む関連化合物を生成する方法をも対象にしている。そのような方法は、ストレプトミセス・アイズネンシス株に由来する細胞を培養するステップ、該培養細胞を所望の化合物の生成に必要とされる期間と同様の時間、成長培地において、好気的にインキュベートするステップ、該培地をメタノールやエタノールなどの溶媒で抽出し、粗抽出物から化合物を精製するステップを含む。本発明の方法に使用されるストレプトミセス・アイズネンシス株はＮＲＲＬ  Ｂ−１１２７７又はその変異体であってもよい。本発明の方法において有用な好ましいストレプトミセス・アイズネンシスの株は、［Ｃ０３］０２３（寄託アクセッション番号ＩＤＡＣ０７０８０３−１）として同定された変異株である。本発明の方法において有用なストレプトミセス・アイズネンシスの最も好ましい株は、［Ｃ０３Ｕ０３］０２３（寄託アクセッション番号ＩＤＡＣ２３１２０３−０２）として同定された変異株である。本発明は、寄託アクセッション番号ＩＤＡＣ０７０８０３−１及びＩＤＡＣ２３１２０３−０２として同定されたストレプトミセス・アイズネンシス株をも包含している。
</span>
&nbsp;&nbsp;The present invention is also directed to methods of producing compound 2 (a) and related compounds comprising Formula I and Formula II as defined herein. Such a method comprises culturing cells derived from a Streptomyces isuzunensis strain, aerobically incubating the cultured cells in a growth medium for a time similar to that required for production of the desired compound. Extracting the medium with a solvent such as methanol or ethanol and purifying the compound from the crude extract. The Streptomyces isenensis strain used in the method of the present invention may be NRRL B-11277 or a variant thereof. A preferred strain of Streptomyces isenensis useful in the methods of the present invention is the mutant strain identified as [C03] 023 (deposited accession number IDAC0700803-1). The most preferred strain of Streptomyces isuzunensis useful in the methods of the invention is the mutant strain identified as [C03U03] 023 (deposited accession number IDAC231203-02). The present invention also includes Streptomyces isenensis strains identified as deposit accession numbers IDAC0700803-1 and IDAC231203-02.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、式Ｉの化合物、式IIの化合物若しくは化合物２（ａ）、又は薬学的に許容される塩に真菌細胞を接触させて、真菌細胞増殖を阻害する方法を包含している。さらに、本発明は、哺乳類における真菌感染の治療方法であって、該感染を患う哺乳類に、治療上有効な量の式Ｉの化合物、式IIの化合物若しくは化合物２（ａ）、又は薬学的に許容される塩を投与することを含む方法を包含している。本発明の方法は、カンジダ・アルビカンス（Candida albicans）によって起こる哺乳類の真菌感染の治療又は真菌細胞の増殖の阻害に特に有用である。本発明は、被験者における他の種類の真菌感染を治療又は阻害する方法を包含し、前記の真菌感染は、カンジダ・グラブラータ（C. glabrata）、カンジダ・ルシタニエ（C. lusitaniae）、カンジダ・パラプシロシス（C. parapsilosis）、カンジダ・クルセイ（C. krusei）、カンジダ・トロピカリス（C. tropicalis）、サッカロマイシス・セレヴィシエ（S. cerevisiae）などのカンジダ種；アスペルギルス・フミガーツス（A. fumigatus）、アスペルギルス・ニガー（A. niger）、アスペルギルス・テレウス（A. terreus）、アスペルギルス・フラーブス（A. flavus）などのアスペルギルス種；フザリウム種（spp.）；セドスポリウム種；クリプトコックス種；ケカビ亜種；ヒストプラスマ種；毛芽胞菌種；及びブラストミセス（Blaspomyces）種 などによって起こる感染を含んでいる。そのような方法では、該真菌感染を患う被験者に治療上有効な量の式Ｉ、式II若しくは化合物２（ａ）、又は薬学的に許容されるその塩を投与する。
</span>
&nbsp;&nbsp;The invention includes a method of inhibiting fungal cell growth by contacting a fungal cell with a compound of formula I, a compound of formula II or compound 2 (a), or a pharmaceutically acceptable salt. Furthermore, the present invention provides a method of treating a fungal infection in a mammal, wherein the mammal suffering from said infection is treated with a therapeutically effective amount of a compound of formula I, a compound of formula II or compound 2 (a), or pharmaceutically. The method includes administering an acceptable salt. The methods of the present invention are particularly useful for treating mammalian fungal infections caused by Candida albicans or inhibiting the growth of fungal cells. The present invention encompasses methods of treating or inhibiting other types of fungal infections in a subject, said fungal infections comprising C. glabrata, C. lusitaniae, Candida parapsilosis ( C. parapsilosis), Candida crusei (C. krusei), Candida tropicalis, Saccharomyces cerevisiae and other Candida species; Aspergillus fumigatus, Aspergillus Aspergillus species such as A. niger, A. terreus, A. flavus; Fusarium species (spp.); Sedsporium species; Cryptocox species; Including infections caused by the genus Bacillus spp .; and Blaspomyces species, etc. . In such methods, a subject having the fungal infection is administered a therapeutically effective amount of Formula I, Formula II, or Compound 2 (a), or a pharmaceutically acceptable salt thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、式Ｉ、式IIの化合物、化合物２（ａ）、又は薬学的に許容されるその塩を癌細胞に接触させることを含む癌細胞の増殖を阻害する方法をも提供する。本発明は、被験者における癌の治療方法であって、前記癌を患う前記被験者に、治療上有効な量の式Ｉ、式IIの化合物若しくは化合物２（ａ）、又は薬学的に許容されるその塩を投与する方法を更に包含している。本発明の方法によって治療又は阻害される癌の例として、白血病、非小細胞肺癌、大腸癌、中枢神経系癌、メラノーマ、卵巣癌、腎臓癌、前立腺癌及び乳癌が挙げられる。
</span>
&nbsp;&nbsp;The invention also provides a method of inhibiting cancer cell growth comprising contacting a cancer cell with a compound of formula I, formula II, compound 2 (a), or a pharmaceutically acceptable salt thereof. The present invention provides a method of treating cancer in a subject, wherein the subject suffering from said cancer is treated with a therapeutically effective amount of a compound of formula I, formula II or compound 2 (a), or a pharmaceutically acceptable Further included is a method of administering a salt. Examples of cancers treated or inhibited by the methods of the present invention include leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, kidney cancer, prostate cancer and breast cancer.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、その生合成遺伝子座が式２（ａ）の化合物の生成に関与しているストレプトミセス・アイズネンシス（ＮＲＲＬ  Ｂ−１１２７７）由来の生合成遺伝子座をも提供している。ストレプトミセス・アイズネンシスが化合物２（ａ）を生成すると報告されたことはなかった。この度本発明者らは、ストレプトミセス・アイズネンシスのゲノムにおいて、化合物２（ａ）の生合成に関与する遺伝子クラスターを発見した。従って、本発明は、式Ｉの化合物及び化合物２（ａ）の生成及び工学技術に有用なポリヌクレオチド及びポリペプチドを提供している。本発明は、式Ｉの化合物及び化合物２（ａ）の化学修飾をも提供している。
</span>
&nbsp;&nbsp;The present invention also provides a biosynthetic locus from Streptomyces isenensis (NRRL B-11277) whose biosynthetic locus is involved in the production of the compound of formula 2 (a). Streptomyces isenensis has never been reported to produce compound 2 (a). The present inventors have now discovered a gene cluster involved in the biosynthesis of compound 2 (a) in the genome of Streptomyces isenensis. Accordingly, the present invention provides polynucleotides and polypeptides useful for the production and engineering techniques of compounds of formula I and compound 2 (a). The present invention also provides a chemical modification of the compound of formula I and compound 2 (a).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  一態様においては、本発明は、式Ｉのポリケチドを生成するための生合成遺伝子座に関しており、一実施形態においては、配列番号２１、２３、２５、２７、２９、３１、３３、３５及び３７のポリケチドシンターゼによって形成されたポリケチドシンターゼシステムのドメインを少なくとも一つコードする核酸を含む式Ｉのポリケチドを生成するための単離、精製又は濃縮した核酸を提供している。
</span>
&nbsp;&nbsp;In one aspect, the invention relates to a biosynthetic locus for producing a polyketide of formula I, and in one embodiment, SEQ ID NOs: 21, 23, 25, 27, 29, 31, 33, 35 and 37. An isolated, purified or enriched nucleic acid for producing a polyketide of formula I comprising a nucleic acid encoding at least one domain of the polyketide synthase system formed by the polyketide synthase of is provided.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、前記核酸は、配列番号２１のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号２２；ｂ）配列番号２２の残基１６９〜３５４の核酸；配列番号２２の残基４２１〜１６９８の核酸；配列番号２２の残基１７８９〜３０９３の核酸；配列番号２２の残基３９１０〜４５５１の核酸；配列番号２２の残基４８０７〜４９９２の核酸；配列番号２２の残基５０６８〜６３５４の核酸；配列番号２２の残基６４０３〜７６８６の核酸；配列番号２２の残基８４９７〜９１３５の核酸；配列番号２２の残基９３８８〜９５７３の核酸；配列番号２２の残基９６４３〜１０９２０の核酸；配列番号２２の残基１０９７８〜１２２６７の核酸；配列番号２２の残基１２３０４〜１２６２４の核酸；配列番号２２の残基１３８３４〜１４４８７の核酸；配列番号２２の残基１４７３１〜１４９１６の核酸；配列番号２２の残基１５０１９〜１６３１４の核酸；配列番号２２の残基１６３７８〜１７６４９の核酸；配列番号２２の残基１８４３９〜１９０８０の核酸；配列番号２２の残基１９３３０〜１９５１５の核酸；配列番号２２の残基１９５８５〜２０８６２の核酸；配列番号２２の残基２０９３５〜２２２０６の核酸；配列番号２２の残基２３１０７〜２３７５４の核酸；配列番号２２の残基２４００４−２４１８９の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 21 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 22; b) SEQ ID NO: 22 nucleic acids of residues 169-354; nucleic acids of residues 421-1698 of SEQ ID NO: 22; nucleic acids of residues 1789-3093 of SEQ ID NO: 22; nucleic acids of residues 3910-4551 of SEQ ID NO: 22; Nucleic acid at residues 4807-4992; nucleic acid at residues 5068-6354 of SEQ ID NO: 22; nucleic acid at residues 6403-7686 of SEQ ID NO: 22; nucleic acid at residues 8497-9135 of SEQ ID NO: 22; residue of SEQ ID NO: 22 9388-9573 nucleic acid; SEQ ID NO: 22 residues 9643-10920 nucleic acid; SEQ ID NO: 22 residues 10978-12267 nucleic acid; SEQ ID NO: 22 Nucleic acids of groups 12304-12624; nucleic acids of residues 13833-14487 of SEQ ID NO: 22; nucleic acids of residues 14733-14916 of SEQ ID NO: 22; nucleic acids of residues 15019-16314 of SEQ ID NO: 22; residues 16378 of SEQ ID NO: 22 ˜17649 nucleic acid; SEQ ID NO: 22 residues 18439-19080 nucleic acid; SEQ ID NO: 22 residues 19330-19515 nucleic acid; SEQ ID NO: 22 residues 19585-20862 nucleic acid; SEQ ID NO: 22 residues 20935-22206 The nucleic acid of residues 23107 to 23754 of SEQ ID NO: 22; the nucleic acid of residues 24004-24189 of SEQ ID NO: 22; c) a nucleic acid having at least 80% identity to the nucleic acid of (a) or (b) And d) a nucleic acid complementary to the nucleic acid of (a), (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、前記核酸は、配列番号２３のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号２４；ｂ）配列番号２４の残基１０９〜１３８６の核酸；配列番号２４の残基１４７７〜２７５７の核酸；配列番号２４の残基２７９４〜３１１４の核酸；配列番号２４の残基４２３１〜４８８１の核酸；配列番号２４の残基５１１６〜５３０１の核酸；配列番号２４の残基５３８０〜６６４５の核酸；配列番号２４の残基６６９４〜７９７７の核酸；配列番号２４の残基８８７８−９５１９の核酸；配列番号２４の残基９７７２〜９９５７の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 23 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 24; b) SEQ ID NO: 24 nucleic acids of residues 109 to 1386; nucleic acids of residues 1477 to 2757 of SEQ ID NO: 24; nucleic acids of residues 2794 to 3114 of SEQ ID NO: 24; nucleic acids of residues 4231 to 4881 of SEQ ID NO: 24; Residue 5116-5301 nucleic acid; SEQ ID NO: 24 residues 5380-6645 nucleic acid; SEQ ID NO: 24 residues 6694-7997 nucleic acid; SEQ ID NO: 24 residues 8878-9519 nucleic acid; SEQ ID NO: 24 residues 9772-9957 nucleic acids; c) a nucleic acid having at least 80% identity to the nucleic acid of (a) or (b); and d) (a), (b) or (c) The nucleic acid to a complementary nucleic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、前記核酸は、配列番号２５のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号２６；ｂ）配列番号２６の残基１０６〜１３８３の核酸；配列番号２６の残基１４４７〜２７２１の核酸；配列番号２６の残基２７５５〜３０８１の核酸；配列番号２６の残基４３１５〜４９６５の核酸；配列番号２６の残基５２０６〜５３９１の核酸；配列番号２６の残基５４９１〜６７６８の核酸；配列番号２６の残基６８４１〜８１４２の核酸；配列番号２６の残基８９４１〜９５８２の核酸；配列番号２６の残基９８３２〜１００１７の核酸；配列番号２６の残基１００８１〜１１３５８の核酸；配列番号２６の残基１１４０７〜１２６７５の核酸；配列番号２６の残基１３４８０〜１４１１８の核酸；配列番号２６の残基１４３８３〜１４５６８の核酸；配列番号２６の残基１４６３８〜１５９１２の核酸；配列番号２６の残基１５９６７〜１７２４４の核酸；配列番号２６の残基１７２７８〜１７５９８の核酸；配列番号２６の残基１８８８０〜１９５３０の核酸；配列番号２６の残基１９７９５〜１９９８０の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 25 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 26; b) SEQ ID NO: 26 nucleic acids of residues 106-1383; nucleic acids of residues 1447-2721 of SEQ ID NO: 26; nucleic acids of residues 2755-3081 of SEQ ID NO: 26; nucleic acids of residues 4315-4965 of SEQ ID NO: 26; Nucleic acids at residues 5206-5391; nucleic acids at residues 5491-6768 of SEQ ID NO: 26; nucleic acids at residues 6841-8142 of SEQ ID NO: 26; nucleic acids at residues 8941-9582 of SEQ ID NO: 26; residues of SEQ ID NO: 26 Nucleic acids from 9832 to 10017; nucleic acids from residues 10081 to 11358 of SEQ ID NO: 26; nucleic acids from residues 11407 to 12675 of SEQ ID NO: 26; 26 nucleic acids of residues 13480-14118; nucleic acids of residues 14383-14568 of SEQ ID NO: 26; nucleic acids of residues 14638-15912 of SEQ ID NO: 26; nucleic acids of residues 15967-17244 of SEQ ID NO: 26; At least 80% of the nucleic acid at residues 17278-17598; the nucleic acid at residues 18880-19530 of SEQ ID NO: 26; the nucleic acid at residues 1979-19980 of SEQ ID NO: 26; c) at least 80% of the nucleic acid at (a) or (b) A nucleic acid having identity; and d) a nucleic acid complementary to the nucleic acid of (a), (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、核酸は、配列番号２７のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号２８；ｂ）配列番号２８の残基１０３〜１３８０の核酸；配列番号２８の残基１４５０〜２７６０の核酸；配列番号２８の残基３５８３〜４２１８の核酸；配列番号２８の残基４４６８〜４６５３の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 27 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 28; b) SEQ ID NO: 28 The nucleic acid of residues 1450 to 2760 of SEQ ID NO: 28; the nucleic acid of residues 3583 to 4218 of SEQ ID NO: 28; the nucleic acid of residues 4468 to 4653 of SEQ ID NO: 28; c) (a) Or a nucleic acid having at least 80% identity to the nucleic acid of (b); and d) a nucleic acid complementary to the nucleic acid of (a), (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、核酸は、配列番号２９のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号３０；ｂ）配列番号３０の残基１０３〜１３８０の核酸；配列番号３０の残基１４５９〜２７５４の核酸；配列番号３０の残基３６５５〜４２９３の核酸；配列番号３０の残基４５４０〜４７２５の核酸；配列番号３０の残基４８０４〜６０８１の核酸；配列番号３０の残基６１３６〜７４１９の核酸；配列番号３０の残基７４５６〜７７７６の核酸；配列番号３０の残基８９３８〜９５８８の核酸；配列番号３０の残基９８３２〜１００１７の核酸；配列番号３０の残基１００８７〜１１３６４の核酸；配列番号３０の残基１１４２８〜１２７１１の核酸；配列番号３０の残基１２７４５〜−１３０６５の核酸；配列番号３０の残基１４２７８〜１４９２８の核酸；配列番号３０の残基１５１８７〜１５３７２の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 29 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 30; b) SEQ ID NO: 30 Residues 103-1380 of nucleic acid; residues 1459-2754 of SEQ ID NO: 30; nucleic acids of residues 3655-4293 of SEQ ID NO: 30; nucleic acids of residues 4540-4725 of SEQ ID NO: 30; residue of SEQ ID NO: 30 Nucleic acid of groups 4804-6081; nucleic acid of residues 6136-7419 of SEQ ID NO: 30; nucleic acid of residues 7456-7776 of SEQ ID NO: 30; nucleic acid of residues 8938-9588 of SEQ ID NO: 30; residue 9832 of SEQ ID NO: 30 ˜10017 nucleic acid; residues 10087 to 11364 nucleic acid of SEQ ID NO: 30; nucleic acids of residues 11428 to 12711 of SEQ ID NO: 30; At least 80 relative to the nucleic acid at residues 15187-15372 of SEQ ID NO: 30; c) the nucleic acid at residues 12187-15289 of SEQ ID NO: 30; A nucleic acid having% identity; and d) a nucleic acid complementary to the nucleic acid of (a), (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、核酸は、配列番号３１のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号３２；ｂ）配列番号３２の残基１０３〜１３８０の核酸；配列番号３２の残基１４３８〜２７４２の核酸；配列番号３２の残基２７７６〜３０９６の核酸；配列番号３２の残基４２６７〜４９１７の核酸；配列番号３２の残基５２０９〜５３９４の核酸；配列番号３２の残基５４６４〜６７４１の核酸；配列番号３２の残基６７８７〜８０７０の核酸；配列番号３２の残基８１０７〜８４２７の核酸；配列番号３２の残基９５６２〜１０２１２の核酸；配列番号３２の残基１０４４７〜１０６３２の核酸；配列番号３２の残基１０７０２〜１１９７９の核酸；配列番号３２の残基１２０４９〜１３３２６の核酸；配列番号３２の残基１３３６６〜１３６８６の核酸；配列番号３２の残基１４９３２〜１５５８２の核酸；配列番号３２の残基１５８５３〜１６０３８の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 31, and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 32; b) SEQ ID NO: 32 Residue 103-1380 nucleic acid; SEQ ID NO: 32 residues 1438-2742 nucleic acid; SEQ ID NO: 32 residues 2776-3096 nucleic acid; SEQ ID NO: 32 residues 4267-4917 nucleic acid; SEQ ID NO: 32 residue Nucleic acid of groups 5209-5394; nucleic acid of residues 5464-6741 of SEQ ID NO: 32; nucleic acid of residues 6787-8070 of SEQ ID NO: 32; nucleic acid of residues 8107-8427 of SEQ ID NO: 32; residue 9562 of SEQ ID NO: 32 -10212 nucleic acids; residues 10447-10632 of SEQ ID NO: 32; nucleic acids of residues 10702-111979 of SEQ ID NO: 32; SEQ ID NO: 3 Nucleic acid at residues 12049-13326 of SEQ ID NO: 32; nucleic acid at residues 13366-13686 of SEQ ID NO: 32; nucleic acid at residues 14932-15582 of SEQ ID NO: 32; nucleic acid at residues 15855-16038 of SEQ ID NO: 32; c) (a) Or a nucleic acid having at least 80% identity to the nucleic acid of (b); and d) a nucleic acid complementary to the nucleic acid of (a), (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、核酸は、配列番号３３のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号３４；ｂ）配列番号３４の残基１０３〜１３８０の核酸；配列番号３４の残基１４４１〜２７５１の核酸；配列番号３４の残基３６１３〜４２４８の核酸；配列番号３４の残基４４９８〜４６８３の核酸；配列番号３４の残基４７５３〜６０３０の核酸；配列番号３４の残基６１９９〜７５１５の核酸；配列番号３４の残基８３５６〜８９９４；配列番号３４の残基９２４７〜９４３２の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 33 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 34; b) SEQ ID NO: 34 The nucleic acids of residues 103-1380 of SEQ ID NO: 34; the nucleic acids of residues 3613-4248 of SEQ ID NO: 34; the nucleic acids of residues 4498-4683 of SEQ ID NO: 34; the rest of SEQ ID NO: 34 Nucleic acids of groups 4753-6030; residues 6199-7515 of SEQ ID NO: 34; residues 8356-8994 of SEQ ID NO: 34; nucleic acids of residues 9247-9432 of SEQ ID NO: 34; c) (a) or (b) A nucleic acid having at least 80% identity to said nucleic acid; and d) a nucleic acid complementary to the nucleic acid of (a), (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、核酸は、配列番号３５のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号３６；ｂ）配列番号３６の残基１１８〜１３９５の核酸；配列番号３６の残基１５０７〜２８２３の核酸；配列番号３６の残基２８６０〜３１８０の核酸；配列番号３６の残基４３６６〜５０１６の核酸；配列番号３６の残基５２５１〜５４３６の核酸；配列番号３６の残基５５０３〜６７８０の核酸；配列番号３６の残基６８４１〜８１５４の核酸；配列番号３６の残基８１９１〜８５１１の核酸；配列番号３６の残基９５６２〜１０６３８の核酸；配列番号３６の残基１０６５１〜１１３０１の核酸；配列番号３６の残基１１５３６〜１１７２１の核酸；配列番号３６の残基１１７９４〜１３０７１の核酸；配列番号３６の残基１３１１７〜１４４０９の核酸；配列番号３６の残基１４４４３〜１４７６３の核酸；配列番号３６の残基１５８９８〜１６５４８の核酸；配列番号３６の残基１６７８９〜１６９７４の核酸；配列番号３６の残基１７０５６〜１８３３３の核酸；配列番号３６の残基１８３９１〜１９６７１の核酸；配列番号３６の残基１９７１４〜２００３４の核酸；配列番号３６の残基２１１８４〜２１８３４の核酸；配列番号３６の残基２２０８７〜２２２７２の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 35 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 36; b) SEQ ID NO: 36 The nucleic acids of residues 118-1395 of SEQ ID NO: 36; the nucleic acids of residues 2860-3180 of SEQ ID NO: 36; the nucleic acids of residues 4366-5016 of SEQ ID NO: 36; the remainder of SEQ ID NO: 36 Nucleic acid of groups 5251-5436; nucleic acid of residues 5503-6780 of SEQ ID NO: 36; nucleic acid of residues 6841-8154 of SEQ ID NO: 36; nucleic acid of residues 8191-8511 of SEQ ID NO: 36; residue 9562 of SEQ ID NO: 36 -10638 nucleic acid; residues 10651-11301 nucleic acid of SEQ ID NO: 36; residues 11536-11721 nucleic acid of SEQ ID NO: 36; SEQ ID NO: 3 The nucleic acid of residues 11117-14409 of SEQ ID NO: 36; the nucleic acid of residues 14443-14763 of SEQ ID NO: 36; the nucleic acid of residues 15898-16548 of SEQ ID NO: 36; the rest of SEQ ID NO: 36 Nucleic acids of groups 16789-16974; nucleic acids of residues 17056-18333 of SEQ ID NO: 36; nucleic acids of residues 18391-19671 of SEQ ID NO: 36; nucleic acids of residues 19714-20034 of SEQ ID NO: 36; residues 21184 of SEQ ID NO: 36 Nucleic acid of ~ 21834; nucleic acid of residues 22087 to 22272 of SEQ ID NO: 36; c) a nucleic acid having at least 80% identity to the nucleic acid of (a) or (b); and d) (a), (b Or a nucleic acid complementary to the nucleic acid of (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、核酸は、配列番号３７のポリケチドシンターゼの１又は２以上のドメインをコードし、以下からなる群から選択される核酸を含む：ａ）配列番号３８；ｂ）配列番号３８の残基１００〜１３７７の核酸；配列番号３８の残基１５０４〜２７７８の核酸；配列番号３８の残基２８１２〜３１３２の核酸；配列番号３８の残基４２５８〜４９０８の核酸；配列番号３８の残基５１４３〜５３２８の核酸；配列番号３８の残基５３９５〜６６７２の核酸；配列番号３８の残基６７３９〜８０１９の核酸；配列番号３８の残基８０５６〜８３７６の核酸；配列番号３８の残基９６０７〜１０２５７の核酸；配列番号３８の残基１０５３７〜１０７２２の核酸；配列番号３８の残基１０９４５〜１１６１６の核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも８０％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;In another embodiment, the nucleic acid encodes one or more domains of the polyketide synthase of SEQ ID NO: 37 and comprises a nucleic acid selected from the group consisting of: a) SEQ ID NO: 38; b) SEQ ID NO: 38 From residues 1001 to 377; nucleic acids from residues 1504 to 2778 of SEQ ID NO: 38; nucleic acids from residues 2812 to 3132 of SEQ ID NO: 38; nucleic acids from residues 4258 to 4908 of SEQ ID NO: 38; The nucleic acid of groups 5143-5328; the nucleic acid of residues 5395-6672 of SEQ ID NO: 38; the nucleic acid of residues 6739-8019 of SEQ ID NO: 38; the nucleic acid of residues 8056-8376 of SEQ ID NO: 38; the residue 9607 of SEQ ID NO: 38 -10257 nucleic acid; residues 10537-10722 nucleic acid of SEQ ID NO: 38; residues 10945-11616 of SEQ ID NO: 38; c) (a) Nucleic acid having the at least 80% identity to the nucleic acid of (b); and d) (a), the nucleic acid complementary to the nucleic acid of (b) or (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、ポリケチドシンターゼシステムのドメインをコードする核酸以外の式Ｉのポリケチドの生合成にかかわる核酸をも提供している。本実施形態においては、以下からなる群から選択される核酸で、単離、精製、濃縮される核酸を提供している：ａ）配列番号：３、５、７、９、１１、１３、１５、１７、２０、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の核酸；ｂ）配列番号：２、４、６、８、１０、１２、１４、１６、１９、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、７１、７３、７５、７７のポリペプチドをコードする核酸；ｃ）（ａ）又は（ｂ）の核酸に対して少なくとも７５％の同一性を有する核酸；及びｄ）（ａ）、（ｂ）又は（ｃ）の核酸に相補的な核酸。
</span>
&nbsp;&nbsp;The present invention also provides nucleic acids involved in biosynthesis of polyketides of formula I other than nucleic acids encoding domains of the polyketide synthase system. In this embodiment, nucleic acids to be isolated, purified and concentrated with a nucleic acid selected from the group consisting of: a) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15 , 17, 20, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78; b) sequence Number: 2, 4, 6, 8, 10, 12, 14, 16, 19, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, A nucleic acid encoding a polypeptide of 71, 73, 75, 77; c) a nucleic acid having at least 75% identity to the nucleic acid of (a) or (b); and d) (a), (b) or A nucleic acid complementary to the nucleic acid of (c).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、ストリンジェントな条件で、上記の核酸のいずれかにハイブリダイズ可能で、かつ式Ｉの化合物の合成を誘導するために特異的にハイブリダイズする核酸に置換可能な核酸をさらに提供している。本発明は、上記核酸の、少なくとも２個、好ましくは３個、より好ましくは５個、さらに好ましくは７個以上の配列を含む、単離、精製又は濃縮された核酸をさらに提供している。
</span>
&nbsp;&nbsp;The invention further provides a nucleic acid capable of hybridizing to any of the above nucleic acids under stringent conditions and capable of substituting with a nucleic acid that specifically hybridizes to induce the synthesis of a compound of formula I. ing. The present invention further provides an isolated, purified or enriched nucleic acid comprising at least 2, preferably 3, more preferably 5, more preferably 7 or more sequences of the above nucleic acids.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、上記の核酸のいずれかを含む発現ベクターをさらに提供している。本発明は、前記発現ベクターで形質転換した宿主細胞をさらに提供している。
</span>
&nbsp;&nbsp;The present invention further provides an expression vector comprising any of the above nucleic acids. The present invention further provides a host cell transformed with the expression vector.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらなる態様においては、本発明は、式Ｉのポリケチドの生成のための遺伝子クラスターを提供している。一つの実施形態においては、遺伝子クラスターは、上記の核酸を少なくとも１０、好ましくは１２、より好ましくは１５、さらに好ましくは２０以上含む場合がある。さらなる実施形態においては、遺伝子クラスターは、ＩＤＡＣアクセッション番号２５０２０３−０１、２５０２０３−０２、２５０２０３−０３、２５０２０３−０４及び２５０２０３−０５として寄託されたコスミドから選択されたコスミドの核酸を含む場合がある。さらなる実施形態においては、産物を発現するために寄託されたコスミドは、原核宿主に挿入される。前記宿主は、大腸菌、ストレプトミセス・リビダンス（Streptomyces lividans）、ストレプトミセス・グリセオフスクス（Streptomyces griseofuscus）、ストレプトミセス・アンボファシエンス（Streptomyces ambofaciens）、他種の放線菌類、又はバチルス属、コリネバクテリウム属若しくはテルモアクチノマイシス属の細菌であってもよい。さらなる実施形態においては、本発明は、ストリンジェントなハイブリダイゼーション条件で、寄託されたコスミドの核酸にハイブリダイズし、ポリエンポリケチドの生合成にかかわる少なくとも一つのタンパク質をコードする核酸を提供している。さらなる実施形態においては、本発明は、化合物２（ａ）の形成のための生合成経路をコードするストレプトミセス・アイズネンシスから単離され、寄託されたコスミドによって形成された遺伝子クラスターを提供している。
</span>
&nbsp;&nbsp;In a further aspect, the present invention provides a gene cluster for the production of polyketides of formula I. In one embodiment, the gene cluster may contain at least 10, preferably 12, more preferably 15, and even more preferably 20 or more of the nucleic acids described above. In a further embodiment, the gene cluster may comprise cosmid nucleic acids selected from cosmids deposited as IDAC accession numbers 250203-01, 250203-02, 250203-03, 250203-04 and 250203-05. . In a further embodiment, the cosmid deposited to express the product is inserted into a prokaryotic host. The host may be Escherichia coli, Streptomyces lividans, Streptomyces griseofuscus, Streptomyces ambofaciens, other species of actinomycetes, or Bacillus, Corynebacterium or It may be a bacterium belonging to the genus Termoactinomysis. In a further embodiment, the present invention provides a nucleic acid that hybridizes to the deposited cosmid nucleic acid under stringent hybridization conditions and encodes at least one protein involved in polyene polyketide biosynthesis. In a further embodiment, the present invention provides a gene cluster formed by a deposited cosmid isolated from Streptomyces isenensis encoding a biosynthetic pathway for the formation of compound 2 (a). .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の態様においては、本発明は、式Ｉのポリケチドの産生のための、単離したポリペプチドに関しており、一つの実施形態においては、配列番号２１、２３、２５、２７、２９、３１、３３、３５及び３７のポリケチドシンターゼドメインのアミノ酸配列をしている。前記ドメインは、β−ケトアシルシンターゼ（ＫＳ）ドメイン、アシルキャリアタンパク質（ＡＣＰ）ドメイン、アシルトランスフェラーゼ（ＡＴ）ドメイン、ケトレダクターゼ（ＫＲ）ドメイン、エノイルレダクターゼ（ＥＲ）ドメイン、チオエステラーゼ（ＴＥ）ドメイン及びデヒドラターゼ（ＤＨ）ドメインであってもよい。一つの実施形態においては、前記ドメインはＫＳドメインであり、前記アミノ酸は、以下のアミノ酸残基からなる群から選択される配列を含む：配列番号２１の残基１４１〜５６６、配列番号２１の残基１６９０〜２１１８、配列番号２１の残基３２１５〜３６４０、配列番号２１の残基５００７〜５４３８、配列番号２１の残基６５２９〜６９５４、配列番号２３の残基３７〜４６２、配列番号２３の残基１７９４〜２２１５、配列番号２５の残基３６〜４６１、配列番号２５の残基１８３１〜２２５６、配列番号２５の残基３３６１〜３７８６、配列番号２５の残基４８８０〜５３０４、配列番号２７の残基３５〜４６０、配列番号２９の残基３５〜４６０、配列番号２９の残基１６０２〜２０２７、配列番号２９の残基３３６３〜３７８８、配列番号３１の残基３５〜４６０、配列番号３１の残基１８２２〜２２４７、配列番号３１の残基３５６８〜３９９３、配列番号３３の残基３５〜４６０、配列番号３３の残基１５８５〜２０１０、配列番号３５の残基４０〜４６５、配列番号３５の残基１８３５〜２２６０、配列番号３５の残基３９３２〜４３５７、配列番号３５の残基５６８６〜６１１１、配列番号３７の残基３４〜４５９、配列番号３７の残基１７９９〜２２２４；及び上記いずれかのアミノ酸残基に対して少なくとも７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another aspect, the invention relates to an isolated polypeptide for the production of a polyketide of formula I, and in one embodiment SEQ ID NO: 21, 23, 25, 27, 29, 31, 33 , 35 and 37 are amino acid sequences of polyketide synthase domains. The domains include β-ketoacyl synthase (KS) domain, acyl carrier protein (ACP) domain, acyltransferase (AT) domain, ketoreductase (KR) domain, enoyl reductase (ER) domain, thioesterase (TE) domain And a dehydratase (DH) domain. In one embodiment, the domain is a KS domain and the amino acid comprises a sequence selected from the group consisting of the following amino acid residues: residues 141-566 of SEQ ID NO: 21, the rest of SEQ ID NO: 21 Groups 1690-2118, residues 3215-3640 of SEQ ID NO: 21, residues 5007-5438 of SEQ ID NO: 21, residues 6529-6695 of SEQ ID NO: 21, residues 37-462 of SEQ ID NO: 23, the remainder of SEQ ID NO: 23 Groups 1794-2215, residues 36-461 of SEQ ID NO: 25, residues 1831-2256 of SEQ ID NO: 25, residues 3361-3786 of SEQ ID NO: 25, residues 4880-5304 of SEQ ID NO: 25, the remainder of SEQ ID NO: 27 Groups 35-460, residues 35-460 of SEQ ID NO: 29, residues 1602-2027 of SEQ ID NO: 29, residues 3363-37 of SEQ ID NO: 29 8, residues 35 to 460 of SEQ ID NO: 31, residues 1822 to 2247 of SEQ ID NO: 31, residues 3568 to 3993 of SEQ ID NO: 31, residues 35 to 460 of SEQ ID NO: 33, residues 1585 of SEQ ID NO: 33 2010, residues 40-465 of SEQ ID NO: 35, residues 1835-2260 of SEQ ID NO: 35, residues 3932-4357 of SEQ ID NO: 35, residues 5686-6111 of SEQ ID NO: 35, residues 34 of SEQ ID NO: 37 459, residues 1799-2224 of SEQ ID NO: 37; and an amino acid sequence having at least 75% identity to any of the above amino acid residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、ドメインはＡＣＰドメインであり、前記アミノ酸は以下のアミノ酸からなる群から選択される配列を含む：配列番号２１の残基５７〜１１８、配列番号２１の残基１６０３〜１６６４、配列番号２１の残基３１３０〜３１９１、配列番号２１の残基４９１１〜４９７２、配列番号２１の残基６４４４〜６５０５、配列番号２１の残基８００２〜８０６３、配列番号２３の残基１７０６〜１７６７、配列番号２３の残基３２５８〜３３１９、配列番号２５の残基１７３６〜１７９７、配列番号２５の残基３２７８〜３３３９、配列番号２５の残基４７９５〜４８５６、配列番号２５の残基６５９９〜６６６０、配列番号２７の残基１４９０〜１５５１、配列番号２９の残基１５１４〜１５７５、配列番号２９の残基３２７８〜３３３９、配列番号２９の残基５０６０〜５１２４、配列番号３１の残基１７３７〜１７９８、配列番号３１の残基３４８３〜３５４４、配列番号３１の残基５２８５〜５３４６、配列番号３３の残基１５００〜１５６１、配列番号３３の残基３０８３〜３１４４、配列番号３５の残基１７５１〜１８１２、配列番号３５の残基３８４６〜３９０７、配列番号３５の残基５５９７〜５６５８、配列番号３５の残基７３６３〜７４２４、配列番号３７の残基１７１５〜１７７６、配列番号３７の残基３５１３〜３５７４、及び上記いずれかのアミノ酸残基に対して少なくとも７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another embodiment, the domain is an ACP domain and the amino acid comprises a sequence selected from the group consisting of the following amino acids: residues 57-118 of SEQ ID NO: 21, residues 1603-1664 of SEQ ID NO: 21 , Residues 3130-3191 of SEQ ID NO: 21, residues 4911-4972 of SEQ ID NO: 21, residues 6444-6505 of SEQ ID NO: 21, residues 8002-8063 of SEQ ID NO: 21, residues 1706-1767 of SEQ ID NO: 23 , Residues 3258-3319 of SEQ ID NO: 23, residues 1736-1797 of SEQ ID NO: 25, residues 3278-3339 of SEQ ID NO: 25, residues 4795-4856 of SEQ ID NO: 25, residues 6599-6660 of SEQ ID NO: 25 , Residues 1490-1551 of SEQ ID NO: 27, residues 1514-1575 of SEQ ID NO: 29, residue 3 of SEQ ID NO: 29 78-3339, residues 5060-5124 of SEQ ID NO: 29, residues 1737-1798 of SEQ ID NO: 31, residues 3483-3544 of SEQ ID NO: 31, residues 5285-5346 of SEQ ID NO: 31, residues of SEQ ID NO: 33 1500-1561, residues 3083-3144 of SEQ ID NO: 33, residues 1751-1812 of SEQ ID NO: 35, residues 3846-3907 of SEQ ID NO: 35, residues 5597-5658 of SEQ ID NO: 35, residues of SEQ ID NO: 35 7363-7424, residues 1715-1776 of SEQ ID NO: 37, residues 3513-3574 of SEQ ID NO: 37, and an amino acid sequence having at least 75% identity to any of the above amino acid residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、ドメインはＡＴドメインであり、前記アミノ酸は以下のアミノ酸からなる群から選択される配列を含む：配列番号２１の残基５９７〜１０１３、配列番号２１の残基２１３５〜２５６２、配列番号２１の残基３６６０〜４０８９、配列番号２１の残基５４６０〜５８８３、配列番号２１の残基６９７９〜７４０２、配列番号２３の残基４９３〜９１９、配列番号２３の残基２２３２〜２６５９、配列番号２５の残基４８３〜９０７、配列番号２５の残基２２８１〜２７１４、配列番号２５の残基３８０３〜４２２５、配列番号２５の残基５３２３〜５７４８、配列番号２７の残基４８４〜９２０、配列番号２９の残基４８７〜９１８、配列番号２９の残基２０４６〜２４７３、配列番号２９の残基３８１０〜４２３７、配列番号３１の残基４８０〜９１４、配列番号３１の残基２２６３〜２６９０、配列番号３１の残基４０１７〜４４４２、配列番号３３の残基４８１〜９１７、配列番号３３の残基２０６７〜２５０５、配列番号３５の残基５０３〜９４１、配列番号３５の残基２２８１〜２７１８、配列番号３５の残基４３７３〜４８０３、配列番号３５の残基６１３１〜６５５７、配列番号３７の残基５０２〜９２６、配列番号３７の残基２２４７〜２６７３；及び上記いずれかのアミノ酸残基に対して７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another embodiment, the domain is an AT domain and the amino acid comprises a sequence selected from the group consisting of the following amino acids: residues 597-1013 of SEQ ID NO: 21, residues 2135-2562 of SEQ ID NO: 21 , SEQ ID NO: 21 residues 3660-4089, SEQ ID NO: 21 residues 5460-5883, SEQ ID NO: 21 residues 6979-7402, SEQ ID NO: 23 residues 493-919, SEQ ID NO: 23 residues 2232-2659 , Residues 483 to 907 of SEQ ID NO: 25, residues 2281 to 2714 of SEQ ID NO: 25, residues 3803 to 4225 of SEQ ID NO: 25, residues 5323 to 5748 of SEQ ID NO: 25, residues 484 to 920 of SEQ ID NO: 27 , Residues 487-918 of SEQ ID NO: 29, residues 2046-2473 of SEQ ID NO: 29, residues 3810-423 of SEQ ID NO: 29 , Residues 480-914 of SEQ ID NO: 31, residues 2263-2690 of SEQ ID NO: 31, residues 4017-4442 of SEQ ID NO: 31, residues 481-917 of SEQ ID NO: 33, residues 2067-2505 of SEQ ID NO: 33 , Residues 503 to 941 of SEQ ID NO: 35, residues 2281 to 2718 of SEQ ID NO: 35, residues 4373 to 4803 of SEQ ID NO: 35, residues 6131 to 6557 of SEQ ID NO: 35, residues 502 to 926 of SEQ ID NO: 37 , Residues 2247-2673 of SEQ ID NO: 37; and an amino acid sequence having 75% identity to any of the above amino acid residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、ドメインはＫＲドメインであり、前記アミノ酸は以下のアミノ酸からなる群から選択される配列を含む：配列番号２１の残基１３０４〜１５１７、配列番号２１の残基２８３３〜３０４５、配列番号２１の残基４６１２〜４８２９、配列番号２１の残基６１４７〜６３６０、配列番号２１の残基７７０３〜７９１８、配列番号２３の残基１４１１〜１６２７、配列番号２３の残基２９６０〜３１７３、配列番号２５の残基１４３９〜１６５５、配列番号２５の残基２９８１〜３１９４、配列番号２５の残基４４９４〜４７０６、配列番号２５の残基６２９４〜６５１０、配列番号２７の残基１１９５〜１４０６、配列番号２９の残基１２１９〜１４３１、配列番号２９の残基２９８０〜３１９６、配列番号２９の残基４７６０〜４９７６、配列番号３１の残基１４２３〜１６３９、配列番号３１の残基３１８８〜３４０４、配列番号３１の残基４９７８〜５１９４、配列番号３３の残基１２０５〜１４１６、配列番号３３の残基２７８６〜２９９８、配列番号３５の残基１４５６〜１６７２、配列番号３５の残基３５５１〜３７６７、配列番号３５の残基５３００〜５５１６、配列番号３５の残基７０６２〜７２８８、配列番号３７の残基１４２０〜１６３６、配列番号３７の残基３２０３〜３４１９；及び上記いずれかのアミノ酸残基に対して少なくとも７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another embodiment, the domain is a KR domain, wherein said amino acid comprises a sequence selected from the group consisting of the following amino acids: residues 1304-1517 of SEQ ID NO: 21, residues 2833-3045 of SEQ ID NO: 21 , Residues 4612 to 4829 of SEQ ID NO: 21, residues 6147 to 6360 of SEQ ID NO: 21, residues 7703 to 7918 of SEQ ID NO: 21, residues 1411 to 1627 of SEQ ID NO: 23, residues 2960 to 3173 of SEQ ID NO: 23 , Residues 1439 to 1655 of SEQ ID NO: 25, residues 2981 to 3194 of SEQ ID NO: 25, residues 4494 to 4706 of SEQ ID NO: 25, residues 6294 to 6510 of SEQ ID NO: 25, residues 1195 to 1406 of SEQ ID NO: 27 , Residues 1219-1431 of SEQ ID NO: 29, residues 2980-3196 of SEQ ID NO: 29, the remainder of SEQ ID NO: 29 4760-4976, residues 1423-1639 of SEQ ID NO: 31, residues 3188-3404 of SEQ ID NO: 31, residues 4978-5194 of SEQ ID NO: 31, residues 1205-1416 of SEQ ID NO: 33, residues of SEQ ID NO: 33 2786-2998, residues 1456-1672 of SEQ ID NO: 35, residues 35551-3767 of SEQ ID NO: 35, residues 5300-5516 of SEQ ID NO: 35, residues 7062-7288 of SEQ ID NO: 35, residues of SEQ ID NO: 37 1420-1636, residues 3203-3419 of SEQ ID NO: 37; and an amino acid sequence having at least 75% identity to any of the above amino acid residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、ドメインはＤＨドメインであり、前記アミノ酸は以下のアミノ酸からなる群から選択される配列を含む：配列番号２１の残基４１０２〜４２０８、配列番号２３の残基９３２〜１０３８、配列番号２５の残基９１９〜１０２７、配列番号２５の残基５７６１〜５８６６、配列番号２９の残基２４８６〜２５９２、配列番号２９の残基４２４９〜４３５５、配列番号３１の残基９２６〜１０３２、配列番号３１の残基２７０３〜２８０９、配列番号３１の残基４４５６〜４５６２、配列番号３５の残基９５４〜１０６０、配列番号３５の残基２７３１〜２８３７、配列番号３５の残基４８１５〜４９２１、配列番号３５の残基６５７２〜６６７８、配列番号３７の残基９３８〜１０４４、配列番号３７の残基２６８６〜２７９２；及び上記いずれかのアミノ酸残基に対して少なくとも７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another embodiment, the domain is a DH domain and the amino acid comprises a sequence selected from the group consisting of the following amino acids: residues 4102-4208 of SEQ ID NO: 21, residues 932-1038 of SEQ ID NO: 23 , Residues 919-1027 of SEQ ID NO: 25, residues 576-5866 of SEQ ID NO: 25, residues 2486-2592 of SEQ ID NO: 29, residues 4249-4355 of SEQ ID NO: 29, residues 926-1032 of SEQ ID NO: 31 , Residues 2703-2809 of SEQ ID NO: 31, residues 4456-4562 of SEQ ID NO: 31, residues 954-1060 of SEQ ID NO: 35, residues 2731-2837 of SEQ ID NO: 35, residues 4815-4921 of SEQ ID NO: 35 , Residues 6572-6678 of SEQ ID NO: 35, residues 938-1044 of SEQ ID NO: 37, residue 2686 of SEQ ID NO: 37 2792; and amino acid sequence having at least 75% identity to any one of the above amino acid residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、ドメインはＥＲドメインであり、前記アミノ酸は以下のアミノ酸からなる群から選択される配列を含む：配列番号３５の残基３１８８〜３５４６、及び配列番号３５の残基３１８８〜３５４６に対して少なくとも７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another embodiment, the domain is an ER domain and the amino acid comprises a sequence selected from the group consisting of the following amino acids: residues 3188-3546 of SEQ ID NO: 35, and residues 3188-3 of SEQ ID NO: 35 Amino acid sequence having at least 75% identity to 3546.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、ドメインはＴＥドメインであり、前記アミノ酸は以下のアミノ酸からなる群から選択される配列を含む：配列番号３７の残基３６４９〜３８７２、及び配列番号３７の残基３６４９〜３８７２に対して少なくとも７５％の同一性を有するアミノ酸配列。
</span>
&nbsp;&nbsp;In another embodiment, the domain is a TE domain and the amino acid comprises a sequence selected from the group consisting of the following amino acids: residues 3649-3872 of SEQ ID NO: 37, and residues 3649-SEQ ID NO: 37 Amino acid sequence having at least 75% identity to 3872.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態においては、本発明は、本発明のポリケチドシンターゼシステムのドメインをコードするポリペプチド以外の式Ｉのポリケチドの生合成にかかわるポリペプチドを提供する。本実施形態においては、本発明は、以下からなる群から選択される、式Ｉのポリケチドを生成するための、単離したポリペプチドを提供している：ａ）配列番号２、４、６、８、１０、１２、１４、１６、１９、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、及び７７；並びにｂ）配列番号２、４、６、８、１０、１２、１４、１６、１９、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５及び７７に対して少なくとも７５％の同一性を有するポリペプチド。
</span>
&nbsp;&nbsp;In another embodiment, the invention provides a polypeptide involved in biosynthesis of a polyketide of formula I other than a polypeptide encoding a domain of the polyketide synthase system of the invention. In this embodiment, the present invention provides an isolated polypeptide for producing a polyketide of formula I selected from the group consisting of: a) SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 19, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, And b) SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, A polypeptide having at least 75% identity to 63, 65, 67, 69, 71, 73, 75 and 77.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の態様においては、本発明は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、及び７７からなる群から選択された配列を有するポリペプチドを生成する方法であり、以下のステップを含む方法を提供する：（ａ）前記ポリペプチドをコードし、機能可能な状態でプロモーターに結合している核酸を、細菌宿主細胞に挿入するステップ、及び（ｂ）ポリペプチドの発現を導くような条件で形質転換宿主細胞を培養するステップ。
</span>
In another aspect, the invention provides SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, A polypeptide having a sequence selected from the group consisting of 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, and 77 Providing a method comprising the steps of: (a) inserting a nucleic acid encoding said polypeptide and operably linked to a promoter into a bacterial host cell; and (B) culturing the transformed host cell under conditions that direct expression of the polypeptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の態様においては、本発明は、上記核酸の寄託されたコスミドを用いて本発明のポリケチドの産生量を増加する方法に関しており、前記方法には、コスミド又は核酸で原核宿主を形質転換するステップと、形質転換した原核宿主を、結果的にポリケチドが発現するような条件下で培養するステップが含まれている。
</span>
&nbsp;&nbsp;In another aspect, the present invention relates to a method for increasing the production amount of the polyketide of the present invention using the deposited cosmid of the nucleic acid, wherein the method comprises the step of transforming a prokaryotic host with the cosmid or nucleic acid. And culturing the transformed prokaryotic host under conditions that result in expression of the polyketide.
</span>
    </p>
  </disclosure>
  <best-mode class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、式Ｉの化合物及び薬学的に許容されるその塩を包含している。
</span>
&nbsp;&nbsp;The present invention includes compounds of Formula I and pharmaceutically acceptable salts thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="15" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000016" he="65" wi="144" file="2007525148.tif" img-format="tif" img-content="drawing" width="576" height="260" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
  式中、Ａは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>、−Ｎ＝ＣＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>、
 <chemistry id="" num="15" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000016" he="65" wi="144" file="2007525148.tif" img-format="tif" img-content="drawing" width="576" height="260" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> In the formula, A represents —NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> , —N═CR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> ,
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="16" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000017" he="23" wi="48" file="2007525148.tif" img-format="tif" img-content="drawing" width="192" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
及び        <br class="style-scope patent-text"> <chemistry id="" num="17" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000018" he="23" wi="39" file="2007525148.tif" img-format="tif" img-content="drawing" width="156" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
からなる群から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>は、それぞれ独立して、H、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、Ｃ<sub class="style-scope patent-text">３−６</sub>シクロアルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>ヘテロシクロアルキル、アリール、ヘテロアリール及びアミノ酸からなる群から選択され、該アルキル、アルケニル、アリール及びヘテロアリールは、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>、ＮＨ<sub class="style-scope patent-text">２</sub>又はアリールから選択される基で置換されていてもよく、該アリールは、さらにハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>又はＮＨ<sub class="style-scope patent-text">２</sub>から独立して選択される１又は２以上の基で置換されていてもよい。<br class="style-scope patent-text">
Ｂは、エテン−１，２−ジイル又は
 <chemistry id="" num="16" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000017" he="23" wi="48" file="2007525148.tif" img-format="tif" img-content="drawing" width="192" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> as well as <br class="style-scope patent-text"> <chemistry id="" num="17" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000018" he="23" wi="39" file="2007525148.tif" img-format="tif" img-content="drawing" width="156" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of <br class="style-scope patent-text"> R <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each independently H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, C <sub class="style-scope patent-text">3-6</sub> cycloalkyl, C <sub class="style-scope patent-text">2-6</sub> heterocycloalkyl, aryl, hetero Selected from the group consisting of aryl and amino acid, wherein the alkyl, alkenyl, aryl and heteroaryl may be substituted with a group selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> , NH <sub class="style-scope patent-text">2</sub> or aryl, It may be substituted with one or more groups independently selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> or NH <sub class="style-scope patent-text">2</sub> . <br class="style-scope patent-text"> B is ethene-1,2-diyl or
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="18" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000019" he="24" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
から選択され、<br class="style-scope patent-text">
式中、Ｒ<sup class="style-scope patent-text">１０</sup>は、オキソ又はＯＲ<sup class="style-scope patent-text">１１</sup>であり、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１１</sup>は、Ｈ又はヘテロシクロアルキルであり、該ヘテロシクロアルキルは、ＯＸ、Ｃ<sub class="style-scope patent-text">１−３</sub>アルキル及び−Ｏ−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択される１〜４個の置換基で置換されていてもよく、ＸがＨであるか、又は、ＯＸである隣接する置換基が少なくとも２個ある場合には、Ｘは該隣接する酸素基が式
 <chemistry id="" num="18" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000019" he="24" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from <br class="style-scope patent-text"> In which R <sup class="style-scope patent-text">10</sup> is oxo or OR <sup class="style-scope patent-text">11</sup> ; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">11</sup> is H or heterocycloalkyl, which is substituted with 1 to 4 substituents selected from OX, C <sub class="style-scope patent-text">1-3</sub> alkyl and —O—C (O) R <sup class="style-scope patent-text">1.</sup> And if X is H or there are at least two adjacent substituents that are OX, then X is an oxygen group of the formula
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="19" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000020" he="25" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール５員環を形成するような結合であってもよい。<br class="style-scope patent-text">
式中、Ｒ<sup class="style-scope patent-text">５</sup>及びＲ<sup class="style-scope patent-text">６</sup>は、それぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル及びＣ<sub class="style-scope patent-text">２−７</sub>アルケニルからなる群より選択され、<br class="style-scope patent-text">
Ｄは、
 <chemistry id="" num="19" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000020" he="25" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> A bond that forms an acetal 5-membered ring may be used. <br class="style-scope patent-text"> Wherein R <sup class="style-scope patent-text">5</sup> and R <sup class="style-scope patent-text">6</sup> are each independently selected from the group consisting of H, C <sub class="style-scope patent-text">1-6</sub> alkyl and C <sub class="style-scope patent-text">2-7</sub> alkenyl, <br class="style-scope patent-text"> D is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="20" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000021" he="32" wi="35" file="2007525148.tif" img-format="tif" img-content="drawing" width="140" height="128" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
−ＮＲ<sup class="style-scope patent-text">１２ａ</sup>Ｒ<sup class="style-scope patent-text">１２ａ</sup>及びＯＲ<sup class="style-scope patent-text">１２  </sup>から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１２</sup>は、Ｈ、１〜２のフェニル基で置換されてもよいＣ<sub class="style-scope patent-text">１−６</sub>アルキルから選択され、該フェニル基は、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル又はハロで置換されていてもよい。<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１２ａ</sup>及びＲ<sup class="style-scope patent-text">１２ａ</sup>は、それぞれ独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、Ｃ<sub class="style-scope patent-text">３−６  </sub>シクロアルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>ヘテロシクロアルキル、アリール、ヘテロアリール及びアミノ酸から選択され、該アルキル、アルケニル、アリール及びヘテロアリールは、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>、ＮＨ<sub class="style-scope patent-text">２</sub>又はアリールから選択される基で置換されていてもよく、該アリールはさらに、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>又はＮＨ<sub class="style-scope patent-text">２</sub>から選択される１又は２以上の基で独立して置換されていてもよい。<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">１</sup>は、
 <chemistry id="" num="20" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000021" he="32" wi="35" file="2007525148.tif" img-format="tif" img-content="drawing" width="140" height="128" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from -NR <sup class="style-scope patent-text">12a</sup> R <sup class="style-scope patent-text">12a</sup> and OR <sup class="style-scope patent-text">12</sup> ; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">12</sup> is selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl optionally substituted with 1-2 phenyl groups, and the phenyl group may be substituted with C <sub class="style-scope patent-text">1-6</sub> alkyl or halo. <br class="style-scope patent-text"> R <sup class="style-scope patent-text">12a</sup> and R <sup class="style-scope patent-text">12a</sup> are each independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, C <sub class="style-scope patent-text">3-6</sub> cycloalkyl, C <sub class="style-scope patent-text">2-6</sub> heterocycloalkyl, aryl, heteroaryl and amino acid. , The alkyl, alkenyl, aryl and heteroaryl may be substituted with a group selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> , NH <sub class="style-scope patent-text">2</sub> or aryl, wherein the aryl is further halogen, OH, NO <sub class="style-scope patent-text">2</sub> or NH <sub class="style-scope patent-text">2</sub> May be independently substituted with one or more groups selected from <br class="style-scope patent-text"> W <sup class="style-scope patent-text">1</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="21" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000022" he="15" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
Ｗ<sup class="style-scope patent-text">２</sup>は、
 <chemistry id="" num="21" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000022" he="15" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">2</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="22" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000023" he="15" wi="37" file="2007525148.tif" img-format="tif" img-content="drawing" width="148" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">３</sup>は、
 <chemistry id="" num="22" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000023" he="15" wi="37" file="2007525148.tif" img-format="tif" img-content="drawing" width="148" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">3</sup> is,
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="23" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000024" he="15" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
  Ｗ<sup class="style-scope patent-text">５</sup>は、
 <chemistry id="" num="23" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000024" he="15" wi="31" file="2007525148.tif" img-format="tif" img-content="drawing" width="124" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">5</sup> is,
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="24" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000025" he="18" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、<br class="style-scope patent-text">
  Ｘ<sup class="style-scope patent-text">１</sup>、Ｘ<sup class="style-scope patent-text">２</sup>、Ｘ<sup class="style-scope patent-text">３</sup>、Ｘ<sup class="style-scope patent-text">４</sup>、Ｘ<sup class="style-scope patent-text">５</sup>、Ｘ<sup class="style-scope patent-text">６</sup>、Ｘ<sup class="style-scope patent-text">７</sup>、Ｘ<sup class="style-scope patent-text">８</sup>、Ｘ<sup class="style-scope patent-text">９</sup>、Ｘ<sup class="style-scope patent-text">１２</sup>及びＸ<sup class="style-scope patent-text">１３</sup>が結合である場合には、２つの該隣接酸素原子及びそれらに付着する炭素原子は一緒に、式
 <chemistry id="" num="24" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000025" he="18" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> When X <sup class="style-scope patent-text">1</sup> , X <sup class="style-scope patent-text">2</sup> , X <sup class="style-scope patent-text">3</sup> , X <sup class="style-scope patent-text">4</sup> , X <sup class="style-scope patent-text">5</sup> , X <sup class="style-scope patent-text">6</sup> , X <sup class="style-scope patent-text">7</sup> , X <sup class="style-scope patent-text">8</sup> , X <sup class="style-scope patent-text">9</sup> , X <sup class="style-scope patent-text">12</sup> and X <sup class="style-scope patent-text">13</sup> are a bond, they are attached to the two adjacent oxygen atoms and to them Together the carbon atoms
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="25" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000026" he="22" wi="22" file="2007525148.tif" img-format="tif" img-content="drawing" width="88" height="88" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール６員環を形成するように、Ｘ<sup class="style-scope patent-text">１</sup>、Ｘ<sup class="style-scope patent-text">２</sup>、Ｘ<sup class="style-scope patent-text">３</sup>、Ｘ<sup class="style-scope patent-text">４</sup>、Ｘ<sup class="style-scope patent-text">５</sup>、Ｘ<sup class="style-scope patent-text">６</sup>、Ｘ<sup class="style-scope patent-text">７</sup>、Ｘ<sup class="style-scope patent-text">８</sup>、Ｘ<sup class="style-scope patent-text">９</sup>、Ｘ<sup class="style-scope patent-text">１２</sup>及びＸ<sup class="style-scope patent-text">１３</sup>は、それぞれ独立してＨ、−Ｃ（Ｏ）−Ｒ<sup class="style-scope patent-text">７</sup>及び結合から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">５</sup>、Ｒ<sup class="style-scope patent-text">６</sup>及びＲ<sup class="style-scope patent-text">７</sup>はそれぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルケニルから選択され、<br class="style-scope patent-text">
  Ｙ<sup class="style-scope patent-text">１</sup>、Ｙ<sup class="style-scope patent-text">２</sup>、Ｙ<sup class="style-scope patent-text">３</sup>、Ｙ<sup class="style-scope patent-text">４</sup>、Ｙ<sup class="style-scope patent-text">５</sup>、Ｙ<sup class="style-scope patent-text">６</sup>、Ｙ<sup class="style-scope patent-text">７</sup>、Ｙ<sup class="style-scope patent-text">８</sup>、Ｙ<sup class="style-scope patent-text">９</sup>、Ｙ<sup class="style-scope patent-text">１０</sup>、Ｙ<sup class="style-scope patent-text">１１</sup>、Ｙ<sup class="style-scope patent-text">１２</sup>、Ｙ<sup class="style-scope patent-text">１３</sup>及びＹ<sup class="style-scope patent-text">１５</sup>は、それぞれ独立してエテン−１，２−ジイル、エタン−１，２−ジイル及び
 <chemistry id="" num="25" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000026" he="22" wi="22" file="2007525148.tif" img-format="tif" img-content="drawing" width="88" height="88" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> So as to form a acetal 6-membered <sup class="style-scope patent-text"> <sup class="style-scope patent-text"> <sup class="style-scope patent-text"> <sup class="style-scope patent-text">ring, X 1, X 2, X</sup> </sup> </sup> </sup> 3, <figure-callout id="4" label="X" filenames="2007525148-214.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 4, <figure-callout id="5" label="X" filenames="2007525148-217.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 5, <figure-callout id="6" label="X" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 6, <figure-callout id="7" label="X" filenames="2007525148-216.png,2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 7, <figure-callout id="8" label="X" filenames="2007525148-232.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 8, <figure-callout id="9" label="X" filenames="2007525148-219.png,2007525148-223.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">X</a></figure-callout> 9, X 12 and <sup class="style-scope patent-text">X 13</sup> are each independently H is selected from -C (O) -R <sup class="style-scope patent-text">7</sup> and bonds, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">5</sup> , R <sup class="style-scope patent-text">6</sup> and R <sup class="style-scope patent-text">7</sup> are each independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkenyl, <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">1</sup> , Y <sup class="style-scope patent-text">2</sup> , Y <sup class="style-scope patent-text">3</sup> , Y <sup class="style-scope patent-text">4</sup> , Y <sup class="style-scope patent-text">5</sup> , Y <sup class="style-scope patent-text">6</sup> , Y <sup class="style-scope patent-text">7</sup> , Y <sup class="style-scope patent-text">8</sup> , Y <sup class="style-scope patent-text">9</sup> , Y <sup class="style-scope patent-text">10</sup> , Y <sup class="style-scope patent-text">11</sup> , Y <sup class="style-scope patent-text">12</sup> , Y <sup class="style-scope patent-text">13</sup> and Y <sup class="style-scope patent-text">15</sup> are each independently ethene-1 , 2-diyl, ethane-1,2-diyl and
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="26" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000027" he="17" wi="27" file="2007525148.tif" img-format="tif" img-content="drawing" width="108" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
から選択され、式中、該エテン−１，２−ジイル及びエタン−１，２−ジイル基は、メチル基で置換されていてもよい。<br class="style-scope patent-text">
ＺはＯＨ、ＮＨＲ<sup class="style-scope patent-text">８</sup>及び
 <chemistry id="" num="26" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000027" he="17" wi="27" file="2007525148.tif" img-format="tif" img-content="drawing" width="108" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Wherein the ethene-1,2-diyl and ethane-1,2-diyl groups may be substituted with a methyl group. <br class="style-scope patent-text"> Z is OH, NHR <sup class="style-scope patent-text">8</sup> and
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="27" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000028" he="26" wi="27" file="2007525148.tif" img-format="tif" img-content="drawing" width="108" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
から選択され、破線が結合のときには、Ｚはオキソ又はＮＲ<sup class="style-scope patent-text">９</sup>であり、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">８</sup>は、独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニルから選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">９</sup>は、アリールで置換されていてもよいＣ<sub class="style-scope patent-text">１−６</sub>アルキルである。
 <chemistry id="" num="27" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000028" he="26" wi="27" file="2007525148.tif" img-format="tif" img-content="drawing" width="108" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Z is oxo or NR <sup class="style-scope patent-text">9</sup> when the dashed line is a bond, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">8</sup> is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">9</sup> is C <sub class="style-scope patent-text">1-6</sub> alkyl <sub class="style-scope patent-text">optionally</sub> substituted with aryl.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  第一の実施形態においては、本発明は、式Ｉの化合物を提供し、式中、Ｚはオキソである。他の全ての基は、先に定義した通りであるか、又はその薬学的に許容される塩である。
</span>
&nbsp;&nbsp;In a first embodiment, the present invention provides a compound of formula I, wherein Z is oxo. All other groups are as defined above, or a pharmaceutically acceptable salt thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  この第一の実施形態内においては、Ｚはオキソであり、Ａは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>であり；及び他の全ての基は先に定義した通りであるか、又はその薬学的に許容される塩である。
</span>Within this first embodiment, Z is oxo, A is —NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> ; and all other groups are as defined above, or pharmaceutically acceptable thereof. It is salt.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、この実施形態内においては、Ｚはオキソであり、Ａは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>であり、Ｄは、
</span>Further within this embodiment, Z is oxo, A is —NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> , and D is</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="28" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000029" he="27" wi="27" file="2007525148.tif" img-format="tif" img-content="drawing" width="108" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、及び他の全ての基は、先に定義された通りであるか、又はその薬学的に許容される塩である。
 <chemistry id="" num="28" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000029" he="27" wi="27" file="2007525148.tif" img-format="tif" img-content="drawing" width="108" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And all other groups are as defined above, or a pharmaceutically acceptable salt thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  この第一の実施形態内においては、本発明は、式Ｉの化合物を提供し、式中、Ｚがオキソであり、Ａが
</span>
&nbsp;&nbsp;Within this first embodiment, the present invention provides a compound of formula I, wherein Z is oxo and A is
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="29" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000030" he="19" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、及び他の全ての基は、先に定義された通りであるか、又はその薬学的に許容される塩である。
 <chemistry id="" num="29" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000030" he="19" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And all other groups are as defined above, or a pharmaceutically acceptable salt thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
さらに、この実施形態内においては、Ｚはオキソであり、Aは
</span>
Further, within this embodiment, Z is oxo and A is
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="30" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000031" he="19" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、及びＤは
 <chemistry id="" num="30" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000031" he="19" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And D is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="31" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000032" he="23" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、他の全ての基は、先に定義されたとおりであるか、又はその薬学的に許容される塩である。
 <chemistry id="" num="31" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000032" he="23" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And all other groups are as defined above, or a pharmaceutically acceptable salt thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  第二の実施形態においては、本発明は、式Ｉの化合物を提供し、以下のことを特徴とする。Ｂは、
</span>
&nbsp;&nbsp;In a second embodiment, the present invention provides a compound of formula I and is characterized by the following: B is
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="32" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000033" he="23" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
であり、Ｒ<sup class="style-scope patent-text">１０</sup>はオキソ又はＯＲ<sup class="style-scope patent-text">１１</sup>であり、及び他の全ての基は、先に定義されたとおりであるか、又はその薬学的に許容される塩である。
 <chemistry id="" num="32" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000033" he="23" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> R <sup class="style-scope patent-text">10</sup> is oxo or OR <sup class="style-scope patent-text">11</sup> and all other groups are as defined above, or a pharmaceutically acceptable salt thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  この第二の実施形態内においては、Ｒ<sup class="style-scope patent-text">１０</sup>はＯＲ<sup class="style-scope patent-text">１１</sup>であり、式中、Ｒ<sup class="style-scope patent-text">１１</sup>は、ヘテロシクロアルキルであり、該ヘテロシクロアルキルは、ＯＸ、Ｃ<sub class="style-scope patent-text">１−３</sub>アルキル及び−Ｏ−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択される１〜４個の置換基で置換されていてもよく、ＸがＨであるか、ＯＸである隣接する置換基が少なくとも２個ある場合には、Ｘは、該隣接する酸素基が式
</span>Within this second embodiment, R <sup class="style-scope patent-text">10</sup> is OR <sup class="style-scope patent-text">11</sup> where R <sup class="style-scope patent-text">11</sup> is heterocycloalkyl, which is OX, C <sub class="style-scope patent-text">1-3</sub> alkyl and —O—C ( O) optionally substituted with 1 to 4 substituents selected from R <sup class="style-scope patent-text">1</sup> , and when X is H or there are at least two adjacent substituents that are OX, X is Adjacent oxygen group is formula</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="33" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000034" he="24" wi="22" file="2007525148.tif" img-format="tif" img-content="drawing" width="88" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール５員環を形成するような結合であってもよい。
 <chemistry id="" num="33" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000034" he="24" wi="22" file="2007525148.tif" img-format="tif" img-content="drawing" width="88" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> A bond that forms an acetal 5-membered ring may be used.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  この実施形態内においては、Ｒ<sup class="style-scope patent-text">１１</sup>はヘテロシクロアルキルであり、該ヘテロシクロアルキルは、ＯＸ、Ｃ<sub class="style-scope patent-text">１−３</sub>アルキル及び−Ｏ−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択される１〜４個の置換基で置換されていてもよく、ＸがＨであるか、ＯＸである隣接する置換基が少なくとも２個ある場合には、Ｘは、該隣接する酸素基が式
</span>Within this embodiment, R <sup class="style-scope patent-text">11</sup> is heterocycloalkyl, which is 1-4 substituents selected from OX, C <sub class="style-scope patent-text">1-3</sub> alkyl and —O—C (O) R <sup class="style-scope patent-text">1.</sup> And when X is H or there are at least two adjacent substituents that are OX, X is an oxygen atom of the formula</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="34" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000035" he="24" wi="21" file="2007525148.tif" img-format="tif" img-content="drawing" width="84" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール５員環を形成するような結合であってよい。及びＡは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>であり、及び全ての他の基は先に定義された通りであるか、又はその薬学的に許容される塩である。
 <chemistry id="" num="34" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000035" he="24" wi="21" file="2007525148.tif" img-format="tif" img-content="drawing" width="84" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Or a bond that forms an acetal 5-membered ring. And A is -NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2,</sup> and all other groups are either as defined above, or a pharmaceutically acceptable salt thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、この実施形態内においては、本発明は式Ｉの化合物を提供し、式中、Ｒ<sup class="style-scope patent-text">１１</sup>はヘテロシクロアルキルであり、該ヘテロシクロアルキルは、ＯＸ、Ｃ<sub class="style-scope patent-text">１−３</sub>アルキル及び−Ｏ−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択される１〜４個の置換基で置換されていてもよく、ＸがＨであるか、ＯＸである隣接する置換基が少なくとも２個ある場合には、Ｘは、該隣接する酸素基が式
</span>Further within this embodiment, the present invention provides a compound of formula I, wherein R <sup class="style-scope patent-text">11</sup> is heterocycloalkyl, wherein the heterocycloalkyl is OX, C <sub class="style-scope patent-text">1-3</sub> alkyl and —O—C. (O) R <sup class="style-scope patent-text">1</sup> may be substituted with 1 to 4 substituents selected from 1, and when X is H or there are at least two adjacent substituents which are OX, X is The adjacent oxygen group is of formula</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="35" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000036" he="24" wi="21" file="2007525148.tif" img-format="tif" img-content="drawing" width="84" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
のアセタール５員環を形成するような結合であってもよい。Ａは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>であり、Ｚはオキソであり、及び全ての他の基は先に定義された通りであるか、又はその薬学的に許容される塩である。
 <chemistry id="" num="35" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000036" he="24" wi="21" file="2007525148.tif" img-format="tif" img-content="drawing" width="84" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> A bond that forms an acetal 5-membered ring may be used. A is —NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> , Z is oxo, and all other groups are as defined above, or a pharmaceutically acceptable salt thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の好ましい化合物は、式IIの化合物を含んでいる。
</span>
&nbsp;&nbsp;Preferred compounds of the invention include compounds of formula II.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="36" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000037" he="17" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
                                式II<br class="style-scope patent-text">
  式中、Ａ<sup class="style-scope patent-text">１</sup>は−ＮＨ<sub class="style-scope patent-text">２</sub>、−Ｎ＝ＣＨ−Ｒ<sup class="style-scope patent-text">１３</sup>、アミノ酸又は−ＮＨ−Ｒ<sup class="style-scope patent-text">１４</sup>であり、Ｒ<sup class="style-scope patent-text">１３</sup>は水素又はフェニルであり、Ｒ<sup class="style-scope patent-text">１４</sup>は、イソプロピル、１−（４−ニトロフェニル）メチル、シクロヘキシルからなる群から選択され、該アミノ酸はその窒素原子を経由して付着しており、
 <chemistry id="" num="36" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000037" he="17" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Formula II <br class="style-scope patent-text"> In the formula, A <sup class="style-scope patent-text">1</sup> is —NH <sub class="style-scope patent-text">2</sub> , —N═CH—R <sup class="style-scope patent-text">13</sup> , an amino acid or —NH—R <sup class="style-scope patent-text">14</sup> , R <sup class="style-scope patent-text">13</sup> is hydrogen or phenyl, R <sup class="style-scope patent-text">14</sup> is isopropyl, 1- (4-nitrophenyl) ) Selected from the group consisting of methyl, cyclohexyl, the amino acid is attached via its nitrogen atom;
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="37" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000038" he="24" wi="88" file="2007525148.tif" img-format="tif" img-content="drawing" width="352" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
式中、Ｒ<sup class="style-scope patent-text">１５</sup>はメチル、イソプロピル、フェニル、４−ニトロフェニル、１−アミノエチル、１−アミノ−１−（４−ヒドロキシフェニル）メチル、１−アミノ−２−（４−ヒドロキシフェニル）エチル、１−アミノ−２−メチルプロピル、２−ピロリジニル及び１−アミノ−２−ヒドロキシエチルからなる群から選択され、<br class="style-scope patent-text">
Ｙ<sup class="style-scope patent-text">２０</sup>はエテン−１，２−ジイル及び
 <chemistry id="" num="37" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000038" he="24" wi="88" file="2007525148.tif" img-format="tif" img-content="drawing" width="352" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> In which R <sup class="style-scope patent-text">15</sup> is methyl, isopropyl, phenyl, 4-nitrophenyl, 1-aminoethyl, 1-amino-1- (4-hydroxyphenyl) methyl, 1-amino-2- (4-hydroxyphenyl) ethyl, Selected from the group consisting of 1-amino-2-methylpropyl, 2-pyrrolidinyl and 1-amino-2-hydroxyethyl; <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">20</sup> is ethene-1,2-diyl and
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="38" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000039" he="20" wi="29" file="2007525148.tif" img-format="tif" img-content="drawing" width="116" height="80" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
からなる群から選択され、<br class="style-scope patent-text">
Ｚ<sup class="style-scope patent-text">１</sup>は
 <chemistry id="" num="38" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000039" he="20" wi="29" file="2007525148.tif" img-format="tif" img-content="drawing" width="116" height="80" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of <br class="style-scope patent-text"> Z <sup class="style-scope patent-text">1</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="39" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000040" he="56" wi="161" file="2007525148.tif" img-format="tif" img-content="drawing" width="644" height="224" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
からなる群から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">２０</sup>は水素及び
 <chemistry id="" num="39" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000040" he="56" wi="161" file="2007525148.tif" img-format="tif" img-content="drawing" width="644" height="224" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of <br class="style-scope patent-text"> R <sup class="style-scope patent-text">20</sup> is hydrogen and
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="40" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000041" he="33" wi="51" file="2007525148.tif" img-format="tif" img-content="drawing" width="204" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
からなる群から選択され、<br class="style-scope patent-text">
Ｙ<sup class="style-scope patent-text">３０</sup>はエテン−１，２−ジイル又はエタン−１，２−ジイルであり、<br class="style-scope patent-text">
Ｄ<sup class="style-scope patent-text">１</sup>はヒドロキシ、メトキシ又は
 <chemistry id="" num="40" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000041" he="33" wi="51" file="2007525148.tif" img-format="tif" img-content="drawing" width="204" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">30</sup> is ethene-1,2-diyl or ethane-1,2-diyl; <br class="style-scope patent-text"> D <sup class="style-scope patent-text">1</sup> is hydroxy, methoxy or
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="41" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000042" he="38" wi="38" file="2007525148.tif" img-format="tif" img-content="drawing" width="152" height="152" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
及び、その薬学的に許容される塩である。
 <chemistry id="" num="41" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000042" he="38" wi="38" file="2007525148.tif" img-format="tif" img-content="drawing" width="152" height="152" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And pharmaceutically acceptable salts thereof.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、式IIの化合物の薬学組成物を含み、前記組成物は、治療上有効な量の式IIの化合物又はその薬学的に許容される塩、及び薬学的に許容される担体を含んでいる。
</span>
&nbsp;&nbsp;The present invention includes a pharmaceutical composition of a compound of formula II, said composition comprising a therapeutically effective amount of a compound of formula II or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. It is out.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の特に好ましい化合物は、式IIの化合物を含んでいる。
</span>
&nbsp;&nbsp;Particularly preferred compounds of the invention include compounds of formula II.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="42" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000043" he="21" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
                                式II<br class="style-scope patent-text">  <chemistry id="" num="42" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000043" he="21" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Formula II <br class="style-scope patent-text"> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ａ<sup class="style-scope patent-text">１</sup>は、アミノ（−ＮＨ<sub class="style-scope patent-text">２</sub>）であり、Ｙ<sup class="style-scope patent-text">２０</sup>、Ｚ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">２０</sup>、Ｙ<sup class="style-scope patent-text">３０</sup>及びＤ<sup class="style-scope patent-text">１</sup>は、下の表Ａに定義されているとおりである。<br class="style-scope patent-text">
<tables num="A" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000044" he="163" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="652" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Ａ<sup class="style-scope patent-text">１</sup>がＮＨ<sub class="style-scope patent-text">２</sub>であることを特徴とする式IIの化合物<br class="style-scope patent-text">
本発明の付加された好ましい化合物は、式IIの化合物を含んでいる。
A <sup class="style-scope patent-text">1</sup> is amino (—NH <sub class="style-scope patent-text">2</sub> ) and Y <sup class="style-scope patent-text">20</sup> , Z <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">20</sup> , Y <sup class="style-scope patent-text">30</sup> and D <sup class="style-scope patent-text">1</sup> are as defined in Table A below. <br class="style-scope patent-text"> <tables num="A" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000044" he="163" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="652" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> Compounds of Formula II, wherein A <sup class="style-scope patent-text">1</sup> is NH <sub class="style-scope patent-text">2</sub> Preferred added compounds of the invention include compounds of formula II.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="43" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000045" he="17" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
                            式II<br class="style-scope patent-text">
  下の表Ｂ及びＣに記載されている様にＹ<sup class="style-scope patent-text">２０</sup>は、エテン−１，２−ジイルであり、<br class="style-scope patent-text">
Ｚ<sup class="style-scope patent-text">１</sup>は、
 <chemistry id="" num="43" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000045" he="17" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Formula II <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">20</sup> is ethene-1,2-diyl as described in Tables B and C below, <br class="style-scope patent-text"> Z <sup class="style-scope patent-text">1</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="44" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000046" he="55" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="220" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Ｒ<sup class="style-scope patent-text">２０</sup>は、
 <chemistry id="" num="44" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000046" he="55" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="220" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> R <sup class="style-scope patent-text">20</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="45" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000047" he="33" wi="50" file="2007525148.tif" img-format="tif" img-content="drawing" width="200" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Ｙ<sup class="style-scope patent-text">３０</sup>は、エテン−１，２−ジイルであり、及び<br class="style-scope patent-text">
Ｄ<sup class="style-scope patent-text">１</sup>は、
 <chemistry id="" num="45" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000047" he="33" wi="50" file="2007525148.tif" img-format="tif" img-content="drawing" width="200" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Y <sup class="style-scope patent-text">30</sup> is ethene-1,2-diyl, and D <sup class="style-scope patent-text">1</sup> is
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="46" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000048" he="26" wi="36" file="2007525148.tif" img-format="tif" img-content="drawing" width="144" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
及び<br class="style-scope patent-text">
Ａ<sup class="style-scope patent-text">１</sup>は、−Ｎ＝ＣＨ−Ｒ<sup class="style-scope patent-text">１３</sup>（表Ｂ）；−NH−Ｒ<sup class="style-scope patent-text">１４</sup>（表Ｃ）である。
 <chemistry id="" num="46" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000048" he="26" wi="36" file="2007525148.tif" img-format="tif" img-content="drawing" width="144" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And A <sup class="style-scope patent-text">1</sup> are —N═CH—R <sup class="style-scope patent-text">13</sup> (Table B); —NH—R <sup class="style-scope patent-text">14</sup> (Table C).
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ａ<sup class="style-scope patent-text">１</sup>が−Ｎ＝ＣＨ−Ｒ<sup class="style-scope patent-text">１３  </sup>であり、Ｙ<sup class="style-scope patent-text">２０</sup>、Ｚ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">２０</sup>、Ｙ<sup class="style-scope patent-text">３０</sup>及びＤ<sup class="style-scope patent-text">１</sup>が上記のように定義されていることを特徴とする式IIの化合物    <br class="style-scope patent-text">
<tables num="B" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000049" he="27" wi="56" file="2007525148.tif" img-format="tif" img-content="drawing" width="224" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
A compound of formula II, wherein A <sup class="style-scope patent-text">1</sup> is —N═CH—R <sup class="style-scope patent-text">13</sup> and Y <sup class="style-scope patent-text">20</sup> , Z <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">20</sup> , Y <sup class="style-scope patent-text">30</sup> and D <sup class="style-scope patent-text">1</sup> are as defined above <br class="style-scope patent-text"> <tables num="B" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000049" he="27" wi="56" file="2007525148.tif" img-format="tif" img-content="drawing" width="224" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ａ<sup class="style-scope patent-text">１</sup>が−NH−Ｒ<sup class="style-scope patent-text">１４</sup>であり、Ｙ<sup class="style-scope patent-text">２０</sup>、Ｚ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">２０</sup>、Ｙ<sup class="style-scope patent-text">３０</sup>及びＤ<sup class="style-scope patent-text">１</sup>が上記のように定義されていることを特徴とする式IIの化合物<br class="style-scope patent-text">
<tables num="C" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000050" he="143" wi="142" file="2007525148.tif" img-format="tif" img-content="drawing" width="568" height="572" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
 ＮＡ＝適用外（not applicable）    <br class="style-scope patent-text">
表Ａ、Ｂ及びＣの化合物は、下記に示されている。
A compound of formula II, wherein A <sup class="style-scope patent-text">1</sup> is —NH—R <sup class="style-scope patent-text">14</sup> and Y <sup class="style-scope patent-text">20</sup> , Z <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">20</sup> , Y <sup class="style-scope patent-text">30</sup> and D <sup class="style-scope patent-text">1</sup> are as defined above <br class="style-scope patent-text"> <tables num="C" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000050" he="143" wi="142" file="2007525148.tif" img-format="tif" img-content="drawing" width="568" height="572" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> NA = not applicable <br class="style-scope patent-text"> The compounds of Tables A, B and C are shown below.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="47" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000051" he="24" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ａ）
 <chemistry id="" num="47" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000051" he="24" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (a)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="48" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000052" he="25" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｂ）
 <chemistry id="" num="48" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000052" he="25" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (b)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="49" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000053" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｃ）
 <chemistry id="" num="49" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000053" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (c)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="50" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000054" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｄ）
 <chemistry id="" num="50" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000054" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (d)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="51" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000055" he="28" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｅ）
 <chemistry id="" num="51" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000055" he="28" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (e)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="52" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000056" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｆ）
 <chemistry id="" num="52" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000056" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (f)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="53" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000057" he="27" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｇ）
 <chemistry id="" num="53" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000057" he="27" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (g)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="54" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000058" he="27" wi="168" file="2007525148.tif" img-format="tif" img-content="drawing" width="672" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
化合物２（ｈ）
 <chemistry id="" num="54" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000058" he="27" wi="168" file="2007525148.tif" img-format="tif" img-content="drawing" width="672" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (h)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="55" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000059" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｉ）
 <chemistry id="" num="55" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000059" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (i)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="56" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000060" he="15" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｊ）
 <chemistry id="" num="56" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000060" he="15" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (j)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="57" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000061" he="26" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｋ）
 <chemistry id="" num="57" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000061" he="26" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (k)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="58" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000062" he="24" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｌ）
 <chemistry id="" num="58" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000062" he="24" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (l)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="59" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000063" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｍ）
 <chemistry id="" num="59" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000063" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (m)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="60" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000064" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｎ）
 <chemistry id="" num="60" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000064" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (n)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="61" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000065" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｏ）
 <chemistry id="" num="61" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000065" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (o)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="62" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000066" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｐ）
 <chemistry id="" num="62" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000066" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (p)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="63" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000067" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｑ）
 <chemistry id="" num="63" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000067" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (q)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="64" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000068" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｒ）
 <chemistry id="" num="64" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000068" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (r)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="65" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000069" he="25" wi="161" file="2007525148.tif" img-format="tif" img-content="drawing" width="644" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｓ）
 <chemistry id="" num="65" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000069" he="25" wi="161" file="2007525148.tif" img-format="tif" img-content="drawing" width="644" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (s)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="66" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000070" he="26" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｔ）
 <chemistry id="" num="66" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000070" he="26" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (t)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="67" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000071" he="25" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｕ）
 <chemistry id="" num="67" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000071" he="25" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (u)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="68" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000072" he="25" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｖ）
 <chemistry id="" num="68" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000072" he="25" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (v)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="69" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000073" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｗ）
 <chemistry id="" num="69" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000073" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (w)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="70" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000074" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｘ）
 <chemistry id="" num="70" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000074" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (x)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="71" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000075" he="25" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｙ）
 <chemistry id="" num="71" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000075" he="25" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (y)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="72" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000076" he="26" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ｚ）
 <chemistry id="" num="72" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000076" he="26" wi="162" file="2007525148.tif" img-format="tif" img-content="drawing" width="648" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (z)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="73" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000077" he="26" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ａａ）
 <chemistry id="" num="73" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000077" he="26" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (aa)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="74" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000078" he="25" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
化合物２（ａｂ）
 <chemistry id="" num="74" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000078" he="25" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> Compound 2 (ab)
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  下記の二価部分は、下に示されているように、命名法に基づいて、ここに言及されている。
</span>
&nbsp;&nbsp;The following divalent moieties are referred to herein based on nomenclature, as shown below.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="75" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000079" he="17" wi="25" file="2007525148.tif" img-format="tif" img-content="drawing" width="100" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
１−オキソ−メチレン−１，１−ジイル
 <chemistry id="" num="75" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000079" he="17" wi="25" file="2007525148.tif" img-format="tif" img-content="drawing" width="100" height="68" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> 1-oxo-methylene-1,1-diyl
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="76" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000080" he="18" wi="24" file="2007525148.tif" img-format="tif" img-content="drawing" width="96" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
１−ヒドロキシメチレン−１，１−ジイル
 <chemistry id="" num="76" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000080" he="18" wi="24" file="2007525148.tif" img-format="tif" img-content="drawing" width="96" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 1-hydroxymethylene-1,1-diyl
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="77" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000081" he="22" wi="24" file="2007525148.tif" img-format="tif" img-content="drawing" width="96" height="88" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
１，３−ジオキサシクロペンタン−２，２−ジイル
 <chemistry id="" num="77" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000081" he="22" wi="24" file="2007525148.tif" img-format="tif" img-content="drawing" width="96" height="88" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 1,3-dioxacyclopentane-2,2-diyl
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="78" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000082" he="25" wi="35" file="2007525148.tif" img-format="tif" img-content="drawing" width="140" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
（２−プロピルアミノ）メチレン−１，１−ジイル
 <chemistry id="" num="78" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000082" he="25" wi="35" file="2007525148.tif" img-format="tif" img-content="drawing" width="140" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> (2-Propylamino) methylene-1,1-diyl
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="79" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000083" he="28" wi="52" file="2007525148.tif" img-format="tif" img-content="drawing" width="208" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
  １−ベンジルイミノメチレン−１，１−ジイル
 <chemistry id="" num="79" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000083" he="28" wi="52" file="2007525148.tif" img-format="tif" img-content="drawing" width="208" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 1-benzyliminomethylene-1,1-diyl
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="80" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000084" he="21" wi="29" file="2007525148.tif" img-format="tif" img-content="drawing" width="116" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
オキシラン−２，３−ジイル。  
 <chemistry id="" num="80" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000084" he="21" wi="29" file="2007525148.tif" img-format="tif" img-content="drawing" width="116" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Oxirane-2,3-diyl.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  下記の一価成分は、示されている学名によって、ここに言及されている。
</span>
&nbsp;&nbsp;The following monovalent components are referred to herein by the indicated scientific names.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="81" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000085" he="25" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    (２−ヒドロキシ−５−オキソ−シクロペンタ−１−エニル)−アミノ              
 <chemistry id="" num="81" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000085" he="25" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> (2-Hydroxy-5-oxo-cyclopent-1-enyl) -amino
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="82" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000086" he="32" wi="47" file="2007525148.tif" img-format="tif" img-content="drawing" width="188" height="128" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
３，４，５−トリヒドロキシ−６−メチル−テトラヒドロピラン−２−イル
 <chemistry id="" num="82" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000086" he="32" wi="47" file="2007525148.tif" img-format="tif" img-content="drawing" width="188" height="128" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「ポリケチド」又は「ポリエンポリケチド」という表現は、式Ｉ又はIIによって定義されているポリケチド化合物の一分類について述べたものである。好ましい本発明のポリケチドは化合物２ａであり、５６−アミノ−１５，１７，３３，３５，３７，４１，４３，４５，４７，５１，５３−ウンデカヒドロキシ−１４，１６，３０−トリメチル−３１−オキソ−２９−（３，４，５−トリヒドロキシ−６−メチル−テトラヒドロ−ピラン−２−イルオキシ）−ヘキサペンタコンタ−２，４，６，８，１２，１８，２０，２２，２４，２６，３８，４８−ドデカン酸（２−ヒドロキシ−５−オキソ−シクロペント−１−エニル）−アミドという系統名を有する。前記の表現は、さらに化学合成における媒介物として用いられるこの分類の化合物を含む。
</span>
&nbsp;&nbsp;The expression “polyketide” or “polyene polyketide” describes a class of polyketide compounds as defined by formula I or II. A preferred polyketide of the present invention is compound 2a, 56-amino-15,17,33,35,37,41,43,45,47,51,53-undecahydroxy-14,16,30-trimethyl-31. -Oxo-29- (3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy) -hexapentaconta-2,4,6,8,12,18,20,22,24, It has the <figure-callout id="26" label="systematic name" filenames="2007525148-219.png,2007525148-223.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="38" label="systematic name" filenames="2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">systematic name</a></figure-callout></a></figure-callout> 26,38,48-dodecanoic acid (2-hydroxy-5-oxo-cyclopent-1-enyl) -amide. The expression further includes this class of compounds used as mediators in chemical synthesis.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「式Ｉの化合物の産生株」及び「式Ｉの化合物を生成する生物」という表現は、式Ｉの化合物を生成するのに必要な遺伝子情報を保有する微生物について述べたものであり、その生物が式Ｉの化合物を生成することが知られているかどうかは無関係である。「式IIの化合物の産生株」及び「式IIの化合物を生成する生物」という表現は、式IIの化合物を生成するのに必要な遺伝子情報を保有する微生物について述べたものであり、生物体が式IIの化合物を生成することが知られているかどうかは無関係である。「化合物２（ａ）の産生株」及び「化合物２（ａ）を生成する生物」という表現は、化合物２（ａ）を生成するのに必要な遺伝子情報を保有する微生物について述べたものであり、生物体が化合物２（ａ）を生成することが知られているかどうかは無関係である。「ポリケチド産生株」という表現は、式Ｉ又はIIのポリケチドを生成するのに必要な遺伝子情報を保有する微生物に言及している。前記の表現は、式Ｉ又はIIの化合物又は化合物２（ａ）を生成するための遺伝子情報を、その微生物本来の自然な環境で保有している微生物、及び前記遺伝子情報を組換え技術によって導入された微生物の両方に平等に適用される。詳細に述べると、ここで検討されている具体的な微生物としては、以下のものが挙げられる：ミクロモノスポラ科、そのなかでも、ミクロモノスポラ属、アクチノプラーネス属、及びダクチロスポランギウム（Dactylosporangium）属が好ましい；ストレプトミセス科、そのなかでも、ストレプトミセス属及びキタサトスポラ（Kitasatospora）属が好ましい；シュードノカルディアセ（Pseudonocardiaceae）科、そのなかでも、アミコラトプシス（Amycolatopsis）属及びサッカロポリスポラ（Saccharopolyspora）属が好ましい；及びアクチノシンエマタシエ（Actinosynnemataceae）科、そのなかでも、サッカロスリックス（Saccharothrix）属及びアクチノシンネマ（Actinosynnema）属が好ましい；しかしながら、前記の表現は、式Ｉ又はIIの化合物又は化合物２（ａ）を生成するのに必要な遺伝子情報を有する全ての微生物を包含している。好ましい式Ｉ又は２の化合物又は化合物２（ａ）の産生株としては、ストレプトミセス・アイズネンシス（ＮＲＲＬ  Ｂ−１１２７７）及び株［Ｃ０３］０２３（ＩＤＡＣアクセッション番号.０７０８０３−０１）及び株［Ｃ０３Ｕ０３］０２３（ＩＤＡＣアクセッション番号.２３１２０３−０２）をはじめとするストレプトミセス・アイズネンシスのあらゆる変異体又は改良株が挙げられる。  
</span>
&nbsp;&nbsp;The expressions “producing strain of the compound of formula I” and “organism producing the compound of formula I” describe a microorganism that possesses the genetic information necessary to produce the compound of formula I. It is irrelevant whether is known to produce compounds of formula I. The expressions “producing strain of the compound of formula II” and “organism producing the compound of formula II” describe microorganisms that possess the genetic information necessary to produce the compound of formula II. It is irrelevant whether is known to produce compounds of formula II. The expressions “compound 2 (a) producing strain” and “organism producing compound 2 (a)” describe a microorganism having genetic information necessary to produce compound 2 (a). It is irrelevant whether the organism is known to produce compound 2 (a). The expression “polyketide producing strain” refers to a microorganism carrying the genetic information necessary to produce a polyketide of formula I or II. The above expression refers to a microorganism that possesses genetic information for producing a compound of formula I or II or compound 2 (a) in its natural environment, and the genetic information is introduced by recombinant technology. Applied equally to both microorganisms. Specifically, the specific microorganisms considered here include the following: Micromonosporidae, among which Micromonospora, Actinoplanes, and Dactyrosporangium (Dactylosporangium) is preferred; Streptomyces, particularly Streptomyces and Kitasatospora are preferred; Pseudonocardiaceae, especially Amycolatopsis and Saccharo The genus Saccharopolyspora is preferred; and the family Actinosynnemataceae, among which the genus Saccharothrix and the genus Actinosynnema are preferred; Or a compound 2 (a) It encompasses all microorganisms with the necessary genetic information. Preferred production strains of the compound of formula I or 2 or compound 2 (a) include Streptomyces isenensis (NRRL B-11277) and strain [C03] 023 (IDAC accession number .070803-01) and strain [C03U03]. Any mutant or improved strain of Streptomyces isenensis including 023 (IDAC Accession No. 231203-02) can be mentioned.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「単離された」という表現は、物質が、その本来の環境、例えばそれが天然物である場合にはその自然環境から除去されていることを意味する。例えば、生体中に存在する天然のポリヌクレオチド又はポリペプチドは単離されていないが、その同じポリヌクレオチド又はポリペプチドが、自然界のシステムで共存している物質の一部又はすべてから分離された場合には、それらは単離されたことになる。そのようなポリヌクレオチドがベクターの一部とすること、及び／又はそのようなポリヌクレオチド又はポリペプチドを組成物の一部とすることも可能であり、その場合も、そのようなポリヌクレオチド又はポリペプチドは、やはり単離されたことになる。なぜなら、そうしたベクター又は組成物は、そのようなポリヌクレオチド又はポリペプチドの自然環境の一部ではないためである。
</span>
&nbsp;&nbsp;The expression “isolated” means that the material has been removed from its original environment, eg, its natural environment if it is a natural product. For example, a natural polynucleotide or polypeptide present in a living body has not been isolated, but the same polynucleotide or polypeptide is separated from some or all of the coexisting substances in the natural system. They are isolated. Such polynucleotides can be part of a vector and / or such polynucleotides or polypeptides can be part of a composition, in which case such polynucleotides or polypeptides The peptide is still isolated. This is because such vectors or compositions are not part of the natural environment of such polynucleotides or polypeptides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「精製された」という表現は、１００％の純度を必要とするものではなく、どちらかといえば、相対的な定義を意味している。従来、ライブラリーから得られた各々の核酸は、電気泳動上で同質となるまで精製されている。本発明の精製された核酸は、生物のゲノムＤＮＡの残存物から少なくとも１０<sup class="style-scope patent-text">４</sup>から１０<sup class="style-scope patent-text">６</sup>倍に精製されたものである。しかしながら、「精製された」という表現は、ゲノムＤＮＡの残存物、又は、ライブラリー若しくは他の環境に存在する他の配列から、少なくとも１０<sup class="style-scope patent-text">１</sup>倍、好ましくは１０<sup class="style-scope patent-text">２</sup>倍又は１０<sup class="style-scope patent-text">３</sup>倍、さらに好ましくは１０<sup class="style-scope patent-text">４</sup>倍又は１０<sup class="style-scope patent-text">５</sup>倍に精製された核酸も含むものである。
</span>The expression “purified” does not require 100% purity, but rather implies a relative definition. Conventionally, each nucleic acid obtained from a library has been purified to be homogeneous on electrophoresis. The purified nucleic acid of the present invention has been purified at least 10 <sup class="style-scope patent-text">4</sup> to 10 <sup class="style-scope patent-text">6</sup> times from the residue of the genomic DNA of the organism. However, the term "purified", remnants of genomic DNA, or from other sequences present in the library or other environment by at least 10 <sup class="style-scope patent-text">1-fold,</sup> preferably 10 <sup class="style-scope patent-text">2-fold</sup> or <sup class="style-scope patent-text">103-fold,</sup> more preferably it is intended to include nucleic acids purified 10 <sup class="style-scope patent-text">4</sup> fold or 10 <sup class="style-scope patent-text">5</sup> fold.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「組換え」とは、核酸が細胞中で、自然環境では共存しない「バックボーン」核酸と共存していることを意味する。「組換え」とは、核酸が、自然環境では隣接しない「バックボーン」核酸に隣接していることを意味するとも定義される。「濃縮された」核酸とは、核酸バックボーン分子群中に数にして５％以上の核酸挿入物が存在することを示している。「バックボーン」分子には、発現ベクター、自己複製核酸、ウィルス、組込型核酸などの核酸、及び目的の核酸の維持又は操作に使用する他のベクター又は核酸などがある。前記濃縮核酸は、組換えバックボーン分子群中に存在する核酸挿入物の総数の１５％以上であることが好ましく、５０％以上であることがより好ましく、９０％以上であることが最も好ましい。
</span>
&nbsp;&nbsp;“Recombinant” means that the nucleic acid coexists in a cell with a “backbone” nucleic acid that does not coexist in the natural environment. “Recombinant” is also defined to mean that the nucleic acid is adjacent to a “backbone” nucleic acid that is not adjacent in the natural environment. A “concentrated” nucleic acid indicates that there are 5% or more nucleic acid inserts in the nucleic acid backbone molecule group. “Backbone” molecules include nucleic acids such as expression vectors, self-replicating nucleic acids, viruses, integrated nucleic acids, and other vectors or nucleic acids used to maintain or manipulate the nucleic acid of interest. The concentrated nucleic acid is preferably 15% or more of the total number of nucleic acid inserts present in the recombinant backbone molecule group, more preferably 50% or more, and most preferably 90% or more.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「組換え」ポリペプチド又はタンパク質とは、組換えＤＮＡ技術によって作製された、すなわち、目的のポリペプチド又はタンパク質をコードする外来ＤＮＡコンストラクトによって形質転換された細胞から作製されたポリペプチド又はタンパク質を示す。「合成」ポリペプチド又はタンパク質とは、化学合成によって調製されたポリペプチド又はタンパク質のことである。
</span>
&nbsp;&nbsp;“Recombinant” polypeptide or protein refers to a polypeptide or protein made by a recombinant DNA technique, ie, made from a cell transformed with a foreign DNA construct encoding the polypeptide or protein of interest. . A “synthetic” polypeptide or protein is a polypeptide or protein prepared by chemical synthesis.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「遺伝子」という表現は、ポリペプチド鎖の生成に関与するＤＮＡのセグメントを意味し、コード領域前後の領域（リーダー及びトレーラー）及び、該当する場合には、個々のコードセグメント（エクソン）間の介在領域（イントロン）を含んでいる。
</span>
&nbsp;&nbsp;The expression “gene” refers to a segment of DNA involved in the production of a polypeptide chain, the region before and after the coding region (leader and trailer) and, if applicable, intervening between individual coding segments (exons) Contains a region (intron).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「遺伝子座」、「遺伝子クラスター」及び「生合成遺伝子座」という表現は、式２ａのポリケチドの生合成に関与する一群の遺伝子又はその変異体について言及している。遺伝子座、遺伝子クラスター、又は生合成遺伝子座の遺伝子修飾は、当業者に知られているあらゆる遺伝子組換え技術について言及しており、式２ａの化合物の変異体を生成するために適応できる核酸の変異誘発性、不活性、又は置換を含む。遺伝子部位、遺伝子クラスター、又は生合成部位の遺伝子修飾は、当該技術分野で知られているあらゆる遺伝子組換え技術について言及しており、式Ｉの化合物の変異体を作出するために適用できる核酸の突然変異誘発、不活化、又は置換を含むものである。
</span>
&nbsp;&nbsp;The expressions “locus”, “gene cluster” and “biosynthetic locus” refer to a group of genes or variants thereof involved in the biosynthesis of the polyketide of formula 2a. Genetic modification of a locus, gene cluster, or biosynthetic locus refers to any genetic recombination technique known to those of skill in the art, and can be adapted to produce nucleic acid variants that can be adapted to generate variants of the compound of formula 2a. Includes mutagenicity, inactivity, or substitution. Genetic modification of gene sites, gene clusters, or biosynthetic sites refers to any genetic recombination technique known in the art, and can be applied to create nucleic acid variants that can be applied to create variants of compounds of formula I. Includes mutagenesis, inactivation, or substitution.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＤＮＡ若しくはヌクレオチド「コード配列」、又は特定のポリペプチド若しくはタンパク質を「コードする配列」とは、適切な制御配列の管理下に置かれた際に、ポリペプチド又はタンパク質に転写及び翻訳されるＤＮＡ配列である。
</span>
&nbsp;&nbsp;A DNA or nucleotide “coding sequence” or a “coding sequence” for a particular polypeptide or protein is a DNA sequence that is transcribed and translated into a polypeptide or protein when placed under the control of appropriate regulatory sequences. It is.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「オリゴヌクレオチド」とは、遺伝子、ｍＲＮＡ、ｃＤＮＡ又はその他目的の核酸をコードするゲノムＤＮＡ分子、ｃＤＮＡ分子、又はｍＲＮＡ分子にハイブリダイズ可能なヌクレオチドを、通常は少なくとも１０個、好ましくは１５個、より好ましくは２０個以上で、好ましくは１００個以下有している核酸について言及している。
</span>
&nbsp;&nbsp;“Oligonucleotide” means usually at least 10, preferably 15 or more nucleotides that can hybridize to a genomic DNA molecule, cDNA molecule, or mRNA molecule encoding a gene, mRNA, cDNA or other nucleic acid of interest. Reference is made to nucleic acids having preferably 20 or more, preferably 100 or less.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  プロモーター配列は、プロモーターにおいて転写を開始するＲＮＡポリメラーゼによって認識されるコード配列に「操作可能に結合され」、コード配列をｍＲＮＡへ転写する。
</span>
&nbsp;&nbsp;A promoter sequence is “operably linked” to a coding sequence recognized by RNA polymerase that initiates transcription at the promoter, and transcribes the coding sequence into mRNA.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＤＮＡの「消化」とは、ＤＮＡにおいて、一定の配列のみを作用させる制限酵素を伴うＤＮＡの酵素による切断のことをいう。ここに用いられている様々な制限酵素は市販されており、それらの反応状況、補因子、及び他の要件を、当業者に公知であるのように用いた。分析用には、通常、２０μｌの緩衝溶液において、ユニットの酵素と共に１μｇのプラスミド又はＤＮＡフラグメントを用いる。プラスミドを構成するためにＤＮＡフラグメントを単離する目的では、通常、より多い容量の２０〜２５０ユニットの酵素で５〜５０μｇのＤＮＡを消化する。特定の酵素の適切な緩衝液及び基質の量は、製造業者によって指定されている。通常は、３７℃で、１時間の培養時間を用いるが、供給業者の指示によって変わることもある。消化後に、望ましいフラグメントを単離するためにゲル電気泳動を実施してもよい。
</span>
&nbsp;&nbsp;“Digestion” of DNA refers to the enzymatic cleavage of DNA with a restriction enzyme that causes only certain sequences to act on the DNA. The various restriction enzymes used here are commercially available and their reaction status, cofactors, and other requirements were used as known to those skilled in the art. For analysis, typically 1 μg of plasmid or DNA fragment is used with 20 units of buffer solution along with the unit enzyme. For the purpose of isolating DNA fragments to construct a plasmid, typically 5-50 μg of DNA is digested with a larger volume of 20-250 units of enzyme. Appropriate buffers and substrate amounts for particular enzymes are specified by the manufacturer. Typically, a 1 hour incubation time at 37 ° C. is used, but may vary depending on the supplier's instructions. After digestion, gel electrophoresis may be performed to isolate the desired fragment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に用いられ、当業者に公知であるように、「同一性」という表現は、配列を比較することによって決定される、２つ以上のポリヌクレオチド配列の関係のことである。同一性とは、そのような配列の文字列間の一致によって決定されるポリヌクレオチド配列の配列関連性のレベルを意味している。同一性は容易に測定することができる。（例えば、Computation Molecular Biology, Lesk, A.M., eds., Oxford University Press, New York (1998), and Biocomputing: Informatics and Genome Projects, Smith, D.W., eds., Academic Press, New York (1993) 参照。両文献とも、参照することによって本明細書に組み込まれる）。２つのポリヌクレオチド配列間を測定する方法は多く存在するが、かかる用語は当業者には公知である。（例えば、Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press (1987); 及びSequence Analysis Primer, Gribskov., M. and Devereux, J., eds., M. Stockton Press, New York (1991) 参照）。配列間における同一性を決定するために一般的に用いられる方法には、例えばCarillo H. 及び Lipman, D., SIAM J. Applied Math. (1988) 48: 1073において開示されているものが含まれる。本明細書に用いられている「ほぼ同一」とは、対象となるポリヌクレオチドの配列間に、高レベルの相同性（好ましくは、１００％配列同一性）が存在することを意味する。しかしながら、９０％又は９５％より高い配列同一性を有するポリヌクレオチドを、本発明に用いるので、遺伝子変異体、株多型性、又は進化的分岐のために予想される多様な配列が含まれる。
</span>
&nbsp;&nbsp;As used herein and as known to those of skill in the art, the expression “identity” refers to the relationship between two or more polynucleotide sequences determined by comparing the sequences. By identity is meant the level of sequence relatedness of the polynucleotide sequences as determined by the match between strings of such sequences. Identity can be easily measured. (See, eg, Computation Molecular Biology, Lesk, AM, eds., Oxford University Press, New York (1998), and Biocomputing: Informatics and Genome Projects, Smith, DW, eds., Academic Press, New York (1993). The literature is also incorporated herein by reference). There are many ways to measure between two polynucleotide sequences, but such terms are known to those skilled in the art. (For example, Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press (1987); and Sequence Analysis Primer, Gribskov., M. and Devereux, J., eds., M. Stockton Press, New York (1991) reference). Commonly used methods for determining identity between sequences include, for example, those disclosed in Carillo H. and Lipman, D., SIAM J. Applied Math. (1988) 48: 1073 . As used herein, “substantially identical” means that there is a high level of homology (preferably 100% sequence identity) between the sequences of the polynucleotide of interest. However, polynucleotides having higher than 90% or 95% sequence identity are used in the present invention and thus include diverse sequences expected for genetic variants, strain polymorphisms, or evolutionary divergence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の生成のための生合成部位は、ＤＮＡの約１７６,０００の塩基対に及び、３８のタンパク質をコードする。１０キロベース以上のＤＮＡ配列を部位の各側で分析し、これらの領域が、一次代謝性遺伝子を含むことが分かった。化合物２（ａ）の生合成部位のタンパク質を示す３８オープンリーディングフレームの順序及び相対位置を図１に示す。図１に関し、化合物２（ａ）の生合成に関連する遺伝子は、隣接する２つのヌクレオチド配列（配列番号１及び１８）に含まれている。隣接するヌクレオチド配列は、化合物２（ａ）生合成部位に見られるように、コンティグ１（配列番号１）のＤＮＡの１１７４０塩基対の３’末端は、コンティグ２（配列番号１８）のＤＮＡ１６４,０５１塩基対の５’末端に隣接していることが分かった。
</span>
&nbsp;&nbsp;The biosynthetic site for the production of compound 2 (a) spans approximately 176,000 base pairs of DNA and encodes 38 proteins. DNA sequences greater than 10 kilobases were analyzed on each side of the site and these regions were found to contain primary metabolic genes. The order and relative position of the 38 open reading frames representing the protein at the biosynthetic site of compound 2 (a) are shown in FIG. Referring to FIG. 1, the gene associated with the biosynthesis of compound 2 (a) is contained in two adjacent nucleotide sequences (SEQ ID NOs: 1 and 18). The contiguous nucleotide sequence is found at the biosynthetic site of compound 2 (a), so that the 11740 <figure-callout id="3" label="base pair" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">base pair</a></figure-callout> 3 ′ end of the contig 1 (SEQ ID NO: 1) DNA is the contig 2 (SEQ ID NO: 18) DNA 164,051. It was found to be adjacent to the 5 'end of the base pair.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
   化合物２（ａ）の部位に関するヌクレオチド配列及びポリペプチド配列は、本出願と共に提出され、本出願の一部をなしている配列表に示されている。配列番号１は、８つのオープンリーディングフレーム、すなわち、配列番号３、５、７、９、１１、１３、１５、及び１７に記載されたＯＲＦ１からＯＲＦ８をそれぞれ構成するコンティグ１の１１７４０の隣接する塩基対である。ＯＲＦ１の遺伝子産物（配列番号２）は、コンティグ１の残基４１８〜２５７７（センス鎖）に由来する配列番号３の核酸配列から推定された７１９アミノ酸である。ＯＲＦ２の遺伝子産物（配列番号４）は、コンティグ１（配列番号１）の残基３００６〜３７６７（センス鎖）に由来する配列番号５の核酸配列から推定された２５３アミノ酸である。ＯＲＦ３の遺伝子産物（配列番号６）は、コンティグ１（配列番号１）の残基４０１６〜６８８６（センス鎖）に由来する配列番号７の核酸配列から推定された９５６アミノ酸である。ＯＲＦ４の遺伝子産物（配列番号８）は、コンティグ１（配列番号１）の残基７５８１〜６９７６（アンチセンス鎖）に由来する配列番号９の核酸配列から推定された２０１アミノ酸である。ＯＲＦ５の遺伝子産物（配列番号１０）は、コンティグ１（配列番号１）の残基８８４８〜７５９８（アンチセンス鎖）に由来する配列番号１１の核酸配列から推定された４１６アミノ酸である。ＯＲＦ６の遺伝子産物（配列番号１２）は、コンティグ１（配列番号１）の残基９０５３〜９６１３（センス鎖）に由来する配列番号１３の核酸配列から推定された１８６アミノ酸である。ＯＲＦ７の遺伝子産物（配列番号１４）は、コンティグ１（配列番号１）の残基９６８２〜１０１７３（センス鎖）に由来する配列番号１５の核酸配列から推定された１６３アミノ酸である。ＯＲＦ８の遺伝子産物（配列番号１６）は、コンティグ１（配列番号１）の残基１０１７０〜１１７１４（センス鎖）に由来する配列番号１７の核酸配列から推定された５１４アミノ酸である。
</span>
&nbsp;&nbsp;&nbsp;The nucleotide and polypeptide sequences for the site of compound 2 (a) are presented in the sequence listing submitted with this application and forming part of this application. SEQ ID NO: 1 comprises 8 open reading frames, ie, adjacent bases of 11740 of <figure-callout id="1" label="contig" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">contig</a></figure-callout> 1 constituting ORF1 to ORF8 described in SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, and 17, respectively. It is a pair. The gene product of ORF1 (SEQ ID NO: 2) is 719 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 3 derived from residues 418 to 2577 (sense strand) of <figure-callout id="1" label="contig" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">contig</a></figure-callout> 1. The gene product of ORF2 (SEQ ID NO: 4) is 253 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 5 derived from residues 3006 to 3767 (sense strand) of contig 1 (SEQ ID NO: 1). The gene product of ORF3 (SEQ ID NO: 6) is 956 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 7 derived from residues 4016 to 6886 (sense strand) of contig 1 (SEQ ID NO: 1). The gene product of ORF4 (SEQ ID NO: 8) is 201 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 9 derived from residues 7581-6976 (antisense strand) of contig 1 (SEQ ID NO: 1). The gene product of ORF5 (SEQ ID NO: 10) is 416 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 11 derived from residues 8848-7598 (antisense strand) of contig 1 (SEQ ID NO: 1). The gene product of ORF6 (SEQ ID NO: 12) is 186 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 13 derived from residues 9053 to 9613 (sense strand) of contig 1 (SEQ ID NO: 1). The gene product of ORF7 (SEQ ID NO: 14) is 163 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 15 derived from residues 9682 to 10173 (sense strand) of contig 1 (SEQ ID NO: 1). The gene product of ORF8 (SEQ ID NO: 16) is 514 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 17 derived from residues 10170 to 11714 (sense strand) of contig 1 (SEQ ID NO: 1).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号１８は、３０のＯＲＦによって構成されるコンティグ２の１６４,０５１の隣接する塩基対、すなわち、それぞれ、配列番号２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６及び７８に例挙されているＯＲＦ９からＯＲＦ３８である。ＯＲＦ９の遺伝子産物（配列番号１９）は、コンティグ２（配列番号１８）の残基１１０９〜６（アンチセンス鎖）に由来する配列番号２０の核酸配列から推定された３６７アミノ酸である。ＯＲＦ１０の遺伝子産物（配列番号２１）は、コンティグ２（配列番号１８）の残基１３７５〜２５８１８（センス鎖）に由来する配列番号２２の核酸配列から推定された８１４７アミノ酸である。ＯＲＦ１１の遺伝子産物（配列番号２３）は、コンティグ２（配列番号１８）の残基２５９０２〜３６１８８（センス鎖）に由来する配列番号２４の核酸配列から推定された３４２８アミノ酸である。ＯＲＦ１２の遺伝子産物（配列番号２５）は、コンティグ２（配列番号１８）の残基３６２１３〜５６４６８（センス鎖）に由来する配列番号２６の核酸配列から推定された６７５１アミノ酸である。ＯＲＦ１３の遺伝子産物（配列番号２７）は、コンティグ２（配列番号１８）の残基５６６００〜６１５７３（センス鎖）に由来する配列番号２８の核酸配列から推定された１６５７アミノ酸である。ＯＲＦ１４の遺伝子産物（配列番号２９）は、コンティグ２（配列番号１８）の残基６１８５２〜７７４７５（センス鎖）に由来する配列番号３０の核酸配列から推定された５２０７アミノ酸である。ＯＲＦ１５の遺伝子産物（配列番号３１）は、コンティグ２（配列番号１８）の残基７７６０６〜９３９０４（センス鎖）に由来する配列番号３２の核酸配列から推定された５４３２アミノ酸である。ＯＲＦ１６の遺伝子産物（配列番号３３）は、コンティグ２（配列番号１８）の残基９４０５７〜１０３７４０（センス鎖）に由来する配列番号３４の核酸配列から推定された３２２７アミノ酸である。ＯＲＦ１７の遺伝子産物（配列番号３５）は、コンティグ２（配列番号１８）の残基１０３７８９〜１２６３２１（センス鎖）に由来する配列番号３６の核酸配列から推定された７５１０アミノ酸である。ＯＲＦ１８の遺伝子産物（配列番号３７）は、コンティグ２（配列番号１８）の残基１２６３８９〜１３８００７（センス鎖）に由来する配列番号３８の核酸配列から推定された３８７２アミノ酸である。ＯＲＦ１９の遺伝子産物（配列番号３９）は、コンティグ２（配列番号１８）の残基１３９０７９〜１３８０６３（アンチセンス鎖）に由来する配列番号４０の核酸配列から推定された３３８アミノ酸である。ＯＲＦ２０の遺伝子産物（配列番号４１）は、コンティグ２（配列番号１８）の残基１４０１１７〜１３９２６６（アンチセンス鎖）に由来する配列番号４２の核酸配列から推定された２８３アミノ酸である。ＯＲＦ２１の遺伝子産物（配列番号４３）は、コンティグ２（配列番号１８）の残基１４１１０３〜１４０１１４（アンチセンス鎖）に由来する配列番号４４の核酸配列から推定された３２９アミノ酸である。ＯＲＦ２２の遺伝子産物（配列番号４５）は、コンティグ２（配列番号１８）の残基１４１４８３〜１４２４３６（センス鎖）に由来する配列番号４６の核酸配列から推定された３１７アミノ酸である。ＯＲＦ２３の遺伝子産物（配列番号４７）は、コンティグ２（配列番号１８）の残基１４２４４０〜１４３０５４（センス鎖）に由来する配列番号４８の核酸配列から推定された２０４アミノ酸である。ＯＲＦ２４の遺伝子産物（配列番号４９）は、コンティグ２（配列番号１８）の残基１４３１３３〜１４４１１９（センス鎖）に由来する配列番号５０の核酸配列から推定された３２８アミノ酸である。ＯＲＦ２５の遺伝子産物（配列番号５１）は、コンティグ２（配列番号１８）の残基１４４１１６〜１４５１０２（センス鎖）に由来する配列番号５２核酸配列から推定された３２８アミノ酸である。ＯＲＦ２６の遺伝子産物（配列番号５３）は、コンティグ２（配列番号１８）の残基１４５０９９〜１４５７４３（センス鎖）に由来する配列番号５４の核酸配列から推定された２１４アミノ酸である。ＯＲＦ２７の遺伝子産物（配列番号５５）は、コンティグ２（配列番号１８）の残基１４５８１８〜１４７２３０（センス鎖）に由来する配列番号５６の核酸配列から推定された４７０アミノ酸である。ＯＲＦ２８の遺伝子産物（配列番号５７）は、コンティグ２（配列番号１８）の残基１４８９６７〜１４７３０６（アンチセンス鎖）に由来する配列番号５８の核酸配列から推定された５５３アミノ酸である。ＯＲＦ２９の遺伝子産物（配列番号５９）は、コンティグ２（配列番号１８）の残基１４９８７１〜１４９１７６（アンチセンス鎖）に由来する配列番号６０の核酸配列から推定された２３１アミノ酸である。ＯＲＦ３０の遺伝子産物（配列番号６１）は、コンティグ２（配列番号１８）の残基１５０７８８〜１４９８６８（アンチセンス鎖）に由来する配列番号６２の核酸配列から推定された３０６アミノ酸である。ＯＲＦ３１の遺伝子産物（配列番号６３）は、コンティグ２（配列番号１８）の残基１５３７６５〜１５０７６９（アンチセンス鎖）に由来する配列番号６４の核酸配列から推定された９９８アミノ酸である。ＯＲＦ３２の遺伝子産物（配列番号６５）は、コンティグ２（配列番号１８）の残基１５４４８５〜１５６０４１（センス鎖）に由来する配列番号６６の核酸配列から推定された５１８アミノ酸である。ＯＲＦ３３の遺伝子産物（配列番号６７）は、コンティグ２（配列番号１８）の残基１５６０７５〜１５７０６４（センス鎖）に由来する配列番号６８の核酸配列から推定された３２９アミノ酸である。ＯＲＦ３４の遺伝子産物（配列番号６９）は、コンティグ２（配列番号１８）の残基１５７３０８〜１５８８７３（センス鎖）に由来する配列番号７０の核酸配列から推定された５２１アミノ酸である。ＯＲＦ３５の遺伝子産物（配列番号７１）は、コンティグ２（配列番号１８）の残基１５８９７０〜１６０２０２（センス鎖）に由来する配列番号７２の核酸配列から推定された４１０アミノ酸である。ＯＲＦ３６の遺伝子産物（配列番号７３）は、コンティグ２（配列番号１８）の残基１６０１９９〜１６１７１９（センス鎖）に由来する配列番号７４の核酸配列から推定された５０６アミノ酸である。ＯＲＦ３７の遺伝子産物（配列番号７５）は、コンティグ２（配列番号１８）の残基１６１９２４〜１６２５７７（センス鎖）に由来する配列番号７６の核酸配列から推定された２１７アミノ酸である。ＯＲＦ３８の遺伝子産物（配列番号７７）は、コンティグ２（配列番号１８）の残基１６２７２３〜１６４０５１（センス鎖）に由来する配列番号７８の核酸配列から推定された４４２アミノ酸である。
</span>
&nbsp;&nbsp;SEQ ID NO: 18 is 164,051 contiguous base pairs of <figure-callout id="2" label="Contig" filenames="2007525148-208.png,2007525148-211.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Contig</a></figure-callout> 2 composed of 30 ORFs, ie, SEQ ID NOs: 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76 and 78, ORF9 to ORF38 . The gene product of ORF9 (SEQ ID NO: 19) is 367 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 20 derived from residues 1109 to 6 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF10 (SEQ ID NO: 21) is 8147 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 22 derived from residues 1375 to 25818 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF11 (SEQ ID NO: 23) is 3428 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 24 derived from residues 25902 to 36188 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF12 (SEQ ID NO: 25) is 6751 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 26 derived from residues 36213 to 56468 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF13 (SEQ ID NO: 27) is 1657 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 28 derived from residues 56600 to 61573 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF14 (SEQ ID NO: 29) is 5207 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 30 derived from residues 61852-77475 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF15 (SEQ ID NO: 31) is 5432 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 32 derived from residues 77606 to 93904 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF16 (SEQ ID NO: 33) is 3227 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 34 derived from residues 94057 to 103740 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF17 (SEQ ID NO: 35) is 7510 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 36 derived from residues 103789-126321 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF18 (SEQ ID NO: 37) is 3872 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 38 derived from residues 126389 to 138007 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF19 (SEQ ID NO: 39) is 338 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 40 derived from residues 139079 to 138063 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF20 (SEQ ID NO: 41) is 283 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 42 derived from residues 140117 to 139266 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF21 (SEQ ID NO: 43) is 329 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 44 derived from residues 141103 to 140114 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF22 (SEQ ID NO: 45) is 317 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 46 derived from residues 141483 to 142436 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF23 (SEQ ID NO: 47) is 204 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 48 derived from residues 142440 to 143054 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF24 (SEQ ID NO: 49) is 328 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 50 derived from residues 143133 to 144119 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF25 (SEQ ID NO: 51) is 328 amino acids deduced from the SEQ ID NO: 52 nucleic acid sequence derived from residues 144116 to 145102 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF26 (SEQ ID NO: 53) is 214 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 54 derived from residues 145099 to 145743 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF27 (SEQ ID NO: 55) is 470 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 56 derived from residues 145818 to 147230 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF28 (SEQ ID NO: 57) is 553 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 58 derived from residues 148967 to 147306 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF29 (SEQ ID NO: 59) is 231 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 60 derived from residues 149871 to 149176 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF30 (SEQ ID NO: 61) is 306 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 62 derived from residues 150788 to 149868 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF31 (SEQ ID NO: 63) is 998 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 64 derived from residues 153765 to 150769 (antisense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF32 (SEQ ID NO: 65) is 518 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 66 derived from residues 1544885 to 156041 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF33 (SEQ ID NO: 67) is 329 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 68 derived from residues 156075 to 157064 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF34 (SEQ ID NO: 69) is 521 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 70 derived from residues 157308 to 158873 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF35 (SEQ ID NO: 71) is 410 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 72 derived from residues 158970-160202 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF36 (SEQ ID NO: 73) is 506 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 74 derived from residues 160199 to 161719 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF37 (SEQ ID NO: 75) is 217 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 76 derived from residues 161924-162577 (sense strand) of contig 2 (SEQ ID NO: 18). The gene product of ORF38 (SEQ ID NO: 77) is 442 amino acids deduced from the nucleic acid sequence of SEQ ID NO: 78 derived from residues 162723-164051 (sense strand) of contig 2 (SEQ ID NO: 18).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に列挙されたいくつかのオープンリーディングフレームは、標準開始コドンＡＴＧ、すなわちＯＲＦ３、５、６、９、１１、１３、２１、２２、２３、２４、２７、３４、３６及び３７（配列番号７、１１、１３、２０、２４、２８、４４、４６、４８、５０、５６、７０、７４及び７６）ではなく、非標準開始コドン（例えば、ＧＴＧ−バリン又はＣＴＧ−ロイシン）で開始する。アミノ末端位置の適切なＭ、Ｖ又はＬで全てのＯＲＦを列挙し、ＯＲＦの最初のコドンの特異性を示す。しかしながら、どんな場合にも、生合成されたタンパク質は、アミノ末端位置でメチオニン残基、より具体的には、ホルミルメチオニン残基を含み、コード遺伝子が非標準開始コドンを特定する場合であっても、細菌におけるタンパク質合成はメチオニン（ホルミルメチオニン）で開始するという公知の原則に則っていることが予測される（例えば、Stryer, Biochemistry 3<sup class="style-scope patent-text">rd</sup> edition, 1998, W. H. Freeman and Co., New York, pp. 752-754）。
</span>Some open reading frames listed herein are standard start codons ATG, <figure-callout id="3" label="ie ORFs" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="5" label="ie ORFs" filenames="2007525148-217.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="6" label="ie ORFs" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="9" label="ie ORFs" filenames="2007525148-219.png,2007525148-223.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="11" label="ie ORFs" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="13" label="ie ORFs" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="21" label="ie ORFs" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="22" label="ie ORFs" filenames="2007525148-219.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="23" label="ie ORFs" filenames="2007525148-219.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="24" label="ie ORFs" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="27" label="ie ORFs" filenames="2007525148-222.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="34" label="ie ORFs" filenames="2007525148-219.png,2007525148-221.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="36" label="ie ORFs" filenames="2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ie ORFs</a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout> 3, 5, 6, 9, 11, 13, 21, 22, 23, 24, 27, 34, 36 and 37 (sequence No. 7, 11, 13, 20, 24, 28, 44, 46, 48, 50, 56, 70, 74 and 76) and start with a non-standard start codon (eg GTG-valine or CTG-leucine) . List all ORFs with the appropriate M, V, or L at the amino terminal position to indicate the specificity of the first codon of the ORF. However, in any case, the biosynthesized protein contains a methionine residue at the amino terminal position, more specifically a formyl methionine residue, even if the coding gene specifies a non-standard start codon. , protein synthesis in bacteria is expected that in accordance with the known principle that begins with methionine (formylmethionine) <sup class="style-scope patent-text">(e.g., Stryer, Biochemistry 3 rd edition,</sup> 1998, WH Freeman and Co., New York, pp. 752-754).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  共に部位全体にまたがる５つのＤＨ１０Ｂ大腸菌沈着物は、それぞれストレプトミセス・アイズネンシス（ＮＲＲＬＢ−１１２７７）の化合物２（ａ）の部分的な生合成部位のコスミドクローンを含み、２００３年２月２５日にInternational Depository Authority of Canada, Bureau of Microbiology, Health Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2に寄託され、寄託アクセッション番号ＩＤＡＣ２５０２０３−０１、ＩＤＡＣ２５０２０３−０２、ＩＤＡＣ２５０２０３−０３、ＩＤＡＣ２５０２０３−０４及びＩＤＡＣ２５０２０３−０５がそれぞれ譲渡された。本明細書に示した配列のあらゆる記載と矛盾する場合には、寄託された株に含まれるポリヌクレオチドの配列及びそれによってコードされるポリペプチドのアミノ酸配列が調整する。
</span>
&nbsp;&nbsp;Five DH10B E. coli deposits that span the entire site each contain a cosmid clone of the partial biosynthetic site of compound 2 (a) of Streptomyces isenensis (NRRLB-11277). Depository Authority of Canada, Bureau of Microbiology, Health Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2 Were each transferred. In case of conflict with any description of the sequences presented herein, the sequence of the polynucleotide contained in the deposited strain and the amino acid sequence of the polypeptide encoded thereby are adjusted.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）を生成する［Ｃ０３］０２３株と称され、式Ｉ及び式IIの化合物を生成するために用いられるストレプトミセス・アイズネンシス（ＮＲＲＬＢ−１１２７７）の自然変異体は、２００３年８月７日に、International Depository Authority of Canada, Bureau of Microbiology, Health Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2に寄託され、寄託アクセッション番号ＩＤＡＣ０７０８０３−１を譲渡された。  
</span>
&nbsp;&nbsp;The natural variant of Streptomyces isenensis (NRRLB-11277), referred to as [C03] 023 strain that produces compound 2 (a) and used to produce compounds of formula I and formula II, was August 2003. On the 7th, it was deposited with International Depository Authority of Canada, Bureau of Microbiology, Health Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2, and deposited accession number IDAC070803-1.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）を生成する［Ｃ０３Ｕ０３］０２３株と称され、式Ｉ及び式IIの化合物を生成するために用いられるストレプトミセス・アイズネンシス（ＮＲＲＬＢ−１１２７７）の自然変異体を、２００３年１２月２３日に、International Depository Authority of Canada, Bureau of Microbiology, Helath Canada, 1015 Arlington Street， Winnipeg, Manitoba, Canada R3E 3R2に寄託し、寄託アクセッション番号ＩＤＡＣ２３１２０３−０２が譲渡された。
</span>
&nbsp;&nbsp;A natural variant of Streptomyces isenensis (NRRLB-11277), referred to as [C03U03] 023 strain that produces compound 2 (a) and used to produce compounds of Formula I and Formula II, was released in December 2003. On December 23, deposits were made at the International Depository Authority of Canada, Bureau of Microbiology, Helath Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2, and the deposit accession number IDAC231203-02 was transferred.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  コスミド及び［Ｃ０３］０２３株及び［Ｃ０３Ｕ０３］０２３株（寄託された株）の寄託を、特許手続上の微生物の寄託の国際的承認に関するブダペスト条約の条項の下に実施した。寄託された株は、特許の発行の際に、制限や条件を伴わずに、必ず公開されるであろう。寄託された株は、単に当業者に便利であるために提供されるものであり、寄託が実施可能性のために必要であることを承認するものではない。寄託された株及びそれに由来する化合物を製造し、使用し、販売するためには認可が必要であり、本明細書は、そのような許可を付与するものではない。
</span>
&nbsp;&nbsp;The deposits of cosmids and [C03] 023 and [C03U03] 023 strains (deposited strains) were carried out under the terms of the Budapest Treaty on the international recognition of the deposit of microorganisms in the patent procedure. Deposited stocks will always be published without any restrictions or conditions at the time of patent issuance. The deposited strain is provided solely for the convenience of those skilled in the art and does not acknowledge that a deposit is necessary for viability. Authorization is required to make, use, and sell the deposited strain and compounds derived therefrom, and this specification does not confer such permission.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）（化合物２（ａ）ＯＲＦ）の生合成部位のタンパク質を示す３８のオープンリーディングフレームの順序及び相対位置は、図１に概略的に図示されている。図１の一番上の線は、塩基対の尺度を示している。グレーの線は、化合物２（ａ）部位にまたがる２つのＤＮＡコンティグを表している。白の矢印は、化合物２（ａ）生合成部位の３８のオープンリーディングフレームを表している。黒の矢印は、化合物２（ａ）部位の全体にまたがる５つの寄託されたコスミドクローンを示している。
</span>
&nbsp;&nbsp;The sequence and relative position of the 38 open reading frames representing the protein at the biosynthetic site of compound 2 (a) (compound 2 (a) ORF) is schematically illustrated in FIG. The top line in FIG. 1 shows the base pair scale. The gray line represents two DNA contigs that span the Compound 2 (a) site. White arrows represent 38 open reading frames at the biosynthetic site of Compound 2 (a). The black arrows indicate five deposited cosmid clones that span the entire compound 2 (a) site.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のある態様は、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の配列の１つを含む単離、精製、濃縮された核酸、その相補配列、又は配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の配列の１つの少なくとも１００、２００、３００、４００、５００、６００、７００、８００又はそれ以上のその連続する塩基若しくはその相補配列を含むフラグメントである。単離、精製、又は濃縮された核酸には、ｃＤＮＡ、ゲノムＤＮＡ及び合成ＤＮＡを含むＤＮＡが含まれる。単鎖がコード鎖（センス）又は非コード鎖（アンチセンス）である場合は、ＤＮＡは二重鎖又は単鎖である。或いは、単離、精製又は濃縮された核酸がＲＮＡを含む場合もある。
</span>
&nbsp;&nbsp;Certain embodiments of the invention include SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44. , 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 , Its complementary sequence, or SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 at least one of 100, 200, 300, 400, 500, 600 700, 800 or more of its consecutive bases or phases thereof A fragment comprising the sequence. Isolated, purified, or enriched nucleic acid includes DNA, including cDNA, genomic DNA, and synthetic DNA. When the single strand is a coding strand (sense) or a non-coding strand (antisense), the DNA is double-stranded or single-stranded. Alternatively, the isolated, purified or concentrated nucleic acid may contain RNA.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  下記に詳述されるように、単離、精製又は濃縮された、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の１つの核酸は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つ、又は配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つの少なくとも５０、７５、１００、２００、３００、５００又はそれ以上の連続するアミノ酸を含むフラグメントを調製するために用いられる。
</span>
&nbsp;&nbsp;SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, isolated, purified or concentrated as detailed below. 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 , SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49 , 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 4 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77. At least 50, 75, 100, 200, 300 of one of the polypeptides. , Used to prepare fragments containing 500 or more contiguous amino acids.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  したがって、本発明の別の態様は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つをコードする単離、精製又は濃縮された核酸、又は配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つの少なくとも５０、７５、１００、２００、３００以上の連続するアミノ酸を含むフラグメントである。これらの核酸のコード配列は、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の核酸の１つのコード配列の１つ、又はそのフラグメントに同一であってもよく、遺伝子コードの冗長性又は縮重の結果、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つをコードする異なるコード配列、又は配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つの少なくとも５０、７５、１００、１５０、２００、３００の連続するアミノ酸を含む異なるフラグメントであってもよい。遺伝子コードは、当業者に公知であり、例えば、Stryer, Biochemistry, 3<sup class="style-scope patent-text">rd</sup> edition, W. H. Freeman &amp; Co., New Yorkから取得することが出来る。
</span>Accordingly, another aspect of the present invention provides SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, Isolation and purification encoding one of the <figure-callout id="45" label="polypeptides" filenames="2007525148-221.png,2007525148-230.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="55" label="polypeptides" filenames="2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="59" label="polypeptides" filenames="2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="63" label="polypeptides" filenames="2007525148-227.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="73" label="polypeptides" filenames="2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="75" label="polypeptides" filenames="2007525148-232.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">polypeptides</a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout> 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Or concentrated nucleic acid or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77. At least 50, 75, 100, 200, 300 of one of the polypeptides. It is a fragment containing the above continuous amino acids. The coding sequences for these nucleic acids are SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, One of the coding sequences of 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 nucleic acids, or a fragment thereof May be the same, and as a result of redundancy or degeneracy of the genetic code, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Different coding sequences encoding one or SEQ ID NOs: 2, 4, 6, 8 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, It may be a different fragment comprising at least 50, 75, 100, 150, 200, 300 contiguous amino acids of one of the 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides. Genetic code, are known to those skilled in the art, <sup class="style-scope patent-text">e.g., Stryer, Biochemistry, 3 rd edition</sup> , WH Freeman &amp; Co., may be obtained from the New York.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つをコードする単離、精製又は濃縮された核酸は、（１）配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の１つのコード配列のみ、（２）配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８のコード配列、及びリーダー配列やプロタンパク質などの追加のコード配列、及び（３）配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８のコード配列、及びコード配列の５’及び／又は３’の非コード配列などの非コード配列、を含むがこれらに限ったものではない。したがって、本明細書に用いられているように、「ポリペプチドをコードするポリヌクレオチド」なる用語は、ポリペプチドのコード配列のみを有するポリヌクレオチドだけでなく、追加のコード配列及び／又は非コード配列を有するポリヌクレオチドを包含している。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, An isolated, purified or enriched nucleic acid encoding one of the polypeptides of 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 is (1) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, only one coding sequence, (2) SEQ ID NOs: 3, 5, 7, 9, 11, 13 , 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 2, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 coding sequences, and addition of leader sequences and proproteins And (3) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 coding sequence, and 5 'and / or 3' of the coding sequence Non-coding sequences, such as, but not limited to. Thus, as used herein, the term “polynucleotide encoding a polypeptide” refers not only to a polynucleotide having only the coding sequence of a polypeptide, but also to additional coding and / or non-coding sequences. A polynucleotide having
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８に基づくポリペプチドであって、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８のポリヌクレオチドがコードするアミノ酸配列を変更しない変化等の「無変化の」ポリヌクレオチドの変化を有するポリヌクレオチドに関連している。本発明は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドのアミノ酸の置換、付加、欠失、融合及び切断の原因となるヌクレオチドの変化を有するポリヌクレオチドにも関連している。これらのヌクレオチドの変化は、部位特異的突然変異誘発、ランダムな化学的突然変異誘発、エキソヌクレアーゼIIIの欠失及び他の組換えＤＮＡ技術などの技術を用いて導入される。
</span>
&nbsp;&nbsp;The present invention relates to SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, A polypeptide based on 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, SEQ ID NOs: 3, 5, 7, 9, 11 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62 , 64, 66, 68, 70, 72, 74, 76, 78 are associated with polynucleotides having "unchanged" polynucleotide changes, such as changes that do not alter the amino acid sequence encoded by the polynucleotide. The present invention relates to SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, Causes of amino acid substitutions, additions, deletions, fusions and truncations of <figure-callout id="55" label="polypeptides" filenames="2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="59" label="polypeptides" filenames="2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="63" label="polypeptides" filenames="2007525148-227.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="73" label="polypeptides" filenames="2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="75" label="polypeptides" filenames="2007525148-232.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">polypeptides</a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout> 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Also related to polynucleotides having nucleotide changes. These nucleotide changes are introduced using techniques such as site-directed mutagenesis, random chemical mutagenesis, exonuclease III deletion and other recombinant DNA techniques.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の単離、精製又は濃縮された核酸、その相補配列、又は配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の配列の１つの連続する塩基を少なくとも１０、１５、２０、２５、３０、３５、４０、５０、７５、１００、１５０、２００、３００、４００、若しくは５００有するフラグメント又はその相補配列は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドをそれぞれコードするＤＮＡを同定し単離するプローブとして用いられる。これらの手順においては、ゲノムＤＮＡライブラリーは、サンプルの微生物又はポリケチドを生成する能力のある微生物を含むサンプルから構成される。配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つをコードするコード配列或いはコード配列のフラグメント、又はそのフラグメントを有するプローブに、その相補配列に特異的にハイブリダイズすることができる条件下でゲノムＤＮＡライブラリーを接触させる。好ましい実施態様においては、プローブは、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６又は７８の核酸に基づいて設計された、長さ約１０から約３０のオリゴヌクレオチドである。次に、プローブにハイブリダイズするゲノムのＤＮＡクローンを、検出し単離する。ＤＮＡクローンの調製及び同定する手順は、Ausubel et al., Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 及び Sambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989において開示されている。別の態様においては、プローブは、制限フラグメント、又は配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８に由来するＰＣＲ増幅された核酸である。
</span>
&nbsp;&nbsp;SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 isolated, purified or enriched nucleic acid, its complementary sequence, or SEQ ID NO: 3, 5, 7 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58 , 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 with at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, one contiguous base. Fragments with 150, 200, 300, 400, or 500 The complementary sequence is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, Used as probes for identifying and isolating DNAs encoding 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, and 77 polypeptides, respectively. It is done. In these procedures, a genomic DNA library is composed of samples containing microorganisms of the sample or microorganisms capable of producing polyketides. SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, Coding sequence encoding one of 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 or a fragment of the coding sequence, or a probe having the fragment And contacting the genomic DNA library under conditions that allow it to specifically hybridize to its complementary sequence. In a preferred embodiment, the probe is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42. 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76 or 78, designed from about 10 lengths About 30 oligonucleotides. Next, genomic DNA clones that hybridize to the probe are detected and isolated. Procedures for the preparation and identification of DNA clones are described in Ausubel et al., Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 and Sambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press , 1989. In another aspect, the probe is a restriction fragment or SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38. , 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78. .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の単離、精製又は濃縮された核酸、その相補配列、又は配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の配列の１つの少なくとも１０、１５、２０、２５、３０、３５、４０、５０、７５、１００、１５０、２００、３００、４００、又は５００のその連続する塩基を有するフラグメント、若しくはその相補配列を、関連する核酸を同定し単離するためのプローブとして用いる。ある態様においては、関連する核酸は、潜在的なポリケチド産生株のゲノムのＤＮＡ（又はｃＤＮＡ）である。これらの手順においては、関連した配列にプローブが特異的にハイブリダイズできる条件下で、潜在的なポリケチド産生株の核酸を含む核酸のサンプルをプローブと接触させる。核酸サンプルは、潜在的なポリケチド産生株のゲノムのＤＮＡ（又はｃＤＮＡ）ライブラリーである。核酸に対するプローブのハイブリダイゼーションは、上述の方法のいずれかを用いて検出される。
</span>
&nbsp;&nbsp;SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78 isolated, purified or enriched nucleic acid, its complementary sequence, or SEQ ID NO: 3, 5, 7 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58 , 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, Fragment with 300, 400 or 500 consecutive bases , Or its complementary sequence, used as a probe to identify and isolate related nucleic acids. In some embodiments, the relevant nucleic acid is the genomic DNA (or cDNA) of a potential polyketide producing strain. In these procedures, a sample of nucleic acid containing the nucleic acid of a potential polyketide producing strain is contacted with the probe under conditions that allow the probe to specifically hybridize to the relevant sequence. The nucleic acid sample is a genomic DNA (or cDNA) library of potential polyketide producing strains. Hybridization of the probe to the nucleic acid is detected using any of the methods described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ハイブリダイゼーションは、低ストリンジェンシー、中程度のストリンジェンシー又は高ストリンジェンシーの条件下で実施される。核酸のハイブリダイゼーションの例として、固定化変性核酸を含むポリマー膜を、先ず、０．９ＭのＮａＣｌ、５０ｍＭのＮａＨ<sub class="style-scope patent-text">２</sub>ＰＯ<sub class="style-scope patent-text">４</sub>、ｐＨ７.０、５.０ｍＭのＮａ<sub class="style-scope patent-text">２</sub>ＥＤＴＡ、０.５％ＳＤＳ、１０×デンハート（Denhardt）試薬、及び０．５ｍｇ／ｍｌポリリボアデニル（polyriboadenylic）酸からなる溶液中、３０分間、４５℃で、プリハイブリダイズする。次に、約２×１０<sup class="style-scope patent-text">７</sup>ｃｐｍ（特異活性４〜９×１０<sup class="style-scope patent-text">８</sup>ｃｐｍ／ｕｇ）の<sup class="style-scope patent-text">３２</sup>Ｐ末端標識オリゴヌクレオチドプローブを、溶液に添加する。培養の１２〜１６時間後、膜は０．５％のＳＤＳを含む１×ＳＥＴ（１５０ｍＭのＮａＣｌ、２０ｍＭのトリス塩酸塩、ｐＨ７．８、１ｍＭのＮａ<sub class="style-scope patent-text">２</sub>ＥＤＴＡ）で、３０分間室温で洗浄し、続いて、新鮮な１×ＳＥＴを融解温度（Ｔｍ）−１０℃で、Ｔｍが融解温度であるオリゴヌクレオチドプローブについて３０分間洗浄する。次に、ハイブリダイゼーションシグナルを検出するために、膜をオートラジオグラフのフィルムに露光する。
</span>Hybridization is performed under conditions of low stringency, moderate stringency or high stringency. As an example of nucleic acid hybridization, a polymer membrane containing immobilized denatured nucleic acid is first prepared with 0.9 M NaCl, 50 mM NaH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> , pH 7.0, 5.0 mM Na <sub class="style-scope patent-text">2</sub> EDTA, 0.5% SDS. Prehybridize in a solution of 10 × Denhardt reagent and 0.5 mg / ml polyriboadenylic acid at 45 ° C. for 30 minutes. Next, <sup class="style-scope patent-text">32 P-end-labeled</sup> oligonucleotide probes of about 2 × <sup class="style-scope patent-text">10</sup> 7 cpm (specific activity <sup class="style-scope patent-text">4~9 × 10 8 cpm / ug)</sup> , it is added to the solution. After 12-16 hours of culture, the membrane was washed with 1 × SET (150 mM NaCl, 20 mM Tris hydrochloride, pH 7.8, 1 mM Na <sub class="style-scope patent-text">2</sub> EDTA) containing 0.5% SDS for 30 minutes at room temperature. Subsequently, the fresh 1 × SET is washed at the melting temperature (Tm) −10 ° C. for 30 minutes for the oligonucleotide probe where Tm is the melting temperature. The membrane is then exposed to autoradiographic film in order to detect the hybridization signal.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  検出可能なプローブにハイブリダイズするゲノムＤＮＡ又はｃＤＮＡなどの核酸を同定するために用いられるハイブリダイゼーション条件のストリンジェンシーを変化させることによって、プローブに対して異なるレベルの相同性を有する核酸を、同定し単離することができる。プローブの融解温度より低温の様々な温度でハイブリダイゼーションを実施するこによって、ストリンジェンシーが変化する。プローブの融解温度は、以下の式を用いて計算することができる。
</span>
&nbsp;&nbsp;Nucleic acids with different levels of homology to the probe are identified by changing the stringency of the hybridization conditions used to identify nucleic acids such as genomic DNA or cDNA that hybridize to the detectable probe. It can be isolated. By performing the hybridization at various temperatures below the melting temperature of the probe, the stringency is changed. The melting temperature of the probe can be calculated using the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  長さ１４から７０ヌクレオチドのオリゴヌクレオチドプローブに関して、融解温度（Ｔｍ）（摂氏）は、式：Ｔｍ＝８１．５＋１６．６（ｌｏｇ［Ｎａ＋］）＋０．４１（フラクションＧ＋Ｃ）−（６００／Ｎ）を用いて計算することができる。ここで、Ｎはオリゴヌクレオチドの長さである。
</span>
&nbsp;&nbsp;For oligonucleotide probes 14 to 70 nucleotides in length, the melting temperature (Tm) (Celsius) is given by the formula: Tm = 81.5 + 16.6 (log [Na +]) + 0.41 (fraction G + C) − (600 / N) Can be used to calculate. Here, N is the length of the oligonucleotide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ハイブリダイゼーションがホルムアミドを含む溶液で実施される場合は、融解温度は、等式：融解温度＝８１．５＋１６．６（ｌｏｇ  ［Ｎａ＋］）＋０．４１（フラクションＧ＋Ｃ）−（０．６３％ホルムアミド）−６００／Ｎ）を用いて計算することができる。ここでＮはプローブの長さである。
</span>
&nbsp;&nbsp;When hybridization is performed in a solution containing formamide, the melting temperature is the equation: Melting temperature = 81.5 + 16.6 (log [Na +]) + 0.41 (fraction G + C) − (0.63% formamide) -600 / N). Here, N is the length of the probe.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  プレハイブリダイゼーションは、６×ＳＳＣ、５×デンハート試薬、０．５％ＳＤＳ、０．１ｍｇ／ｍｌの変性し断片化したサケの精子ＤＮＡ又は６×ＳＳＣ、５×デンハート試薬、０．５％ＳＤＳ、０．１ｍｇ／ｍｌの変性し断片化したサケの精子ＤＮＡ、５０％ホルムアミドで実施される。ＳＳＣの組成物及びデンハートの溶液は上記Sambrook et al.に列挙されている。
</span>
&nbsp;&nbsp;Prehybridization consists of 6 × SSC, 5 × Denhart reagent, 0.5% SDS, 0.1 mg / ml denatured and fragmented salmon sperm DNA or 6 × SSC, 5 × Denhart reagent, 0.5% SDS , 0.1 mg / ml denatured and fragmented salmon sperm DNA, 50% formamide. SSC compositions and Denhardt's solutions are listed in Sambrook et al., Supra.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ハイブリダイゼーションは、上記に列挙されているハイブリダイゼーション溶液に対して検出可能なプローブを付加することによって実施される。プローブが二重鎖ＤＮＡを構成する箇所は、高温で培養し、ハイブリダイゼーション溶液に添加する前に素早く冷却することによって変性される。二次構造の形成又はオリゴマ形成を排除又は減少させるたに、単鎖プローブについても、同じように変性させるのが望ましい。相補的又は相同的な配列を含むｃＤＮＡ又はゲノムのＤＮＡをプローブがハイブリダイズできるように、十分な期間、フィルターをハイブリダイゼーション溶液と接触させる。長さが２００より長いヌクレオチドを有するプローブに関しては、融解温度より、１５〜２５℃低温でハイブリダイゼーションを実施する。オリゴヌクレオチドプローブなどの、より短いプローブについては、融解温度より５〜１０℃低い温度でハイブリダイゼーションを実施する。好ましくは、より短いプローブではハイブリダイゼーションは、６×ＳＳＣで実施される。好ましくは、より長いプローブ用の溶液を含む５０％のホルムアミドにおいてハイブリダイゼーションを実施する。前記のハイブリダイゼーションは全て、高ストリンジェンシー条件下で実施されるハイブリダイゼーションの例として考えられる。
</span>
&nbsp;&nbsp;Hybridization is performed by adding a detectable probe to the hybridization solution listed above. The site where the probe constitutes double-stranded DNA is denatured by culturing at high temperature and quickly cooling before adding to the hybridization solution. In order to eliminate or reduce the formation of secondary structures or oligomers, it is desirable to denature single-stranded probes as well. The filter is contacted with the hybridization solution for a sufficient period of time so that the probe can hybridize to cDNA or genomic DNA containing complementary or homologous sequences. For probes having nucleotides longer than 200, hybridization is performed at 15-25 ° C. below the melting temperature. For shorter probes, such as oligonucleotide probes, hybridization is performed at a temperature 5-10 ° C. below the melting temperature. Preferably, for shorter probes, hybridization is performed at 6 × SSC. Preferably, hybridization is performed in 50% formamide containing a solution for longer probes. All of the above hybridizations are considered examples of hybridization performed under high stringency conditions.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ハイブリダイゼーションに続いて、少なくとも１５分間、２×ＳＳＣ、０．１％ＳＤＳで、望ましいストリンジェンシーで室温又はそれより高い温度で、フィルターを洗浄する。次に、３０分間から１時間、室温で（再度）０．１×ＳＳＣ、０．５％ＳＤＳでフィルターを洗浄する。プローブにハイブリダイズした核酸を、従来のオートラジオグラフィー及び非放射性の検出方法で同定する。
</span>
&nbsp;&nbsp;Following hybridization, the filter is washed for at least 15 minutes with 2 × SSC, 0.1% SDS at room temperature or higher at the desired stringency. The filter is then washed with 0.1 × SSC, 0.5% SDS (again) at room temperature for 30 minutes to 1 hour. Nucleic acids hybridized to the probe are identified by conventional autoradiography and non-radioactive detection methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  プローブ配列に対する相同性レベルが減少した核酸を同定するために、上記の手順を改良してもよい。例えば、検出可能なプローブに対する相同性が減少する核酸を得るために、よりストリンジェンシーの低い条件を用いる。例えば、約１ＭのＮａ＋濃度を有するハイブリダイゼーション緩衝液において、ハイブリダイゼーションの温度を６８℃から４２℃まで５℃ずつ低下させる。ハイブリダイゼーションに続いて、ハイブリダイゼーション温度で、２×ＳＳＣ、０．５％ＳＤＳでフィルターを洗浄する。これらの条件は、５０℃より高温の「中程度のストリンジェンシー」及び５０℃より低温の「低ストリンジェンシー」条件と考えられる。「中程度のストリンジェンシー」ハイブリダイゼーション条件の具体例は、上記のハイブリダイゼーションが５５℃で実施される場合である。「低ストリンジェンシー」のハイブリダイゼーション条件の具体例は、上記のハイブリダイズが４５℃で実施される場合である。
</span>
&nbsp;&nbsp;The above procedure may be modified to identify nucleic acids with reduced levels of homology to the probe sequence. For example, lower stringency conditions are used to obtain nucleic acids with reduced homology to detectable probes. For example, in a hybridization buffer having a Na + concentration of about 1M, the hybridization temperature is decreased by 5 ° C. from 68 ° C. to 42 ° C. Following hybridization, the filter is washed with 2 × SSC, 0.5% SDS at the hybridization temperature. These conditions are considered “moderate stringency” above 50 ° C. and “low stringency” conditions below 50 ° C. A specific example of “moderate stringency” hybridization conditions is when the above hybridization is performed at 55 ° C. A specific example of “low stringency” hybridization conditions is when the above hybridization is carried out at 45 ° C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  あるいは、４２℃の温度でホルミアミドを含む６×ＳＳＣのような緩衝液においてハイブリダイゼーションを実施する。この場合、プローブに対する相同性のレベルが減少したクローンを同定するために、ハイブリダイゼーション緩衝液におけるホルミアミドの濃度を、５０％から０％まで５％ずつ減少させる。ハイブリダイゼーションに続いて、６×ＳＳＣ、０．５％ＳＤＳで、５０℃で、フィルターを洗浄する。これらの条件は、２５％以上のホルムアミドである「中程度のストリンジェンシー」条件、及び２５％以下のホルムアミドである「低ストリンジェンシー」条件であると考えられる。「中程度のストリンジェンシー」のハイブリダイゼーション条件の具体例は、上記のハイブリダイゼーションが３０％ホルムアミドで実施される場合である。「低ストリンジェンシー」のハイブリダイズ条件の具体例は、上記のハイブリダイゼーションが、１０％ホルムアミドで実施される場合である。プローブにハイブリダイゼーションした核酸を、従来のオートラジオグラフィー及び非放射性の検出方法によって同定する。
</span>
&nbsp;&nbsp;Alternatively, hybridization is performed in a buffer such as 6 × SSC containing formamide at a temperature of 42 ° C. In this case, to identify clones with reduced levels of homology to the probe, the concentration of formamide in the hybridization buffer is decreased by 5% from 50% to 0%. Following hybridization, the filter is washed with 6 × SSC, 0.5% SDS at 50 ° C. These conditions are considered to be “moderate stringency” conditions with 25% or more formamide and “low stringency” conditions with 25% or less formamide. A specific example of “moderate stringency” hybridization conditions is when the above hybridization is carried out with 30% formamide. A specific example of “low stringency” hybridization conditions is when the above hybridization is carried out with 10% formamide. Nucleic acids hybridized to the probe are identified by conventional autoradiography and non-radioactive detection methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  先の方法は、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の配列からなる群から選択される核酸配列に、少なくとも９７％、少なくとも９５％、少なくとも９０％、少なくとも８５％、少なくとも８０％、又は少なくとも７０％の配列同一性を有する核酸、少なくとも１０、１５、２０、２５、３０、３５、４０、５０、７５、１００、１５０、２００、３００、４００、又は５００のその連続する塩基によって構成されるフラグメント、及びその相補配列を単離するために用いられる。単離された核酸は、本明細書に記載されているコード配列の、自然発生する１つの対立遺伝子の変異体であるコード配列を有する。これらの対立遺伝子の変異体は、配列番号３、５、７、９、１１、１３、１５、１７、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６４、６６、６８、７０、７２、７４、７６、７８の核酸、又はその相補配列と比較して、１又は２以上のヌクレオチドの置換、欠失又は付加を有する。
</span>
&nbsp;&nbsp;The previous method is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, at least 97%, at least 97% of the nucleic acid sequence selected from the group consisting of Nucleic acids having 95%, at least 90%, at least 85%, at least 80%, or at least 70% sequence identity, at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, Used to isolate 200, 300, 400, or 500 fragments composed of its contiguous bases, and their complementary sequences. An isolated nucleic acid has a coding sequence that is a naturally occurring allelic variant of the coding sequence described herein. These allelic variants are SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42. , 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, or a complementary sequence thereof, or 1 or Has two or more nucleotide substitutions, deletions or additions.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、上記の手順を使用して、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７の１つの配列を有するポリペプチドに、少なくとも９９％、少なくとも９５％、少なくとも９０％、少なくとも８５％、少なくとも８０％、又は少なくとも７０％の同一性を有するポリペプチドをコードする核酸、又はデフォルトパラメーターを用いたＢＬＡＳＴＰ版２．２．２アルゴリズムを使用して測定される、少なくとも５０、７５、１００、１５０、２００、３００の連続するアミノ酸によって構成されるそのフラグメントを単離する。
</span>
&nbsp;&nbsp;Furthermore, using the above procedure, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, at least 99% of the polypeptide A nucleic acid encoding a polypeptide having at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% identity, or using the BLASTP version 2.2.2 algorithm with default parameters Isolating a fragment thereof composed of at least 50, 75, 100, 150, 200, 300 consecutive amino acids, as determined by
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７の１つの配列を含む単離或いは精製されたポリペプチド、又は少なくとも５０、７５、１００、１５０、２００、３００の連続するそのアミノ酸を含むフラグメントである。本明細書に記載されているように、これらのポリペプチドは、適切な宿主でコードされたポリペプチドを発現させることができる配列にコード配列が操作可能に結合するように、ポリペプチドをコードする核酸をベクターに挿入することによって得られる。例えば、発現ベクターは、プロモーター、翻訳開始のためのリボソーム結合部位及び転写ターミネーターを含んでいる。ベクターはまた、発現レベル、複製起点及び選択的マーカーを調節するための適切な配列を含んでいる。
</span>
&nbsp;&nbsp;Another aspect of the present invention is SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, An isolated or purified polypeptide comprising one sequence of 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77; Or a fragment comprising at least 50, 75, 100, 150, 200, 300 consecutive amino acids thereof. As described herein, these polypeptides encode polypeptides such that the coding sequence is operably linked to a sequence capable of expressing the encoded polypeptide in a suitable host. It is obtained by inserting a nucleic acid into a vector. For example, expression vectors include a promoter, a ribosome binding site for translation initiation, and a transcription terminator. The vector also includes appropriate sequences for controlling expression levels, origins of replication and selective markers.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  細菌内のポリペプチド又はフラグメントを発現するのに適したプロモーターには、大腸菌のｌａｃプロモーター又はｔｒｐプロモーター、ｌａｃｌプロモーター、ｌａｃＺプロモーター、Ｔ３プロモーター、Ｔ７プロモーター、ｇｐｔプロモーター、ラムダＰ<sub class="style-scope patent-text">Ｒ</sub>プロモーター、ラムダＰ<sub class="style-scope patent-text">Ｌ</sub>プロモーター、３−ホスホグリセリン酸キナーゼ（ＰＧＫ）などの解糖酵素をコードするオペロンのプロモーター、及び酸性ホスフォターゼプロモーターが含まれる。真菌のプロモーターには、α因子プロモーターが含まれる。真核生物のプロモーターには、ＣＭＶ即時性初期プロモーター、ＨＳＶチミジンキナーゼプロモーター、熱ショックプロモーター、初期及び後期ＳＶ４０プロモーター、レトロウィルスのＬＴＲ及びマウスのメタロチオネイン−Ｉプロモーターが含まれる。原核細胞若しくは真核細胞又はそれらのウィルスにおいて、遺伝子発現を制御することが知られている他のプロモーターも用いられる。
</span>Promoters suitable for expressing the polypeptide or fragment of bacterial, lac promoter or trp promoter of E. coli, lacl promoter, lacZ promoter, T3 promoter, T7 promoter, gpt promoter, the lambda <sub class="style-scope patent-text">P R</sub> promoter, the lambda <sub class="style-scope patent-text">P L</sub> promoter , An operon promoter encoding a glycolytic enzyme such as 3-phosphoglycerate kinase (PGK), and an acid phosphatase promoter. Fungal promoters include the alpha factor promoter. Eukaryotic promoters include CMV immediate early promoter, HSV thymidine kinase promoter, heat shock promoter, early and late SV40 promoter, retroviral LTR and mouse metallothionein-I promoter. Other promoters known to control gene expression in prokaryotic or eukaryotic cells or their viruses are also used.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  哺乳類発現ベクターはまた、複製の起源、必要なリボソーム結合部位、ポリアデニル化部位、スプライスドナー部位及び受容部位、転写末端配列及び５’フランキング非転写配列を含む。ある態様においては、ＳＶ４０スプライス及びポリアデニル化部位に由来するＤＮＡ配列を用いて、必要とされる非転写遺伝子要素を提供する。
</span>
&nbsp;&nbsp;Mammalian expression vectors also contain the origin of replication, the necessary ribosome binding sites, polyadenylation sites, splice donor and acceptor sites, transcription termination sequences and 5 'flanking non-transcribed sequences. In some embodiments, DNA sequences derived from SV40 splices and polyadenylation sites are used to provide the required non-transcribed genetic elements.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  真核細胞においてポリペプチド又はフラグメントを発現するベクターは、発現レベルを向上させるための転写促進因子を含んでいてもよい。転写促進因子は、ＤＮＡのシス作用性の要素であり、通常は、転写を増加させるプロモーターに作用する約１０から約３００ｂｐの長さである。例には、転写起源ｂｐ１００から２７０までの後期部位に対するＳＶ４０転写促進因子、サイトメガウィルス初期プロモーター転写促進因子、起源転写の後期部位に対するポリオーマ転写促進因子、及びアデノウィルス転写促進因子が含まれる。
</span>
&nbsp;&nbsp;A vector that expresses a polypeptide or fragment in a eukaryotic cell may contain a transcription promoting factor for improving the expression level. Transcription facilitators are cis-acting elements of DNA, usually about 10 to about 300 bp in length that act on promoters that increase transcription. Examples include the SV40 transcription promoter for the late site of <figure-callout id="100" label="transcription origin bp" filenames="2007525148-224.png,2007525148-225.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">transcription origin bp</a></figure-callout> 100 to 270, the cytomegavirus early promoter transcription promoter, the polyoma transcription promoter for the late site of origin transcription, and the adenovirus transcription promoter.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、好ましくは、発現ベクターが、ベクターを有する宿主細胞の選択を可能にする１又は２以上の選択可能なマーカー遺伝子を含む。使用される選択可能なマーカーの例には、ヒドロ葉酸還元酵素をコードする遺伝子、真核生物細胞培養物に対するネオマイシン耐性を与える遺伝子、又は大腸菌及び酵母遺伝子ＴＲＰ１にトラサイクリン若しくはアンピシリン耐性を与える遺伝子が含まれる。
</span>
&nbsp;&nbsp;Furthermore, preferably the expression vector comprises one or more selectable marker genes that allow selection of host cells carrying the vector. Examples of selectable markers used include genes encoding hydrofolate reductase, genes conferring neomycin resistance to eukaryotic cell cultures, or genes conferring tracyclin or ampicillin resistance to the E. coli and yeast genes TRP1. included.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある態様においては、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つをコードする核酸、又は少なくとも５０、７５、１００、１５０、２００又は３００の連続するアミノ酸を含むそのフラグメントは、翻訳ポリペプチド又はそのフラグメントの分泌を誘導することのできるリーダー配列によって、適切な段階で構築される。状況に応じて、核酸は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つ、又は少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０の連続するアミノ酸を含むフラグメントが、安定性が増加した又は精製若しくは検出が単純化した等の望ましい性質を伝達する、Ｎ末端同定ペプチドなどの異種性ペプチド又はポリペプチドに融合するような融合ポリペプチドをコードすることができる。
</span>
&nbsp;&nbsp;In some embodiments, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45 , 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, a nucleic acid encoding one of the polypeptides, or at least 50, 75, 100 The fragments comprising 150, 200 or 300 contiguous amino acids are constructed at the appropriate stage by a leader sequence capable of inducing secretion of the translated polypeptide or fragment thereof. Depending on the situation, the nucleic acid is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, or at least 5, 10, 15, N-terminal identification where fragments containing 20, 25, 30, 35, 40, 50, 75, 100 or 150 contiguous amino acids convey desirable properties such as increased stability or simplified purification or detection A fusion polypeptide can be encoded such that it is fused to a heterologous peptide or polypeptide, such as a peptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  適切なＤＮＡ配列は、様々な手順によってベクターに挿入される。一般的に、              <br class="style-scope patent-text">
適切な制限エンドヌクレアーゼを有するベクターと挿入断片の消化に続き、ＤＮＡ配列をベクターの望ましい位置に結合する。或いは、適切な制限酵素部位は、ＰＣＲによってＤＮＡ配列に組み込むことができる。様々なクローニング技術が、Ausbel et al. Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997及びSambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbour Laboratory Press, 1989に開示されている。これらの手順及び他の手順は、当業者の技術の範囲内と考えらる。
</span>The appropriate DNA sequence is inserted into the vector by a variety of procedures. Typically, <br class="style-scope patent-text"> Following digestion of the vector and insert with the appropriate restriction endonuclease, the DNA sequence is ligated to the desired location in the vector. Alternatively, suitable restriction enzyme sites can be incorporated into the DNA sequence by PCR. Various cloning techniques are disclosed in Ausbel et al. Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 and Sambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989. ing. These and other procedures are considered within the skill of the artisan.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ベクターは、例えば、プラスミド、ウィルス粒子、又はファージの形態である。<br class="style-scope patent-text">
他のベクターには、染色体、非染色体、及び合成ＤＮＡ配列、ウィルス、細菌プラスミド、ファージＤＮＡ、バキュロウィルス、酵母プラスミド、プラスミドとファージＤＮＡとの組合せに由来するベクター、ワクチン、アデノウィルス、家禽ジフテリアウイルス及び仮性狂犬病などのウィルス性ＤＮＡが含まれる。原核宿主及び真核宿主に用いられる様々なクローニング及び発現ベクターは、Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, N. Y., (1989) に記載されている。
</span>The vector is, for example, in the form of a plasmid, viral particle or phage. <br class="style-scope patent-text"> Other vectors include chromosomal, non-chromosomal and synthetic DNA sequences, viruses, bacterial plasmids, phage DNA, baculovirus, yeast plasmids, vectors derived from combinations of plasmids and phage DNA, vaccines, adenoviruses, poultry diphtheria viruses and Viral DNA such as pseudorabies is included. Various cloning and expression vectors used for prokaryotic and eukaryotic hosts are described in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, NY, (1989).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  用いられる特定の細菌ベクターには、公知のクローニングベクターｐＢＲ３２２（ＡＴＣＣ３７０１７）、ｐＫＫ２２３−３（Pharmacia Fine Chemicals, Uppsala, Sweden）、ｐＧＥＭ１ (Promega Biotec, Madison, WI, USA)、ｐＱＥ７０、ｐＱＥ６０、ｐＱＥ−９（Qiagen）、ｐＤ１０、ｐｈｉＸ１７４、ｐＢｌｕｅｓｃｒｉｐｔ<sup class="style-scope patent-text">ＴＭ</sup>ＩＩＫＳ、ｐＮＨ８Ａ、ｐＮＨ１６ａ、ｐＮＨ１８Ａ、ｐＮＨ４６Ａ(Stratagene)、ｐｔｒｃ９９ａ、ｐＫＫ２２３−３、ｐＫＫ２３３−３、ｐＤＲ５４０、ｐＲＩＴ５(Pharmacia)、ｐＫＫ２３２−８及びｐＣＭ７の、遺伝子要素を有する市販のプラスミドが含まれる。特定の真核生物ベクターには、ｐＳＶ２ＣＡＴ、ｐＯＧ４４、ｐＸＴ１、ｐＳＧ(Stratagene)、ｐＳＶＫ３、ｐＢＰＶ、ｐＭＳＧ、及びｐＳＶＬ(Pharmacia)が含まれる。しかしながら、宿主細胞において複製可能且つ安定してさえいれば、他のあらゆるベクターも用いることができる。
</span>Specific bacterial vectors used include the known cloning vectors pBR322 (ATCC37017), pKK223-3 (Pharmacia Fine Chemicals, Uppsala, Sweden), pGEM1 (Promega Biotec, Madison, Wis., USA), pQE70, pQE60, pQE-9. (Qiagen), pD10, phiX174, pBluescript <sup class="style-scope patent-text">™</sup> IIKS, pNH8A, pNH16a, pNH18A, pNH46A (Stratagene), ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 (Pharmacia), pK232 Commercially available plasmids are included. Specific eukaryotic vectors include pSV2CAT, pOG44, pXT1, pSG (Stratagene), pSVK3, pBPV, pMSG, and pSVL (Pharmacia). However, any other vector can be used as long as it is replicable and stable in the host cell.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  宿主細胞は、当業者に公知であればどのような宿主細胞でもよく、原核細胞又は真核細胞が含まれる。適切な宿主の代表例としては、大腸菌、ストレプトミセス・リビダンス、ストレプトミセス・グリセオフスクス、ストレプトミセス・アンボファシエンス、バチルス菌（Bacillus subtilis）、ネズミチフス菌（Salmonella typhimurium）及びシュードモナ（Pseudomonas）属、ストレプトミセス属、バチルス属及びブドウ球菌の様々な種等の細菌細胞、イースト菌等の真菌細胞、ショウジョウバエＳ２（Drosophila S2）及びスポドプテラＳｆ９（Spodoptera Sf9）等の昆虫細胞、ＣＨＯ、ＣＯＳ又はＢｏｗｅｓメラノーマ、及びアデノウィルス等の動物細胞が挙げられる。適切な宿主を選択することは、当業者の能力の範囲である。
</span>
&nbsp;&nbsp;The host cell may be any host cell known to those skilled in the art, including prokaryotic cells or eukaryotic cells. Representative examples of suitable hosts include Escherichia coli, Streptomyces lividans, Streptomyces griseooffus, Streptomyces ambofaciens, Bacillus subtilis, Salmonella typhimurium and Pseudomonas genus, Streptomyces. Bacterial cells such as various species of genus, Bacillus and staphylococci, fungal cells such as yeast, insect cells such as Drosophila S2 and Spodoptera Sf9, CHO, COS or Bowes melanoma, adenovirus, etc. Animal cells. Selecting an appropriate host is within the ability of one skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
エレクトロポレーション、形質転換、形質移入、形質導入、ウィルス感染、遺伝子銃、又はチタンを媒介とした遺伝子導入を含む様々な技術を用いて、ベクターを宿主細胞に導入する。適切であれば、プロモーターを活性化させる、形質転換体を選択する、又は本発明の遺伝子を増幅するのに適するように改良された従来の栄養培地で、操作された宿主細胞を培養することができる。適切な宿主株の形質転換、及び宿主株が適当な細胞密度になった後、適当な手段（例えば、温度調節又は化学作用による誘発）によって選択したプロモーターを誘発し、所望のポリペプチド又はそのフラグメントを生成できるように、かかる細胞を更なる期間培養する。
</span>
The vector is introduced into the host cell using a variety of techniques including electroporation, transformation, transfection, transduction, viral infection, gene gun, or titanium-mediated gene transfer. If appropriate, the engineered host cells can be cultured in conventional nutrient media modified to be suitable for activating promoters, selecting transformants, or amplifying the genes of the invention. it can. After transformation of the appropriate host strain, and after the host strain is at the appropriate cell density, the selected promoter is induced by appropriate means (eg, temperature regulation or chemical induction) to produce the desired polypeptide or fragment thereof Such cells are cultured for an additional period of time so that can be produced.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  遠心分離によって細胞を収集し、物理的又は化学手段で破壊し、その結果生じた未精製抽出物を、更に精製するために保持する。タンパク質発現のために使用される微生物細胞を、凍結融解サイクリング、超音波処理、機械的破壊、又は細胞溶解剤の使用等の、あらゆる便利な方法で破壊することができる。これらの方法は、当業者に公知である。硫安塩析又はエタノール沈澱、酸抽出、陽イオン又は陰イオン交換クロマトグラフィー、ホスホセルロースクロマトグラフィー、疎水的相互作用クロマトグラフィー、アフィニティークロマトグラフィー、ヒドロキシルアパタイトクロマトグラフィー及びレクチンクロマトグラフィーを含む方法によって、発現ポリペプチド又はそのフラグメントを組換え細胞培養物から回復させ精製することができる。必要であれば、ポリペプチドの配置を完成させるために、タンパク質リフォールディングステップを用いることができる。望ましい場合は、高速液体クロマトグラフィー（ＨＰＬＣ）を、精製の最終ステップで使用する。
</span>
&nbsp;&nbsp;Cells are collected by centrifugation, disrupted by physical or chemical means, and the resulting crude extract is retained for further purification. Microbial cells used for protein expression can be destroyed by any convenient method, such as freeze-thaw cycling, sonication, mechanical disruption, or the use of cytolytic agents. These methods are known to those skilled in the art. Expression of poly (ethylene sulfate) by methods including ammonium sulfate precipitation or ethanol precipitation, acid extraction, cation or anion exchange chromatography, phosphocellulose chromatography, hydrophobic interaction chromatography, affinity chromatography, hydroxylapatite chromatography and lectin chromatography. The peptide or fragment thereof can be recovered and purified from the recombinant cell culture. If necessary, a protein refolding step can be used to complete the polypeptide arrangement. If desired, high performance liquid chromatography (HPLC) is used in the final step of purification.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  様々な哺乳類細胞培養システムを使用して、組換えタンパク質を発現することもできる。哺乳類の発現システムの例には、サル腎臓線維芽細胞のＣＯＳ−７株（Gluzman Cell，23:175 (1981) によって記載）、及びＣ１２７、３Ｔ３、ＣＨＯ、ヒーラー及びＢＨＫ細胞株等の互換ベクター(compatible vector)のタンパク質を発現する能力を有する他の細胞株が含まれる。宿主細胞における作成物を、組換え配列がコードする遺伝子産物を生成するための従来の方法で用いる。本発明のポリペプチドは、開始メチオニンのアミノ酸残基も含んでいてもよいし、含んでいなくてもよい。
</span>
&nbsp;&nbsp;Various mammalian cell culture systems can also be used to express recombinant protein. Examples of mammalian expression systems include monkey kidney fibroblast COS-7 strain (described by Gluzman Cell, 23: 175 (1981)), and compatible vectors such as C127, 3T3, CHO, Healer and BHK cell lines ( Other cell lines capable of expressing compatible vector proteins are included. The construct in the host cell is used in a conventional manner to produce the gene product encoded by the recombinant sequence. The polypeptide of the present invention may or may not contain the amino acid residue of the starting methionine.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチド、又は少なくとも５０、７５、１００、２００又は３００の連続するアミノ酸を含むフラグメントは、従来のポリペプチドシンセサイザーによる合成で生成される。別の態様においては、ポリヌクレオチドのフラグメント又は部分を使用して、ペプチド合成によって、対応する全長のポリペプチドを生成する。したがって、かかるフラグメントは、全長のポリペプチドを生成するための中間体として使用される。
</span>
&nbsp;&nbsp;Also, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, Contains 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides, or at least 50, 75, 100, 200 or 300 consecutive amino acids Fragments are produced by synthesis with conventional polypeptide synthesizers. In another embodiment, a fragment or portion of a polynucleotide is used to produce the corresponding full length polypeptide by peptide synthesis. Such fragments are therefore used as intermediates to produce full-length polypeptides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  細胞を含まない翻訳システムを使用し、ポリペプチド又はそのフラグメントをコードする核酸に操作可能に結合するプロモーターを含むＤＮＡ作成物から転写されたｍＲＮＡを用いて、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つ、又は、少なくとも５０、７５、１００、１５０、２００又は３００の連続するアミノ酸を含むフラグメントを生成することができる。ある態様においては、インビトロで転写反応を行う前に、ＤＮＡ作成物を直線化する。所望のポリペプチド又はそのフラグメントを生成するために、ウサギ網状赤血球抽出物等の細胞を含まない適当な翻訳抽出物(translation extract)と共に、転写したｍＲＮＡを培養する。
</span>
&nbsp;&nbsp;Using mRNA transcribed from a DNA construct comprising a promoter operably linked to a nucleic acid encoding a polypeptide or fragment thereof using a cell-free translation system, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, Generating a fragment comprising one of the 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides, or at least 50, 75, 100, 150, 200 or 300 consecutive amino acids. it can. In some embodiments, the DNA construct is linearized prior to performing the transcription reaction in vitro. To produce the desired polypeptide or fragment thereof, the transcribed mRNA is cultured with a suitable translation extract that does not contain cells, such as a rabbit reticulocyte extract.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、また、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの変異体、又は少なくとも５０、７５、１００、１５０、２００又は３００の連続するアミノ酸を含むフラグメントに関する。「変異体」なる用語には、これらのポリペプチドの派生物又は類似体が含まれる。特に、変異体は、あらゆる組合せで存在する１又は２以上の置換、付加、欠失、融合、及び切断によって、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドのアミノ酸配列が異なる。
</span>
&nbsp;&nbsp;The present invention also includes SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptide variants, or at least 50, 75, 100, 150, Relates to fragments containing 200 or 300 consecutive amino acids. The term “variant” includes derivatives or analogs of these polypeptides. In particular, variants may be represented by SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21 by one or more substitutions, additions, deletions, fusions, and truncations present in any combination. 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 73, 75, 77 polypeptides differ in amino acid sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記の変異体は、自然発生的に又はインビトロで作成される。特に、前記の変異体は、部位特異的突然変異誘発、ランダムな化学的突然変異誘発、エキソヌクレアーゼIII欠失方法及び標準的なクローニング技術などの遺伝子工学技術を用いて作成される。あるいは、前記の変異体、フラグメント、類似体又は派生物は、化学的合成又は改良方法を用いて作成される。
</span>
&nbsp;&nbsp;Said variants are made spontaneously or in vitro. In particular, the variants are generated using genetic engineering techniques such as site-directed mutagenesis, random chemical mutagenesis, exonuclease III deletion methods and standard cloning techniques. Alternatively, the variants, fragments, analogs or derivatives are made using chemical synthesis or improved methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  変異体を作成するための他の方法も当業者には公知である。これらには、天然の単離物から得られた拡酸配列を改良して、産業上又は実験的な利用においてそれらの価値を高めるような特徴を有するポリペプチドをコードする核酸を産生する手続きが含まる。これらの手順において、自然単離物から得られた配列に関して１又は２以上のヌクレオチド差を有する多くの変異配列を、生成し、特徴付ける。好ましくは、これらのヌクレオチド差によって、自然単離物の核酸がコードするポリペプチドに関して、アミノ酸が変化する。
</span>
&nbsp;&nbsp;Other methods for creating variants are also known to those skilled in the art. These include procedures to improve nucleic acid sequences obtained from natural isolates to produce nucleic acids encoding polypeptides having characteristics that increase their value in industrial or experimental applications. Included. In these procedures, a number of mutated sequences with one or more nucleotide differences with respect to sequences obtained from natural isolates are generated and characterized. Preferably, these nucleotide differences result in amino acid changes with respect to the polypeptide encoded by the naturally isolated nucleic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  例えば、変異体は変異性ＰＣＲを用いて作成される。変異性ＰＣＲでは、高率の点変異がＰＣＲ産物の全長に沿って得られるように、ＤＮＡポリメラーゼのフィデリティーが低い条件で、ＤＮＡの増幅が行われる。変異性ＰＣＲは、Leung, D. W., et al., Technique, 1:11-15 (1989) 及びCaldwell, R. C. &amp; Joyce G. F., PCR Methods Applic., 2:28-33 (1992) に記載されている。変異体は、あらゆる目的のクローン化したＤＮＡセグメントにおいて、部位特異的突然変異を産生するために、部位特異的突然変異誘発を用いて作成される。オリゴヌクレオチドの突然変異誘発については、Reidhaar-Olson, J. F. &amp; Sauer, R. T., et al., Science, 241:53-57 (1998) に記載されている。変異体はまた、米国特許第６，３６１，９７４号及び第６，３７２，４９７に記載されているような直接的な進化方法（directed evolution strategies）を用いて作成される。配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５及び７７のポリペプチドの変異体は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５又は７７のポリペプチドの１又は２以上のアミノ酸残基が、保存又は非保存アミノ酸残基（好ましくは、保存アミノ酸残基）で置換される変異体である。これらの置換アミノ酸残基は、遺伝子コードによってコードされてもよく、されなくてもよい。
</span>
&nbsp;&nbsp;For example, mutants are created using mutated PCR. In mutation PCR, DNA amplification is performed under conditions where the fidelity of DNA polymerase is low so that a high rate of point mutation can be obtained along the entire length of the PCR product. Mutational PCR is described in Leung, D.W., et al., Technique, 1: 11-15 (1989) and Caldwell, R.C. &amp; Joyce G.F., PCR Methods Applic., 2: 28-33 (1992). Variants are created using site-directed mutagenesis to produce site-specific mutations in any desired cloned DNA segment. Oligonucleotide mutagenesis is described in Reidhaar-Olson, J. F. &amp; Sauer, R. T., et al., Science, 241: 53-57 (1998). Variants are also created using directed evolution strategies as described in US Pat. Nos. 6,361,974 and 6,372,497. SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75 and 77 variants of the polypeptides are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65 , 67, 69, 71, 73, 75, or 77, wherein one or more amino acid residues are substituted with conserved or non-conserved amino acid residues (preferably conserved amino acid residues). . These substituted amino acid residues may or may not be encoded by the genetic code.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  保存的な置換は、ポリペプチドの所定のアミノ酸を、類似の特徴を有する別のアミノ酸によって置換するものである。保存的な置換として典型的に見られるのは、アラニン、バリン、ロイシン及びイソロイシン等の脂肪族アミノ酸と別の脂肪族アミノ酸との置換、セリンとトレオニンとの置換、又はその逆、アスパラギン酸、グルタミン酸等の酸残基と別の酸残基との置換、アスパラギン酸又はグルタミン酸などのアミド基を有する残基とアミド基を有する別の残基との置換、リジン、アルギニン等の塩基性残基と別の塩基性残基との置換、及びフェニルアラニン又はチロシン等の芳香族残基と別の芳香族残基との置換である。
</span>
&nbsp;&nbsp;A conservative substitution is one in which a given amino acid of a polypeptide is replaced with another amino acid having similar characteristics. Typical conservative substitutions include substitution of an aliphatic amino acid such as alanine, valine, leucine and isoleucine with another aliphatic amino acid, substitution of serine with threonine, or vice versa, aspartic acid, glutamic acid Substitution of an acid residue such as an acid residue with another acid residue, substitution of a residue having an amide group such as aspartic acid or glutamic acid with another residue having an amide group, and a basic residue such as lysine or arginine Substitution with another basic residue, and substitution of an aromatic residue such as phenylalanine or tyrosine with another aromatic residue.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他の変異体は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１又は２以上のアミノ酸残基が、置換基を含む変異体である。さらに、他の変異体は、ポリペプチドの半減期を増加させる化合物（例えば、ポリエチレングリコール）等の別の化合物とポリペプチドとが結合した変異体である。更なる変異体は、リーダー配列、分泌配列、プロタンパク質配列又はポリペプチドの精製、濃縮又は安定化を促進する配列な等のポリペプチドに、更なるアミノ酸が融合した変異体である。
</span>
&nbsp;&nbsp;Other variants are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77. One or more amino acid residues of the polypeptide have a substituent. It is a mutant containing. Furthermore, other variants are variants in which the polypeptide is bound to another compound, such as a compound that increases the half-life of the polypeptide (eg, polyethylene glycol). Additional variants are variants in which additional amino acids are fused to a polypeptide such as a leader sequence, secretory sequence, proprotein sequence or polypeptide that facilitates purification, enrichment or stabilization of the polypeptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある態様においては、フラグメント、派生物及び類似体は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドと同じ生物学的機能又は作用を保持する。他の態様においては、フラグメント、派生物又は類似体は、フラグメント、派生物、若しくは類似体から酵素で全体或いは部分的に切断可能なポリペプチドの精製、濃縮、検出、安定化又は分泌を促進する異種の融合配列を含んでいる。
</span>
&nbsp;&nbsp;In some embodiments, the fragments, derivatives and analogs are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Biological functions Or keep the action. In other embodiments, the fragment, derivative, or analog facilitates purification, enrichment, detection, stabilization, or secretion of a polypeptide that can be wholly or partially cleaved enzymatically from the fragment, derivative, or analog. Contains heterologous fusion sequences.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５及び７７のポリペプチドの１つと少なくとも７０％、少なくとも８０％、少なくとも８５％、少なくとも９０％、又は９５％以上の同一性を有するポリペプチド若しくははフラグメント、又は少なくとも５０、７５、１００、１５０、２００又は３００の連続するそのアミノ酸を含むフラグメントである。アミノ酸の「同一性」が、上述の保存的な置換を含むことは理解されるであろう。
</span>
&nbsp;&nbsp;Another aspect of the present invention is SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, One of 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75 and 77 and at least 70%, at least 80%, at least A polypeptide or 85%, at least 90%, or 95% or more identity or fragment is a fragment, or a fragment comprising at least 50, 75, 100, 150, 200 or 300 consecutive amino acids thereof. It will be understood that amino acid "identity" includes the conservative substitutions described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つと相同性を有するポリペプチド若しくはフラグメント、又は少なくとも５０、７５、１００、１５０、２００又は３００のその連続するアミノ酸を含むフラグメントを、上述の技術を用いて、それらをコードする核酸を単離することによって得る。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, A polypeptide or fragment having homology with one of the polypeptides of 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, or at least 50, 75, 100, Fragments containing 150, 200 or 300 consecutive amino acids thereof are obtained by isolating the nucleic acids that encode them using the techniques described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  あるいは、相同的なポリペプチド又はフラグメントは、生物学的濃縮又は精製手順をによって得られる。潜在的に相同的なポリペプチド又はフラグメントの配列は、タンパク分解の消化、ゲル電気泳動及び／又はマイクロシーケンシングによって決定される。予想される相同的なポリペプチド又はフラグメントの配列は、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つ、又は少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０の連続するアミノ酸を含むフラグメントと比較することができる。
</span>
&nbsp;&nbsp;Alternatively, homologous polypeptides or fragments are obtained by biological enrichment or purification procedures. The sequence of a potentially homologous polypeptide or fragment is determined by proteolytic digestion, gel electrophoresis and / or microsequencing. The sequence of the expected homologous polypeptide or fragment is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, One of the polypeptides of 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, or at least It can be compared to a fragment containing 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100 or 150 consecutive amino acids.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチド、又は少なくとも４０、５０、７５、１００、１５０、２００又は３００の連続するそのアミノ酸を含むフラグメント、派生物又は類似体を、様々な用途に用いる。例えば、ポリペプチド又はフラグメント、派生物若しくは類似体を使用して、明細書の他の箇所に記載されるように、生化学的反応を触媒する。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides, or at least 40, 50, 75, 100, 150, 200 or 300 consecutive thereof Fragments, derivatives or analogs containing amino acids are used for various applications. For example, polypeptides or fragments, derivatives or analogs are used to catalyze biochemical reactions as described elsewhere in the specification.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチド、又は少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０のその連続するアミノ酸を含むフラグメント、派生物若しくは類似体を使用して、ポリペプチド又はフラグメント、派生物若しくは類似体に特異的に結合する抗体を産生する。配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７から産生された抗体を使用して、生物学的サンプルが、ストレプトミセス・アイズネンシス又は関連する微生物を含むかどうかを判断する。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides, or at least 5, 10, 15, 20, 25, 30, 35, 40, 50 , 75, 100 or 150 of its contiguous amino acids, fragments, derivatives or analogs thereof are used to produce antibodies that specifically bind to the polypeptide or fragment, derivative or analog. SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, Using antibodies produced from 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, the biological sample is Streptomyces isnensis or related Determine if it contains microorganisms.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  これらの手順では、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドの１つ、又は少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０の連続するアミノ酸を含むフラグメントに特異的に結合することができる抗体と、生物学的サンプルとを接触させる。抗体に結合する生体サンプルの能力は、そこで決定される。例えば、蛍光剤、酵素ラベル又は放射性同位元素等の検出可能なラベルで抗体を標識化することによって結合を判断する。あるいは、サンプルに対する抗体の結合を、これらの検出可能なラベルを有する二次抗体を用いて検出する。サンプルにおける、ポリケチド産生株の存在、ストレプトミセス・アイズネンシスの存在、又は配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７に関連したポリペプチドの存在を検出するのに用いられる様々なプロトコルアッセイは、当業者には公知である。特定のアッセイには酸素免疫測定法アッセイ、サンドイッチアッセイ、放射性免疫測定法、及びウェスタンブロット法が含まれる。あるいは、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７から生成された抗体を使用して、生体サンプルが、ポリケチドの生合成にかかわる関連ポリペプチドを含むかどうかを決定する。
</span>
&nbsp;&nbsp;In these procedures, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, or at least 5, 10, 15, 20, 25 The biological sample is contacted with an antibody that can specifically bind to a fragment comprising 30, 35, 40, 50, 75, 100 or 150 consecutive amino acids. The ability of the biological sample to bind to the antibody is then determined. For example, binding is determined by labeling the antibody with a detectable label such as a fluorescent agent, an enzyme label or a radioisotope. Alternatively, antibody binding to the sample is detected using secondary antibodies with these detectable labels. Presence of polyketide producing strain, presence of Streptomyces isonensis in the sample, or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33 , 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Various protocol assays used to detect the presence are known to those skilled in the art. Specific assays include oxygen immunoassay assays, sandwich assays, radioimmunoassays, and Western blots. Alternatively, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Using biological antibodies, the biological sample is involved in polyketide biosynthesis Determine whether to include the polypeptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチドに対して産生されたポリクローナル抗体、又は少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０のその連続するアミノ酸を含むフラグメントは、動物へのポリペプチドの直接注入、又は動物、好ましくは非ヒト動物へのポリペプチド投与によって得られる。このようにして得られた抗体は、ポリペプチド自体を結合する。このように、ポリペプチドのフラグメントのみをコードする配列を使用しても、未変性のポリペプチド全体に結合する抗体を産生することができる。次に、これらの抗体を使用して、そのポリペプチドを発現する細胞からポリペプチドを単離することができる。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, Polyclonal antibodies raised against 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides, or at least 5, 10, 15, 20, 25 , 30, 35, 40, 50, 75, 100 or 150 fragments thereof, obtained by direct injection of the polypeptide into an animal or administration of the polypeptide to an animal, preferably a non-human animal. The antibody thus obtained binds the polypeptide itself. Thus, antibodies that bind to the entire native polypeptide can be produced using sequences that encode only a fragment of the polypeptide. These antibodies can then be used to isolate the polypeptide from cells that express the polypeptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  モノクロナール抗体の調製に関しては、連続継代性細胞培養株によって生成される抗体を提供するあらゆる技術が用いられる。例には、ハイブリドーマ法（Kholer and Milstein, 1975, Nature, 256:495-497）、トリオーマ法、ヒトＢ細ハイブリドーマ法（Kozbor et al., 1983, Immunology Today 4:72）及びＥＢＶ−ハイブリドーマ法（Cole, et al., 1985, in Monoclonal Antibodies and Cancer Therapy,  Alan R. Liss, Inc., pp. 77-96）が含まれる。
</span>
&nbsp;&nbsp;For the preparation of monoclonal antibodies, any technique that provides antibodies produced by continuous cell cultures is used. Examples include the hybridoma method (Kholer and Milstein, 1975, Nature, 256: 495-497), the trioma method, the human B fine hybridoma method (Kozbor et al., 1983, Immunology Today 4:72) and the EBV-hybridoma method ( Cole, et al., 1985, in Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., pp. 77-96).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  単鎖抗体の生成について記載した技術（米国特許第４，９４６，７７８号）を、配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチド、又は、少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０の連続するアミノ酸を含むフラグメントに対する単鎖抗体を生成するために使用する。また、トランスジェニックマウスを使用して、これらのポリペプチド又はフラグメントに対するヒト化抗体を発現させる。
</span>
&nbsp;&nbsp;Techniques described for the production of single chain antibodies (US Pat. No. 4,946,778) are adapted from SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 Used to generate single chain antibodies to polypeptides or fragments comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100 or 150 consecutive amino acids. Transgenic mice are also used to express humanized antibodies against these polypeptides or fragments.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６５、６７、６９、７１、７３、７５、７７のポリペプチド、又は少なくとも５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００又は１５０その連続するアミノ酸を含むフラグメントに対して産生された抗体を、生物体を含むサンプル又は細胞を含まない抽出物から、類似のポリペプチドをスクリーニングする際に用いる。これらの技術において、サンプル由来のポリペプチドを抗体と接触させ、抗体に特異的に結合するポリペプチドを検出する。上述の手順のいずれを使用して、抗体結合を検出してもよい。これらのスクリーニングアッセイの１つは、“Methods for measuring Cellulase Activities,” Methods in Enzymology, Vol 160, pp. 87-116に記載されている。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77 polypeptides, or at least 5, 10, 15, 20, 25, 30, 35, 40, 50 Antibodies raised against fragments containing 75, 100 or 150 contiguous amino acids are used in screening for similar polypeptides from samples containing organisms or extracts containing no cells. In these techniques, a polypeptide derived from a sample is contacted with an antibody, and a polypeptide that specifically binds to the antibody is detected. Any of the procedures described above may be used to detect antibody binding. One of these screening assays is described in “Methods for measuring Cellulase Activities,” Methods in Enzymology, <figure-callout id="160" label="Vol" filenames="2007525148-227.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Vol</a></figure-callout> 160, pp. 87-116.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）部位における遺伝子の機能を同定するために、デフォルトパラメーターを用いたＢＬＡＳＴＰ版２．２．１アルゴリズムを使用して、米国国立バイオテクノロジー情報センター（ＮＣＢＩ）の非冗長タンパク質のデータベース及び微生物遺伝子、経路及び天然産物のＤＥＣＩＰＨＥＲ<sup class="style-scope patent-text">a</sup>データベース（Ecopia BioSciences Inc. St-Laurent, QC, Canada）における配列と、ＯＲＦ１〜３８とを比較した。
</span>Using the BLASTP version 2.2.1 algorithm with default parameters to identify the function of the gene at the Compound 2 (a) site, the National Center for Biotechnology Information (NCBI) database of non-redundant proteins and DECIPHER <sup class="style-scope patent-text">a</sup> database of microbial genes, pathways and natural products were compared (Ecopia BioSciences Inc. St-Laurent, QC, Canada) and sequences in, and ORF1～38.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  このブラスト解析のＧｅｎＢａｎｋでヒットした上位のもののアクセッション番号を、対応するＥ値と共に表１に示す。Ｅ値は、確認されたアラインメントスコアと少なくとも等しいアラインメントスコアを有するアラインメント確率（chance alignments）の予測数に関する。Ｅ値が０．００である場合は、完全な相同体を示している。Ｅ値は、Altschul et al. J. Mol. Biol., 215, 403-410 (1990) に記載さるように計算されている。相同体であるという推定を正当化するために十分な類似性を２つの配列が示すかどうかを決定する際に、かかるＥ値は有用である。
</span>
&nbsp;&nbsp;Table 1 shows the accession numbers of the top hits in GenBank of the blast analysis together with the corresponding E values. The E value relates to a predicted number of alignment alignments having an alignment score that is at least equal to the confirmed alignment score. An E value of 0.00 indicates a complete homologue. The E value is calculated as described in Altschul et al. J. Mol. Biol., 215, 403-410 (1990). Such E values are useful in determining whether two sequences show sufficient similarity to justify the assumption of being a homolog.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <tables num="1" class="style-scope patent-text">
            </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000087" he="179" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="716" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000088" he="179" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="716" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000089" he="179" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="716" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000090" he="181" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="724" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000091" he="180" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="720" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000092" he="202" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="808" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000093" he="211" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="844" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000094" he="211" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="844" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000095" he="181" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="724" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        
        <tables num="1" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000087" he="179" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="716" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        </tables>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000088" he="179" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="716" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000089" he="179" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="716" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000090" he="181" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="724" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000091" he="180" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="720" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000092" he="202" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="808" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000093" he="211" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="844" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000094" he="211" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="844" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000095" he="181" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="724" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
      
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）部位におけるＯＲＦ１〜３８の各々の遺伝子産物に、表１で定めた、既知のタンパク質の構造に類似の配列に基づくタンパク質ファミリーを割り当てる。推定上の機能は、各タンパク質ファミリーの構成要素の既知の機能に基づく化合物２（ａ）部位、生合成部位のそれぞれの遺伝子産物によるものであると考えられる。各タンパク質ファミリーは、明細書及び図面を通して用いられている４文字の記号で表されている。例えば、ＯＲＦ２１（配列番号４３）の遺伝子産物を含むタンパク質ファミリーＡＢＣＤの構成要素は、膜透過トランスポーターである。ＯＲＦ３３（配列番号６７）の遺伝子産物を含むタンパク質ファミリーＡＤＨＹの構成要素は、アミジノヒドラーゼである。ＯＲＦ３４（配列番号６９）の遺伝子産物を含むタンパク質ファミリーＡＤＳＮの構成要素は、アデニル化／縮合酵素である。ＯＲＦ１９及び３５（配列番号３９及び７１）を含むタンパク質ファミリーＡＹＴＦ及びＡＹＴＰの構成要素は、アシルトランスフェラーゼである。タンパク質ファミリーＣＡＬＢの構成要素は、ＯＲＦ２７及び３６（配列番号５５及び７３）を含むアシルＣｏＡリガーゼである。ＯＲＦ３２（配列番号６５）を含むタンパク質ファミリーＣＴＦＣの構成要素は、カルボキシルトランスフェラーゼ／デカルボキラーゼである。ＯＲＦ２５及び２２（配列番号５１及び４５）を含むタンパク質ファミリーＤＥＰＡ及びＤＥＰＬの構成要素は、デヒドラターゼ／エピメラーゼである。ＯＲＦ２３（配列番号４７）を含むタンパク質ファミリーＥＰＩＭの構成要素は、エピメラーゼである。ＯＲＦ９（配列番号１９）を含むタンパク質ファミリーＧＴＦＡの構成要素は、グリコシルトランスフェラーゼである。ＯＲＦ２０（配列番号４１）を含むタンパク質ファミリーＭＥＡＹの構成要素は、膜タンパク質である。ＯＲＦ２４（配列番号４９）を含むタンパク質ファミリーＮＵＴＡの構成要素は、ヌクレオチジルトランスフェラーゼである。ＯＲＦ１０、１１、１２、１３、１４、１５、１６、１７及び１８（配列番号２１、２３、２５、２７、２９、３１、３３、３５及び３７）を含むタンパク質ファミリーＰＫＳＨの構成要素は、Ｉ型のタンパク質であるポリケチドシンターゼである。ＯＲＦ２９（配列番号５９）を含むタンパク質ファミリーＰＰＴＦの構成要素は、フォスフォパンテエチニル（phosphopantetheinyl）トランスフェラーゼである。ＯＲＦ３及び３１（配列番号６及び６３）を含むタンパク質ファミリーＲＥＧＤの構成要素は、転写レギュレーターである。ＯＲＦ４（配列番号８）を含むタンパク質ファミリーＲＲＥＢの構成要素は、応答レギュレーターである。ＯＲＦ５（配列番号１０）を含むタンパク質ファミリーＳＰＫＫの構成要素は、感受性プロテインキナーゼである。ＯＲＦ２及び２６（配列番号４及び５３）を含むタンパク質ファミリーＴＥＳＡの構成要素は、チオエステラーゼである。ＯＲＦ２８（配列番号５７）を含むタンパク質ファミリーＴＭＯＡの構成要素は、モノオキシゲナーゼである。各タンパク質ファミリーの機能に関するより詳細な説明は、表２に示されている。各タンパク質ファミリーの構造と機能の相関関係は、表２に示されている。
</span>
&nbsp;&nbsp;Each gene product of <figure-callout id="1" label="ORFs" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORFs</a></figure-callout> 1 to 38 at the site of compound 2 (a) is assigned a protein family based on a sequence similar to the known protein structure defined in Table 1. The putative function is thought to be due to the respective gene products of the compound 2 (a) site and biosynthetic site based on the known functions of the components of each protein family. Each protein family is represented by a four letter symbol used throughout the specification and drawings. For example, a component of protein family ABCD that includes the gene product of ORF21 (SEQ ID NO: 43) is a transmembrane transporter. A component of the protein family ADHY containing the gene product of ORF33 (SEQ ID NO: 67) is amidinohydrase. A component of the protein family ADSN containing the gene product of ORF34 (SEQ ID NO: 69) is an adenylation / condensation enzyme. A member of the protein families AYTF and AYTP, including <figure-callout id="19" label="ORFs" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORFs</a></figure-callout> 19 and 35 (SEQ ID NOs: 39 and 71) are acyltransferases. A component of the protein family CALB is an acyl CoA <figure-callout id="27" label="ligase comprising ORFs" filenames="2007525148-222.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ligase comprising ORFs</a></figure-callout> 27 and 36 (<figure-callout id="55" label="SEQ ID NOs" filenames="2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SEQ ID NOs</a></figure-callout> 55 and 73). A component of the protein family CTFC containing ORF32 (SEQ ID NO: 65) is a carboxyltransferase / decarboxylase. Members of the protein families DEPA and DEPL, including <figure-callout id="25" label="ORFs" filenames="2007525148-219.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORFs</a></figure-callout> 25 and 22 (SEQ ID NOs: 51 and 45) are dehydratases / epimerases. A component of the protein family EPIM containing ORF23 (SEQ ID NO: 47) is epimerase. A component of the protein family GTFA containing ORF9 (SEQ ID NO: 19) is a glycosyltransferase. A component of the protein family MEAY including ORF20 (SEQ ID NO: 41) is a membrane protein. A component of the protein family NUTA containing ORF24 (SEQ ID NO: 49) is a nucleotidyl transferase. The components of the protein family <figure-callout id="10" label="PKSH including ORF" filenames="2007525148-219.png,2007525148-221.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="11" label="PKSH including ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="12" label="PKSH including ORF" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="13" label="PKSH including ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="14" label="PKSH including ORF" filenames="2007525148-212.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="15" label="PKSH including ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="16" label="PKSH including ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="17" label="PKSH including ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">PKSH including ORF</a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout></a></figure-callout> 10, 11, 12, 13, 14, 15, 16, 17 and 18 (SEQ ID NO: 21, 23, 25, 27, 29, 31, 33, 35 and 37) are type I It is a polyketide synthase that is a protein of A component of the protein family PPTF containing ORF29 (SEQ ID NO: 59) is phosphopantetheinyl transferase. A component of the protein family <figure-callout id="3" label="REGD including ORFs" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">REGD including ORFs</a></figure-callout> 3 and 31 (SEQ ID NOs: 6 and 63) is a transcriptional regulator. A component of the protein family RREB containing ORF4 (SEQ ID NO: 8) is a response regulator. A member of the protein family SPKK containing ORF5 (SEQ ID NO: 10) is a sensitive protein kinase. A component of the protein family <figure-callout id="2" label="TESA including ORFs" filenames="2007525148-208.png,2007525148-211.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TESA including ORFs</a></figure-callout> 2 and 26 (SEQ ID NOs: 4 and 53) is a thioesterase. A component of the protein family TMOA containing ORF28 (SEQ ID NO: 57) is a monooxygenase. A more detailed description of the function of each protein family is given in Table 2. The correlation between structure and function of each protein family is shown in Table 2.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <tables num="2" class="style-scope patent-text">
            </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000096" he="213" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="852" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000097" he="127" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="508" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        
        <tables num="2" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000096" he="213" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="852" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        </tables>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000097" he="127" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="508" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
      
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の生合成は、図１に示されているＯＲＦ１０〜１８（配列番号２１、２３、２５、２７、２９、３１、３３、３５及び３７）のマルチモジュラーＩ型ポリケチドシンターゼシステム（ＰＫＳ）に関連する。Ｉ型ＰＫＳは、連続的に（sequential manner）アシルチオエステルを縮合する大きなモジューラータンパク質である。ＰＫＳシステムは、１又は２以上の多機能ポリペプチドからなり、各々がモジュールで構成される。Ｉ型のＰＫＳモジュールはそれぞれ、β−ケトアシルタンパク質シンターゼ（ＫＳ）、アシルトランスフェラーゼ（ＡＴ）及びアシルキャリアタンパク質（ＡＣＰ）の３つのドメインを有する。ケトレダクターゼ（ＫＲ）、デヒドラターゼ（ＤＨ）及びエノイルレダクターゼ（ＥＲ）などの付加的な酵素活性を与えるドメインも、ＰＫＳモジュールに見られる。これらの付加的なドメインによって、延長するポリケチド鎖のβ−ケト基が様々なレベルで減少する。各モジュールは、β−ケトアシル単位の１回の縮合及び減少の原因となる。モジュールの数とポリケチド鎖の長さの間だけでなく、モジュールのドメイン組成物とポリケチド産物の減少レベルと間にも、直接的な相関関係がある。最終的なポリケチド産物は、ＰＫＳシステムの最終的なモジュールに見られるチオエステラーゼドメインの作用によって、ＰＫＳタンパク質から遊離される。ほとんどのＩ型のＰＫＳ酵素の遺伝子構成は、ポリケチド鎖を生じる生化学反応の順序と、同一線形に並んでいる。当業者であれば、これらの特徴によって、所定の生合成経路に見られるＰＫＳモジュールの構築に基づいて、ポリケチド核構造の予測が可能であることを直ちに理解するであろう。[Hopwood, Chem. Rev., 97: 24, 65-24, 97 (1997) ]。
</span>
&nbsp;&nbsp;The biosynthesis of compound 2 (a) is the multi-modular type I polyketide synthase system of ORF 10-18 (SEQ ID NO: 21, 23, 25, 27, 29, 31, 33, 35 and 37) shown in FIG. PKS). Type I PKS is a large modular protein that condenses acylthioesters in a sequential manner. The PKS system is composed of one or more multifunctional polypeptides, each of which is composed of modules. Each type I PKS module has three domains: β-ketoacyl protein synthase (KS), acyltransferase (AT) and acyl carrier protein (ACP). Domains that confer additional enzymatic activity such as ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) are also found in the PKS module. These additional domains reduce the β-keto group of the extending polyketide chain at various levels. Each module is responsible for a single condensation and reduction of β-ketoacyl units. There is a direct correlation not only between the number of modules and the length of the polyketide chain, but also between the domain composition of the module and the level of polyketide product reduction. The final polyketide product is released from the PKS protein by the action of the thioesterase domain found in the final module of the PKS system. The genetic makeup of most type I PKS enzymes is aligned with the sequence of biochemical reactions that produce the polyketide chain. One skilled in the art will readily appreciate that these features allow prediction of the polyketide nuclear structure based on the construction of the PKS module found in a given biosynthetic pathway. [Hopwood, Chem. Rev., 97: 24, 65-24, 97 (1997)].
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）部位のＰＫＳシステムは、ＯＲＦ１０〜１８（配列番号２１、２３、２５、２７、２９、３１、３３、３５及び３７）から構成され、表３に示されているように、合計２７のモジュールを有する。第一のモジュールは、ＡＣＰドメインのみを含み、付加モジュール（モジュール０）に対応する。一方、残りの２６のモジュールは、ＫＲ、ＤＨ及びＥＲドメインとの様々な組合せにおいて、ＫＳ、ＡＴ及びＡＣＰのドメインを含む。ＯＲＦ１８／モジュール２６に存在するチオエステラーゼドメインは、このモジュールがポリケチド鎖の生合成における最終的なモジュールであることを示している。モジュール６と１１におけるデヒドラターゼドメイン及びモジュール１２におけるケトレダクターゼドメインは、触媒作用に重要な高度に保存された領域に非保存アミノ酸残基が存在するので、不活性である。
</span>
&nbsp;&nbsp;The PKS system for the Compound 2 (a) site is composed of ORFs 10-18 (SEQ ID NOs: 21, 23, 25, 27, 29, 31, 33, 35 and 37) and totaled as shown in Table 3. It has 27 modules. The first module includes only the ACP domain and corresponds to the additional module (module 0). On the other hand, the remaining 26 modules contain KS, AT and ACP domains in various combinations with KR, DH and ER domains. The thioesterase domain present in ORF18 / <figure-callout id="26" label="module" filenames="2007525148-219.png,2007525148-223.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 26 indicates that this module is the final module in polyketide chain biosynthesis. The dehydratase domain in <figure-callout id="6" label="modules" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="11" label="modules" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">modules</a></figure-callout></a></figure-callout> 6 and 11 and the ketoreductase domain in <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 are inactive because there are non-conserved amino acid residues in highly conserved regions important for catalysis.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）部位ＰＫＳドメイン配位<br class="style-scope patent-text">
<tables num="3" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000098" he="215" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="860" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000099" he="237" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="948" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000100" he="237" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="948" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000101" he="237" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="948" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000102" he="159" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="636" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
Compound 2 (a) site PKS domain coordination <br class="style-scope patent-text"> <tables num="3" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000098" he="215" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="860" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000099" he="237" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="948" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000100" he="237" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="948" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000101" he="237" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="948" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000102" he="159" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="636" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（a）の部位ＰＫＳシステム（図２）に存在するＫＳドメインの複合アミノ酸配列が、ドメインの全体的な類似性、並びにアミノ酸残基の保存及び活性に重要なドメイン領域の保存を示していることから、当業者であれば、全てのＫＳドメインが機能的であることを理解するであろう。同様に、ＡＴドメイン（図３）、ＥＲドメイン（図５）、ＡＣＰドメイン（図７）及びＴＥドメイン（図８）の複合アミノ酸配列は、関連するドメインの全体的な類似性や、タンパク質領域の高度な保存及び触媒活性に重要なアミノ酸残基の保存を示している。化合物２（ａ）の部位ＰＫＳに一度だけ発生するドメイン、すなわち、ＯＲＦ１７(配列番号３５)におけるエノイルレダクターゼ（ＥＲ）ドメイン及びＯＲＦ１８（配列番号３７）におけるチオエステラーゼ（ＴＥ）ドメインを、ニスタチンのＩ型ポリケチドのシステムの原型ドメインと比較する（図５及び８）（上記Brauteset et al.参照）。
</span>
&nbsp;&nbsp;The complex amino acid sequence of the KS domain present in the site PKS system of compound 2 (a) (FIG. 2) shows the overall similarity of the domains and the conservation of domain regions important for amino acid residue conservation and activity. Thus, those skilled in the art will understand that all KS domains are functional. Similarly, the complex amino acid sequences of the AT domain (FIG. 3), ER domain (FIG. 5), ACP domain (FIG. 7) and TE domain (FIG. 8) are related to the overall similarity of related domains and the protein region. It shows the conservation of amino acid residues important for high conservation and catalytic activity. Domains that occur only once at the site PKS of compound 2 (a), ie, the enoyl reductase (ER) domain in ORF17 (SEQ ID NO: 35) and the thioesterase (TE) domain in ORF18 (SEQ ID NO: 37), are designated as nystatin I Compared to the prototype domain of the type polyketide system (FIGS. 5 and 8) (see Brauteset et al. Above).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（a）の部位ＰＫＳに見られるＤＨドメインの比較は、触媒活性に重要なアミノ酸残基の高度な保存を示している（図４）。しかしながら、２つのＤＨドメインは、高度な配列保存領域に非保存アミノ酸置換を含むので、不活性である。図４にハイライトで表示されているように、ＯＲＦ１１（配列番号２３）におけるモジュール６のＤＨドメイン及びＯＲＦ１２（配列番号２５）におけるモジュール１１のＤＨドメインは、非荷電脂肪族アミノ酸の荷電アミノ酸アルギニン及びグルタミン酸の置換をそれぞれ含んでいる。
</span>
&nbsp;&nbsp;Comparison of the DH domains found at site PKS of compound 2 (a) shows a high degree of conservation of amino acid residues important for catalytic activity (FIG. 4). However, the two DH domains are inactive because they contain non-conserved amino acid substitutions in highly conserved regions. As highlighted in FIG. 4, the DH domain of <figure-callout id="6" label="module" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 6 in ORF11 (SEQ ID NO: 23) and the DH domain of <figure-callout id="11" label="module" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 11 in ORF12 (SEQ ID NO: 25) are the charged amino acid arginine of the uncharged aliphatic amino acid and Each contains a glutamic acid substitution.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の部位ＰＫＳシステムに見られるＫＲドメインの比較も、ＯＲＦ１３（配列番号２７）に見られるモジュール１２のＫＲドメインを除いて、触媒に重要な活性部位及びアミノ酸残基の保存を示している。図６は、高度に保存されたチロシン（Ｙ）アミノ酸残基のグルタミン（Q）の置換のモジュールの存在を示している。この非保存アミノ酸置換によって、ＯＲＦ１３（配列番号２７）（ＯＲＦ１３、ｐＫＲ０１）において、モジュール１２のＫＲドメインの酵素活性が不活性となる。
</span>
&nbsp;&nbsp;A comparison of the KR domains found in the site PKS system of compound 2 (a) also shows the conservation of the active site and amino acid residues important for the catalyst, except for the KR domain of <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 found in ORF13 (SEQ ID NO: 27). ing. FIG. 6 shows the presence of a highly conserved tyrosine (Y) amino acid residue glutamine (Q) substitution module. This non-conservative amino acid substitution renders the enzyme activity of the KR domain of <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 inactive in ORF13 (SEQ ID NO: 27) (ORF13, pKR01).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（a）の部位ＰＫＳのＡＴドメインの系統的分析を実施し、延長するポリケチド鎖に組み込まれているβ−ケトアシルユニットの性質を評価した。化合物２（ａ）の部位ＰＫＳのＡＴのドメインを、２つのドメイン、ＡＡＦ７１７７９ｍｏｄ０３及びＡＡＦ７１７６６ｍｏｄ１１と比較した。これらは、ニスタチンＰＫＳシステムに由来し[Brautaset、上記]、マロニル−ＣｏＡ及びメチルマロニルＣｏＡの取り込みをそれぞれ特定している。図９は、化合物２（a）の部位ＰＫＳにおけるＯＲＦ１３（配列番号２７）のモジュール１２及びＯＲＦ１６（配列番号３３）のモジュール１９と２０は、ポリケチド鎖にメチルマロニルを取り込み、残りのＡＴドメインは全て、マロネート増量剤(malonate extender)β−ケトアシルユニットを組み込むことを示し、様々なＡＴドメインの系統的な関連性を表している。
</span>
&nbsp;&nbsp;A systematic analysis of the AT domain of the site PKS of compound 2 (a) was performed to evaluate the nature of the β-ketoacyl unit incorporated into the extending polyketide chain. The AT domain of the site PKS of compound 2 (a) was compared with two domains, AAF71779mod03 and AAF71766mod11. These are derived from the nystatin PKS system [Brautaset, supra] and specify the incorporation of malonyl-CoA and methylmalonyl CoA, respectively. FIG. 9 shows that <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 of ORF13 (SEQ ID NO: 27) and <figure-callout id="19" label="modules" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="20" label="modules" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">modules</a></figure-callout></a></figure-callout> 19 and 20 of ORF16 (SEQ ID NO: 33) at site PKS of compound 2 (a) incorporate methylmalonyl into the polyketide chain and all remaining AT domains Have shown the incorporation of a malonate extender β-ketoacyl unit, indicating the systematic relevance of various AT domains.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の部位ＰＫＳシステムのドメイン分析は、ポリケチド核構造の合成を明らかに示している。あらゆる特定の作用機序又は生合成の図式に限定する意図はないが、化合物２（ａ）の部位ＰＫＳのモジュールの性質及び構造によって、化合物２（ａ）の合成を説明することができる。図１０は、化合物２（ａ）の推定されたドメイン構造とポリケチド核との相互関係に基づき、ポリケチドシンターゼシステムによって触媒された一連の反応を模式的にハイライトで表している。それらによって達成されるＩ型のＰＫＳドメイン及び反応は、当業者に公知であり、文献に詳しく説明されている。例えば、Hopwood、上記参照。
</span>
&nbsp;&nbsp;Domain analysis of the site PKS system of compound 2 (a) clearly shows the synthesis of the polyketide core structure. Without intending to be limited to any particular mechanism of action or biosynthesis scheme, the nature and structure of the module of the site PKS of compound 2 (a) can explain the synthesis of compound 2 (a). FIG. 10 schematically highlights a series of reactions catalyzed by the polyketide synthase system based on the interrelationship between the presumed domain structure of compound 2 (a) and the polyketide nucleus. The type I PKS domains and reactions achieved by them are known to those skilled in the art and are described in detail in the literature. See, for example, Hopwood, above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  γ−アミノブチリル−ＣｏＡスターターユニットを生成するための生合成の経路も、示されている。ＯＲＦ２８（配列番号５７）の遺伝子産物は、タンパク質ファミリーＴＭＯＡの構成要素であり、４−グアニジノブタンアミド（4-guanidinobutanamide）を構成するアルギニンの脱炭素による酸化（decarboxylative oxidation）を触媒する。ＯＲＦ３３（配列番号６７）の遺伝子産物はタンパク質ファミリーＡＤＨＹの構成要素であり、どちらもタンパク質ファミリーＣＡＬＢの構成要素であるＯＲＦ２７又は３６（それぞれ配列番号５５及び７３）によって更に活性化されるγ−アミノブタンアミドを構成するアミジノ基の加水分解を触媒し、γ−アミノブチリル−ＣｏＡを産生する(図１０ａ)。図１０ｂに示されているように、タンパク質ファミリーＡＹＴＦの構成要素であるＯＲＦ１９（配列番号３９）の遺伝子産物は、この特別な増量剤のユニットを、タンパク質ファミリーＰＫＳＨの構成要素であるＯＲＦ１０（配列番号２１）の負荷モジュール（モジュール０）のＡＣＰドメインに負荷する。特定のドメインによって、マロニル−ＣｏＡ及びメチルマロニル−ＣｏＡ増量剤ユニットの連続的な縮合によって、ポリケチド鎖は延長し続けるが、これらの増量剤ユニットは特異的なドメインによって様々なレベルにまで更に低下(reduce)する。ＯＲＦ１１（配列番号２３）のモジュール６及びＯＲＦ１２（配列番号２５）のモジュール１１のデヒドラターゼドメイン、及びＯＲＦ１３（配列番号２７）のモジュール１２におけるケトレダクターゼドメインは不活性であり、結果的に各々の還元反応を触媒しない。図１０ｂに示されているように、成熟したポリケチド鎖は、タンパク質ファミリーＰＫＳＨの構成要素であるＯＲＦ１８(配列番号３７)に見られるチオエステラーゼのドメインの活性によって遊離する。化合物２（ａ）部位のＰＫＳドメインの構造から予測されるポリケチド核構造は、化合物２（ａ）のポリケチドの部分と完全に一致している。
</span>
&nbsp;&nbsp;A biosynthetic pathway to produce a γ-aminobutyryl-CoA starter unit is also shown. The gene product of ORF28 (SEQ ID NO: 57) is a component of the protein family TMOA and catalyzes the decarboxylative oxidation of arginine that constitutes 4-guanidinobutanamide. The gene product of ORF33 (SEQ ID NO: 67) is a component of protein family ADHY, both of which are further activated by ORF27 or 36 (SEQ ID NOs: 55 and 73, respectively) that are components of protein family CALB. It catalyzes the hydrolysis of the amidino group constituting the amide to produce γ-aminobutyryl-CoA (FIG. 10a). As shown in FIG. 10b, the gene product of ORF19 (SEQ ID NO: 39), a component of the protein family AYTF, combines this special bulking unit with ORF10 (SEQ ID NO: 5), a component of the protein family PKSH. 21) load the ACP domain of the load module (module 0). Depending on the particular domain, the polyketide chain continues to be extended by successive condensation of malonyl-CoA and methylmalonyl-CoA extender units, but these extender units are further reduced to various levels by specific domains ( reduce). The dehydratase domain of <figure-callout id="6" label="module" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 6 of ORF11 (SEQ ID NO: 23) and the <figure-callout id="11" label="module" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 11 of ORF12 (SEQ ID NO: 25) and the ketoreductase domain of <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 of ORF13 (SEQ ID NO: 27) are inactive, resulting in respective reduction reactions. Do not catalyze. As shown in FIG. 10b, the mature polyketide chain is released by the activity of the thioesterase domain found in ORF18 (SEQ ID NO: 37), a component of the protein family PKSH. The polyketide core structure predicted from the structure of the PKS domain at the site of compound 2 (a) is completely consistent with the polyketide moiety of compound 2 (a).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の部位は、化合物２（ａ）の部位の化学的構造に見られる他の２つの成分の合成に関係する遺伝子を含む。図１１ａは、化合物２（ａ）の部位に見られるアミノヒドロキシ−シクロペンテノン成分を生成するための生合成経路を示している。タンパク質ファミリーＡＹＴＰの構成要素であるＯＲＦ３５（配列番号７１）の遺伝子産物は、５−アミノルブリン酸を形成するサクシニル−ＣｏＡを用いてグリシンを縮合する。かかる中間体は、タンパク質ファミリーＣＡＬＢの両構成要素であるＯＲＦ２７又は３６（それぞれ配列番号５５及び７３）の遺伝子産物の作用を通して更に活性化し、５−アミルブリン酸−ＣｏＡを形成するが、５−アミルブリン酸−ＣｏＡは自然に環化して、アミノヒドロキシシクロペンテノンを生成する。続いて、かかる成分を、図１０ｃに示されているタンパク質ファミリーＡＤＳＮの構成要素であるＯＲＦ３４（配列番号６９）の遺伝子産物の作用によって、ポリケチド鎖の活性化したカルボキシ末端で縮合する。
</span>
&nbsp;&nbsp;The site of compound 2 (a) contains genes involved in the synthesis of the other two components found in the chemical structure of the site of compound 2 (a). FIG. 11a shows the biosynthetic pathway for producing the aminohydroxy-cyclopentenone component found at the site of compound 2 (a). The gene product of ORF35 (SEQ ID NO: 71), a component of the protein family AYTP, condenses glycine using succinyl-CoA that forms 5-aminorubric acid. Such intermediates are further activated through the action of the gene products of ORF27 or 36 (SEQ ID NOs: 55 and 73, respectively) that are both components of the protein family CALB to form 5-amylbrinic acid-CoA, -CoA spontaneously cyclizes to produce aminohydroxycyclopentenone. Subsequently, such components are condensed at the activated carboxy terminus of the polyketide chain by the action of the gene product of ORF34 (SEQ ID NO: 69), a component of the protein family ADSN shown in FIG. 10c.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  図１１ｂは、化合物２（ａ）のデオキシ糖成分の生合成経路を示している。タンパク質ファミリーＮＵＴＡの構成要素であるＯＲＦ２４（配列番号４９）の遺伝子産物は、ｄＮＤＰ−Ｄ−グルコースを形成するＤ−グルコースを活性化する。ｄＮＤＰ−Ｄ−グルコースをその後、ｄＮＤＰ−４−ケト−４，６−ジデオキシ−Ｄ−グルコースを形成するタンパク質ファミリーＤＥＰＡの構成要素であるＯＲＦ２５（配列番号５１）の遺伝子産物の作用によって脱水する。タンパク質ファミリーＤＥＰＬの構成要素であるＯＲＦ２２（配列番号４５）の遺伝子産物は、ｄＮＤＰ−Ｌ−ラムノースを生成するタンパク質ファミリーＥＰＩＭの構成要素であるＯＲＦ２３（配列番号４７）の遺伝子産物によって後にエピマー化するｄＮＤＰ−Ｄ−フコースを形成する本中間体を更に還元する。
</span>
&nbsp;&nbsp;FIG. 11b shows the biosynthetic pathway of the deoxy sugar component of compound 2 (a). The gene product of ORF24 (SEQ ID NO: 49), a component of the protein family NUTA, activates D-glucose to form dNDP-D-glucose. dNDP-D-glucose is then dehydrated by the action of the gene product of ORF25 (SEQ ID NO: 51), a component of the protein family DEPA that forms dNDP-4-keto-4,6-dideoxy-D-glucose. The gene product of ORF22 (SEQ ID NO: 45), a component of the protein family DEPL, is later epimerized by the gene product of ORF23 (SEQ ID NO: 47), a component of the protein family EPIM that produces dNDP-L-rhamnose. The intermediate that forms -D-fucose is further reduced.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  図１０ｃに図示されるように、グリコシルトランスフェラーゼ、すなわちタンパク質ファミリーＧＴＦＡの構成要素であるＯＲＦ９（配列番号１９）の遺伝子産物の作用によって、最終的なデオキシ糖成分をポリケチド核構造のヒドロキシル基に転移する。図１０ｃは、タンパク質ファミリーＣＡＬＢの構成要素であるＯＲＦ３４（配列番号６９）の遺伝子産物及びタンパク質ファミリーＧＴＦＡの構成要素であるＯＲＦ９（配列番号１９）の遺伝子産物によって触媒される反応のタイミングに関する図式を提示している。しかしながら、本発明は、図１０ｃに示されるような、実際のタイミング及び反応の順序にあるのではないことは、容易に理解されるであろう。
</span>
&nbsp;&nbsp;As illustrated in FIG. 10c, the action of the gene product of glycosyltransferase, ORF9 (SEQ ID NO: 19), a component of the protein family GTFA, transfers the final deoxysugar component to the hydroxyl group of the polyketide core structure. . FIG. 10c presents a diagram for the timing of reactions catalyzed by the gene product of ORF34 (SEQ ID NO: 69), a component of the protein family CALB, and the gene product of ORF9 (SEQ ID NO: 19), a component of the protein family GTFA. is doing. However, it will be readily understood that the present invention is not in actual timing and reaction sequence, as shown in FIG. 10c.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の部位を形成する更なるタンパク質は、ＯＲＦ２（配列番号４）の遺伝子産物及びタンパク質ファミリーＴＥＳＡの構成要素を含み、ポリケチドプライミングの校正機能を有することが予測される。タンパク質ファミリーＲＥＧＤ、ＲＲＥＢ、ＳＰＫＫ及びＲＥＧＤの構成要素である、ＯＲＦ３、４、５及び３１の各遺伝子産物（配列番号６、８、１０及び６３）は、化合物２（ａ）の合成を制御することが予測される。タンパク質ファミリーＵＮＥＷ及びＡＢＣＤの構成要素であるＯＲＦ６及び２１の各遺伝子産物（配列番号１２及び４３）は、膜透過輸送に関連している。タンパク質ファミリーＰＰＴＦの構成要素であるＯＲＦ２９（配列番号５９）の遺伝子産物は、フォスフォパンテエチニル化（phosphopantetheinylation）によってＡＣＰドメインを活性化する。
</span>
&nbsp;&nbsp;Additional proteins forming the site of compound 2 (a) include the gene product of ORF2 (SEQ ID NO: 4) and components of the protein family TESA and are predicted to have polyketide priming proofreading functions. Each gene product of <figure-callout id="3" label="ORF" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="4" label="ORF" filenames="2007525148-214.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="5" label="ORF" filenames="2007525148-217.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORF</a></figure-callout></a></figure-callout></a></figure-callout> 3, 4, 5 and 31 (SEQ ID NO: 6, 8, 10 and 63), which is a component of protein families REGD, RREB, SPKK and REGD, controls the synthesis of compound 2 (a) Is predicted. The gene products of <figure-callout id="6" label="ORFs" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="21" label="ORFs" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORFs</a></figure-callout></a></figure-callout> 6 and 21, which are components of the protein families UNEW and ABCD (SEQ ID NOs: 12 and 43) are associated with transmembrane transport. The gene product of ORF29 (SEQ ID NO: 59), a component of the protein family PPTF, activates the ACP domain by phosphopantetheinylation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の部位の遺伝子を組み換えることによって、式Ｉ及び式IIの化合物並びに化合物２（ａ）の構造を改変することができる。ＰＫＳ生合成の部位の遺伝子組換えは、当業界では公知である。特許公報ＷＯ０１／３４８１６は、ラパマイシン合成に関する部位における、遺伝子の遺伝子組換えに由来するマクロライドポリケチドラパマイシンの構造的変異体のライブラリーの構築を教示している。教示されている遺伝子組換えには、遺伝子の不活性化、遺伝子挿入及び遺伝子置換が含まれる。ラパマイシン部位内の異なる位置でこれらの改変を単独で、又は組み合わせて行うとポリケチドスターターユニット、鎖長、及び立体特異性が、ラパマイシンにおいて変わる。同様に、McDaniel et al. [Proc Natl Acad Sci USA, 1999, 96: 18646-51] は、遺伝子不活性化、マイクロライド鎖長及びエリスロマイシン生合成遺伝子のヒドロキシル立体特異性改変を含む遺伝子改変の組合せを用いて、マイクロライド系抗生物質エリスロマイシンの５０より多くの派生物のライブラリーを産生した。
</span>
&nbsp;&nbsp;By recombining the gene at the site of compound 2 (a), the structures of compounds of formula I and formula II and compound 2 (a) can be modified. Genetic recombination at the site of PKS biosynthesis is known in the art. Patent publication WO 01/34816 teaches the construction of a library of structural variants of the macrolide polyketidrapamycin derived from genetic recombination at a site related to rapamycin synthesis. The genetic recombination taught includes gene inactivation, gene insertion and gene replacement. When these modifications are made alone or in combination at different positions within the rapamycin site, the polyketide starter unit, chain length, and stereospecificity are altered in rapamycin. Similarly, McDaniel et al. [Proc Natl Acad Sci USA, 1999, 96: 18646-51] is a combination of genetic modifications including gene inactivation, microride chain length and hydroxyl stereospecific modification of the erythromycin biosynthesis gene. Was used to produce a library of more than 50 derivatives of the microride antibiotic erythromycin.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２ａの生合成をコードする核酸配列の解明によって、生物学的ツールが提供されるが、このツールを用いることによって、当業者は化合物２ａの変異体を産生するための生合成の経路の遺伝子的改変を行うことができる。特に、モジュール数やカルボン酸に対する特異性を変更することによって、また、還元活性を有するドメインを不活性化又は挿入することによって、Ｉ型のＰＫＳシステムを操作する (Katz, Chem. Rev. v. 97, 2557-2575, 1997) 。したがって、ドメインを改変、付加又は欠失させることによって、又は他のＩ型のＰＫＳ酵素から得たドメインに置換することによって、化合物２（ａ）のポリケチドシンターゼシステムを操作する。式Ｉの化合物は、化合物２ａの生成のためのポリケチドシンターゼシステムに基づいて作成された改変ＰＫＳシステムを用いて生成される。好ましい改変ＰＫＳシステムは、ＫＳ、ＡＴ、ＫＲ、ＤＨ又はＥＲドメインが不活性化又は欠失されたシステムである。
</span>
&nbsp;&nbsp;The elucidation of the nucleic acid sequence encoding the biosynthesis of compound 2a provides a biological tool by which one skilled in the art can generate genes in the biosynthetic pathway to produce a variant of compound 2a. Alterations can be made. In particular, the type I PKS system is manipulated by changing the number of modules and specificity for carboxylic acids, and by inactivating or inserting a domain having a reducing activity (Katz, Chem. Rev. v. 97, 2557-2575, 1997). Thus, the polyketide synthase system of compound 2 (a) is manipulated by modifying, adding or deleting domains, or by replacing domains obtained from other type I PKS enzymes. Compounds of formula I are produced using a modified PKS system made on the basis of a polyketide synthase system for the production of compound 2a. Preferred modified PKS systems are those in which the KS, AT, KR, DH or ER domain is inactivated or deleted.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある態様において、本発明は、改変されたポリケチドシンターゼシステムから得られた式Ｉ又はIIのポリケチドの調製に関し、前記の改変には、本発明の１又は２以上のドメインの欠失、変異誘発体、不活性化、又は置換が含まれる。改変されたポリケチドシンターゼシステムによって、大きさ、飽和レベル、及び酸化レベルが式２ａの化合物とは異なる式Ｉの化合物が生成される。別の態様においては、本発明は、化合物２（ａ）の部位のポリケチドシンターゼシステムの遺伝子組換えによって生成された式Ｉ又はIIの化合物に関する。
</span>
&nbsp;&nbsp;In certain embodiments, the present invention relates to the preparation of a polyketide of Formula I or II obtained from a modified polyketide synthase system, wherein said modification includes deletion of one or more domains of the present invention, mutants , Inactivation, or substitution. The modified polyketide synthase system produces a compound of formula I that differs in size, saturation level, and oxidation level from the compound of formula 2a. In another aspect, the invention relates to a compound of formula I or II produced by genetic recombination of the polyketide synthase system at the site of compound 2 (a).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物を、薬学的に許容される担体と組合せて、式Ｉの化合物を含む薬学的組成物に処方してもよい。
</span>
&nbsp;&nbsp;The compounds of the present invention may be formulated into a pharmaceutical composition comprising a compound of formula I in combination with a pharmaceutically acceptable carrier.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、細菌感染、真菌感染及び癌の治療に有用である。
</span>
&nbsp;&nbsp;The compounds of the present invention are useful for the treatment of bacterial infections, fungal infections and cancer.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書において用いられる分子用語は、他に明記されない限り、一般的な意味を有する。
</span>
&nbsp;&nbsp;Molecular terms used herein have a general meaning unless otherwise specified.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アルキルなる用語は、直線の又は分枝の炭化水素基に関する。アルキル基の例には、メチル、エチル、ｎ−プロピル、イソプロピル、ｎ−ブチル、ペンチル、ヘキシル、ヘプチル、シクロペンチル、シクロヘキシル、シクロヘキシメチル等が含まれるが、これらに限定されない。アルキル基は、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボオキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘトロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルフォニル、オキソ、グアニジノ及びホルミルから選択される１又は２以上の置換基によって任意に置換されてもよい。
</span>
&nbsp;&nbsp;The term alkyl relates to straight or branched hydrocarbon groups. Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, pentyl, hexyl, heptyl, cyclopentyl, cyclohexyl, cyclohexylmethyl and the like. Alkyl groups are acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxamido, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryl It may be optionally substituted with one or more substituents selected from oxy, sulfinyl, sulfonyl, oxo, guanidino and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アルケニルなる用語は、少なくとも１つの炭素炭素二重結合を含む直線の、分枝の、又は環状炭化水素基に関する。アルケニル基の例には、ビニル、１−プロペン−２−イル、１−ブテン−４−イル、２−ブテン−４−イル、１−ペンテン−５−イル等が含まれるが、これらに限定されない。アルケニル基は、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルフォニル、ホルミル、オキソ及びグアニジノから選択される１又は２以上の置換基によって任意に置換されてもよい。不飽和炭化水素鎖の二重結合部位は、シス型立体配置又はトランス配列のいずれであってもよい。
</span>
&nbsp;&nbsp;The term alkenyl relates to straight, branched or cyclic hydrocarbon groups containing at least one carbon-carbon double bond. Examples of alkenyl groups include, but are not limited to, vinyl, 1-propen-2-yl, 1-buten-4-yl, 2-buten-4-yl, 1-penten-5-yl and the like. . Alkenyl groups are acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy , Sulfinyl, sulfonyl, formyl, oxo and guanidino may be optionally substituted with one or more substituents. The double bond site of the unsaturated hydrocarbon chain may be either a cis configuration or a trans sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  シクロアルキル又はシクロアルキル環なる用語は、３から１５の員環を有する炭素単環又は縮合炭素環における飽和又は部分的に不飽和の炭素環に関する。シクロアルキル基の例には、シクロプロピル、シクロブチル、シクロヘキシル及びシクロヘプチルが含まれるが、これらに限定されない。シクロアルキル基は、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スフィニル、スルフォニル及びホルミルから選択される１又は２以上の置換基によって任意に置換されてもよい。
</span>
&nbsp;&nbsp;The term cycloalkyl or cycloalkyl ring relates to a saturated or partially unsaturated carbocycle in a carbomonocyclic or fused carbocycle having 3 to 15 membered rings. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclohexyl and cycloheptyl. Cycloalkyl groups are acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryl It may be optionally substituted with one or more substituents selected from oxy, sufinyl, sulfonyl and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ヘテロシクロアルキル、複素環、アルキル複素環なる用語は、３〜１５の員環を有する単独又は融合の複素環システムにおけるＯ、Ｎ、ＮＨ、ＮＲ<sup class="style-scope patent-text">Ｘ</sup>、ＰＯ<sub class="style-scope patent-text">２</sub>、Ｓ、ＳＯ又はＳＯ<sub class="style-scope patent-text">２</sub>から選択される１〜４のヘテロ原子又はヘテロ基を含む飽和又は部分的不飽和環に関する。ヘテロシクロアルキル基の例は、モルホリニル、ピペリジニル及びピロリジニルを含むが、これに限定されない。ヘテロシクロアルキル基は、アシル、アミノ、アシルアミノ、アシルオキシ、オキソ、チオカルボニル、イミノ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルフォニル及びホルミルから選択される１又は２以上の置換基で置換されてもよい。
</span>The term heterocycloalkyl, heterocyclic, alkyl heterocycle, selected <sup class="style-scope patent-text"> <sub class="style-scope patent-text">O, N, NH, NR X</sub> </sup> , <figure-callout id="2" label="PO" filenames="2007525148-208.png,2007525148-211.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">PO</a></figure-callout> 2, S, from SO or SO <sub class="style-scope patent-text">2</sub> in a single or fused heterocyclic ring system having 3 to 15-membered ring To saturated or partially unsaturated rings containing 1 to 4 heteroatoms or heterogroups. Examples of heterocycloalkyl groups include, but are not limited to, morpholinyl, piperidinyl and pyrrolidinyl. Heterocycloalkyl groups are acyl, amino, acylamino, acyloxy, oxo, thiocarbonyl, imino, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, It may be substituted with one or more substituents selected from aryl, heteroaryl, alkoxy, aryloxy, sulfinyl, sulfonyl and formyl.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アミノ酸なる用語は、天然アミノ酸、合成アミノ酸又は天然アミノ酸の合成派生物に関する。天然アミノ酸は例えば、アラニン、アルギニン、アスパラギン、アスパラギン酸、システイン、グルタミン酸、グルタミン、グリシン、ヒスチジン、イソロイシン、ロイシン、リシン、メチオニン、フェニルアラニン、プロリン、セリン、トレオニン、トリプトファン、チロシン及びバリンを含むが、これに限定されない。
</span>
&nbsp;&nbsp;The term amino acid relates to natural amino acids, synthetic amino acids or synthetic derivatives of natural amino acids. Natural amino acids include, for example, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine. It is not limited to.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ハロなる用語は、臭素、塩素、フッ素又はヨード原子として定義される。
</span>
&nbsp;&nbsp;The term halo is defined as a bromine, chlorine, fluorine or iodo atom.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アリール又はアリール環なる用語は、５〜１５の員環を有する単独又は融合の環系から成る芳香族基に関する。アリール基の例は、フェニル、ナフチル、ビフェニル、テルフェニルを含むが、これに限定されない。アリール基は、アシル、アミノ、アシルアミノ、アシルオキシ、アジド、アルキチオ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルフォニル及びホルミルから選択される１又は２以上の置換基で置換されてもよい。
</span>
&nbsp;&nbsp;The term aryl or aryl ring relates to an aromatic group consisting of a single or fused ring system having 5 to 15 membered rings. Examples of aryl groups include, but are not limited to, phenyl, naphthyl, biphenyl, terphenyl. Aryl groups are acyl, amino, acylamino, acyloxy, azide, alkthio, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, It may be substituted with one or more substituents selected from alkoxy, aryloxy, sulfinyl, sulfonyl and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ヘテロアリール又はヘテロアリール環なる用語は、５〜１５の員環を有し、Ｏ、Ｎ、Ｓ、ＳＯ及びＳＯ<sub class="style-scope patent-text">２</sub>等のヘテロ原子を少なくとも一つ含む単独又は融合環系から成る芳香属基に関する。ヘテロアリール基の例は、ピリジニル、チアゾリル、チアジアゾリル（thiadiazoyl）、イソキノリニル、ピラゾリル、オキサゾリル、オキサジアゾイル（oxadiazoyl）、トリアゾリル及びピロリル基を含むが、これに限定されない。ヘテロアリール基は、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、チオカルボニル、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルフォニル及びホルミルから選択されるた１又は２以上の置換基で置換されてもよい。
</span>The term heteroaryl or heteroaryl ring having 5-15 membered ring, O, N, S, relates aromatic Shokumoto consisting solely or fused ring system containing at least one hetero atom <sub class="style-scope patent-text">2</sub> such as SO and SO . Examples of heteroaryl groups include, but are not limited to, pyridinyl, thiazolyl, thiadiazoyl, isoquinolinyl, pyrazolyl, oxazolyl, oxadiazoyl, triazolyl and pyrrolyl groups. Heteroaryl groups are acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, thiocarbonyl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, It may be substituted with one or more substituents selected from alkoxy, aryloxy, sulfinyl, sulfonyl and formyl.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書中に記載される、「治療」なる表現は、障害、すなわち疾病又は状態、疾患の症状は疾患の傾向がある患者に、疾患、疾患の症状又は疾患の傾向を治療、治癒、緩和、軽減、変化、改善、好転、影響する目的で、治療薬を投与又は塗布すること、又は患者から単離した組織又は細胞株に治療薬を投与又は塗布すること、に関する。
</span>
&nbsp;&nbsp;As used herein, the term “treatment” refers to treating, curing, or alleviating a disease, a symptom of a disease, or a propensity of a disease in a disorder, ie, a disease or condition, a symptom of the disease being a propensity of the disease. , To administer or apply a therapeutic agent, or to administer or apply a therapeutic agent to a tissue or cell line isolated from a patient for the purpose of mitigating, changing, improving, improving, or affecting.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書中に使用される、「薬学的な組成物」とは、ファルネシルジベンゾジアゼピノン（farnesyl dibenzodiazepinone）及び薬学的に許容される担体の薬学的な有効量を含む。本明細書中に使用される、「薬学的な有効量」、「治療的な有効量」、又は単に「有効量」とは、目的とする薬理学的、治療的又は予防的結果を産出するために有効なファルネシルジベンゾジアゼピノンの量に関する。例えば、もし、ある一定の医療処置が、疾病又は疾患に関連した測定可能なパラメーターが少なくとも２５％の減少した時に、有効であるとみなされるのならば、かかる疾病又は疾患の治療の治療的なに有効量とは、そのパラメーターが少なくとも２５％減少する効果を及ぼすために必要な量のことである。
</span>
&nbsp;&nbsp;As used herein, “pharmaceutical composition” includes a pharmaceutically effective amount of farnesyl dibenzodiazepinone and a pharmaceutically acceptable carrier. As used herein, “pharmaceutically effective amount”, “therapeutically effective amount”, or simply “effective amount” yields the intended pharmacological, therapeutic or prophylactic result. In relation to the amount of farnesyl dibenzodiazepinone effective. For example, if a certain medical procedure is considered effective when a measurable parameter associated with the disease or disorder is reduced by at least 25%, it is therapeutic for the treatment of such disease or disorder. An effective amount is that amount necessary to have the effect of reducing the parameter by at least 25%.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「薬学的に許容される担体」なる用語は、治療薬の投与のための担体に関する。前記の担体は、生理食塩水、緩衝生理食塩水、ブドウ糖、水、グリセロール、エタノール及びそれらの組合せを含むが、これに限定されない。かかる用語は、特に細胞培養培地を除外している。経口投与薬に関しては、薬学的に許容される担体とは、不活性希釈剤、崩壊剤、結合剤、潤滑剤、甘味剤、着味剤、着色剤、及び防腐剤などの薬学的に許容される賦形剤を含むが、これに限定されない。適切な不活性希釈剤には、炭酸ナトリウム及び炭酸カルシウム、リン酸ナトリウム及びリン酸カルシウム及び乳糖を含まれるが、コーンスターチとアルギン酸は適切な崩壊剤である。結合剤は、スターチ及びゼラチンを含むことができるが、潤滑剤は、存在する場合は、一般的にステアリン酸マグネシウム、ステアリン酸又はタルクである。必要に応じて、錠剤は、消化管における吸収を遅らせるために、モノステアリン酸グリセリル又はジステアリン酸グリセリル等の物質によってコーティングされてもよい。
</span>
&nbsp;&nbsp;The term “pharmaceutically acceptable carrier” relates to a carrier for administration of a therapeutic agent. Such carriers include, but are not limited to, saline, buffered saline, dextrose, water, glycerol, ethanol and combinations thereof. Such terms specifically exclude cell culture media. For orally administered drugs, pharmaceutically acceptable carriers are pharmaceutically acceptable, such as inert diluents, disintegrants, binders, lubricants, sweeteners, flavoring agents, colorants, and preservatives. However, it is not limited to this. Suitable inert diluents include sodium carbonate and calcium carbonate, sodium phosphate and calcium phosphate and lactose, but corn starch and alginic acid are suitable disintegrants. Binders can include starch and gelatin, but lubricants, if present, are generally magnesium stearate, stearic acid or talc. If desired, tablets may be coated with a substance such as glyceryl monostearate or glyceryl distearate to delay absorption in the gastrointestinal tract.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  薬学的に許容される塩は、酸付加塩及び塩基付加塩を含む。塩の性質は、薬学的に許容されれば、臨界的でない。酸付加塩の例としては、塩酸、臭化水素、よう化水素、窒素、炭酸、硫酸、リン酸、ギ酸、酢酸、クエン酸、酒石酸、コハク酸、シュウ酸、リンゴ酸、グルタミン酸、プロピオン酸、グリコール酸、グルコン酸、マレイン酸、エンボン酸（パモン酸）、メタンスルホン酸、エタンスルホン酸、２−ヒドロキシエタンスルホン酸、パントテン酸、ベンゼンスルホン酸、トルエンスルホン酸、スルファニル酸、メシリック（mesylic）、シクロエキシアミノスルホン酸、ステアリン酸、アルギン酸、β−ヒドロキシ酪酸、マロン酸、ガランタンティック（galactantic）、ガラクツロン等が含まれるが、これに限定されない。適切な薬学的に許容される本発明の化合物の塩基付加塩は、アルミニウム、カルシウム、リチウム、マグネシウム、カリウム、ナトリウム及び亜鉛からできる金属塩、Ｎ’−ジメチレンジアミン、クロロプロカイン、コリン、ジエタノール、エチレンジアミン、Ｎ−メチルグルカミン、リシン、プロカイン等を含むが、これに限定されない。薬学的に許容される塩のさらなる例は、Journal of Pharmaceutical Sciences, 1977, 66:2に記載されている。これらの全ての塩は、従来の方法で式Ｉの対応する化合物から適切な酸又は塩基を処理して調製することができる。
</span>
&nbsp;&nbsp;Pharmaceutically acceptable salts include acid addition salts and base addition salts. The nature of the salt is not critical if it is pharmaceutically acceptable. Examples of acid addition salts include hydrochloric acid, hydrogen bromide, hydrogen iodide, nitrogen, carbonic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, citric acid, tartaric acid, succinic acid, oxalic acid, malic acid, glutamic acid, propionic acid, Glycolic acid, gluconic acid, maleic acid, embonic acid (pamonic acid), methanesulfonic acid, ethanesulfonic acid, 2-hydroxyethanesulfonic acid, pantothenic acid, benzenesulfonic acid, toluenesulfonic acid, sulfanilic acid, mesylic, Examples include, but are not limited to, cyclooxyaminosulfonic acid, stearic acid, alginic acid, β-hydroxybutyric acid, malonic acid, galactantic, galacturon, and the like. Suitable pharmaceutically acceptable base addition salts of the compounds of the invention include metal salts made from aluminum, calcium, lithium, magnesium, potassium, sodium and zinc, N′-dimethylenediamine, chloroprocaine, choline, diethanol, Including, but not limited to, ethylenediamine, N-methylglucamine, lysine, procaine and the like. Further examples of pharmaceutically acceptable salts are described in Journal of Pharmaceutical Sciences, 1977, 66: 2. All of these salts can be prepared from the corresponding compound of formula I by treatment with the appropriate acid or base in a conventional manner.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、１又は２以上の非対称性の炭素原子を有することができ、ラセミ又は非ラセミ化合物を形成しながら、光学異性体として存在することができる。本発明の化合物は、単独の異性体又は立体化学的な異性体の形態として有用である。ジアステオ異性体、すなわち、重ねあわせることが出来ない立体化学異性体は、クロマトグラフィー、蒸留、結晶化及び昇華等の従来の方法で分離することができる。光学異性体は、従来の過程に従って、ラセミ混合物の分割によって得ることができる。
</span>
&nbsp;&nbsp;The compounds of the present invention can have one or more asymmetric carbon atoms and can exist as optical isomers, forming racemic or non-racemic compounds. The compounds of the present invention are useful as single isomers or stereochemical isomer forms. Diastero isomers, ie stereochemical isomers that cannot be superposed, can be separated by conventional methods such as chromatography, distillation, crystallization and sublimation. Optical isomers can be obtained by resolution of racemic mixtures according to conventional processes.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、単離された化合物を包含する。単離された化合物は、本発明の化合物が、当業者に既知の従来の生物学分析で検査した際に、抗菌、抗真菌又は抗癌作用を含む生化学的活性を実証できる程度（すなわち統計学的に有意である）有するという条件で、ある混合物内の本発明の化合物が少なくとも１０％、２０％、５０％及び８０％含まれる化合物に関する。
</span>
&nbsp;&nbsp;The present invention includes isolated compounds. The isolated compound is such that the compound of the present invention can demonstrate biochemical activity including antibacterial, antifungal or anticancer activity when tested by conventional biological analysis known to those skilled in the art (ie, statistics). Which is at least 10%, 20%, 50% and 80% of a compound of the invention in a mixture, provided that
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物又はその薬学的に許容される塩は、特に細菌感染及び真菌感染症などの疾患の治療的又は予防的処置のための経口、静脈内、筋肉内、皮下投与、局所投与又は非経口投与するための形態で製剤化することができる。経口又は非経口の投与には、本発明の化合物は、従来の薬学的な担体及び賦形剤と混合し、錠剤、カプセル、エルキシル剤、懸濁液、シロップ、ウェハー等の形態で用いることができる。本発明の化合物を含む組成物は、活性化合物を約０．１〜約９９．９重量％、約５〜約９５重量％、約１０〜約８０重量％、又は約１５〜約６０重量％含む。
</span>
&nbsp;&nbsp;The compounds of the present invention or pharmaceutically acceptable salts thereof can be administered orally, intravenously, intramuscularly, subcutaneously, topically or non-particularly for the therapeutic or prophylactic treatment of diseases such as bacterial and fungal infections. It can be formulated in a form for oral administration. For oral or parenteral administration, the compounds of the present invention may be mixed with conventional pharmaceutical carriers and excipients and used in the form of tablets, capsules, elixirs, suspensions, syrups, wafers, etc. it can. Compositions containing the compounds of the invention contain from about 0.1 to about 99.9%, from about 5 to about 95%, from about 10 to about 80%, or from about 15 to about 60% by weight of the active compound. .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書中に開示される薬学的な調製物は、標準の手順に従って調製され、細菌感染及び真菌感染を軽減、予防、又は除去するために選択される投与量を投与する（ヒトの治療のための様々な抗菌剤を投与する方法の一般的な記載に関しては、Remington’s Pharmaceutical Sciences, Mack Publishing Company, Easton, PA及びGoodman and Gilman’s the Pharmaceutical Basis of Therapeutics, Pergamon Press, New York, NY参照。  その内容は参照のために組み込まれている）。本発明の組成物は、放出性デリバリーシステム（例えば、カプセル）又は、持続性デリバリーシステム（例えば、生化学的侵食性基質 (bioerodable matrices)）を用いてデリバリーすることが出来る。本発明の組成物（好ましくは式Ｉ）の投与に適切なドラッグデリバリーの放出遅延性デリバリーシステムの例は、米国特許番号４，４５２，７７５（Kent）５，２３９，６６０（Leonard）３，８５４，４８０（Zaffaroni）に記載されている。
</span>
&nbsp;&nbsp;The pharmaceutical preparations disclosed herein are prepared according to standard procedures and are administered at a dosage selected to reduce, prevent, or eliminate bacterial and fungal infections (human therapeutics). For a general description of how to administer various antibacterial agents, see Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, PA and Goodman and Gilman's the Pharmaceutical Basis of Therapeutics, Pergamon Press, New York, NY. Are incorporated for reference). The compositions of the invention can be delivered using releasable delivery systems (eg, capsules) or sustained delivery systems (eg, biochemical erodible matrices). Examples of drug delivery delayed release delivery systems suitable for administration of the compositions of the invention (preferably Formula I) are described in US Pat. No. 4,452,775 (Kent) 5,239,660 (Leonard) 3,854. 480 (Zaffaroni).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
 本発明の薬学的に許容される組成物は、本明細書中でまとめて「担体」の物質と言及される、１つ又は２以上の非毒性の薬学的に許容される担体及び／又は希釈剤及び／又はアジュバンド及び／又は賦形剤と、必要に応じて、他の活性成分と共に、１又は２以上の本発明の化合物を含む。組成物は、コーンスターチ、ゼラチン、乳糖、ショ糖、微結晶性セルロース、カオリン、マンニトール、第二リン酸カルシウム、塩化ナトリウム及びアルギン酸等の一般的な担体及び賦形剤を含む。組成物はクロサルメロース・ナトリウム（crosarmellose sodium）、微結晶性セルロース、グリコール酸ナトリウムスターチ及びアルギン酸を含むことができる。
</span>
&nbsp;The pharmaceutically acceptable compositions of the present invention comprise one or more non-toxic pharmaceutically acceptable carriers and / or dilutions collectively referred to herein as “carrier” materials. One or more compounds of the invention are included, along with agents and / or adjuvants and / or excipients, and optionally other active ingredients. The composition includes common carriers and excipients such as corn starch, gelatin, lactose, sucrose, microcrystalline cellulose, kaolin, mannitol, dicalcium phosphate, sodium chloride and alginic acid. The composition can include crosarmellose sodium, microcrystalline cellulose, sodium glycolate starch and alginic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  使用可能な潤滑剤は、ステアリン酸マグネシウム又は他のステアリン酸金属、ステアリン酸、シリコン液、タルク、ワックス、油分及びコロイド状のシリカを含む。
</span>
&nbsp;&nbsp;Lubricants that can be used include magnesium stearate or other metal stearate, stearic acid, silicone fluid, talc, wax, oils and colloidal silica.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ペパーミント、ウィンターグリーンの油、チェリー味の着味剤を用いることができる。剤型の外観をより美的にするため、又は本発明の化合物を含む製品を識別しやすくするために、着色剤を添加することが望ましい。
</span>
&nbsp;&nbsp;Peppermint, winter green oil, cherry flavoring agents can be used. It is desirable to add a colorant to make the appearance of the dosage form more aesthetic or to make it easier to identify products containing the compounds of the invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  経口投与には、薬学的な組成物は、例えば、錠剤、カプセル、懸濁液又は液体の形態である。経口での使用には、錠剤やカプセル等のなどの固形製剤が特に有用である。持続性製剤又は経腸的にコーティングされた製剤も考案することができる。錠剤の結合剤としては、アカシア、メチルセルロース、カルボキシメチルセルロースナトリウム、ポリビニエルピロリドン、プロビドン（providone）、ヒドロキシプロピルメチルセルロース、ショ糖、スターチ及びエチルセルロースを含むことができる。小児及び老人への投与では、懸濁液、シロップ、及びチュアブルな錠剤が特に適切である。薬学的な組成物は、活性成分の治療的な有効量を含む投与ユニットの形態で作られるのが好ましい。かかる投与ユニットの例は、錠剤及びカプセルである。治療上の目的で、活性成分に加えて、錠剤やカプセルは、例えばアカシアゴム、ゼラチン、ポリビニルピロリドン、ソルビトール又はトラガカント等の結合剤；リン酸カルシウム、グリシン、乳糖、コーンスターチ、ソルビトール又はショ糖等の賦形剤；ステアリン酸マグネシウム、ポリエチレングリコール、シリカ又はタルクなどの潤滑剤；ポテトスターチ等の崩壊剤；着味剤や着色剤又は許容できる湿潤剤、等従来の担体を含むことができる。経口液体調整物は、通常、水溶液又は油液の形態であり、懸濁液、乳濁液、シロップやエリキシル剤は懸濁剤、乳化剤、非水溶剤、防腐剤、着色剤及び着味剤等の従来の添加物を含むことができる。液体製剤の添加物の例としては、アカシア、アーモンド油、エチルアルコール、ヤシ油、ゼラチン、グルコースシロップ、グリセリン、水素化食用油脂、レシチン、メチルセルロース、メチル又はプロピルｐ−ヒドロキシ安息香酸、プロピリングリコール、ソルビトール、又はソルビン酸を含むことができる。
</span>
&nbsp;&nbsp;For oral administration, the pharmaceutical composition is in the form of, for example, a tablet, capsule, suspension or liquid. For oral use, solid preparations such as tablets and capsules are particularly useful. Sustained preparations or enterally coated preparations can also be devised. Tablet binders can include acacia, methylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidone, providone, hydroxypropylmethylcellulose, sucrose, starch and ethylcellulose. For administration to children and the elderly, suspensions, syrups and chewable tablets are particularly suitable. The pharmaceutical composition is preferably made in the form of a dosage unit containing a therapeutically effective amount of the active ingredient. Examples of such administration units are tablets and capsules. For therapeutic purposes, in addition to the active ingredient, tablets and capsules may be formed by binding agents such as gum acacia, gelatin, polyvinylpyrrolidone, sorbitol or tragacanth; and calcium phosphate, glycine, lactose, corn starch, sorbitol or sucrose Agents; lubricants such as magnesium stearate, polyethylene glycol, silica or talc; disintegrants such as potato starch; flavoring agents, colorants or acceptable wetting agents, and the like conventional carriers can be included. Oral liquid preparations are usually in the form of aqueous solutions or oils, and suspensions, emulsions, syrups and elixirs are suspensions, emulsifiers, non-aqueous solvents, preservatives, colorants and flavoring agents, etc. Conventional additives. Examples of liquid formulation additives include acacia, almond oil, ethyl alcohol, coconut oil, gelatin, glucose syrup, glycerin, hydrogenated edible fats, lecithin, methylcellulose, methyl or propyl p-hydroxybenzoic acid, propylene glycol, Sorbitol, or sorbic acid can be included.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  静脈内（ＩＶ）に使用する際には、本発明の化合物は、注入投与に一般的に用いられる静脈内輸液に、溶解又は懸濁することが出来る。静脈内輸液には、生理食塩水又はリンガー溶液が含まれるが、これに限定されない。
</span>
&nbsp;&nbsp;When used intravenously (IV), the compounds of the invention can be dissolved or suspended in intravenous infusions commonly used for infusion administration. Intravenous infusion includes, but is not limited to, saline or Ringer's solution.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  非経口投与の製剤は、水溶性又は非水溶性の無菌性等張注射溶液又は懸濁液の形態であってもよい。これらの溶液又は懸濁液は、経口投与用の製剤に使用されると記載された担体を１又は２以上有する無菌性粉末又は顆粒から調製することができる。かかる化合物は、ポリエチレングリコール、プロピレングリコール、エタノール、コーン油、ベンジルアルコール、塩化ナトリウム及び／又は様々な緩衝液に溶解してもよい。
</span>
&nbsp;&nbsp;Formulations for parenteral administration may be in the form of water-soluble or water-insoluble sterile isotonic injection solutions or suspensions. These solutions or suspensions can be prepared from sterile powders or granules having one or more carriers described as being used in formulations for oral administration. Such compounds may be dissolved in polyethylene glycol, propylene glycol, ethanol, corn oil, benzyl alcohol, sodium chloride and / or various buffers.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  筋肉内投与の製剤は、本発明の化合物の無菌性製剤又はかかる化合物を形成する適切な可溶化塩は、注射水（ＷＦＩ）、生理食塩水、又は５％のグルコース等の薬学的な希釈剤に溶解及び投与してもよい。かかる化合物の適切な不溶性の形態は、例えばオレイン酸エチル等の長鎖脂肪酸のエステルといった水溶性基剤又は薬学的に許容できる油性基剤内に懸濁液として調製及び投与してもよい。
</span>
&nbsp;&nbsp;Formulations for intramuscular administration are sterile formulations of the compounds of the invention or suitable solubilizing salts forming such compounds are pharmaceutical diluents such as water for injection (WFI), saline, or 5% glucose And may be dissolved and administered. Suitable insoluble forms of such compounds may be prepared and administered as a suspension in a water soluble base such as an ester of a long chain fatty acid such as ethyl oleate or a pharmaceutically acceptable oil base.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  局所使用に関しては、本発明の化合物は、皮膚、鼻や喉の粘液膜に塗布する適切な形態で調製することができ、クリーム、軟膏、液体スプレーや吸入剤、トローチ剤又は喉への塗布剤の形態を取ることが出来る。かかる局所用の製剤は、活性成分の表面浸透を容易にするために、ジメチルスホキサイド等の化学化合物をさらに含むことが出来る。
</span>
&nbsp;&nbsp;For topical use, the compounds of the present invention can be prepared in any suitable form for application to the mucous membranes of the skin, nose and throat, creams, ointments, liquid sprays and inhalants, lozenges or throat applications. Can take the form of Such topical formulations can further comprise a chemical compound such as dimethyl sulfoxide to facilitate surface penetration of the active ingredient.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  眼や耳への投与に関しては、本発明の化合物は、軟膏、クリーム、ローション、塗布剤又は散剤等の、疎水性又は親水基質として製剤化した液体又は半液体の形態をとることが出来る。
</span>
&nbsp;&nbsp;For administration to the eye or ear, the compounds of the invention can take the form of liquids or semi-liquids formulated as hydrophobic or hydrophilic substrates, such as ointments, creams, lotions, coatings or powders.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  直腸投与には、本発明の化合物は、ココアバター、ワックス又は他のグリセリド等の従来の担体と混合した座薬の形態で投与することが出来る。
</span>
&nbsp;&nbsp;For rectal administration, the compounds of the invention can be administered in the form of suppositories mixed with a conventional carrier such as cocoa butter, wax or other glycerides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、本発明の化合物は、デリバリーの際に、適切な薬学的に許容できる担体で再構築するために粉末形態であってもよい。別の態様において、かかる化合物の投与ユニットは、無菌の密閉されたアンプル内の適切な希釈剤における化合物の溶液またはその塩であってもよい。
</span>
&nbsp;&nbsp;The compounds of the present invention may also be in powder form for reconstitution with an appropriate pharmaceutically acceptable carrier upon delivery. In another embodiment, the compound administration unit may be a solution of the compound or a salt thereof in a suitable diluent in a sterile sealed ampoule.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  投与ユニットあたりの本発明の化合物の量は、対象レシピエント、投与の経路又は頻度によって変化する、本発明の活性化合物の少なくとも一つの治療上有効な量を含む。対象レシピエントは、植物、細胞培養、又はヒツジ等の動物やヒトを含む哺乳類などの動物に関する。
</span>
&nbsp;&nbsp;The amount of the compound of the present invention per dosage unit includes at least one therapeutically effective amount of the active compound of the present invention, which varies depending on the target recipient, the route or frequency of administration. The target recipient relates to animals such as plants, cell cultures, animals such as sheep, and mammals including humans.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の本態様によると、本明細書中に開示されている新規組成物は、薬学的に許容できる担体内に配置され、既知のドラッグデリバリーの方法に従って対象レシピエント（ヒトの対象を含む）にデリバリーされる。一般的に、本発明の組成物をインビボでデリバリーする本発明の方法は、当該技術で認められているプロトコルにおける薬剤で本発明の化合物を置換する、実質上の改変だけを行って、薬剤をデリバリーするための当該技術で認められているプロトコルを用いる。
</span>
&nbsp;&nbsp;In accordance with this aspect of the present invention, the novel compositions disclosed herein are placed in a pharmaceutically acceptable carrier and are targeted to recipients (including human subjects) according to known drug delivery methods. Delivered to. In general, the methods of the present invention for delivering the compositions of the present invention in vivo involve only substantially modifying the drug of the present invention with a drug in a protocol recognized in the art, making the drug Use art-recognized protocols for delivery.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  同様に、クレーム記載の組成物を培養中の細胞を処理するために使用する方法、例えば、細胞培養の細菌又は真菌混入を排除又は減少させる方法は、当該技術で認められているプロトコルにおける薬剤で本発明の化合物を置換する、実質上の改変だけを行って、抗細菌剤や抗真菌剤で細胞培養を処理するための当該技術で認められているプロトコルを用いる。
</span>
&nbsp;&nbsp;Similarly, methods of using the claimed compositions to treat cells in culture, such as methods for eliminating or reducing bacterial or fungal contamination of cell cultures, can be achieved with agents in protocols recognized in the art. Art-recognized protocols for treating cell cultures with antibacterial and antifungal agents are used, with only substantial modifications replacing the compounds of the present invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、細菌感染、真菌感染又は前癌性若しくは癌症状態の治療方法を提供している。本明細書中に記載される、投与ユニットという用語は、目的とする治療反応を誘因する本発明の化合物の治療上有効な量に関する。本明細書中に記載される治療上有効な量なる表現は、発症を予防し、症状を緩和し、細菌感染、真菌感染又は前癌性若しくは癌症状の進行を止める本発明の化合物の量を意味している。治療という表現は、対象に、細菌、真菌感染又は前癌性若しくは癌症状の発症を予防するか、細菌、真菌感染又は前癌性若しくは癌症状を制御又は排除するために、少なくとも１つの本発明の化合物の治療上有効な量を投与することと定義している。目的とする治療反応という表現は、対象レシピエントにおいて、細菌、真菌感染又は前癌性若しくは癌症状を改善、進行を抑制、又は予防するように、対象レシピエントを本発明の化合物で処置することを意味している。
</span>
&nbsp;&nbsp;The compounds of the present invention provide methods for the treatment of bacterial infections, fungal infections or precancerous or cancerous conditions. As used herein, the term administration unit relates to a therapeutically effective amount of a compound of the invention that elicits a desired therapeutic response. The expression therapeutically effective amount described herein refers to the amount of a compound of the invention that prevents the onset, alleviates symptoms, and stops the progression of bacterial, fungal or precancerous or cancerous symptoms. I mean. The expression treatment is intended to prevent the development of a bacterial, fungal infection or precancerous or cancerous condition in a subject or to control or eliminate a bacterial, fungal infection or precancerous or cancerous condition. Is defined as administering a therapeutically effective amount of the compound. The expression therapeutic response of interest refers to treating a subject recipient with a compound of the present invention so as to ameliorate, inhibit or prevent bacterial, fungal infection or precancerous or cancerous symptoms in the subject recipient. Means.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、１日１回、又は１日に数回、投与されてもよい。治療方法は、数日間又は２から４週間の長期間の投与が必要となる場合がある。１回の投与量、又は投与の合計量は、感染の性質や程度、対象レシピエントの年齢や健康、対象レシピエントの化合物に対する耐性、及び細菌や真菌感染の種類、又は癌の種類といった要因によって変化する。
</span>
&nbsp;&nbsp;The compounds of the present invention may be administered once a day or several times a day. Treatment methods may require long-term administration of several days or 2 to 4 weeks. The single dose or total dose depends on factors such as the nature and extent of the infection, the age and health of the target recipient, resistance to the compound of the target recipient, and the type of bacterial or fungal infection, or the type of cancer. Change.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、患者又は動物の食事又は餌に投与してもよい。動物への食餌は、通常の食糧に化合物を添加しても、前もって混ぜたものでもよい。
</span>
&nbsp;&nbsp;The compounds of the present invention may be administered to the diet or food of a patient or animal. The food for the animals may be a compound added to normal food or may be premixed.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、治療を必要としている対象レシピエントを治療するために、臨床的に認められている抗菌、抗真菌又は抗癌剤と一緒に又は別々に組み合わせて摂取してもよい。
</span>
&nbsp;&nbsp;The compounds of the present invention may be taken in conjunction with or separately in combination with clinically recognized antibacterial, antifungal or anticancer agents to treat a subject recipient in need of treatment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物は、表４に記載されている成長培地内でアクチノミセス種（Actinomyetes species）を、２４℃〜３４℃の温度で、培養培地を通気するために３〜４０日間振盪して培養することによって、生合成的に得ることができる。式Ｉの化合物は、遠心分離、クロマトグラフィー、吸着、ろ過、抽出又は他の分離方法を含む当業者に知られている方法によって、細菌培養から抽出され単離される。
</span>
&nbsp;&nbsp;The compound of formula I is cultured in the growth medium listed in Table 4 by shaking Actinomytes species at a temperature of 24 ° C.-34 ° C. for 3-40 days to aerate the culture medium. Can be obtained biosynthetically. The compounds of formula I are extracted and isolated from bacterial cultures by methods known to those skilled in the art including centrifugation, chromatography, adsorption, filtration, extraction or other separation methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物は、様々な微生物から生合成することができる。本発明の化合物を合成する微生物は、Actinomycetalesの目（order）、すなわちアクチノミセテスの細菌を含むが、これに限定されない。アクチノミセテスの属としては、ノカルジア（Nocardia）、ゲオデルマトフィルス（Geodermatophilus）、アクチノプラーネス（Atinoplanes）、マイクロモノスポラ（Micromonospor）、  ノカルジオイド（Nocardiodes）、サッカロスリス（Saccharothrix）、アミコラトプシス（Amycolatopsis）、クツネリア（Kutzneria）、サッカロモノスポラ（Saccharomonospora）、サッカロポリスポラ（Saccharopolyspora）、キタサトスポラ（Kitasatospora）、ストレプトミセス（Sterptomyces）、マイクロビスポラ（Microbispora）、ストレプトスポランギム（Streptosporangium）、アクチノマヅラ（Actinomadura）を含むが、これに限定されない。アクチノミセテスの分類法は複雑であり、本発明の化合物を合成することができる属に関して、以下の文献が参考のために組み込まれている：Goodfellow (1989) Suprageneric classification of actinomycetes, Bergey’s Manual of Systematic Bacteriology, Vol. 4, Williams and Wilkins, Baltimore, pp 2322-2339；Embley and Stackebrandt, (1994) 及びThe molecular phylogeny and systematics of the actinomycetes, Annu. Rev. Microbiol. 48, 257-289 (1994)。
</span>
&nbsp;&nbsp;The compounds of formula I can be biosynthesized from various microorganisms. Microorganisms that synthesize the compounds of the present invention include, but are not limited to, Actinomycetales orders, ie, Actinomycetes bacteria. The genus of Actinomycetes includes Nocardia, Geodermatophilus, Atinoplanes, Micromonospor, Nocardiodes, Saccharothrix, Saccharothrix, Amycolatopsis Kutzneria, Saccharomonospora, Saccharopolyspora, Kitasatospora, Streptomyces, Microbispora, Streptosporangium (eptaporangium, Streptosporangium) Including, but not limited to. The taxonomy of Actinomycetes is complex and the following references are incorporated by reference for the genus from which the compounds of the invention can be synthesized: Goodfellow (1989) Suprageneric classification of actinomycetes, Bergey's Manual of Systematic Bacteriology, Vol. 4, Williams and Wilkins, Baltimore, pp 2322-2339; Embryy and Stackebrandt, (1994) and The molecular phylogeny and systematics of the actinomycetes, Annu. Rev. Microbiol. 48, 257-289 (1994).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物を生合成的に生成する微生物は、同化有機炭素、窒素及び任意の無機塩並びに他の既知の成長因子を有するアクチノミセテス用の栄養性原料を含むｐＨ約６〜約９の培養培地で培養される。成長培地は表４に例示されているが、これに限定されない。
</span>
&nbsp;&nbsp;A microorganism that biosynthetically produces a compound of formula I is a culture medium having a pH of about 6 to about 9, comprising a nutrient source for Actinomycetes having anabolic organic carbon, nitrogen and any inorganic salts and other known growth factors. Incubated in The growth medium is exemplified in Table 4, but is not limited thereto.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式Ｉの化合物を生成するための成長培地の例<br class="style-scope patent-text">
<tables num="4" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000103" he="114" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="456" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000104" he="49" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="196" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
指定しない限り、全ての原料は、ｇｍ／Ｌで表す。<br class="style-scope patent-text">
<sup class="style-scope patent-text">*3</sup>  微量元素溶液は、以下を含む：１リットル当たり、ＺｎＣｌ<sub class="style-scope patent-text">２</sub>４０  ｍｇ；Ｆｅ  Ｃｌ<sub class="style-scope patent-text">３</sub>  ６Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（２００ｍｇ）；ＣｕＣｌ<sub class="style-scope patent-text">２</sub>２Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（１０ｍｇ）；ＭｎＣｌ<sub class="style-scope patent-text">２、</sub>４Ｈ<sub class="style-scope patent-text">２</sub>Ｏ；Ｎａ<sub class="style-scope patent-text">２</sub>Ｂ<sub class="style-scope patent-text">４</sub>Ｏ<sub class="style-scope patent-text">７</sub>．１０Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（１０ｍｇ）；（ＮＨ<sub class="style-scope patent-text">４</sub>）<sub class="style-scope patent-text">６</sub>Ｍｏ<sub class="style-scope patent-text">７</sub>Ｏ<sub class="style-scope patent-text">２４</sub>．４Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（１０ｍｇ）。  <br class="style-scope patent-text">
<sup class="style-scope patent-text">*4</sup>  成分を８００ｍｌの水に溶解し、オートクレーブし、後に以下を添加する：<br class="style-scope patent-text">
１０ｍｌのＫＨ<sub class="style-scope patent-text">２</sub>ＰＯ<sub class="style-scope patent-text">４</sub>（０．５％溶液）；８０ｍｌのＣａＣｌ<sub class="style-scope patent-text">２</sub>．２Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（３．６８％溶液）；１５ｍｌのＬ−プロリン（２０％溶液）；１００ｍｌＴＥＳ緩衝液（５．７３％溶液、ｐＨ７．２）；５ｍｌのＮａＯＨ（１Ｎ溶液）及び２ｍｌの微量元素溶液。<br class="style-scope patent-text">
<sup class="style-scope patent-text">*5</sup>  ｐＨは、ＣａＣｏ<sub class="style-scope patent-text">３</sub>を含む培地にＣａＣｏ<sub class="style-scope patent-text">３</sub>を添加する前に、前記の通り調整する。
Examples of growth media for producing compounds of formula I <br class="style-scope patent-text"> <tables num="4" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000103" he="114" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="456" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000104" he="49" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="196" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> Unless otherwise specified, all raw materials are expressed in gm / L. <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 3</sup> Trace element solutions include: ZnCl <sub class="style-scope patent-text">2</sub> 40 mg per liter; FeCl <sub class="style-scope patent-text">3</sub> 6H <sub class="style-scope patent-text">2</sub> O (200 mg); CuCl <sub class="style-scope patent-text">2</sub> 2H <sub class="style-scope patent-text">2</sub> O (10 mg); MnCl <sub class="style-scope patent-text">2,</sub> 4H <sub class="style-scope patent-text">2</sub> O; Na <sub class="style-scope patent-text">2</sub> B <sub class="style-scope patent-text">4</sub> O <sub class="style-scope patent-text">7</sub> . <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">10H 2 O (10mg); (</sub> </sub> </sub> NH 4) 6 Mo 7 <figure-callout id="24" label="O" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">O</a></figure-callout> 24. 4H <sub class="style-scope patent-text">2</sub> O (10mg). <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 4</sup> ingredients are dissolved in 800 ml water, autoclaved and later add: <br class="style-scope patent-text"> 10 ml KH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> (0.5% solution); 80 ml CaCl <sub class="style-scope patent-text">2</sub> . 2H <sub class="style-scope patent-text">2</sub> O (3.68% solution); 15 ml L-proline (20% solution); 100 ml TES buffer (5.73% solution, pH 7.2); 5 ml NaOH (1N solution) and 2 ml trace element solution . <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 5 The</sup> pH is adjusted as described above before adding CaCo <sub class="style-scope patent-text">3</sub> to a medium containing CaCo <sub class="style-scope patent-text">3</sub> .
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物を生合成的に生成する微生物を播種する培養培地は、例えば、回転式振盪機又は温水槽を振盪して、播種した培養培地を攪拌してインキュベートすることによって通気することができる。さらに、インキュベーション中に播種した培養培地に、空気、酸素又は適切なガス混合物を注入して、通気を行うこともできる。
</span>
&nbsp;&nbsp;The culture medium inoculating the microorganism that biosynthesizes the compound of formula I can be aerated by, for example, shaking the inoculated culture medium by shaking a rotary shaker or a hot water bath. . In addition, air can be aerated by injecting air, oxygen or a suitable gas mixture into the culture medium seeded during the incubation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物の培養及び生成後に、化合物は、例えば遠心分離、クロマトグラフィー、吸着等当業者に既知の技術及び／又は、本明細書中に開示されている技術で、培養した培養培地から抽出、単離することができる。例えば、ｎ−ブタノール、ｎ−ブチル酢酸及び４−メチル−２−ペンタノン等の適切な有機溶媒と混合してもよく、かかる有機層は、溶媒除去後の遠心分離、乾燥に至るまでの蒸発、真空状態での乾燥等によって分離することができる。その結果生じた残基は、例えば、水、エタノール、酢酸エチル、メタノール又はそれらの混合物によって再構築し、ヘキサン、四塩化炭素、塩化メチレン又はそれらの混合物等の適切な有機溶媒によって再抽出することができる。溶媒を除去した後に、式Ｉの化合物は、クロマトグラフィー等の標準的技術で、さらに精製することができる。
</span>
&nbsp;&nbsp;After culturing and production of the compound of formula I, the compound is extracted from the cultured culture medium using techniques known to those skilled in the art, such as centrifugation, chromatography, adsorption, and / or techniques disclosed herein. Can be isolated. For example, it may be mixed with an appropriate organic solvent such as n-butanol, n-butylacetic acid and 4-methyl-2-pentanone, and the organic layer is centrifuged after removing the solvent, evaporated to dryness, They can be separated by drying in a vacuum state or the like. The resulting residue may be reconstituted with, for example, water, ethanol, ethyl acetate, methanol or mixtures thereof and re-extracted with a suitable organic solvent such as hexane, carbon tetrachloride, methylene chloride or mixtures thereof. Can do. After removal of the solvent, the compound of formula I can be further purified by standard techniques such as chromatography.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  微生物で生合成される式Ｉの化合物は、式Ｉの化合物の派生物又は構造類似体である化合物を形成するために、無作為及び／又は定方向の化学的修飾を行ってもよい。類似の機能活性を有する式Ｉの化合物の派生物又は構造類似体は、本発明の範囲内にある。式Ｉの化合物は、本明細書中に記載される、及び当業者に既知の方法を用いて修飾してもよい。
</span>
&nbsp;&nbsp;Compounds of formula I that are biosynthesized in microorganisms may be subjected to random and / or directed chemical modifications to form compounds that are derivatives or structural analogs of compounds of formula I. Derivatives or structural analogs of compounds of formula I having similar functional activity are within the scope of the invention. Compounds of formula I may be modified using methods described herein and known to those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特に指定されていない限り、分子量、反応条件、ＩＣ<sub class="style-scope patent-text">５</sub>等、明細書及びクレームに用いられている、構成要素の量や性質を表す全ての数は、「約」(about)という用語によって、全ての場合において変更されてもよいと理解されたい。したがって、反対の指示がない限り、本明細書及びクレームに記載される数値のパラメーターは、近似値である。最低限、又はクレームの範囲の均等論で明細書を限定せずに、各々の数値のパラメーターは、少なくとも、有効桁数を鑑みて通常の端数整理の技術を適用して分析される。本発明の広い範囲として記載され数値域及びパラメーターは近似値であるが、実施例、表及び図に記載される数値は可能な限り正確に報告されている。全ての数値は、実験、検査測定、統計分析等で生じる誤差を含む場合がある。
</span>Unless otherwise specified, all numbers representing the amount or nature of a component used in the specification and claims, such as molecular weight, reaction conditions, IC <sub class="style-scope patent-text">5,</sub> etc., are all expressed by the term “about”. It should be understood that changes may be made in this case. Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and claims are approximations. Without limiting the description with a minimum or claim scope equivalent, each numerical parameter is analyzed by applying a common fractionalization technique in view of at least the number of significant digits. Although the numerical ranges and parameters described as broad ranges of the present invention are approximate, the numerical values described in the examples, tables and figures are reported as accurately as possible. All numerical values may include errors arising from experiments, laboratory measurements, statistical analysis, and the like.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉ、式IIの化合物及び化合物２（ａ）は、本明細書中に記載され、当該技術で既知の方法を用いて、化学的に修飾してもよい。
</span>
&nbsp;&nbsp;Compounds of Formula I, Formula II and Compound 2 (a) may be chemically modified using methods described herein and known in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、バイオ発酵（biofermentation）及び周知の化学図式によって生成される。本明細書中に記載される図式は、例示であり、本明細書中に記載される構造を提供する当業者に既知の化学合成プロセスを用いることができ、したがって、本発明に包含される。
</span>
&nbsp;&nbsp;The compounds of the present invention are produced by biofermentation and well-known chemical schemes. The schemes described herein are exemplary and chemical synthesis processes known to those skilled in the art that provide the structures described herein can be used and are therefore encompassed by the present invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式１  アシル化反応<br class="style-scope patent-text">
  ＥＤＣ＝１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミド<br class="style-scope patent-text">
保護基は、Ｎ−ベンジルオキシカルボニル（ＣＢＺ）、Ｎ−ブトキシカルボニル<br class="style-scope patent-text">
（ＢＯＣ）、Ｎ−フルオレン−９−イルメトキシカルボニル（ＦＭＯＣ）を含む。<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">Ｘ</sup>は、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、アリール又はヘテロアリールを表す。ＡＡは、自然発生アミノ酸を表す。<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000105" he="141" wi="169" file="2007525148.tif" img-format="tif" img-content="drawing" width="676" height="564" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<figure-callout id="1" label="Scheme" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 1 Acylation EDC = 1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide protecting groups are N-benzyloxycarbonyl (CBZ), N-butoxycarbonyl (BOC), N-fluoren-9-yl Includes methoxycarbonyl (FMOC). <br class="style-scope patent-text"> R <sup class="style-scope patent-text">X</sup> represents C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, aryl or heteroaryl. AA represents a naturally occurring amino acid. <br class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000105" he="141" wi="169" file="2007525148.tif" img-format="tif" img-content="drawing" width="676" height="564" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式２  末端窒素のアミノ化／還元的アミノ化<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000106" he="75" wi="144" file="2007525148.tif" img-format="tif" img-content="drawing" width="576" height="300" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
Ｒ<sup class="style-scope patent-text">１</sup>は、前に定義したとおりである。
<figure-callout id="2" label="Scheme" filenames="2007525148-208.png,2007525148-211.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 2 Amination of terminal nitrogen / reductive amination <br class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000106" he="75" wi="144" file="2007525148.tif" img-format="tif" img-content="drawing" width="576" height="300" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> R <sup class="style-scope patent-text">1</sup> is as previously defined.
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式３  オレフィン反応<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000107" he="107" wi="137" file="2007525148.tif" img-format="tif" img-content="drawing" width="548" height="428" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<figure-callout id="3" label="Scheme" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 3 Olefin reaction <br class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000107" he="107" wi="137" file="2007525148.tif" img-format="tif" img-content="drawing" width="548" height="428" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式４  ケトン反応<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">1</sup>及びＲ<sup class="style-scope patent-text">8</sup>は、先に定義したとおりである。<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000108" he="111" wi="159" file="2007525148.tif" img-format="tif" img-content="drawing" width="636" height="444" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<figure-callout id="4" label="Scheme" filenames="2007525148-214.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 4 Ketone reactions R <sup class="style-scope patent-text">1</sup> and R <sup class="style-scope patent-text">8</sup> are as defined above. <br class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000108" he="111" wi="159" file="2007525148.tif" img-format="tif" img-content="drawing" width="636" height="444" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式５  Ｏ反応<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">５</sup>及びＲ<sup class="style-scope patent-text">６</sup>は、先に定義したとおりである。<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000109" he="126" wi="137" file="2007525148.tif" img-format="tif" img-content="drawing" width="548" height="504" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
Scheme 5 O Reactions R <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">5</sup> and R <sup class="style-scope patent-text">6</sup> are as defined above. <br class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000109" he="126" wi="137" file="2007525148.tif" img-format="tif" img-content="drawing" width="548" height="504" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式６  加水分解／エステル化<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000110" he="111" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="444" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
<figure-callout id="6" label="Scheme" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 6 Hydrolysis / Esterification <br class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000110" he="111" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="444" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式１は、化合物２（ａ）から、化合物２（ｍ）、２（ｎ）、２（ｏ）、２（ｐ）、  ２（ｑ）、２（ｒ）、２（ｓ）、２（ｔ）、２（ｕ）、２（ｖ）、２（ｗ）、２（ｘ）、  ２（ｙ）、２（ｚ）、２（ａａ）及び２（ａｂ）を得るために用いられる。
</span>
<figure-callout id="1" label="Scheme" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 1 shows that from compound 2 (a) to compound 2 (m), 2 (n), 2 (o), 2 (p), 2 (q), 2 (r), 2 (s), 2 (t ), 2 (u), 2 (v), 2 (w), 2 (x), 2 (y), 2 (z), 2 (aa) and 2 (ab).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式３は、化合物２（ａ）から、化合物２（ｂ）を得るために用いられる。
</span>
<figure-callout id="3" label="Scheme" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 3 is used to obtain compound 2 (b) from compound 2 (a).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式４は、化合物２（ａ）から、化合物２（ｃ）、２（ｄ）、２（ｅ）及び２（ｆ）<br class="style-scope patent-text">
を得るために用いられる。
</span><figure-callout id="4" label="Scheme" filenames="2007525148-214.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 4 shows compounds 2 (a) to 2 (c), 2 (d), 2 (e) and 2 (f) <br class="style-scope patent-text"> Used to obtain</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
図式６は、化合物２（ａ）から、化合物（ｇ）、２（ｈ）、２（ｉ）及び２（ｊ）<br class="style-scope patent-text">
を得るために用いられる。
</span><figure-callout id="6" label="Scheme" filenames="2007525148-226.png,2007525148-228.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Scheme</a></figure-callout> 6 can be obtained from compound 2 (a) to compounds (g), 2 (h), 2 (i) and 2 (j). <br class="style-scope patent-text"> Used to obtain</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の特徴については、以下の実施例を参照してさらに詳述されるが、その範囲を限定するものではない。
</span>
&nbsp;&nbsp;The features of the present invention will be described in more detail with reference to the following examples, but the scope thereof is not limited.
</span>
    </p>
  </best-mode>
  <mode-for-invention mode-num="1" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
発酵による化合物２（ａ）の生成<br class="style-scope patent-text">
［実施例１（Ａ）］<br class="style-scope patent-text">
［Ｃ０３Ｕ０３］０２３株の生成<br class="style-scope patent-text">
［Ｃ０３］０２３株<br class="style-scope patent-text">
  ストレプトミセス・アイズネンシスＮＲＲＬＢ−１１２７７を、３つのトマトペーストオートミール寒天（ＡＴＣＣ培地１３６０）プレートに２８℃で胞子形成のために播種した。プレートを、５〜７日間の期間インキュベートし、その後、胞子を、各々のプレートから５ｍｌの滅菌蒸留水内に回収し、５０００ｒｐｍ（１０分）の遠心分離で沈降し、２０ｍｌの滅菌水に分散した。同様の条件下で２回目の遠心分離後に、ぺレットを１０ｍｌの滅菌水に再懸濁した。本来の胞子懸濁液の一連の１０倍希釈液を調製し、０．５ｍｌずつの分割量が、胞子形成が起きるするまで（５日〜７日間）トマトペーストオートミール寒天上にプレートした。よく単離されたコロニーを単独で有するプレートに由来する個々のクローンは（胞子懸濁液の１０<sup class="style-scope patent-text">−８</sup>〜１０<sup class="style-scope patent-text">−１０</sup>の希釈液から生成）を選択し、保存する胞子を生成するためにトマトペーストオートミール寒天の一つのプレートに移動した。各クローンを、化合物２（ａ）の生成用に、２５×１５０ｍｍのグラス内で育成した。合計３８５個のクローンの、化合物２（ａ）生成レベルのを検査した。クローン［０３］０２３は、野生型株と比べて３倍生成した。このクローンを選択、保存し、突然変異誘発に使用した。
</span>Production of Compound 2 (a) by Fermentation [Example 1 (A)] <br class="style-scope patent-text"> Generation of [C03U03] 023 strain [C03] 023 strain Streptomyces isuzunensis NRRLB-11277 was seeded on three tomato paste oatmeal agar (ATCC medium 1360) plates at 28 ° C. for sporulation. The plates were incubated for a period of 5-7 days, after which the spores were collected from each plate in 5 ml of sterile distilled water, sedimented by centrifugation at 5000 rpm (10 minutes) and dispersed in 20 ml of sterile water. . After a second centrifugation under similar conditions, the pellet was resuspended in 10 ml of sterile water. A series of 10-fold dilutions of the original spore suspension was prepared and 0.5 ml aliquots were plated on tomato paste oatmeal agar until spore formation occurred (5-7 days). Individual clones derived from plates with well-isolated colonies alone (produced from a 10 <sup class="style-scope patent-text">−8</sup> to 10 <sup class="style-scope patent-text">−10</sup> dilution of spore suspension) are selected and tomatoes produced to produce preserved spores Moved to one plate of paste oatmeal agar. Each clone was grown in a 25 × 150 mm glass for the production of compound 2 (a). A total of 385 clones were examined for compound 2 (a) production levels. Clone [03] 023 was generated 3 times compared to the wild type strain. This clone was selected, stored and used for mutagenesis.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
［Ｃ０３Ｕ０３］０２３株<br class="style-scope patent-text">
  ［Ｃ０３］０２３の水性胞子懸濁液は、異なるエネルギーレベル（１表面積あたりのｍジュールで表す）で、紫外線照射（２５４ｎｍ）によって、突然変異を起こした。０．４ｍＪ／１ｃｍ<sup class="style-scope patent-text">２</sup>で得られたクローン［Ｃ０３Ｕ０３］０２３は、親クローン［Ｃ０３］０２３よりも３倍より少し多い生成を示した。新規クローンによる化合物２（ａ）の生成は、振盪フラスコ（５００ｍｌの培地ＱＢ又は２Ｌ−調節（baffled）フラスコのＶＡ）と培地ＶＡを有する１００−L発酵槽との両方で、常に再現可能である。
</span>[C03U03] 023 strain The aqueous spore suspension of [C03] 023 was mutated by UV irradiation (254 nm) at different energy levels (expressed in mJoules per surface area). The clone [C03U03] 023 obtained at 0.4 mJ / 1 cm <sup class="style-scope patent-text">2</sup> showed slightly more production than the parent clone [C03] 023. The production of compound 2 (a) by the new clone is always reproducible in both shake flasks (500 ml medium QB or 2L-baffled flask VA) and 100-L fermentor with medium VA. .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
［実施例１（Ｂ）］<br class="style-scope patent-text">
［Ｃ０３Ｕ０３］０２３株の凍結乾燥したサンプルの活性化<br class="style-scope patent-text">
  ［Ｃ０３Ｕ０３］０２３株は、凍結乾燥したぺレットとして提供された。凍結乾燥したサンプルを無菌状態で開け、細胞懸濁液を作るために０．３〜０．５ｍｌのＩＴＳＢ培地をサンプルに添加した。液体培養を形成するために、細胞懸濁液を１２５ｍｌのフラスコ内のＩＴＳＢ培地（下記に記載）２５ｍｌに移動した。液体培養は、目に見える増殖が起きるまで、３日〜５日間２８℃でインキュベートした。培養の純度は、ＩＳＰ２寒天プレート上でループをストリークして検査した。
</span>[Example 1 (B)] <br class="style-scope patent-text"> Activation of lyophilized sample of [C03U03] 023 strain [C03U03] 023 strain was provided as a lyophilized pellet. The lyophilized sample was opened aseptically and 0.3-0.5 ml of ITSB medium was added to the sample to make a cell suspension. To form a liquid culture, the cell suspension was transferred to 25 ml of ITSB medium (described below) in a 125 ml flask. Liquid cultures were incubated at 28 ° C. for 3-5 days until visible growth occurred. Culture purity was checked by streaking the loop on an ISP2 agar plate.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
［実施例１（Ｃ）］<br class="style-scope patent-text">
［Ｃ０３Ｕ０３］０２３株のグリセロールストックの調製及び保存<br class="style-scope patent-text">
  ［Ｃ０３Ｕ０３］０２３株を、いくつかのトマトペーストオートミール寒天プレート上で、２８℃で７日〜１０日間育成した。表面の増殖を、各プレートから、無菌蒸留水に回収し、５０００ｒｐｍ（１０分間）の遠心分離で沈降し、１０ｍｌの滅菌水に分散した。同様の条件下で２回目の遠心分離後に、ぺレットを２ｍｌの無菌のグリコール２５％に再懸濁し、０．５ｍｌずつの分割量をねじ口ガラス瓶に−８０℃で保存した。グリセロール貯蔵物に加えて、回収した細胞塊を１５％の無菌の脱脂粉乳に再懸濁し、０．５ｍｌずつの分割量をガラス製アンプルに分配し、標準的な方法に従って凍結乾燥した。
</span>[Example 1 (C)] <br class="style-scope patent-text"> Preparation and Storage of [C03U03] 023 Glycerol Stock The [C03U03] 023 strain was grown on several tomato paste oatmeal agar plates at 28 ° C. for 7 days to 10 days. Surface growth was collected from each plate in sterile distilled water, sedimented by centrifugation at 5000 rpm (10 minutes), and dispersed in 10 ml of sterile water. After a second centrifugation under similar conditions, the pellets were resuspended in 2 ml of <figure-callout id="25" label="sterile glycol" filenames="2007525148-219.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">sterile glycol</a></figure-callout> 25% and 0.5 ml aliquots were stored at −80 ° C. in screw cap glass bottles. In addition to the glycerol stock, the recovered cell mass was resuspended in 15% sterile nonfat dry milk and 0.5 ml aliquots were dispensed into glass ampoules and lyophilized according to standard methods.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
［実施例１（Ｄ）］<br class="style-scope patent-text">
種培養の調製<br class="style-scope patent-text">
  実施例１（Ｃ）に記載されたように調製された凍結菌糸を含むバイアルを冷凍庫から取り出し、ドライアイス上で保存した。無菌状態で、ループフルの凍結培養を取り、トマトペーストオートミール寒天プレートの表面上でストリークし、増殖型菌体が現れるまで（５日〜７日間）２８℃でインキュベートした。種培養を開始するために、トマトペーストオートミール寒天プレートから得た表面の増殖は、３００μｌのＩＴＳＢ培地を含む１．５ｍｌのエッペンドルフ型チューブに移動した。寒天フラグメントを有する菌糸を均質化し、１ｍｌのＩＴＳＢ培地を懸濁液に添加した。内容物は２５ｍｌの無菌培地を含む２個の１２５ｍｌフラスコに播種するために用いた。フラスコは２５０ｒｐｍの回転式振盪機で、６５〜７０時間、２８℃でインキュベートした。この種培養は、生成培地ＱＢ又はＶＡを播種するために用いた。
</span>[Example 1 (D)] <br class="style-scope patent-text"> Preparation of seed cultures Vials containing frozen mycelia prepared as described in Example 1 (C) were removed from the freezer and stored on dry ice. Under aseptic conditions, a loopful frozen culture was taken, streaked on the surface of a tomato paste oatmeal agar plate, and incubated at 28 ° C. until proliferating cells appeared (5-7 days). To initiate seed culture, surface growth from tomato paste oatmeal agar plates was transferred to a 1.5 ml Eppendorf tube containing 300 μl ITSB medium. The mycelium with agar fragments was homogenized and 1 ml of ITSB medium was added to the suspension. The contents were used to inoculate two 125 ml flasks containing 25 ml of sterile medium. The flask was incubated at 28 ° C. for 65-70 hours on a 250 rpm rotary shaker. This seed culture was used to seed the production medium QB or VA.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
［実施例１（Ｅ）］<br class="style-scope patent-text">
発酵による化合物２（ａ）の生成<br class="style-scope patent-text">
  上記実施例１（Ｄ）に記載されたように調製した種培養のサンプルは、汚染の有無を顕微鏡で確認した。種培養のサンプルは、次に、１つのＩＳＰ２プレート（コントロールプレート）にストリークし、２８℃でインキュベートした。無菌状態の種培養から、１０ｍｌを取り、５００ｍｌの無培地ＱＢ又はＶＡを含む各２リットルの調節フラスコをインキュベートするために用いた。発酵したバッチを７日間、２８℃で振盪（２５０ｒｐｍ）しながら、好気的にインキュベートした。３日〜５日間のインキュベーション後に、コントロールプレートの培養純度を検査した。
</span>[Example 1 (E)] <br class="style-scope patent-text"> Production of Compound 2 (a) by Fermentation The seed culture sample prepared as described in Example 1 (D) above was checked for contamination by a microscope. The seed culture samples were then streaked into one ISP2 plate (control plate) and incubated at 28 ° C. 10 ml from a sterile seed culture was taken and used to incubate each 2 liter controlled flask containing 500 ml medium-free QB or VA. The fermented batch was incubated aerobically with shaking (250 rpm) at 28 ° C. for 7 days. After incubation for 3-5 days, the culture purity of the control plate was examined.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  実施例１Ａ〜１Ｅに用いた成長培地の組成物を以下に示す。生成培地ＱＢ又はＶＡのどちらも、化合物２（ａ）の生成に用いられることができる。しかしながら、生成培地ＶＡは、大規模に発酵を行う場合好ましい。
</span>
&nbsp;&nbsp;The composition of the growth medium used in Examples 1A to 1E is shown below. Either production medium QB or VA can be used to produce compound 2 (a). However, the production medium VA is preferred when performing fermentation on a large scale.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
種培養ＩＴＳＢ<br class="style-scope patent-text">
トリプチカーゼ大豆培養液  （Difco）                    ３０ｇ<br class="style-scope patent-text">
酵母抽出物（Sigma）                                    ３ｇ<br class="style-scope patent-text">
ＭｇＳＯ４（Sigma）                                    ２ｇ<br class="style-scope patent-text">
グルコース（Sigma）                                    ５ｇ<br class="style-scope patent-text">
麦芽糖（Sigma）                                        ４ｇ<br class="style-scope patent-text">
蒸留水                                                  １Ｌ
</span>Seed culture ITSB <br class="style-scope patent-text"> Trypticase soy broth (Difco) 30g <br class="style-scope patent-text"> Yeast extract (Sigma) 3g <br class="style-scope patent-text"> MgSO4 (Sigma) 2g <br class="style-scope patent-text"> Glucose (Sigma) 5g <br class="style-scope patent-text"> Maltose (Sigma) 4g <br class="style-scope patent-text"> 1L of distilled water</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
生成培地ＶＡ<br class="style-scope patent-text">
グルコース                                              ５０ｇ<br class="style-scope patent-text">
大豆紛                                                  ３０ｇ<br class="style-scope patent-text">
ＣａＣＯ<sub class="style-scope patent-text">３</sub>                                                ６ｇ<br class="style-scope patent-text">
ＮａＣｌ                                                  ５ｇ<br class="style-scope patent-text">
（ＮＨ<sub class="style-scope patent-text">４</sub>）<sub class="style-scope patent-text">２</sub>ＳＯ<sub class="style-scope patent-text">４</sub>                                          ３ｇ<br class="style-scope patent-text">
蒸留水                                                    １Ｌ
</span>Production medium VA <br class="style-scope patent-text"> Glucose 50g <br class="style-scope patent-text"> 30g soybean powder <br class="style-scope patent-text"> CaCO <sub class="style-scope patent-text">3</sub> 6g <br class="style-scope patent-text"> NaCl 5g <br class="style-scope patent-text"> (NH <sub class="style-scope patent-text">4</sub> ) <sub class="style-scope patent-text">2</sub> SO <sub class="style-scope patent-text">4</sub> 3 g <br class="style-scope patent-text"> 1L of distilled water</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
生成培地ＱＢ<br class="style-scope patent-text">
可溶性澱粉  （Sigma）                                  １０ｇ<br class="style-scope patent-text">
グルコース  （Sigma）                                  １２ｇ<br class="style-scope patent-text">
Pharmamedia  (Traders protein)                         １０ｇ<br class="style-scope patent-text">
コーンスティープリカー (Sigma)                            ５ｇ<br class="style-scope patent-text">
Profloオイル (Traders Protein)                            ４ｍＬ<br class="style-scope patent-text">
蒸留水                                                     １Ｌ<br class="style-scope patent-text">
* ｐＨを７．２に合わせ、Profloオイルを添加する
</span>Production medium QB <br class="style-scope patent-text"> Soluble starch (Sigma) 10g <br class="style-scope patent-text"> Glucose (Sigma) 12g <br class="style-scope patent-text"> Pharmamedia (Traders protein) 10g <br class="style-scope patent-text"> Corn steep liquor (Sigma) 5g <br class="style-scope patent-text"> Proflo oil (Traders Protein) 4mL <br class="style-scope patent-text"> 1L of distilled water <br class="style-scope patent-text"> * Adjust pH to 7.2 and add Proflo oil</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
トマトペーストオートミール寒天<br class="style-scope patent-text">
オートミール離乳食（Ｈeinz）                            ２０ｇ<br class="style-scope patent-text">
トマトペースト                                          ２０ｇ<br class="style-scope patent-text">
寒天                                                    １５ｇ<br class="style-scope patent-text">
水道水                                                    １Ｌ<br class="style-scope patent-text">
ｐＨ７．０
</span>Tomato paste oatmeal agar oatmeal baby food (Heinz) 20g <br class="style-scope patent-text"> Tomato paste 20g <br class="style-scope patent-text"> Agar 15g <br class="style-scope patent-text"> Tap water 1L <br class="style-scope patent-text"> pH 7.0</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の生成は、上記の表４に記載の組成物を有する生成培地において、望ましい順に行うことができる。
</span>
&nbsp;&nbsp;Compound 2 (a) can be produced in the desired order in the production medium having the composition described in Table 4 above.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="2" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）の単離<br class="style-scope patent-text">
  実施例１Ｅの調製フラスコの発酵ブロスからの化合物２（a）の回収の３０分前に、再生、洗浄し、ウエットパックされた、最初の発酵ビール容量の１２％に等しい量のDiaion ＨＰ−２０aを、実施例１Ｅの発酵ブロス全体に添加し、３０分間緩やかに攪拌した。回収時に、２×５００ｍｌのフラスコからの発酵ブロスを遠心分離し、上澄みを樹脂及び菌糸ペレットからデカントした。ペレットを、水中１５％ＭｅＯＨに再懸濁し（本来の発酵ビールの半量）、緩やかに攪拌し、再度遠心分離し、上澄みを残基からデカントした。残基は、同様に、別の水中１５％ＭｅＯＨで二回目の洗浄を行い、最後にメタノール：水（７：３ｖ／ｖ）（本来の発酵ビールの半量）で１回洗浄し、よく洗浄された残基を得た。よく洗浄した菌糸：樹脂残基は、１００％エタノールで３回抽出し、各抽出物は、本来の発酵ビールの２０％であった。３つの抽出物を合わせ、真空下で、回転式蒸発器で乾燥するまで濃縮した。
</span>Isolation of Compound 2 (a) Preparation of <figure-callout id="12" label="Example 1E" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Example 1E</a></figure-callout> 12% of the original fermented beer volume that was regenerated, washed and wet packed 30 minutes prior to recovery of Compound 2 (a) from the fermentation broth of the flask An amount of Diaion HP-20a equal to was added to the entire fermentation broth of Example 1E and stirred gently for 30 minutes. At the time of recovery, the fermentation broth from the 2 × 500 ml flask was centrifuged and the supernatant decanted from the resin and mycelium pellets. The pellet was resuspended in 15% MeOH in water (half of the original fermented beer), gently stirred, centrifuged again and the supernatant decanted from the residue. The residue is similarly washed with another 15% MeOH in water and finally washed once with methanol: water (7: 3 v / v) (half of the original fermented beer) and washed well. Residue was obtained. Well washed mycelia: Resin residues were extracted three times with 100% ethanol, each extract being 20% of the original fermented beer. The three extracts were combined and concentrated to dryness on a rotary evaporator under vacuum.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ３つの抽出物（２×５００ｍｌフラスコの物質）を合わせ、紙上でろ過し、真空下で濃縮し、有機溶媒を除去した。その結果生じた粗化合物２（ａ）の半固体残基（水溶液）は、それぞれの化合物の９０％以上であり、２５％の純度であった。水溶液を一晩凍結乾燥し、４６０ｍｇのこげ茶色の個体を得た。個体を１０ｍｌのエタノールで攪拌し、２分間遠心分離し、不溶性物質を除去した。<br class="style-scope patent-text">
  粗化合物２（ａ）の半個体残基を、以下の勾配表（表５）を使用して、５ｍＭの水性重炭酸アンモニウムからアセトニトリルで、Waters Xterra a preparative MS C-18カラムを用いて、直径１９ｍｍ×長さ１５０ｍｍの寸法の１０μｍパッキングと共に精製した。
</span>The three extracts (2 × 500 ml flask material) were combined, filtered on paper and concentrated in vacuo to remove the organic solvent. The resulting semi-solid residue (aqueous solution) of crude compound 2 (a) was 90% or more of each compound and 25% pure. The aqueous solution was lyophilized overnight to obtain 460 mg of a dark brown solid. The solid was stirred with 10 ml of ethanol and centrifuged for 2 minutes to remove insoluble material. <br class="style-scope patent-text"> Semi-solid residues of crude compound 2 (a) were measured using a Waters Xterra a preparative MS C-18 column with 5 mM aqueous ammonium bicarbonate to acetonitrile using the following gradient table (Table 5). Purified with 10 μm packing of <figure-callout id="19" label="dimensions" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">dimensions</a></figure-callout> 19 mm × length 150 mm.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000111" he="28" wi="117" file="2007525148.tif" img-format="tif" img-content="drawing" width="468" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000111" he="28" wi="117" file="2007525148.tif" img-format="tif" img-content="drawing" width="468" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  溶出物を３９０ｎｍでモニタリングし、１回の運転は、０．５ｍｌのメタノール内の２３ｍｇの粗残基で行われ、３．４分に溶出するピークの保守的な切断（conservative cut）を行い、化合物２（ａ）を生成した。１９回運転し、約９５％の純度の生成物３３ｍｇを産出した。
</span>
&nbsp;&nbsp;The eluate was monitored at 390 nm, one run was performed with 23 mg crude residue in 0.5 ml methanol and a conservative cut of the peak eluting at 3.4 minutes, Compound 2 (a) was produced. It was run 19 times to yield 33 mg of product with a purity of about 95%.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="3" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）の構造決定<br class="style-scope patent-text">
  化合物２（ａ）の構造は、質量、紫外線、ＮＭＲ分光法を含む遺伝子情報及び分光学的データを組み合わせて決定した。質量は、エレクトロスプレー質量分析によって、１２９７（図１３）であることが決定し、ＵＶl<sub class="style-scope patent-text">ｍａｘ</sub>は、３１９，３３３，３５０であることがわかった（図１４）。ＮＭＲデータは、ＭｅOH−ｄ４に溶解した化合物２（ａ）と共に５００ＭＨｚで回収し、プロトン(図１５ａ)、炭素―１３（図１５ｂ）、多次元的パルスシークエンスｇＤＱＣＯＳＹ、ｇHＳＱＣ、ｇＨＭＢＣ及びＴＯＣＳＹ（それぞれ、図１５Ｃ、１５Ｄ、１５Ｅ及び１５Ｆ）が含まれていた。
</span>Structure determination of compound 2 (a) The structure of compound 2 (a) was determined by combining mass, ultraviolet light, gene information including NMR spectroscopy and spectroscopic data. The mass was determined to be 1297 (FIG. 13) by electrospray mass spectrometry and the UVl <sub class="style-scope patent-text">max</sub> was found to be 319,333,350 (FIG. 14). NMR data was collected at 500 MHz with compound 2 (a) dissolved in MeOH-d4, proton (Figure 15a), carbon-13 (Figure 15b), multidimensional pulse sequences gDQCOSY, gHSQC, gHMBC and TOCSY (respectively, 15C, 15D, 15E and 15F) were included.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトミセス・アイズネンシスＮＲＲＬＢ−１１２７７は、５〜７日間オートミール寒天プレート上で生育した。表面増殖を回収し、水で洗浄し、ＤＮＡは以下の標準的手順（T. Kiesser et al. Practical Streptomyces Genetics, The John Innes Foundation, Norwick, UK, 2000）に従って抽出した。ゲノムライブラリーを、コスミド及びプラスミドベクター内で生成し、ゲノムはE. Zazopoulos et al., Nature Biotechnology 21:187-190 (2003) に記載されている二次代謝産物の生合成に関連した遺伝子配列タグ（ＧＳＴ）の有無を調べるためにスキャンした。ＧＳＴは、化合物２（ａ）遺伝子座を含むコスミドを単離するために用いた。化合物２（ａ）遺伝子座内のＰＫＳシステムは、２７のモジュールを含む９のＰＫＳ遺伝子を含むことがわかった。（かかるＰＫＳシステムの分析は、本明細書中に完全に記載されている。例えば、表IIIとそのテキストを参照のこと）。ＰＫＳと関連遺伝子の分析により、以下の式Ｉの構造を予測した。
</span>
&nbsp;&nbsp;Streptomyces isuzunensis NRRLB-11277 grew on oatmeal agar plates for 5-7 days. Surface growth was collected, washed with water, and DNA was extracted according to the following standard procedure (T. Kiesser et al. Practical Streptomyces Genetics, The John Innes Foundation, Norwick, UK, 2000). Genomic libraries are generated in cosmids and plasmid vectors, the genomes are gene sequences related to the biosynthesis of secondary metabolites described in E. Zazopoulos et al., Nature Biotechnology 21: 187-190 (2003) Scanning was performed to check for the presence of a tag (GST). GST was used to isolate a cosmid containing the compound 2 (a) locus. The PKS system within the compound 2 (a) locus was found to contain 9 PKS genes including 27 modules. (The analysis of such a PKS system is fully described herein; see, for example, Table III and its text). The structure of Formula I below was predicted by analysis of PKS and related genes.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="83" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></chemistry></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000112" he="38" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="152" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000112" he="38" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="152" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        
      
      <br class="style-scope patent-text">
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
糖部分のグリコシド結合の位置は、遺伝子分析によって決定することができなｋった。しかし、アミノヒドロキシシクロペンテノン（aminohydroxycyclopentenone）ユニットの位置は、他のアクチノミセス代謝物の配置との類似性によって決定した（Colabomycin A from Streptpomyces griseoflavus Tue 2880, J. Antibot. 1988, 41, 1178-85, 1186-1195 or Enopeptin-A from Streptomyces griseus, Osada et al., J. Antibot. 44, 1463-6, 1991）。
</span>
The position of the glycosidic bond in the sugar moiety could not be determined by genetic analysis. However, the position of the aminohydroxycyclopentenone unit was determined by its similarity to the arrangement of other actinomycin metabolites (Colabomycin A from Streptpomyces griseoflavus Tue 2880, J. Antibot. 1988, 41, 1178-85 , 1186-1195 or Enopeptin-A from Streptomyces griseus, Osada et al., J. Antibot. 44, 1463-6, 1991).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  これらの遺伝子を発現し、この生合成経路の最終産物を得るために、Ｓ．アイズネンシスＮＲＲＬＢ−１１２７７を複数の異なる二次代謝物の生成のための培地で振盪フラスコ中で生育した。回収時に、ブロスは、細胞溶解を誘発するために等量のメタノールで希釈し、希釈した澄んだブロスを１０倍に濃縮した。各培地の濃縮物の分割量（５０mＬ）は、１ｍＬ／分の流速で、Waters Xterra C-18 ＨＰＬＣ カラム (１９×１５０ｍｍ)でクロマトグラフを行い、ダイオードアレー検出器（ＤＡＤ）ＵＶと、陽イオン及び陰イオン質量分析によってモニタリングした。画分（８００μＬ）を回収し、指示株のパネルに対する抗菌活性を検査した。複数の異なる培地の抽出物から、３９〜４５領域のＨＰＬＣ画分はカンジダ・アルカンスに対して強い活性を示し、ＵＶ吸収lmax３１９、３３３及び３５１ｎｍ、ｍ／ｚ１２９８（陽イオンモード）及び１２９６（陰イオンモード）で強いＭＳピークを示した。これらの化学特性は、式１の代謝物と完全に一致した。
</span>
&nbsp;&nbsp;In order to express these genes and obtain the end product of this biosynthetic pathway, Izenensis NRRLB-11277 was grown in shake flasks in medium for the production of several different secondary metabolites. At the time of collection, the broth was diluted with an equal volume of methanol to induce cell lysis and the diluted clear broth was concentrated 10-fold. The aliquot (50 mL) of each medium concentrate was chromatographed on a Waters Xterra C-18 HPLC column (19 × 150 mm) at a flow rate of 1 mL / min, diode array detector (DAD) UV, and cation. And monitored by anion mass spectrometry. Fractions (800 μL) were collected and tested for antimicrobial activity against the panel of indicator strains. From several different media extracts, the HPLC fractions in the 39-45 region show strong activity against Candida alkanes, UV absorption lmax 319, 333 and 351 nm, m / z 1298 (cation mode) and 1296 (anion) Mode) showed a strong MS peak. These chemical properties were in complete agreement with the metabolite of <figure-callout id="1" label="Formula" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Formula</a></figure-callout> 1.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  高収率の培地を選択し、生物を２リットルで再度生育した。化合物１（ａ）を、菌糸ペレットとから、メタノールとアセトンとで抽出し、Ｄｉａｏｎ  ＨＰ−２０<sup class="style-scope patent-text">a</sup>残基からは、残基をメタノール：水＝３：２で洗浄した後にメタノールで抽出した。粗抽出物をWaters Xterra C-18カラム（１９×１５０ｍｍ）上で、水性（５ｍＭ重炭酸アンモニウム）／アセトニトリル勾配を使用してＨＰＬＣで精製した。
</span>A high yield medium was selected and the organisms were grown again in 2 liters. Compound 1 (a), and a mycelium pellet was extracted with methanol and acetone, from Diaon HP-20 <sup class="style-scope patent-text">a</sup> residue, methanol residues: water = 3: extracted with methanol after washing with 2. The crude extract was purified by HPLC on a Waters Xterra C-18 column (19 × 150 mm) using an aqueous (5 mM ammonium bicarbonate) / acetonitrile gradient.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）、ＭＷ１２９７Ｄａ（Ｃ<sub class="style-scope patent-text">７０</sub>Ｈ<sub class="style-scope patent-text">１０８</sub>Ｎ<sub class="style-scope patent-text">２</sub>Ｏ<sub class="style-scope patent-text">２０</sub>は１２９６．７５を要する）l<sub class="style-scope patent-text">max</sub>３１９、３３４及び３５１ｎｍの黄色の固体は、ＣＭＲ、<sup class="style-scope patent-text">１</sup>Ｈ−ＮＭＲ、ｇＤＱＣＯＳＹ、ｇＨＳＱＣ、ｇＨＭＢＣ、ＴＯＣＳＹ、ｇＨＳＱＣＴＯＸＹ及びいくつかの１ＤＴＯＣＳＹ実験を含む一連の１Ｄ及び２ＤＮＭＲ測定の対象となった。図１５Ａ〜１５Ｅ参照。これらのスペクトラを分析したところ、図１７の化合物２（ａ）が示す割当となった。シグナルの相当量の重複により、特定のプロトン及び炭素に対する全てのシグナルの曖昧な割合を非実用的なものとしたが、曖昧に生成しうるものは、ゲノムから予測された構造を確認した。
</span>Compound 2 (a), MW 1297 Da (C <sub class="style-scope patent-text">70</sub> H <sub class="style-scope patent-text">108</sub> N <sub class="style-scope patent-text">2</sub> O <sub class="style-scope patent-text">20</sub> requires 1296.75) l <sub class="style-scope patent-text">max</sub> 319, 334 and 351 nm yellow solids are CMR, <sup class="style-scope patent-text">1</sup> H-NMR, gDQCOSY, gHSQC, gHMBC, TOCSY , GHSQCTOXY and a series of 1D and 2D NMR measurements including several 1DTOCSY experiments. See Figures 15A-15E. When these spectra were analyzed, the assignment shown by Compound 2 (a) in FIG. 17 was obtained. The duplication of a significant amount of signals made the ambiguous ratio of all signals to a specific proton and carbon impractical, but those that could be produced ambiguously confirmed the structure predicted from the genome.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ４．０１ｐｐｍでよく単離したプロトン共鳴と、１０２．６ｐｐｍのアノマー炭素との間のｇＨＭＢＣスペクトラムの主要なクロスピークは、示すように糖を配置し、かかるプロトンが、完全に割当てた炭素とプロトンシグナルを有する主要な鎖の１４炭素セクションに入るようにした。高い信号対雑音比を有するよく分離した炭素スペクトラムにより、割当てられていないメチレン炭素が、４２．０、４５．３、４５．４及び４６．６ｐｐｍであることを示した。ｈＨＳＱＣの分析は、それらが、それぞれ２．２４、１．６２、１．５０及び１．５５ｐｐｍであったことを示した。同様に、６６．２、６６．２（分離）及び６７．２、６９．０ｐｐｍで割当てられていないかルビノールは、それぞれ４．０６、４．０８、４．２２及び３．８９ｐｐｍでプロトンに結合した。割当てられていないオレフィン炭素は、１２９．１、１３１．０、１３１．９、１３３．３、１３３．７、１３４．３、１３４．８、１３６．５、及び１３８．０ｐｐｍで、それぞれ５．７２、５．７２、６．２８、６．２５、６．２８、６．２５、６．１９、５．５３及び５．８６に結合した。アミノヒドロキシシクロペンテノンシグナルは、直線的でなく、この部分の互変異性平衡に反映した。アップフィールドのメチレンシグナルとダウンフィールドのカルボニルシグナルは、他の互変異体の強度の約１０％しか有さなかった。この部分のＣ−１のシグナルは検出されなかったが、以前に同一の構造ユニットの互変異性に割当てられたものである。Ｈe,Ｈ.; Sｈen, B.; Korshella, J.; Siegel, M. M.; Carter, G. T. J. Antibiot. 2000，53，191-195参照。
</span>
&nbsp;&nbsp;The major cross peak of the gHMBC spectrum between the proton resonance well isolated at 4.01 ppm and the anomeric carbon of 102.6 ppm places the sugar as shown, and this proton is assigned to the fully assigned carbon and proton. It was made to enter the 14 carbon section of the main chain with signal. A well-separated carbon spectrum with a high signal-to-noise ratio indicated that the unassigned methylene carbons were 42.0, 45.3, 45.4 and 46.6 ppm. Analysis of hHSQC showed that they were 2.24, 1.62, 1.50 and 1.55 ppm, respectively. Similarly, unassigned at 66.2, 66.2 (separated) and 67.2, 69.0 ppm or rubinol bound to protons at 4.06, 4.08, 4.22 and 3.89 ppm, respectively. did. The unassigned olefinic carbons are 129.1, 131.0, 131.9, 133.3, 133.7, 134.3, 134.8, 136.5, and 138.0 ppm, respectively, 5.72. Bound to 5.72, 6.28, 6.25, 6.28, 6.25, 6.19, 5.53 and 5.86. The aminohydroxycyclopentenone signal was not linear and reflected in the tautomeric equilibrium of this part. The upfield methylene signal and the downfield carbonyl signal had only about 10% of the strength of the other tautomers. This portion of the C-1 signal was not detected, but was previously assigned to tautomerism of the same structural unit. See He, H .; Shen, B .; Korshella, J .; Siegel, M. M .; Carter, G. T. J. Antibiot. 2000, 53, 191-195.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="4" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）の最小発育阻止濃度（ＭＩＣ）の決定<br class="style-scope patent-text">
  真菌及び細菌のＭＩＣ測定は、米国臨床検査標準委員会（ＮＣＣＬＳ）Ｍ２７−Ａ（Vol. 17 番号. 9, 1997）、 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard guidelines: M23-A: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard, vol. 22, No. 16 から適用したブロス微量希釈アッセイで行った。
</span>Determination of Minimum Inhibitory Concentration (MIC) of Compound 2 (a) The MIC measurement of fungi and bacteria was determined by the National Committee for Clinical Laboratory Standards (NCCLS) M27-A (Vol. 17 No. 9, 1997), Reference Method for Broth. Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard guidelines: M23-A: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi;</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
材料<br class="style-scope patent-text">
・  被検真菌株及び細菌株を一晩培養したブロス<br class="style-scope patent-text">
・  ＤＭＳＯ内３．２ｍｇ／ｍｌの化合物２（ａ）のストック溶液<br class="style-scope patent-text">
・  標準９６ウェル丸底プレート、無菌<br class="style-scope patent-text">
・  陽イオン調整したミューラー・ヒントンブロス又はブレインハートインフュージョンブロス（抗菌検査用）<br class="style-scope patent-text">
・  モルフォリンプロパンスルホン酸（ＭＯＰＳ）緩衝ＲＰＭＩ−１６４０培地（抗菌検査用）<br class="style-scope patent-text">
・  無菌等張食塩水（０．８５％）<br class="style-scope patent-text">
・  マックファーランド０．５硫酸バリウム；濁度基準１００×３．２ｍｇ／ｍｌ
</span>Materials • Broth with overnight culture of test fungal and bacterial strains • Stock solution of 3.2 mg / ml compound 2 (a) in DMSO • Standard 96 well round bottom plate, sterile • Cation-adjusted Mueller Hinton broth Or brain heart infusion broth (for antibacterial testing) <br class="style-scope patent-text">・ Morpholine propane sulfonic acid (MOPS) buffered RPMI-1640 medium (for antibacterial testing) <br class="style-scope patent-text">・ Sterile isotonic saline (0.85%) <br class="style-scope patent-text">・ McFarland 0.5 barium sulfate; turbidity standard 100 x 3.2 mg / ml</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
被検化合物の調製<br class="style-scope patent-text">
  被検物質を、ＤＭＳＰ内で１００×ストック溶液として調製し、濃度の範囲は、３．２ｍｇ／ｍｌ〜０．０６２５ｍｇ／ｍｌであった（２倍希釈１０ポイント以上）。最初の希釈液（３．２ｍｇ／ｍｌ）は、各被検物質をＤＭＳＯ１５６．２５μｌに再懸濁して調製した。ストックを順次2倍量で希釈し、所望の濃度を得た。
</span>Preparation of test compound The test substance was prepared as a 100 × stock solution in DMSP, and the concentration range was 3.2 mg / ml to 0.0625 mg / ml (2 fold dilution over 10 points). The first dilution (3.2 mg / ml) was prepared by resuspending each test substance in 156.25 μl of DMSO. The stock was diluted sequentially in two volumes to obtain the desired concentration.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
接種菌液の調製<br class="style-scope patent-text">
  菌株には、接種菌液を以下のように調製した。酵母培地ブロス内で一晩培養した後、細胞濃度が０．８５％の食塩水で０．５マックファーランドに調整した。このプロセスにより、約５×１０<sup class="style-scope patent-text">６</sup>細胞／ｍｌのストック懸濁液が産出された。ボルテックスを経て、作業する懸濁液を、ＲＰＭＩ１６４０でストックを１：５０に希釈し、さらにＲＰＭＩ１６４０で１：２０に希釈し、２×検査接種菌液（約５×１０<sup class="style-scope patent-text">６</sup>細胞／ｍｌ）を得た。糸状の真菌には、接種菌液を、以下のように調製した。４℃で保存した胞子懸濁液から、０．０９から０．１１である最終吸光濃度６００を得るために、０．８５％の食塩水内で適切に希釈し、最終的に０．０９〜０．１１の光学濃度６００を得た。作業懸濁液は、胞子懸濁液をＲＰＭＩに５０回希釈して調製し、２×被検接種菌液（約１×１０５ＣＦＵ／ｍｌ）を得た。
</span>Preparation of inoculum solution The inoculum solution was prepared as follows. After overnight culture in yeast medium broth, the cell concentration was adjusted to 0.5 McFarland with 0.85% saline. This process yielded a stock suspension of approximately 5 × 10 <sup class="style-scope patent-text">6</sup> cells / ml. After vortexing, the working suspension is diluted 1:50 in RPMI 1640 and 1:20 in RPMI 1640 to give 2 × test inoculum (approximately 5 × 10 <sup class="style-scope patent-text">6</sup> cells / ml). It was. For filamentous fungi, an inoculum was prepared as follows. To obtain a final absorbance concentration 600 from 0.09 to 0.11 from a spore suspension stored at 4 ° C., it is diluted appropriately in 0.85% saline and finally 0.09 to An optical density 600 of 0.11 was obtained. The working suspension was prepared by diluting the <figure-callout id="50" label="spore suspension" filenames="2007525148-229.png,2007525148-232.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">spore suspension</a></figure-callout> 50 times in RPMI to obtain 2 × test inoculum (approximately 1 × 10 5 CFU / ml).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ＭＩＣ測定<br class="style-scope patent-text">
  １００×被検物質溶液を、ＲＰＭＩ１６４０、ＭＨ又はＢＨＩ培地において５０回希釈し、１カラムあたり１濃度で、合計１０のカラムで９６ウェルプレートに分配した。１１番目のカラムは、細胞とＲＰＭＩ１６４０、１％ＤＭＳＯを有し、１２番目のカラムは１００μｌのＲＰＭＩ１６４０だけを有した。
</span><figure-callout id="100" label="MIC measurement A" filenames="2007525148-224.png,2007525148-225.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">MIC measurement A</a></figure-callout> 100 × test substance solution was diluted 50 times in RPMI 1640, MH or BHI medium and distributed to a 96-well plate with a total of 10 columns at 1 concentration per column. The eleventh column had cells and <figure-callout id="1" label="RPMI" filenames="2007525148-203.png,2007525148-208.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">RPMI</a></figure-callout> 1640, 1% DMSO, and the twelfth column had only 100 μl RPMI 1640.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  各指定菌株の最終細胞希釈（酵母、糸状真菌又は細菌）を、５０μｌの希釈薬剤又は培地のみを有するマイクロプレートのそれぞれのウェルに添加した。アッセイプレートは、３５℃で７２時間インキュベートした。カンジダ種及び亜スペルギルス種のＭＩＣリーディングは、２４時間と７２時間に測定し、クリプトコッカス・ネオフォルマンス（Cryptococcus neoformans）は４８時間と７２時間で測定した。各指定株のＭＩＣは、増殖がまったくみられない被検化合物の最低濃度とた。
</span>
&nbsp;&nbsp;The final cell dilution (yeast, filamentous fungus or bacteria) of each designated strain was added to each well of a microplate with 50 μl of diluted drug or medium only. The assay plate was incubated at 35 ° C. for 72 hours. The MIC readings of Candida and Subspergillus species were measured at 24 hours and 72 hours, and Cryptococcus neoformans were measured at 48 hours and 72 hours. The MIC of each designated strain was the lowest concentration of the test compound that did not show any growth.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
各種酵母株、真菌株の化合物２（ａ）のＭＩＣ（mｇ／ｍｌ）<br class="style-scope patent-text">
<tables num="6" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000113" he="128" wi="117" file="2007525148.tif" img-format="tif" img-content="drawing" width="468" height="512" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
*４８時間リーディング；<sup class="style-scope patent-text">*＊</sup>７２時間リーディング
MIC (mg / ml) of compound 2 (a) of various yeast strains and fungal strains <br class="style-scope patent-text"> <tables num="6" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000113" he="128" wi="117" file="2007525148.tif" img-format="tif" img-content="drawing" width="468" height="512" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> * 48 hours reading; <sup class="style-scope patent-text">**</sup> 72 hours reading
    <p class="style-scope patent-text"></p>
  </mode-for-invention>
  <mode-for-invention mode-num="5" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
アスペルギルス種に対する化合物２（ａ）のインビトロ活性<br class="style-scope patent-text">
  アスペルギルス種（アスペルギルス・フミガーツス及びアスペルギルス・フラーブス）に対する化合物２（ａ）の抗真菌活性を測定するために、ディスク拡散アッセイが、Wong GK, Griffth S, Kojima I and Demain AL. Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin. J. Antibiotics, 51 (5):487-491, 1998に記載のように、最小有効濃度（ＭＥＣ）を測定するために用いた。かかるアッセイは、アスペルギルス種のような糸状真菌に対する抗真菌活性を解明するために一般的に用いられている（Arikan S, Yurdakul P, Hascelik G. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrobial Agents and Chemotherapy 47 (8) : 2640-2643,2003）。
</span>In vitro activity of Compound 2 (a) against Aspergillus sp. To determine the antifungal activity of Compound 2 (a) against Aspergillus sp. (Aspergillus fumigatus and Aspergillus flavus), a disk diffusion assay was performed by Wong GK, Griffth S, Kojima I and Demain AL. Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin. Minimum effective concentration (MEC) as described in J. Antibiotics, 51 (5): 487-491, 1998 Was used to measure. Such assays are commonly used to elucidate antifungal activity against filamentous fungi such as Aspergillus species (Arikan S, Yurdakul P, Hascelik G. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrobial Agents and Chemotherapy 47 (8): 2640-2643,2003).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
接種菌液の調製<br class="style-scope patent-text">
  ＹＭ寒天（細胞培養フラスコ）に散布後、アスペルギルス株（アスペルギルス・フラーブス-ＡＴＣＣ２０４３０４及びアスペルギルス・フミガーツスＬＳＰＱ-２０４３０５）を４〜５日間３５℃で放置し胞子形成した。１０〜２０ｍｌの食塩水（０．８５％ＮａＣｌ）を添加後、使い捨て植菌ループで分生子柄の表面を緩やかにこすって回収した。アスペルギルス胞子懸濁液は、４℃で保存し、ディスクアッセイの接種菌液として用いた。
</span>Preparation of inoculum solution After spraying on YM agar (cell culture flask), Aspergillus strains (Aspergillus flavus-ATCC204304 and Aspergillus fumigatus LSPQ-204305) were left at 35 ° C. for 4-5 days to form spores. After adding 10-20 ml of saline solution (0.85% NaCl), the surface of the conidia stalk was gently rubbed and collected with a disposable inoculation loop. The Aspergillus spore suspension was stored at 4 ° C. and used as the inoculum for the disc assay.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ディスクの調製<br class="style-scope patent-text">
  メタノール内のストック溶液（５ｍｇ／ｍｌ）及びメタノールのストック溶液の一連の希釈液により調製した希釈液内のストック溶液（０．２５、０．５、１．０、２．５、５．０、７．５、１０．０及び５０．０mｇ／ｍｌ）は、被検物質及びコントロール化合物用に調製した。イトラコナゾール及びカスポファンギンをポジティブコントロールとして使用し、フルコナゾール又はＤＭＳＯ単独でネガティブコントロールとして使用した。薬剤を含むディスクは、正しい薬剤溶液（又はコントロールとしてメタノール）１０μｌを滴下して調製し、その後空気乾燥した。
</span>Preparation of discs Stock solutions in dilution (0.25, 0.5, 1.0, 2.5, 5) prepared by a series of dilutions of stock solution in methanol (5 mg / ml) and methanol stock solution. 0.0, 7.5, 10.0 and 50.0 mg / ml) were prepared for the test substance and the control compound. Itraconazole and caspofungin were used as positive controls and fluconazole or DMSO alone were used as negative controls. The disc containing the drug was prepared by dropping 10 μl of the correct drug solution (or methanol as a control) and then air-dried.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
寒天プレートの調製<br class="style-scope patent-text">
  アスペルギルス胞子懸濁液は、食塩水内で５３０ｎｍで透過率約８１％に調整した。調整した接種菌液２００mｌを、０．８％の融合ＹＭ寒天（５０℃まで冷却）と混合し、満遍なく混合し、１５０ｍｍペトリ皿に注いだ。寒天の設置後、調製したフィルターはプレートの上に置き、３５℃でインキュベートした。真菌増殖の抑制領域（ＺＯＩ）は、インキュベーションの２４時間後に測定した。
</span>Preparation of Agar Plate Aspergillus spore suspension was adjusted to a transmittance of about 81% at 530 nm in saline. 200 ml of the prepared inoculum was mixed with 0.8% fused YM agar (cooled to 50 ° C.), mixed evenly and poured into a 150 mm Petri dish. After installation of the agar, the prepared filter was placed on a plate and incubated at 35 ° C. The area of inhibition of fungal growth (ZOI) was measured after 24 hours of incubation.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結果<br class="style-scope patent-text">
  表７のデータは、真菌増殖の抑制を誘導する最小有効濃度（ＭＥＣ）と、化合物２（ａ）及びコントロールのかかる濃度における対応するＺＯＩを示す。その結果は、化合物２（ａ）は、アスペルギルス・フミガーツス及びアスベルギルス・フラーブスに対して活性化することを示した。イトラコナゾール及びカスポファギンでは同様の効果を得たが、フルコナゾールは不活性であった。
</span>Results The data in Table 7 shows the minimum effective concentration (MEC) that induces inhibition of fungal growth and the corresponding ZOI at such concentrations of Compound 2 (a) and the control. The results showed that compound 2 (a) was activated against Aspergillus fumigatus and Asberggillus flavus. Similar effects were obtained with itraconazole and caspofagin, but fluconazole was inactive.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <tables num="7" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000114" he="54" wi="147" file="2007525148.tif" img-format="tif" img-content="drawing" width="588" height="216" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
ＭＥＣ：最小有効濃度<br class="style-scope patent-text">
ＺＯＩ：各ＭＥＣに産出した真菌増殖の抑制領域
 <tables num="7" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000114" he="54" wi="147" file="2007525148.tif" img-format="tif" img-content="drawing" width="588" height="216" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> MEC: Minimum effective concentration ZOI: Area of inhibition of fungal growth produced by each MEC
    <p class="style-scope patent-text"></p>
  </mode-for-invention>
  <mode-for-invention mode-num="6" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
播種性カンジダ症のマウスモデルにおける化合物２（ａ）の抗真菌活性の評価<br class="style-scope patent-text">
  化合物２（ａ）は、推測純度９５＋％の乾燥粉末として提供された。ファンギゾン（比較対象として用いるアンホテリシンＢデオキシコール酸）も、推測純度が２（ａ）の乾燥粉末として提供された。化合物２（ａ）及びファンギゾンは、投与する日まで、−８０℃で乾燥粉末として保存した。
</span>Evaluation of antifungal activity of compound 2 (a) in a mouse model of disseminated candidiasis Compound 2 (a) was provided as a dry powder with an estimated purity of 95 +%. Fungizone (amphotericin B deoxycholic acid used as a comparison target) was also provided as a dry powder with a predicted purity of 2 (a). Compound 2 (a) and fungizone were stored as a dry powder at −80 ° C. until the day of administration.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  体重が２２〜２４ｇまでの雌のマウス（ハツカネズミ属、ＣＤ−１株、Charles River）を研究に用いた。動物は、処置前に３日間観察した。全ての動物実験は、病院の倫理委員会の動物実験の倫理方針に沿って、聖ジュスティヌ病院（モントリオール、ケベック）にて行われた。研究中に、死亡した動物又は明らかに病気の動物は直ちに取り除き、病気のマウスは、ケージから出した後安楽死させた。
</span>
&nbsp;&nbsp;Female mice (Mus musculus, CD-1 strain, Charles River) weighing up to 22-24 g were used for the study. The animals were observed for 3 days before treatment. All animal experiments were conducted at St. Justine Hospital (Montreal, Quebec) in accordance with the ethics policy of animal experiments of the hospital ethics committee. During the study, dead or apparently ill animals were immediately removed and ill mice were euthanized after removal from the cage.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  動物は、温度（２３±２℃）、湿度（４５±５％）、光周期性（１２時間の光／１２時間の闇）及び換気を管理した条件の室内で維持した。動物は、食料及び水を与えられるようなポリカーポネートのケージに入れた（１ケージあたり４匹）。無菌の経木を、動物の寝床に使用し、寝床は一日おきに取り替えた。食料（Harlam Tecklab, Canada）とオートクレーブした水道水が自由にに提供され、食料は、ケージの上の金属製の蓋内に置いた。水のボトルにはゴム栓と吸うチューブがつけられ、一週間に一度洗浄、殺菌し取り替えられた。
</span>
&nbsp;&nbsp;Animals were maintained in a room with controlled conditions of temperature (23 ± 2 ° C.), humidity (45 ± 5%), photoperiodicity (12 hours light / 12 hours darkness) and ventilation. The animals were placed in polycarbonate cages (4 per cage) that were fed food and water. Sterile trees were used for the animal bed and the bed was changed every other day. Food (Harlam Tecklab, Canada) and autoclaved tap water were provided ad libitum and food was placed in a metal lid on the cage. The water bottle was fitted with a rubber stopper and a sucking tube and was washed, sterilized and replaced once a week.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  マウスの6つのグループ（１グループあたり１０マウス）は、文献（Dubois, N., et al., Microbiology 1998, 1442,299-2310参照）記載のとおり、カンジダ・アルビカンＳＣ５３１４を３×１０<sup class="style-scope patent-text">６Ｃ</sup>ＣＦＵで、経静脈から感染した。感染の２４時間後に、マウスの各グループは、化合物２（ａ）（１又は３ｍｇ／ｋｇｉ．ｐ．）、コンパレーターとしてのファンギゾン（０．２５、０．５又は１ｍｇ／ｋｇｉ．ｐ．）又は、５％のデキストローズと３％のＤＭＳＯ含有無菌水で処置した。各動物は被検溶液１００mｌで処置した。
</span>Six groups of mice (10 mice per group) were prepared with 3 × 10 <sup class="style-scope patent-text">6 C</sup> CFU of Candida albican SC5314 as described in the literature (see Dubois, N., et al., Microbiology 1998, 1442,299-2310). Infected through the veins. Twenty-four hours after infection, each group of mice received compound 2 (a) (1 or 3 mg / kg ip), fungizone (0.25, 0.5 or 1 mg / kg ip) as a comparator or Treated with sterile water containing 5% dextrose and 3% DMSO. Each animal was treated with 100 ml of the test solution.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  治療計画を、１日１回、合計４日間繰り返した。２１日間に渡ってマウスの罹患の徴候を１日２回観察した。瀕死の動物は非生存としてスコアリングし、二酸化炭素を吸入させ安楽死させた。カプラン−マイヤー法の推定量（product limit estimate）で生存データを分析し、生存時間関数をプロットした。
</span>
&nbsp;&nbsp;The treatment plan was repeated once a day for a total of 4 days. The mice were observed twice daily for signs of disease over 21 days. Drunken animals were scored as non-viable and euthanized by inhalation of carbon dioxide. Survival data was analyzed with Kaplan-Meier method product limit estimates and the survival function was plotted.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）及びファンギゾンの接種後の経時生存率<br class="style-scope patent-text">
<tables num="8" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000115" he="54" wi="125" file="2007525148.tif" img-format="tif" img-content="drawing" width="500" height="216" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Survival rate over time after inoculation with compound 2 (a) and fungizone <br class="style-scope patent-text"> <tables num="8" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000115" he="54" wi="125" file="2007525148.tif" img-format="tif" img-content="drawing" width="500" height="216" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  表８に示すように、化合物２（ａ）は、ファンギゾン０．２５ｍｇ／ｋｇを投与したときと同様の抗真菌活性をインビボで示し、感染マウスの平均生存期間を４倍にした。
</span>
&nbsp;&nbsp;As shown in Table 8, Compound 2 (a) showed the same antifungal activity in vivo as when administered 0.25 mg / kg of fungizone and quadrupled the average survival time of infected mice.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  データ（生存率対摂取後の日数の割合）をプロットした。結果を表すグラフを図１６に示す。
</span>
&nbsp;&nbsp;Data (survival rate vs. days after ingestion) was plotted. A graph representing the results is shown in FIG.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="7" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）のインビトロの抗腫瘍活性<br class="style-scope patent-text">
  化合物２（ａ）のインビトロによる制癌性の研究は、細胞増殖の５０％抑制濃度（ＩＣ<sub class="style-scope patent-text">５０</sub>）を決定するために、癌細胞株のパネルに対して米国立癌研究所（米国保険研究所、Bethesda, Maryland, USA）が行った。この独特なスクリーニング作業は、白血病、メラノーマ及び肺癌、大腸癌、脳腫瘍、卵巣癌、乳癌、前立腺癌及び腎臓癌を代表する６０の異なるヒト腫瘍細胞株を用いた。化合物２（ａ）は、推定純度９０＋％の凍結乾燥した粉末として提供された。化合物は使用する日まで―２０℃で保存した。
</span>In Vitro Antitumor Activity of Compound 2 (a) In vitro antitumor studies of Compound 2 (a) were conducted against a panel of cancer cell lines to determine the 50% inhibitory concentration (IC <sub class="style-scope patent-text">50</sub> ) of cell proliferation. The National Cancer Institute (American Insurance Institute, Bethesda, Maryland, USA). This unique screening work used 60 different human tumor cell lines representing leukemia, melanoma and lung cancer, colon cancer, brain tumor, ovarian cancer, breast cancer, prostate cancer and kidney cancer. Compound 2 (a) was provided as a lyophilized powder with an estimated purity of 90 +%. Compounds were stored at −20 ° C. until the day of use.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  癌スクリーニングパネル（cancer-screening panel）のヒト腫瘍細胞株は、５％のウシ胎児血清及び２ｍＭのＬ−グルタミンを含むＲＰＭＩ１６４０培地で育成した。典型的なスクリーニング実験として、細胞を１００μｌずつ、各細胞株が倍増する時間によって、５０００〜４０，０００細胞／ウェルの各プレート密度で、９６ウェルマイクロタイタオープレートに播種した（表８）。細胞を播種した後、実験薬剤を添加する２４時間前に、マイクロタイタープレートを３７℃、５％ＣＯ<sub class="style-scope patent-text">２</sub>、９５％空気、１００％相対湿度でインキュベートした。
</span>Cancer-screening panel human tumor cell lines were grown in RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine. As a typical screening experiment, cells were seeded in 96-well microtiter plates at 100 μl, each plate density of 5000-40,000 cells / well, depending on the time each cell line doubled (Table 8). After seeding the cells, the microtiter plate was incubated at 37 ° C., 5% CO <sub class="style-scope patent-text">2</sub> , 95% air, 100% relative humidity, 24 hours before adding the experimental drug.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ２４時間後、各細胞株の２つのプレートをＴＣＡでインサイチュで固定し、薬剤添加時（Ｔｚ）の各細胞株の細胞群を決定した。化合物２（ａ）はジメチルスルホン酸で、所望の最終最大濃度の４００倍で可溶化し、使用するまで凍結保存した。薬剤添加時に、凍結した濃縮物の分割量を解凍し、５０μｌ／ｍｌゲンタマイシンを含む完全な培地で、所望の最終最大濃度の２倍に希釈した。合計５つの薬物濃度と、コントロールを得るために、さらに４つの段階希釈を調製した。異なる薬剤の希釈液の１００μｌの分割量を、１００μｌの培地を既に含む適切なマイクロタイターに添加し、所望の最終薬剤濃度（２．５×１０<sup class="style-scope patent-text">−５</sup>Ｍ〜２．５×１０<sup class="style-scope patent-text">−９</sup>Ｍ）を得た。
</span>After 24 hours, two plates of each cell line were fixed in situ with TCA, and the cell group of each cell line at the time of drug addition (Tz) was determined. Compound 2 (a) was dimethyl sulfonic acid solubilized at 400 times the desired final maximum concentration and stored frozen until use. At drug addition, aliquots of frozen concentrate were thawed and diluted to 2 times the desired final maximum concentration with complete medium containing 50 μl / ml gentamicin. Four additional serial dilutions were prepared to obtain a total of 5 drug concentrations and controls. 100 μl aliquots of different drug dilutions are added to a suitable microtiter already containing 100 μl of medium and the desired final drug concentration (2.5 × 10 <sup class="style-scope patent-text">−5</sup> M to 2.5 × 10 <sup class="style-scope patent-text">−9</sup> M). Got.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  薬物を添加した後、プレートをさらに３７℃、５％ＣＯ<sub class="style-scope patent-text">２</sub>、９５％空気、１００％相対湿度で４８時間インキュベートした。接着細胞については、冷たいＴＣＡを添加してアッセイを終了した。インサイチュで冷たい５０％（ｗ／ｖ）ＴＣＡ（最終濃度、１０％ＴＣＡ）を緩やかに添加し、４℃で６０分間インキュベーションして細胞を固定した。上清を除去し、プレートを水道水で５回洗浄し、風乾した。スルホローダミンＢ（ＳＲＢ）溶液（１００μｌ）を０．４％（ｗ／ｖ）、１％酢酸を各ウェルに添加し、各プレートを室温で１０分間インキュベートした。染色後、結合していない染料を１％酢酸５回洗浄して除去し、プレートを風乾燥した。結合した染料を順次１０ｍＭトリズマ塩基で可溶化し、吸光度を、５１５nmの波長で自動プレートリーダーで読み取った。懸濁細胞については、配置した細胞を５０μｌの８０％ＴＣＡ（最終濃度、１６％ＴＣＡ）を緩やかに添加してウェルの底に固定してアッセイを終了した以外は、手順は同じであった。
</span>After drug addition, the plates were further incubated for 48 hours at 37 ° C., 5% CO <sub class="style-scope patent-text">2</sub> , 95% air, 100% relative humidity. For adherent cells, cold TCA was added to terminate the assay. Cells were fixed by gently adding in situ cold 50% (w / v) TCA (final concentration, 10% TCA) and incubating at 4 ° C. for 60 minutes. The supernatant was removed and the plate was washed 5 times with tap water and air dried. Sulforhodamine B (SRB) solution (100 μl) was added to each well 0.4% (w / v), 1% acetic acid, and each plate was incubated at room temperature for 10 minutes. After staining, unbound dye was removed by washing with 1% <figure-callout id="5" label="acetic acid" filenames="2007525148-217.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">acetic acid</a></figure-callout> 5 times and the plate was air dried. The bound dye was sequentially solubilized with 10 mM Trizma base and the absorbance was read with an automatic plate reader at a wavelength of 515 nm. For suspended cells, the procedure was the same except that 50 μl of 80% TCA (final concentration, 16% TCA) was gently added to the placed cells and fixed to the bottom of the well to terminate the assay.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物の２（ａ）の増殖阻害力は、従来のＩＣ<sub class="style-scope patent-text">５０</sub>値ではなく、ＧＩ<sub class="style-scope patent-text">５０</sub>値を使用してＮＣＩで測定した。ＧＩ<sub class="style-scope patent-text">５０</sub>値は、０時間時における細胞計数の修正を強調し、７つの吸光度測定値［０時間（Ｔｚ）、コントロール増殖（Ｃ）、及び５つの濃度レベルにおける薬物存在下の試験増殖（Ｔｉ）］を使用した。ＧＩ<sub class="style-scope patent-text">５０</sub>は、［（Ｔｉ−Ｔｚ）／（Ｃ−Ｔｚ）×１００＝−５０］として計算し、これは、薬剤インキュベーション中のコントロール細胞におけるタンパク質の純増（ＳｒＢ染色によって測定）である。
</span>The growth inhibitory potency of compound 2 (a) was measured by NCI using GI <sub class="style-scope patent-text">50</sub> values instead of conventional IC <sub class="style-scope patent-text">50</sub> values. The GI <sub class="style-scope patent-text">50</sub> value highlights the correction of the cell count at <figure-callout id="0" label="time" filenames="2007525148-207.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="7" label="time" filenames="2007525148-216.png,2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">time</a></figure-callout></a></figure-callout> 0, 7 absorbance measurements [0 time (Tz), control growth (C), and test growth in the presence of drug at 5 concentration levels (Ti). ]It was used. The GI <sub class="style-scope patent-text">50</sub> is calculated as [(Ti−Tz) / (C−Tz) × 100 = −50], which is the net increase in protein (measured by SrB staining) in control cells during drug incubation.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ＮＣＩ開発治療プログラム  化合物２（ａ）のインビトロ検査結果<br class="style-scope patent-text">
<tables num="9" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000116" he="177" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="708" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000117" he="146" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="584" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
NCI development treatment program In vitro test results of compound 2 (a) <br class="style-scope patent-text"> <tables num="9" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000116" he="177" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="708" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </tables> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000117" he="146" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="584" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  この結果は、化合物２（ａ）がＮＣＩスクリーニングパネルで分析した全てのヒト腫瘍細胞株に対し、有効であることを示し、いくつかのヒトの癌に対し、幅広い抗癌活性を有することを示唆した。実際、全ての細胞株で計算したＧＩ５０は、抗癌剤の薬学的活性としては有意なレベルである１０×１０−６Ｍ以下であった。いくつかの例では、ナノモル又はピコモルレベルに達した（ＳＮ１２Ｃ／腎臓癌；HＯＰ９２／非小細胞肺癌種；ＨＣＣ２９９８大腸癌種）。<br class="style-scope patent-text">

</span>This result indicates that compound 2 (a) is effective against all human tumor cell lines analyzed by the NCI screening panel and suggests that it has broad anti-cancer activity against several human cancers. did. In fact, the GI50 calculated for all cell lines was 10 × 10 −6 M or less, which is a significant level for the pharmaceutical activity of anticancer agents. In some cases nanomolar or picomolar levels have been reached (SN12C / kidney cancer; HOP92 / non-small cell lung cancer species; HCC2998 colon cancer species). <br class="style-scope patent-text"> </span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="8" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ポリケチドシンターゼシステムにおける不活性ドメインの活性化
</span>
Activation of inactive domains in the polyketide synthase system
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="84" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000118" he="26" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
  ストレプトミセス・アイズネンシス株ＮＲＲＬ Ｂ−１１２７７から発生した化合物２（ａ）をコード遺伝子群は、ＯＲＦ１３モジュール１２においてコードされたケトレダクターゼ（ＫＲ）を再活性するのに遺伝子的に修飾されている。この修飾は、化合物２（ａ）の糖分子、ヒドロキシル基に隣接している中央カルボニル基の転換に帰する（図１２ａに示されている）。
 <chemistry id="" num="84" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000118" he="26" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> The gene group encoding compound 2 (a) generated from Streptomyces isuzunensis strain NRRL B-11277 is genetically modified to reactivate the ketoreductase (KR) encoded in <figure-callout id="12" label="ORF13 module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORF13 module</a></figure-callout> 12. This modification is attributed to the conversion of the central carbonyl group adjacent to the sugar molecule, hydroxyl group of compound 2 (a) (shown in FIG. 12a).
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）遺伝子座においては、ＯＲＦ１３内に存在するＫＲドメイン、モジュール１２は不活性である。実施例７の化合物をもたらすために、ＫＲドメインは再活性化されるか、活性ＫＲドメインと交換される。ＫＲドメインの再活性化は、機能性ＫＲドメインに必要な重要な活性部位残基の完全性の診断を要する。活性部位残基は、ＫＲ酵素の補酵素活性化に必要とされるものと触媒作用に必要とされるものとに分けることができる。ケトレダクターゼ活性のための特定の残基を同定する実験（Ried et. al. Biochemistry, 2003, 42:72‐79; Udo et. al., Biochemistry, 1997, 36:34‐40）は、機能性ＫＲ補酵素結合部位残基は、グリシン（Ｇ）、グリシン（Ｇ）、グリシン（Ｇ）、アラニン（Ａ）を含み、機能性ＫＲ活性部位残基は、セリン（Ｓ）、チロシン（Ｙ）、及びアスパラギン（Ｎ）を含むことを明らかにしている。これらの残基は、図６ａ及び６ｂに強調表示されている。化合物２（ａ）遺伝子座におけるＫＲドメイン配列は、補酵素活性部位残基が、この部位が確かに活性していることを示すグリシン（Ｇ）、グリシン（Ｇ）、グリシン（Ｇ）、アラニン（Ａ）であることを示している。しかしながら、触媒活性を担うＫＲ部位で見られるアミノ酸残基は、触媒作用部位がおそらく不活性であることを示す、セリン（Ｓ）、グルタミン（Ｑ）及びアスパラギン（Ｎ）である。この知見は、化合物２（ａ）は、その特定の位置において、カルボニル基を含むという事実によって確認される（図１０、モジュール１２）。グルタミンをコードするコドンを、チロシンをコードするコドンへと修飾すると、ＰＫＳモノマーの機能性ケト還元に必要な活性部位残基がもたらされる。これは、図１２ａに示されているように、適当な宿主細胞を修飾して実施例７の化合物２（ａ）変異体を生成するために用いられる、化合物２（ａ）の遺伝子座の改変核酸配列を生む結果となる。
</span>
&nbsp;&nbsp;At the compound 2 (a) locus, the KR domain present in ORF13, <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12, is inactive. To yield the compound of Example 7, the KR domain is reactivated or replaced with an active KR domain. Reactivation of the KR domain requires a diagnosis of the integrity of key active site residues required for functional KR domains. Active site residues can be divided into those required for KR enzyme coenzyme activation and those required for catalysis. Experiments to identify specific residues for ketoreductase activity (Ried et. Al. Biochemistry, 2003, 42: 72-79; Udo et. Al., Biochemistry, 1997, 36: 34-40) KR coenzyme binding site residues include glycine (G), glycine (G), glycine (G), alanine (A), and functional KR active site residues include serine (S), tyrosine (Y), And asparagine (N). These residues are highlighted in FIGS. 6a and 6b. The KR domain sequence at the Compound 2 (a) locus shows that the coenzyme active site residue is glycine (G), glycine (G), glycine (G), alanine (which indicates that this site is indeed active). A). However, the amino acid residues found at the KR site responsible for catalytic activity are serine (S), glutamine (Q) and asparagine (N), indicating that the catalytic site is probably inactive. This finding is confirmed by the fact that compound 2 (a) contains a carbonyl group at that particular position (FIG. 10, module 12). Modification of the codon encoding glutamine to a codon encoding tyrosine results in the active site residues necessary for functional keto reduction of the PKS monomer. This is a modification of the locus of compound 2 (a) used to modify the appropriate host cell to produce compound 2 (a) mutant of Example 7, as shown in FIG. 12a. The result is a nucleic acid sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グルタミンのチロシンへの修飾は、不適合二重鎖の融解温度未満の温度で、天然ヌクレオチド配列にハイブリダイズする不適合のプライマーを用いて導入される場合がある。前記プライマーは、プライマーの長さ及び塩基組成を狭い範囲内に保ち、Zoller and Smith’ Methods in Enzymol. (1983) 100:468 に記載されているように、変異塩基が中央に位置するように保つことによって固有に保たれる。プライマーの伸張は、ＤＮＡポリメラーゼを用いることで実現される。産物は、クローン化され、プライマーの伸張した鎖（primer extended strand）の分離によって得られる、変異ＤＮＡを有する陽性クローンが選択される。選択は、ハイブリッド形成のプローブとして、変異プライマーを用いて行う（Dalbie‐McFarland et al Proc. Natl. Acad Sci. USA (1982) 79:6409）。
</span>
&nbsp;&nbsp;The modification of glutamine to tyrosine may be introduced with an incompatible primer that hybridizes to the native nucleotide sequence at a temperature below the melting temperature of the incompatible duplex. The primer keeps the length and base composition of the primer within a narrow range and keeps the mutant base in the center as described in Zoller and Smith 'Methods in Enzymol. (1983) 100: 468. To keep it unique. The extension of the primer is realized by using a DNA polymerase. The product is cloned and positive clones with mutated DNA obtained by separation of the primer extended strand are selected. Selection is performed using mutant primers as hybridization probes (Dalbie-McFarland et al Proc. Natl. Acad Sci. USA (1982) 79: 6409).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  実施例７の化合物を生成する別の方法は、化合物２（ａ）（ＯＲＦ１３モジュール１２）の遺伝子座からの不活性ケトレダクターゼドメインを、同一又は異なる遺伝子座からの活性ケトレダクターゼドメインと交換することを伴う。交換に適した同一遺伝子座内のドメインの例として、メチルマロネート伸張ユニット（methyl malonate extender unit）の組み入れをコードするモジュール内に発生する活性ケトレダクターゼ、すなわち、ＯＲＦ１６のモジュール１９又は２０が挙げられる。ＰＫＳ遺伝子座間のアシルトランスフェラーゼドメインの交換は、Oliynyk et al. Chem Biol, 1996, 3 (10) : 833-9によって実証されており、６−デオキシエリスロノライド（6-deoxyerythronolide）（ＤＥＢＳ）のモジュール１の中のアシルトランスフェラーゼドメインをコードする遺伝子が、ラパマイシンモジュール２のアシルトランスフェラーゼをコードする遺伝子と交換され、２つのアシルトランスフェラーゼが異なるアシル特異性を有するので、新規のトリケチドの合成を生む結果となっている。Hans et. al. J. Am Chem Soc, 2003, 125 (18): 5366-74においては、アシルトランスフェラーゼドメインの交換の結果としての、産物形成の動力学的側面が教示されている。
</span>
&nbsp;&nbsp;Another method of generating the compound of Example 7 is to replace the inactive ketoreductase domain from the locus of compound 2 (a) (ORF13 module 12) with an active ketoreductase domain from the same or a different locus. Accompanied by. Examples of domains within the same locus that are suitable for exchange include the active ketoreductase that occurs within the module that encodes the incorporation of a methyl malonate extender unit, ie, <figure-callout id="19" label="ORF16 module" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="20" label="ORF16 module" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORF16 module</a></figure-callout></a></figure-callout> 19 or 20. . The exchange of acyltransferase domains between PKS loci has been demonstrated by Oliynyk et al. Chem Biol, 1996, 3 (10): 833-9 and is a module of 6-deoxyerythronolide (DEBS) The gene encoding the acyltransferase domain in 1 is exchanged for the gene encoding the acyltransferase of <figure-callout id="2" label="rapamycin module" filenames="2007525148-208.png,2007525148-211.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rapamycin module</a></figure-callout> 2, resulting in the synthesis of a novel triketide because the two acyltransferases have different acyl specificities. ing. Hans et. Al. J. Am Chem Soc, 2003, 125 (18): 5366-74 teaches the kinetic aspects of product formation as a result of the exchange of acyltransferase domains.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ドメインの交換は、Kao et. al. Science, 1994, 265:509-512によって開発された技術を用いて実現される。この遺伝子学的方法では、大腸菌における二重組換え現象を用い、温度に対して感受性のあるドナープラスミドと受容体のシャトルベクターとを、インビボで組換えることができるように、ｐＭＡＫ７０５の誘導体を活用する。交換されるドメインの両側の領域のＡｍｐ<sup class="style-scope patent-text">Ｒ</sup>Ｔｃ<sup class="style-scope patent-text">Ｒ</sup>受容体サブクローン、ｐＣＫ５が作られ、これは両側の隣接配列を１ｋｂ有している。エンドヌクレアーゼの制限部位は、このドメインの境界において、Ｐｓｔｌが左側の３’末端に、Ｘｂａｌが右側の５’末端に導入される。交換されるドメインのサブクローンｐＣＫ６Ｃｍ<sup class="style-scope patent-text">Ｒ</sup>が生成され、エンドヌクレアーゼ制限部位は、このドメインの境界に導入される。制限部位Ｐｓｔｌは、ＫＲドメインの５’境界に導入され、Ｘｂａｌ部位は、このドメインの３’境界に導入される。制限部位は、ＰＣＲの突然変異誘発によってサブクローンに導入される。ドメインを含む断片は切除され、温度に対して感受性のあるＣｍ<sup class="style-scope patent-text">Ｒ</sup>ドナープラスミド、ｐＣＫ６に結合される。この受容体プラスミドは、上記のKao et al.によって概説されている選択方法を用い、宿主株の中のプラスミドをインビボで組換えることによって生成される。選択後、目的ドメインが元のドメインと入れ替わり、組換え株が生成される。
</span>Domain exchange is achieved using techniques developed by Kao et. Al. Science, 1994, 265: 509-512. In this genetic method, a double recombination phenomenon in E. coli is used and a derivative of pMAK705 is utilized so that a donor plasmid sensitive to temperature and a receptor shuttle vector can be recombined in vivo. . An Amp <sup class="style-scope patent-text">R</sup> Tc <sup class="style-scope patent-text">R</sup> receptor subclone, pCK5, was created on both sides of the domain to be exchanged, which has 1 kb of flanking sequences on both sides. Endonuclease restriction sites are introduced at the boundary of this domain with Pstl at the left 3 'end and Xbal at the right 5' end. A subclone pCK6Cm <sup class="style-scope patent-text">R of the</sup> domain to be exchanged is generated and an endonuclease restriction site is introduced at the boundary of this domain. The restriction site Pstl is introduced at the 5 ′ boundary of the KR domain and the Xbal site is introduced at the 3 ′ boundary of the domain. Restriction sites are introduced into subclones by PCR mutagenesis. Fragment containing the domains are excised, Cm <sup class="style-scope patent-text">R</sup> donor plasmid sensitive to temperature, is coupled to PCK6. This receptor plasmid is generated by recombining the plasmid in the host strain in vivo using the selection method outlined by Kao et al., Supra. After selection, the target domain is replaced with the original domain, and a recombinant strain is generated.</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="9" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ポリケチドシンターゼシステム内の機能性ドメインの不活性化<br class="style-scope patent-text">
<chemistry id="" num="85" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000119" he="24" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Inactivation of functional domains within the polyketide synthase system <br class="style-scope patent-text"> <chemistry id="" num="85" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000119" he="24" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトミセス・アイズネンシス株に由来する化合物２（ａ）をコードする遺伝子座は、ＯＲＦ１７のモジュール２２におけるエノイルレダクターゼ(ＥＲ)のドメインを不活性化するために、遺伝子的に修飾される。このドメインを不活性化すると、化合物２（ａ）のモジュール２１及び２２によって組み込まれている、アシル単位間の二重結合から単結合への変換を(図１２ｅに示されているように)無効にする。
</span>
&nbsp;&nbsp;The locus encoding compound 2 (a) from the Streptomyces isuzunensis strain is genetically modified to inactivate the enoyl reductase (ER) domain in <figure-callout id="22" label="module" filenames="2007525148-219.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 22 of ORF17. Inactivation of this domain invalidates the double-to-single bond conversion (as shown in FIG. 12e) between the acyl units incorporated by <figure-callout id="21" label="modules" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="22" label="modules" filenames="2007525148-219.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">modules</a></figure-callout></a></figure-callout> 21 and 22 of compound 2 (a). To.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  実施例８の化合物の生成は、Oh and Chater, 1997, Journal of Bacteriology 179:122-127によって開発された二重交差技術（double crossover techniques）の、挿入による不活性化を経て実現される。ストレプトミセス属におけるポリケチド生合成に関与する、挿入による遺伝子の不活性の例は、当技術分野において周知である。Arrwosmith et. al., 1992, Mol Gen Genet 234: 254-264は、ストレプトミセス・シナモネンシス（Streptomyces cinnamonensis）によるモネンシンの生成における二次代謝関連遺伝子のカセットの役割を同定するため、これらの技術を用いた。Paradkar, et. al., 2001, Appl Environ Microbiol 67:2292-7は、ストレプトミセス・クラブリゲルス（Streptomyces clavuligerus）におけるセファマイシンＣの生成を阻害するため、リシンアミノトランスフェラーゼがセファマイシン経路における第一段階を破壊するようにコードするlat遺伝子を不活性化した。同様に、これらの著者は、反足細胞のクラバム合成（antipodal clavam synthesis）の最終段階に関わるｃｖｍ１遺伝子を不活性化した。ポリケチド系におけるドメインの不活性化の方法には、挿入による遺伝子不活化による標的破壊とともに、実施例７に記載のドメイン交換が挙げられる。このため、複製プラスミド媒介性相同的組換えは、ストレプトミセス・アイズネンシスに適用される。相同的組換えのためのプラスミドは、修飾される遺伝子の左側及び右側領域の間のカナマイシン耐性マーカーをクローン化することによって構成される。このような構成体は、破壊プラスミドを生成するチオストレプトン耐性によって特徴づけられる伝達プラスミドにクローン化される。このプラスミドは、ＰＥＧ媒介性プロトプラスト形質転換、エレクトロポレーション又はファージによる自然感染のいずれかによって、ストレプトミセス・アイズネンシスに導入される（Keiser et al (2000) Practical Streptomyces genetics, John Innes Foundation, Norwich）。各々の形質転換体又は接合組換え体（transconjugants）からの胞子は、組換えを誘発するために中性プレート上で培養される。組換えの機会を増すために、このサイクルを３回繰り返す。次に、目的となる遺伝子組換え体をもたらす交差（crossovers）を、単一交差にはカナマイシン及びチオストレプトンを、二重交差にはカナマイシンを用いて選択、選別する。二重交差の不活性を確認するために、レプリカ平板法及びサザンハイブリッド形成法が用いられる（上記Keiser et al (2000)）。
</span>
&nbsp;&nbsp;The generation of the compound of Example 8 is achieved through inactivation by insertion of double crossover techniques developed by Oh and Chater, 1997, Journal of Bacteriology 179: 122-127. Examples of gene inactivity by insertion involved in polyketide biosynthesis in Streptomyces are well known in the art. Arrwosmith et. Al., 1992, Mol Gen Genet 234: 254-264 uses these techniques to identify the role of secondary metabolism-related gene cassettes in the production of monensin by Streptomyces cinnamonensis. It was. Paradkar, et. Al., 2001, Appl Environ Microbiol 67: 2292-7 inhibits the production of cephamycin C in Streptomyces clavuligerus, so that lysine aminotransferase is the first in the cephamycin pathway. The lat gene encoding to disrupt the step was inactivated. Similarly, these authors inactivated the cvm1 gene involved in the final steps of antipodal clavam synthesis. Examples of the domain inactivation method in the polyketide system include domain exchange described in Example 7 together with target destruction by gene inactivation by insertion. For this reason, replication plasmid-mediated homologous recombination applies to Streptomyces isenensis. A plasmid for homologous recombination is constructed by cloning a kanamycin resistance marker between the left and right regions of the gene to be modified. Such a construct is cloned into a transfer plasmid characterized by thiostrepton resistance that produces a disrupted plasmid. This plasmid is introduced into Streptomyces isenensis by either PEG-mediated protoplast transformation, electroporation or natural infection with phage (Keiser et al (2000) Practical Streptomyces genetics, John Innes Foundation, Norwich). Spores from each transformant or conjugated transconjugants are cultured on neutral plates to induce recombination. This cycle is repeated three times to increase the chance of recombination. Next, the crossovers resulting in the desired recombinants are selected and screened using kanamycin and thiostrepton for single crossovers and kanamycin for double crossovers. In order to confirm the inactivity of the double crossing, the replica plate method and the Southern hybridization method are used (Keiser et al (2000) above).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="10" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
グリコシルトランスフェラーゼ活性の不活性化<br class="style-scope patent-text">
<chemistry id="" num="86" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000120" he="24" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Inactivation of glycosyltransferase activity <br class="style-scope patent-text"> <chemistry id="" num="86" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000120" he="24" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）遺伝子座のＯＲＦ９をコードするグリコシルトランスフェラーゼ遺伝子（ＧＴＦＡ）の不活性化は（図１２ｂに示されている通り）、この実施例の化合物を提供している。ＧＦＴＡを不活性化すると、糖成分の化合物２（ａ）の主鎖への移動を分断する。糖成分が欠如する結果、グリコシル化されていない型の化合物２（ａ）がもたらされる。ストレプトミセス属のポリケチド生合成において、挿入によってＧＴＦＡ遺伝子を不活化することは、周知の技術である。Blanco et. al., 2000, Mol Gen Genet 262: 991-1000は、これらの遺伝子の不活性化に際して、グリコシル化されていないミトラマイシンが生成されたことにより、ミトラマイシン生合成遺伝子クラスターのうち、２つの遺伝子をグリコシルトランスフェラーゼとして同定した。Chen et.al., Gene, 2001, 263:255-64は、ピクロマイシン、ナルボマイシン、メチマイシン及びネオメチマイシンをコードする、生合成経路においてグリコシル化を担う遺伝子を研究し、同様の観察を行っている。
</span>
&nbsp;&nbsp;Inactivation of the glycosyltransferase gene (GTFA) encoding ORF9 at the compound 2 (a) locus (as shown in FIG. 12b) provides the compounds of this example. Inactivation of GFTA disrupts the migration of the sugar component to the main chain of compound 2 (a). The lack of a sugar component results in a non-glycosylated form of compound 2 (a). Inactivation of the GTFA gene by insertion in Streptomyces polyketide biosynthesis is a well-known technique. Blanco et. Al., 2000, Mol Gen Genet 262: 991-1000 is one of the mitramycin biosynthetic gene clusters due to the generation of unglycosylated mitramycin upon inactivation of these genes. Two genes were identified as glycosyltransferases. Chen et.al., Gene, 2001, 263: 255-64 studied the genes responsible for glycosylation in the biosynthetic pathway, encoding picromycin, nalbomycin, methimycin and neomethymycin, with similar observations. Yes.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グリコシルトランスフェラーゼ活性を標的にした不活性化は、実施例８に記載されているように、挿入によって遺伝子破壊する方法を用いて実現される。
</span>
&nbsp;&nbsp;Inactivation targeted to glycosyltransferase activity is achieved using a method of gene disruption by insertion, as described in Example 8.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="11" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
アミノヒドロキシシクロペンテノンのユニットの除外<br class="style-scope patent-text">
<chemistry id="" num="87" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000121" he="24" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Exclusion of aminohydroxycyclopentenone units <br class="style-scope patent-text"> <chemistry id="" num="87" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000121" he="24" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）遺伝子座の、以下の３つのいずれかのＯＲＦを不活性化することにより、末端アミノヒドロキシシクロペンテノンの単位を除外することができる。第一に、ＯＲＦ３５を破壊すると、サクシニル−補酵素Ａ及びグリシンが縮合して５−アミノレブリン酸を形成することができないようする、（図１２ｃに示されているような）アシルトランスフェラーゼ（ＡＹＴＰ）活性の不活性化をもたらす。第二に、ＯＲＦ３６を破壊すると、アシル補酵素Ａリガーゼ（ＣＡＬＢ）が不活性化され、５−アミノレブリン酸が、環化してアミノヒドロキシシクロペンテノンを形成する５−アミノレブリン酸補酵素Ａに転換するのを阻止する。第三に、ＯＲＦ３４（ＡＤＳＮ）を破壊すると、アミノヒドロキシシクロペンテノンの単位が、ポリケチド鎖へと移動するのを阻止する。したがって、実施例１０の化合物は、少なくともＯＲＦ３４、３５及び３６のうち１つを遺伝子的に修飾することにより、提供される。３つの遺伝子全てを、挿入によって不活性化するために用いる方法は、実施例９に記載されている。
</span>
&nbsp;&nbsp;By inactivating any of the following three ORFs at the compound 2 (a) locus, the terminal aminohydroxycyclopentenone unit can be excluded. First, acyltransferase (AYTP) activity (as shown in FIG. 12c) prevents ORF35 from disrupting succinyl-coenzyme A and glycine to condense to form 5-aminolevulinic acid. Cause inactivation. Second, destruction of ORF36 inactivates acyl coenzyme A ligase (CALB) and converts 5-aminolevulinic acid to 5-aminolevulinate coenzyme A, which cyclizes to form aminohydroxycyclopentenone. To prevent it. Third, disruption of ORF34 (ADSN) prevents the aminohydroxycyclopentenone units from migrating to the polyketide chain. Thus, the compound of Example 10 is provided by genetically modifying at least one of <figure-callout id="34" label="ORFs" filenames="2007525148-219.png,2007525148-221.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="35" label="ORFs" filenames="2007525148-220.png,2007525148-222.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="36" label="ORFs" filenames="2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORFs</a></figure-callout></a></figure-callout></a></figure-callout> 34, 35 and 36. The method used to inactivate all three genes by insertion is described in Example 9.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="12" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
末端アミノ基のグアニジノ基による置換<br class="style-scope patent-text">
<chemistry id="" num="88" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000122" he="23" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Substitution of terminal amino group by guanidino group <br class="style-scope patent-text"> <chemistry id="" num="88" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000122" he="23" wi="170" file="2007525148.tif" img-format="tif" img-content="drawing" width="680" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  末端アミンのグアニジノ基による置換は、実施例９に記載されている方法を用いて、挿入によってＯＲＦ３３（ＡＤＨＹ）を不活性化することで達成される。ＯＲＦ３３ＡＤＨＹを不活性化すると、（図１２ｄに示されているように）、ガンマアミノブタンアミドの合成を破壊し、４−グアニジノブタンアミドの蓄積に至る。集積した４−グアニジノブタンアミドは、ＯＲＦ２７ＣＡＬＢによって４−グアニジノブチリル−補酵素Ａに変換され、次にＯＲＦ１９（ＡＹＴＦ）の作用を通して、ポリケチド合成酵素に（図１０ｂにおいてＯＲＦ１０、モジュール０に示されているように）付着する。
</span>
&nbsp;&nbsp;Replacement of the terminal amine with a guanidino group is accomplished by inactivating ORF33 (ADHY) by insertion using the method described in Example 9. Inactivation of ORF33ADHY (as shown in FIG. 12d) disrupts the synthesis of gamma aminobutanamide, leading to the accumulation of 4-guanidinobutanamide. The accumulated 4-guanidinobutanamide is converted to 4-guanidinobutyryl-coenzyme A by ORF27CALB, and then to the polyketide synthase through the action of ORF19 (AYTF) (shown in ORF10, <figure-callout id="0" label="module" filenames="2007525148-207.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 0 in FIG. 10b). To adhere).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="13" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａ）のエポキシ化による化合物２（ｂ）の合成<br class="style-scope patent-text">
<chemistry id="" num="89" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000123" he="24" wi="167" file="2007525148.tif" img-format="tif" img-content="drawing" width="668" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
  
Synthesis of Compound 2 (b) by Epoxidation of Compound 2 (a) <br class="style-scope patent-text"> <chemistry id="" num="89" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000123" he="24" wi="167" file="2007525148.tif" img-format="tif" img-content="drawing" width="668" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に化合物２（ａ）を溶解した混合物に、１当量のｍ−クロロ過安息香酸を添加する。反応物を氷浴で冷却し、０℃で１〜２時間攪拌する。次に、反応混合物を乾燥するまで蒸発させ、メタノール中に再溶解し、セファデックスＬＨ−２０カラム上で液体クロマトグラフィーにかけ、化合物２（ｂ）を単離する。
</span>
&nbsp;&nbsp;One equivalent of m-chloroperbenzoic acid is added to a mixture of compound 2 (a) in tetrahydrofuran (THF). The reaction is cooled in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol and subjected to liquid chromatography on a Sephadex LH-20 column to isolate compound 2 (b).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  少量の塩酸水溶液（１．０Ｎ）で化合物２（ｂ）を処理することにより化合物２（ｂ）のエポキシド基を、加水分解させ、これにより式：
</span>
&nbsp;&nbsp;Treatment of compound 2 (b) with a small amount of aqueous hydrochloric acid (1.0N) hydrolyzes the epoxide group of compound 2 (b), thereby yielding the formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="90" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000124" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>  <br class="style-scope patent-text">
に相当するジオールを形成する。
 <chemistry id="" num="90" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000124" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> A diol corresponding to
    <p class="style-scope patent-text"></p>
  </mode-for-invention>
  <mode-for-invention mode-num="14" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
３１オキソ基の還元による化合物２（ｃ）の合成<br class="style-scope patent-text">
<chemistry id="" num="91" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000125" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
<br class="style-scope patent-text">
        アセトニトリルに化合物２（ａ）を溶解した溶液を、１．５当量のＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>で処理する。反応物を、室温で１時間攪拌する。次に、反応混合物を濃縮して乾燥させ、メタノールに溶解する。混合物をろ過し、ろ過液をセファデックスＬＨ−２０のカラム上で液体クロマトグラフィーにかけ、化合物２（ｃ）を単離する。または、水素化ホウ素リチウム（ＬｉＢＨ<sub class="style-scope patent-text">４</sub>）を用いても、３１位のオキソ基を還元することができる。
Synthesis of compound 2 (c) by reduction of 31 oxo group <br class="style-scope patent-text"> <chemistry id="" num="91" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000125" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> <br class="style-scope patent-text"> A solution of compound 2 (a) in acetonitrile is treated with 1.5 equivalents of NaCNBH <sub class="style-scope patent-text">3</sub> . The reaction is stirred at room temperature for 1 hour. The reaction mixture is then concentrated to dryness and dissolved in methanol. The mixture is filtered and the filtrate is subjected to liquid chromatography on a Sephadex LH-20 column to isolate compound 2 (c). Alternatively, even when lithium borohydride (LiBH <sub class="style-scope patent-text">4</sub> ) is used, the oxo group at the 31-position can be reduced.
    <p class="style-scope patent-text"></p>
  </mode-for-invention>
  <mode-for-invention mode-num="15" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
３１位のアセタール環の付加による化合物２（ｄ）の合成<br class="style-scope patent-text">
<chemistry id="" num="92" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000126" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of Compound 2 (d) by Addition of Acetal Ring at <figure-callout id="31" label="Position" filenames="2007525148-221.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Position</a></figure-callout> 31 <br class="style-scope patent-text"> <chemistry id="" num="92" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000126" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフランに化合物２（ａ）を溶解した溶液を、微量のトルエンスルホン酸の存在下で、３当量の２，２−ジメチル−１, ３−ジオキサシクロペンタンで処理する。反応物を室温で一晩攪拌し、乾燥するまで蒸発させ、乾燥ＴＨＦ中に取り込み、次にセファデックスＬＨ−２０のカラム上で、液体クロマトグラフィーにかけて精製する。２，２−ジメチル−１, ３−ジオキサシクロペンタンは、微量のトルエンスルホン酸の存在下で、水を除去するために分子ふるいにかけながら、アセトンとエチレングリコールを反応させて合成される。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) in tetrahydrofuran is treated with 3 equivalents of 2,2-dimethyl-1,3-dioxacyclopentane in the presence of a trace amount of toluenesulfonic acid. The reaction is stirred at room temperature overnight, evaporated to dryness, taken up in dry THF and then purified by liquid chromatography on a Sephadex LH-20 column. 2,2-Dimethyl-1,3-dioxacyclopentane is synthesized by reacting acetone and ethylene glycol in the presence of a small amount of toluenesulfonic acid while passing through a molecular sieve to remove water.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  または、微量のトルエンスルホン酸の存在下で、化合物２（ａ）を過剰量のエチレングリコールと反応させることでも、３１位のアセタール環を付加することができる。反応は、水を除去するために、分子ふるいにかけながら行う。
</span>
&nbsp;&nbsp;Alternatively, the 31-position acetal ring can also be added by reacting compound 2 (a) with an excess amount of ethylene glycol in the presence of a small amount of toluenesulfonic acid. The reaction is carried out with molecular sieving to remove water.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="16" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｅ）の合成<br class="style-scope patent-text">
<chemistry id="" num="93" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000127" he="25" wi="167" file="2007525148.tif" img-format="tif" img-content="drawing" width="668" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (e) <br class="style-scope patent-text"> <chemistry id="" num="93" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000127" he="25" wi="167" file="2007525148.tif" img-format="tif" img-content="drawing" width="668" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ベンゼン又はトルエンに化合物２（ａ）を溶解した溶液に、１０当量のベンジルアミンを添加する。反応物を、室温で一晩撹拌する。反応は、水を除去するために、分子ふるいを使用しながら行う。または、ディーンスターク・トラップを用いて、ベンゼン又はトルエンとの共沸混合物として、還流によって水を除去することもできる。反応混合物を、真空下で濃縮し、残留試薬は、一晩室温で高真空下に置いて除去する。
</span>
&nbsp;&nbsp;10 equivalents of benzylamine are added to a solution of compound 2 (a) in benzene or toluene. The reaction is stirred overnight at room temperature. The reaction is carried out using a molecular sieve to remove water. Alternatively, water can be removed by reflux as an azeotrope with benzene or toluene using a Dean-Stark trap. The reaction mixture is concentrated under vacuum and residual reagents are removed by placing under high vacuum at room temperature overnight.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ｅ）とＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">４</sub>（１．５当量）をアセトニトリル中で反応させることにより、化合物２（ｅ）の炭素−窒素の二重結合が、アミンに還元され、次の構造の化合物を形成する：
</span>By reacting compound 2 (e) with NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">4</sub> (1.5 equivalents) in acetonitrile, the carbon-nitrogen double bond of compound 2 (e) is reduced to an amine and has the following structure: Form a compound:</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="94" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></chemistry></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000128" he="24" wi="167" file="2007525148.tif" img-format="tif" img-content="drawing" width="668" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000128" he="24" wi="167" file="2007525148.tif" img-format="tif" img-content="drawing" width="668" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
  </mode-for-invention>
  <mode-for-invention mode-num="17" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｆ）の合成<br class="style-scope patent-text">
<chemistry id="" num="95" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000129" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (f) <br class="style-scope patent-text"> <chemistry id="" num="95" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000129" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに１当量の化合物２（ａ）を溶解した溶液に、１０当量のイソブチルアミノを添加する。反応物を、室温で２時間攪拌する。ベンゼン（１／１０の容量）を添加し、混合物を回転式蒸発装置にて真空下で、乾燥するまで濃縮する。
</span>
&nbsp;&nbsp;10 equivalents of isobutylamino are added to a solution of 1 equivalent of compound 2 (a) in acetonitrile. The reaction is stirred at room temperature for 2 hours. Benzene (1/10 volume) is added and the mixture is concentrated to dryness in a rotary evaporator under vacuum.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  次に、シッフ塩基をＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">３</sub>（１．５当量）のアセトニトリル溶液で処理し、イミンの炭素−窒素二重結合をアミンに還元し、化合物２（ｆ）を形成する。
</span>The Schiff base is then treated with a solution of NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">3</sub> (1.5 eq) in acetonitrile to reduce the imine carbon-nitrogen double bond to an amine to form compound 2 (f).</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="18" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｇ）の合成<br class="style-scope patent-text">
<chemistry id="" num="96" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000130" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
Synthesis of compound 2 (g) <br class="style-scope patent-text"> <chemistry id="" num="96" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000130" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ｇ）は、実施例９に記載されているように、生合成的に合成される。または、化合物２（ｇ）は、化合物２（ａ）の加水分解によっても調製することができる。これは、メーヤワイン（Meerwein）試薬（トリエチルオキソニムテトラフルオロホウ酸）で、ジエチルエーテル／ＴＨＦを含む化合物２（ａ）を、室温で２時間処理し、次に−２０℃まで冷却し、酢酸水溶液を含むＴＨＦに滴下することで実施できる。反応混合物を２０分間攪拌し、その間に温度を室温まで上げることができる。次に混合物を水（２倍容量）で希釈し、ＨＰ−２０ポリエスチレン樹脂を添加する。この混合物を３０分間攪拌し、ろ過し、樹脂を、水でよく洗浄し、産物を１００％のエタノールで溶出する。溶出物を、真空下で濃縮すると、化合物２（ｇ）が得られる。
</span>
&nbsp;&nbsp;Compound 2 (g) is synthesized biosynthetically as described in Example 9. Alternatively, compound 2 (g) can also be prepared by hydrolysis of compound 2 (a). This is done by treating a compound 2 (a) containing diethyl ether / THF with a Meerwein reagent (triethyloxonim tetrafluoroboric acid) for 2 hours at room temperature, then cooling to −20 ° C. and adding an aqueous acetic acid solution. It can implement by dripping to THF containing. The reaction mixture can be stirred for 20 minutes, during which time the temperature can be raised to room temperature. The mixture is then diluted with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water and the product is eluted with 100% ethanol. The eluate is concentrated under vacuum to give compound 2 (g).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="19" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｈ）の合成<br class="style-scope patent-text">
<chemistry id="" num="97" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000131" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (h) <br class="style-scope patent-text"> <chemistry id="" num="97" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000131" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  メタノールに０．１当量の化合物２（ｇ）を溶解した溶液に、ジエチルエーテルに０．５当量のジアゾメタンを溶解した溶液を添加する。反応混合物を、一晩室温に放置し、真空下で溶媒を除去すると、化合物２（ｈ）が得られる。
</span>
&nbsp;&nbsp;A solution of 0.5 equivalent of diazomethane in diethyl ether is added to a solution of 0.1 equivalent of Compound 2 (g) in methanol. The reaction mixture is left overnight at room temperature and the solvent is removed under vacuum to give compound 2 (h).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="20" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｉ）の合成<br class="style-scope patent-text">
<chemistry id="" num="98" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000132" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (i) <br class="style-scope patent-text"> <chemistry id="" num="98" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000132" he="24" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  メタノールに化合物２（ａ）を溶解した溶液を、等量の０．１ＮのＨＣｌで処理し、反応混合物を、室温で一晩攪拌する。次に混合物を、水（２容積）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。この混合物を、３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を、１００％のエタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｉ）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) in methanol is treated with an equal volume of 0.1N HCl and the reaction mixture is stirred overnight at room temperature. The mixture is then diluted with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water, and the product is eluted with 100% ethanol. Concentrate the eluate under vacuum to give compound 2 (i).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="21" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｊ）の合成<br class="style-scope patent-text">
<chemistry id="" num="99" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000133" he="18" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (j) <br class="style-scope patent-text"> <chemistry id="" num="99" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000133" he="18" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ｊ）は、化合物２（ｇ）を加水分解して調製する。この加水分解は、前記の実施例１９に記載の、化合物２（ａ）が化合物２（ｉ）に加水分解されるのと同様の方法で行うことができる。
</span>
&nbsp;&nbsp;Compound 2 (j) is prepared by hydrolyzing compound 2 (g). This hydrolysis can be carried out in the same manner as described in Example 19 in which compound 2 (a) is hydrolyzed to compound 2 (i).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="22" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｋ）の合成<br class="style-scope patent-text">
<chemistry id="" num="100" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000134" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (k) <br class="style-scope patent-text"> <chemistry id="" num="100" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000134" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ｋ）は、実施例８に記載のように、エノイルレダクターゼを不活性化することによって生合成的に調製される。
</span>
&nbsp;&nbsp;Compound 2 (k) is prepared biosynthetically by inactivating enoyl reductase as described in Example 8.
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="23" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｌ）の合成<br class="style-scope patent-text">
<chemistry id="" num="101" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000135" he="31" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="124" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (l) <br class="style-scope patent-text"> <chemistry id="" num="101" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000135" he="31" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="124" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに化合物２（ｋ）を溶解した溶液を、１．５当量のＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>で処理する。反応物を、室温で１時間攪拌する。反応混合物を、乾燥するまで濃縮し、メタノールに溶解する。この混合物をろ過し、ろ過液を、セファデックスＬＨ−２０のカラム上で液体クロマトグラフィーにかけ、化合物２（ｌ）を単離する。または、水素化ホウ素リチウム（ＬｉＢＨ<sub class="style-scope patent-text">４</sub>）を用いても、３１位のオキソ基を還元することができる。
</span>A solution of compound 2 (k) in acetonitrile is treated with 1.5 equivalents of NaCNBH <sub class="style-scope patent-text">3</sub> . The reaction is stirred at room temperature for 1 hour. The reaction mixture is concentrated to dryness and dissolved in methanol. The mixture is filtered and the filtrate is subjected to liquid chromatography on a Sephadex LH-20 column to isolate compound 2 (l). Alternatively, even when lithium borohydride (LiBH <sub class="style-scope patent-text">4</sub> ) is used, the oxo group at the 31-position can be reduced.</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="24" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｍ）の合成<br class="style-scope patent-text">
<chemistry id="" num="102" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000136" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (m) <br class="style-scope patent-text"> <chemistry id="" num="102" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000136" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに１０当量の化合物２（ａ）を溶解した溶液を、１当量のアセトアルデビトで処理する。反応物を、室温で２時間攪拌する。ベンゼン（１／１０容量）を添加し、混合物を、回転式蒸発装置にて真空下で乾燥し濃縮すると、化合物２（ｍ）が得られる。
</span>
&nbsp;&nbsp;A solution of 10 equivalents of compound 2 (a) in acetonitrile is treated with 1 equivalent of acetaldehyde. The reaction is stirred at room temperature for 2 hours. Benzene (1/10 volume) is added and the mixture is dried in a rotary evaporator under vacuum and concentrated to give compound 2 (m).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ｍ）は、ＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">４</sub>（１．５当量）のアセトニトリル溶液で処理することができ、イミン炭素−窒素二重結合をアミンに還元する。
</span>Compound 2 (m) can be treated with a solution of NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">4</sub> (1.5 eq) in acetonitrile to reduce the imine carbon-nitrogen double bond to an amine.</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="25" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｎ）の合成<br class="style-scope patent-text">
<chemistry id="" num="103" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000137" he="24" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (n) <br class="style-scope patent-text"> <chemistry id="" num="103" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000137" he="24" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに１０当量の化合物２（ａ）を溶解した溶液を、１当量のベンズアルデビトで処理する。反応物を、室温で２時間攪拌する。ベンゼン（１／１０容量）を添加し、混合物を、回転式蒸発装置にて真空下で乾燥し濃縮すると、化合物２（ｎ）が得られる。
</span>
&nbsp;&nbsp;A solution of 10 equivalents of compound 2 (a) in acetonitrile is treated with 1 equivalent of benzaldevito. The reaction is stirred at room temperature for 2 hours. Benzene (1/10 volume) is added and the mixture is dried in a rotary evaporator under vacuum and concentrated to give compound 2 (n).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ｎ）は、ＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">４</sub>（１．５当量）のアセトニトリル溶液で処理することができ、イミン炭素−窒素二重結合をアミンに還元する。
</span>Compound 2 (n) can be treated with a solution of NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">4</sub> (1.5 eq) in acetonitrile to reduce the imine carbon-nitrogen double bond to an amine.</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="26" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｏ）の合成<br class="style-scope patent-text">
<chemistry id="" num="104" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000138" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (o) <br class="style-scope patent-text"> <chemistry id="" num="104" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000138" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドフランに化合物２（ａ）を溶解した溶液を、１当量のシアナミドで処理する。反応混合物を、室温で一晩攪拌する。反応混合物から溶媒を真空下で除去すると、化合物２（о）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) in tetrahydrane is treated with 1 equivalent of cyanamide. The reaction mixture is stirred overnight at room temperature. Removal of the solvent from the reaction mixture under vacuum gives compound 2 (о).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="27" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｐ）の合成<br class="style-scope patent-text">
<chemistry id="" num="105" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000139" he="28" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (p) <br class="style-scope patent-text"> <chemistry id="" num="105" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000139" he="28" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="112" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに１０当量の化合物２（ａ）を溶解した溶液に、１当量のアセトンを添加する。反応物を、室温で２時間攪拌する。ベンゼン（１／１０の容量）を添加し、混合物を回転式蒸発装置にて真空下で、乾燥するまで濃縮する。
</span>
&nbsp;&nbsp;1 equivalent of acetone is added to a solution of 10 equivalents of compound 2 (a) in acetonitrile. The reaction is stirred at room temperature for 2 hours. Benzene (1/10 volume) is added and the mixture is concentrated to dryness in a rotary evaporator under vacuum.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られたシッフ塩基イミンをＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">４</sub>（１．５当量）のアセトニトリル溶液で処理し、イミンの炭素−窒素二重結合をアミンに還元し、化合物２（ｐ）を形成する。
</span>The resulting Schiff base imine is treated with a solution of NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">4</sub> (1.5 eq) in acetonitrile to reduce the imine carbon-nitrogen double bond to an amine to form compound 2 (p).</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="28" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｑ）の合成<br class="style-scope patent-text">
<chemistry id="" num="106" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000140" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (q) <br class="style-scope patent-text"> <chemistry id="" num="106" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000140" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに１０当量の化合物２（ａ）を溶解した溶液に、1当量の４−ニトロベンズアルデヒドを添加する。反応物を、室温で２時間攪拌する。ベンゼン（１／１０の容量）を添加し、混合物を回転式蒸発装置にて真空下で、乾燥するまで濃縮する。
</span>
&nbsp;&nbsp;1 equivalent of 4-nitrobenzaldehyde is added to a solution of 10 equivalents of compound 2 (a) in acetonitrile. The reaction is stirred at room temperature for 2 hours. Benzene (1/10 volume) is added and the mixture is concentrated to dryness in a rotary evaporator under vacuum.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られたシッフ塩基イミンを、次に、ＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">４</sub>（１．５当量）のアセトニトリル溶液で処理し、イミンの炭素−窒素二重結合をアミンに還元し、化合物２（ｑ）を形成する。
</span>The resulting Schiff base imine is then treated with an acetonitrile solution of NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">4</sub> (1.5 eq) to reduce the imine carbon-nitrogen double bond to an amine to form compound 2 (q). To do.</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="29" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｒ）の合成<br class="style-scope patent-text">
<chemistry id="" num="107" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000141" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 
  
Synthesis of compound 2 (r) <br class="style-scope patent-text"> <chemistry id="" num="107" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000141" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アセトニトリルに１０当量の化合物２（ａ）を溶解した溶液に、１当量のシクロヘキシルホルムアルデビドを添加する。反応物を、室温で２時間攪拌する。ベンゼン（１／１０の容量）を添加し、混合物を回転式蒸発装置にて真空下で、乾燥するまで濃縮する。
</span>
&nbsp;&nbsp;1 equivalent of cyclohexylformaldehyde is added to a solution of 10 equivalents of compound 2 (a) in acetonitrile. The reaction is stirred at room temperature for 2 hours. Benzene (1/10 volume) is added and the mixture is concentrated to dryness in a rotary evaporator under vacuum.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られたシッフ塩基イミンを、次に、ＮａＣＮＢＨ<sub class="style-scope patent-text">３</sub>又はＬｉＢＨ<sub class="style-scope patent-text">４</sub>（１．５当量）のアセトニトリル溶液で処理し、イミンの炭素−窒素二重結合をアミンに還元し、化合物２（ｒ）を形成する。
</span>The resulting Schiff base imine is then treated with a solution of NaCNBH <sub class="style-scope patent-text">3</sub> or LiBH <sub class="style-scope patent-text">4</sub> (1.5 eq) in acetonitrile to reduce the imine carbon-nitrogen double bond to an amine to form compound 2 (r). To do.</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="30" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｓ）の合成<br class="style-scope patent-text">
<chemistry id="" num="108" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000142" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (s) <br class="style-scope patent-text"> <chemistry id="" num="108" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000142" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフランに化合物２（ａ）を溶解した溶液に、１当量の無水酢酸及び２当量のトリエチルアミンを添加する。反応物を、室温で２時間攪拌する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｓ）が得られる。
</span>
&nbsp;&nbsp;To a solution of compound 2 (a) in tetrahydrofuran is added 1 equivalent of acetic anhydride and 2 equivalents of triethylamine. The reaction is stirred at room temperature for 2 hours. The mixture is then diluted with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water, and the product is eluted with 100% ethanol. The eluate is concentrated in vacuo to give compound 2 (s).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="31" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｔ）の合成<br class="style-scope patent-text">
<chemistry id="" num="109" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000143" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (t) <br class="style-scope patent-text"> <chemistry id="" num="109" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000143" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液に、１当量のイソブチル無水物及び２当量のトリエチルアミンを添加する。反応物を、室温で２時間攪拌する。混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を、３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｔ）が得られる。
</span>
&nbsp;&nbsp;To a solution of compound 2 (a) is added 1 equivalent of isobutyl anhydride and 2 equivalents of triethylamine. The reaction is stirred at room temperature for 2 hours. The mixture is diluted with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water, and the product is eluted with 100% ethanol. Concentrate the eluate under vacuum to give compound 2 (t).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="32" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｕ）の合成<br class="style-scope patent-text">
<chemistry id="" num="110" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000144" he="26" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (u) <br class="style-scope patent-text"> <chemistry id="" num="110" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000144" he="26" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液に、１当量の安息香酸無水物及び２当量のトリエチルアミンを添加する。反応物を、室温で２時間攪拌する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｕ）が得られる。
</span>
&nbsp;&nbsp;To a solution of compound 2 (a) is added 1 equivalent of benzoic anhydride and 2 equivalents of triethylamine. The reaction is stirred at room temperature for 2 hours. The mixture is then diluted with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water, and the product is eluted with 100% ethanol. The eluate is concentrated in vacuo to give compound 2 (u).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="33" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｖ）の合成<br class="style-scope patent-text">
<chemistry id="" num="111" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000145" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (v) <br class="style-scope patent-text"> <chemistry id="" num="111" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000145" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液に、１当量のｐ−ニトロ安息香酸無水物及び２当量のトリエチルアミノを添加する。反応物を、室温で２時間攪拌する。次に、混合物を、水（２倍容量）で洗浄し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を、３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｖ）が得られる。
</span>
&nbsp;&nbsp;To a solution of compound 2 (a) is added 1 equivalent of p-nitrobenzoic anhydride and 2 equivalents of triethylamino. The reaction is stirred at room temperature for 2 hours. The mixture is then washed with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water, and the product is eluted with 100% ethanol. The eluate is concentrated in vacuo to give compound 2 (v).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="34" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｗ）の合成<br class="style-scope patent-text">
<chemistry id="" num="112" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000146" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of Compound 2 (w) <br class="style-scope patent-text"> <chemistry id="" num="112" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000146" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液を、１当量のＮ保護アラニン活性エステルと反応させる。アラニンのアミノ基を、ＤＣＣ（ジシクロヘキシルジカルボジイミド）又はＥＤＣ（１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミド）とアラニンとを反応させることによって保護し、カルボキシル酸基を、Ｎ−ヒドロキシスクシンイミドエステルなどの活性エステルに転換する。Ｎ保護活性エステルを、テトラヒドロフランなどの不活性溶媒に溶解した化合物２（ａ）に添加する。混合物を還流下で１時間加熱する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｗ）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) is reacted with 1 equivalent of N-protected alanine active ester. The amino group of alanine is protected by reacting DCC (dicyclohexyldicarbodiimide) or EDC (1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide) with alanine, and the carboxylic acid group is protected with N-hydroxy. Convert to active ester such as succinimide ester. The N-protected active ester is added to compound 2 (a) dissolved in an inert solvent such as tetrahydrofuran. The mixture is heated under reflux for 1 hour. The mixture is then diluted with water (2 volumes) and HP-20 polystyrene resin is added. The mixture is stirred for 30 minutes, filtered, the resin is washed well with water, and the product is eluted with 100% ethanol. The eluate is concentrated in vacuo to give compound 2 (w).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="35" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｘ）の合成<br class="style-scope patent-text">
<chemistry id="" num="113" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000147" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (x) <br class="style-scope patent-text"> <chemistry id="" num="113" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000147" he="25" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液を、１当量のＮ保護パラヒドロキシフェニルグリシン活性エステルと反応させる。パラヒドロキシフェニルグリシンのアミノ基を、ＤＣＣ（ジシクロヘキシルジカルボジイミド）又はＥＤＣ（１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミドとアラニンとを反応させることによって保護し、カルボキシル酸基を、Ｎ−ヒドロキシスクシンイミドエステルなどの活性エステルに転換する。Ｎ保護活性エステルを、テトラヒドロフランなどの不活性溶媒に溶解した化合物２（ａ）に添加する。混合物を還流下で１時間加熱する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｘ）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) is reacted with 1 equivalent of N-protected parahydroxyphenylglycine active ester. The amino group of parahydroxyphenylglycine is protected by reacting DCC (dicyclohexyldicarbodiimide) or EDC (1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide with alanine, and the carboxylic acid group is protected with N -Convert to an active ester such as hydroxysuccinimide ester, add N protected active ester to compound 2 (a) dissolved in an inert solvent such as tetrahydrofuran, etc. Heat the mixture at reflux for 1 hour. Dilute with water (2 volumes) and add HP-20 polystyrene resin, stir the mixture for 30 minutes, filter, wash the resin well with water and elute the product with 100% ethanol. Is concentrated in vacuo to give compound 2 (x).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="36" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｙ）の合成<br class="style-scope patent-text">
<chemistry id="" num="114" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000148" he="27" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (y) <br class="style-scope patent-text"> <chemistry id="" num="114" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000148" he="27" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液を、１当量のＮ保護チロシン活性エステルと反応させる。チロシンのアミノ基を、ＤＣＣ（ジシクロヘキシルジカルボジイミド）又はＥＤＣ（１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミドとアラニンとを反応させることによって保護し、カルボキシル酸基を、Ｎ−ヒドロキシスクシンイミドエステルなどの活性エステルに転換する。Ｎ保護活性エステルを、テトラヒドロフランなどの不活性溶媒に溶解した化合物２（ａ）に添加する。混合物を還流下で１時間加熱する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｙ）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) is reacted with 1 equivalent of N-protected tyrosine active ester. The amino group of tyrosine is protected by reacting DCC (dicyclohexyldicarbodiimide) or EDC (1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide with alanine, and the carboxylic acid group is protected with N-hydroxysuccinimide. Convert to an active ester, such as an ester, add the N protected active ester to compound 2 (a) dissolved in an inert solvent, such as tetrahydrofuran, and heat the mixture at reflux for 1 hour. HP-20 polystyrene resin is added and the mixture is stirred for 30 minutes, filtered, the resin washed well with water, and the product eluted with 100% ethanol. To give compound 2 (y).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="37" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ｚ）の合成<br class="style-scope patent-text">
<chemistry id="" num="115" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000149" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of compound 2 (z) <br class="style-scope patent-text"> <chemistry id="" num="115" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000149" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液を、１当量のＮ保護バリン活性エステルと反応させる。バリンのアミノ基を、ＤＣＣ（ジシクロヘキシルジカルボジイミド）又はＥＤＣ（１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミドとアラニンとを反応させることによって保護し、カルボキシル酸基を、Ｎ−ヒドロキシスクシンイミドエステルなどの活性エステルに転換する。Ｎ保護活性エステルを、テトラヒドロフランなどの不活性溶媒に溶解した化合物２（ａ）に添加する。混合物を還流下で１時間加熱する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ｚ）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) is reacted with 1 equivalent of N-protected valine active ester. The amino group of valine is protected by reacting DCC (dicyclohexyldicarbodiimide) or EDC (1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide with alanine, and the carboxylic acid group is protected with N-hydroxysuccinimide. Convert to an active ester, such as an ester, add the N protected active ester to compound 2 (a) dissolved in an inert solvent, such as tetrahydrofuran, and heat the mixture at reflux for 1 hour. HP-20 polystyrene resin is added and the mixture is stirred for 30 minutes, filtered, the resin washed well with water, and the product eluted with 100% ethanol. To give compound 2 (z).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="38" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａａ）の合成<br class="style-scope patent-text">
<chemistry id="" num="116" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000150" he="24" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of Compound 2 (aa) <br class="style-scope patent-text"> <chemistry id="" num="116" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000150" he="24" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液を、１当量のＮ保護プロリン活性エステルと反応させる。プロリンのアミノ基を、ＤＣＣ（ジシクロヘキシルジカルボジイミド）又はＥＤＣ（１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミドとアラニンとを反応させることによって保護し、カルボキシル酸基を、Ｎ−ヒドロキシスクシンイミドエステルなどの活性エステルに転換する。Ｎ保護活性エステルを、テトラヒドロフランなどの不活性溶媒に溶解した化合物２（ａ）に添加する。混合物を還流下で１時間加熱する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ａａ）が得られる。
</span>
&nbsp;&nbsp;A solution of compound 2 (a) is reacted with 1 equivalent of N-protected proline active ester. The amino group of proline is protected by reacting DCC (dicyclohexyldicarbodiimide) or EDC (1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide with alanine, and the carboxylic acid group is protected with N-hydroxysuccinimide. Convert to an active ester, such as an ester, add the N protected active ester to compound 2 (a) dissolved in an inert solvent, such as tetrahydrofuran, and heat the mixture at reflux for 1 hour. HP-20 polystyrene resin is added and the mixture is stirred for 30 minutes, filtered, the resin washed well with water, and the product eluted with 100% ethanol. To give compound 2 (aa).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="39" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
化合物２（ａｂ）の合成<br class="style-scope patent-text">
<chemistry id="" num="117" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000151" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> 

Synthesis of Compound 2 (ab) <br class="style-scope patent-text"> <chemistry id="" num="117" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000151" he="24" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  化合物２（ａ）の溶液を、１当量のＮ保護セリン活性エステルと反応させる。セリンのアミノ基を、ＤＣＣ（ジシクロヘキシルジカルボジイミド）又はＥＤＣ（１−エチル−３−（３−ジメチルアミノプロピル）−カルボジイミドとアラニンとを反応させることによって保護し、カルボキシル酸基を、Ｎ−ヒドロキシスクシンイミドエステルなどの活性エステルに転換する。Ｎ保護活性エステルを、テトラヒドロフランなどの不活性溶媒に溶解した化合物２（ａ）に添加する。混合物を還流下で１時間加熱する。次に混合物を、水（２倍容量）で希釈し、ＨＰ−２０ポリスチレン樹脂を添加する。混合物を３０分間攪拌し、ろ過し、樹脂を水でよく洗浄し、産物を１００％エタノールで溶出する。この溶出物を真空下で濃縮すると、化合物２（ａｂ）が得られる。
</span>
&nbsp;&nbsp;The solution of compound 2 (a) is reacted with 1 equivalent of N-protected serine active ester. The amino group of serine is protected by reacting DCC (dicyclohexyldicarbodiimide) or EDC (1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide with alanine, and the carboxylic acid group is protected with N-hydroxysuccinimide. Convert to an active ester, such as an ester, add the N protected active ester to compound 2 (a) dissolved in an inert solvent, such as tetrahydrofuran, and heat the mixture at reflux for 1 hour. HP-20 polystyrene resin is added and the mixture is stirred for 30 minutes, filtered, the resin washed well with water, and the product eluted with 100% ethanol. To give compound 2 (ab).
</span>
    </p>
  </mode-for-invention>
  <mode-for-invention mode-num="40" class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
心臓血管疾患治療のための化合物２（ａ）
</span>
Compound 2 (a) for the treatment of cardiovascular disease
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ポリエン化合物は、一般的に消化管からは吸収されず、経口投与後に消化管内でコレステロールと結合し、低コレステロール血症の特性を示す。ポリエン化合物による低コレステロール血症の特性は、犬の研究においてはじめて明らかになった（Schaffner, C. P. and Gordon H. W. The Hypocholesterolemic activity of orally administered polyene macrolides. P. N. A. S. 61: 36-41, 1968.）。トリを用いた別の研究では、飼料中の少量のポリエン化合物は、腸肝コレステロール循環の阻害を誘導し、糞便中の脂質排出を増加し、及びアテローム発生を減少させた（Fisher, H., Griminger P. and Siller W. Effect of candicidin on plasma cholesterol and avian atherosclerosis. Proceedings of the Society for Experimental Biology and Medicine, 145: 836-839, 1974）。経口投与されたポリエン化合物がコレステロール脂質の代謝に及ぼす有益な効果は、ヒト、ラット、イヌ及びトリなどの複数の種において示されているように、種依存的ではない（Pagliano FM, Correction of hyperdyslipidemia using polyene-structure substances. Controlled clinical trail. Arch Sci Med (Torino). 136: 303-308, 1979; Barbaro A. and Casella G. Action of a polyene macrolide on hyperdislipidaemic disorders. Archivio per Scienze Mediche 137: 211-216, 1980; Singhal, A. K., Mosbach, E. H. and Schaffner, C. P. Effect of candicidin on cholesterol and bile acid metabolism in the rat. Lipids, 16: 423-426, 1981.）。
</span>
&nbsp;&nbsp;Polyene compounds are generally not absorbed from the gastrointestinal tract, but bind to cholesterol in the gastrointestinal tract after oral administration and exhibit hypocholesterolemic properties. The characteristics of hypocholesterolemia due to polyene compounds were first revealed in a dog study (Schaffner, C.P. and Gordon H.W. The Hypocholesterolemic activity of orally administered polyene macrolides. P.N.A.S. 61: 36-41, 1968.). In another study using birds, small amounts of polyene compounds in the diet induced inhibition of enterohepatic cholesterol circulation, increased fecal lipid excretion, and decreased atherogenesis (Fisher, H., Griminger P. and Siller W. Effect of candicidin on plasma cholesterol and avian atherosclerosis. Proceedings of the Society for Experimental Biology and Medicine, 145: 836-839, 1974). The beneficial effect of orally administered polyene compounds on cholesterol lipid metabolism is not species-dependent, as shown in several species such as humans, rats, dogs and birds (Pagliano FM, Correction of hyperdyslipidemia). Using polyene-structure substances. Controlled clinical trail. Arch Sci Med (Torino). 136: 303-308, 1979; Barbaro A. and Casella G. Action of a polyene macrolide on hyperdislipidaemic disorders. Archivio per Scienze Mediche 137: 211-216 Singhal, AK, Mosbach, EH and Schaffner, CP Effect of candicidin on cholesterol and bile acid metabolism in the rat. Lipids, 16: 423-426, 1981.).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  高コレステロール症、異常脂質血症、及びアテローム性動脈硬化症などの心臓血管疾患の治療に用いる化合物２（ａ）の治療可能性を、ウサギに経口投与した化合物２（ａ）の効果を測定することにより示した。ニュージーランドウサギを、光及び温度が制御された条件下で飼育し、通常のウサギ用飼料（コントロール）、及び高コレステロール症を誘発させるためにコレステロールを０．５〜１％含む飼料を、異なる二種類の飼料として数週間与えた。１ヶ月にわたって、毎日、ウサギに、化合物２（ａ）（３，１０，３０ｍｇ／体重ｋｇ）又は賦形剤を、強制飼養により投与した。飼料摂取量及びウサギの体重を、実験期間中、毎日測定した。コレステロール、リポタンパク質及びトリグリセリドを測定するための血液サンプルを、実験期間中には４日毎に採取したのと同様に、実験の開始時と終了時においても、耳動脈に挿入したカテーテルから採取した。血清コレステロール、リポタンパク質及びトリグリセリドを、製造者（Sigma Chemical Co）に指定されたとおりに、及びStraprans I, Pan X-M, Rapp JH, Feingold KRに記載されているとおりに市販のキットを使用して、酵素アッセイにより測定した。飼料中の酸化コレステロールにより、コレステロール飼料摂取ラビットにおいて、アテローム性大動脈硬化の発症が促進される。Arteriosclerois, Thrombosis and Vascular Biology, 18: 977-983, 1998。実験の終了時、最後の血液サンプルを採取後に、動物に麻酔を施して、下行大動脈を露出し、切除し、ホルマリンに固定して組織学的検索のために加工する。すなわち、パラフィン縦断面又は横断面（５ミクロン）を、スーダンブラック（脂質染色）で染色して、マッソントリクロムで対比染色する。脈管内膜、中膜、及び外膜領域の形態的定量を、画像解析により実施した。大動脈の脂質沈着を、脂肪染色で視覚化した損傷で覆われた大動脈の割合を求めることで判定する。コレステロールの動脈中濃度を、Thiery J, Nebendahl K, Rapp K, Kluge R, Teupser D and Seidel D. Low atherosclerotic response of a strain of rabbits to diet-induced hypercholesterolemia. Arteriosclerosis, Thrombosis and Vascular Biology, 15: 1181-1188, 1995で説明されているように、脂質の抽出後に測定する。
</span>
&nbsp;&nbsp;The therapeutic potential of compound 2 (a) used for the treatment of cardiovascular diseases such as hypercholesterolemia, dyslipidemia, and atherosclerosis is measured for the effect of compound 2 (a) administered orally to rabbits. By showing. New Zealand rabbits are bred under light and temperature controlled conditions, two different types of feed: normal rabbit diet (control) and diet containing 0.5-1% cholesterol to induce hypercholesterolemia For several weeks. Rabbits were dosed daily by gavage with Compound 2 (a) (3, 10, 30 mg / kg body weight) or vehicle for one month. Feed intake and rabbit body weight were measured daily throughout the experiment. Blood samples for measuring cholesterol, lipoproteins and triglycerides were taken from catheters inserted into the ear artery at the start and end of the experiment, as was taken every 4 days during the experiment. Serum cholesterol, lipoproteins and triglycerides are obtained using commercially available kits as specified by the manufacturer (Sigma Chemical Co) and as described in Straprans I, Pan XM, Rapp JH, Feingold KR. Measured by enzyme assay. Oxidized cholesterol in the feed promotes the development of atherosclerosis in the rabbit fed with cholesterol feed. Arteriosclerois, Thrombosis and Vascular Biology, 18: 977-983, 1998. At the end of the experiment, after the last blood sample is taken, the animals are anesthetized to expose the descending aorta, excised, fixed in formalin and processed for histological search. That is, a paraffin longitudinal section or a transverse section (5 microns) is stained with Sudan black (lipid staining) and counterstained with Masson trichrome. Morphological quantification of the intima, media and adventitial regions was performed by image analysis. Aortic lipid deposition is determined by determining the percentage of aorta covered with damage visualized by fat staining. Arteriosclerosis, Thrombosis and Vascular Biology, 15: 1181--Cholesterol concentration in the arteries was measured by Thiery J, Nebendahl K, Rapp K, Kluge R, Teupser D and Seidel D. Low atherosclerotic response of a strain of rabbits to diet-induced hypercholesterolemia. Measured after lipid extraction as described in 1188, 1995.
</span>
    </p>
  </mode-for-invention>
  <description-of-drawings class="style-scope patent-text">
    <p class="style-scope patent-text">
      <figref num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ストレプトミセス・アイズネンシスについて、化合物２（ａ）の生合成遺伝子座を示す図である。また、２５０２０３−０１、２５０２０３−０２、２５０２０３−０３、２５０２０３−０４及び２５０２０３−０５のアクセッション番号でＩＤＡＣに寄託されているコスミドの位置が示されており、これらは化合物２（ａ）の遺伝子座の長さに及んでいる。</span>It is a figure which shows the biosynthetic locus of the compound 2 (a) about Streptomyces isuzunensis. In addition, the positions of cosmids deposited with IDAC are indicated by the accession numbers of 250203-01, 250203-02, 250203-03, 250203-04, and 250203-05, and these are the genes of compound 2 (a). It extends to the length of the seat.</span>
      </figref>
      <figref num="2a" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を合成するポリケチドシンターゼ（ＰＫＳ）に存在する、２６ＫＳドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＫＳドメインの境界及び重要な残基（黒で強調表示されている）は、Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997)  による記載に従って選択された。</span>The composite amino acid sequence which compares the 26KS domain (ORF10-18) which exists in the polyketide synthase (PKS) which synthesize | combines the compound 2 (a). The boundary of this KS domain and important residues (highlighted in black) were selected as described by Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997).</span>
      </figref>
      <figref num="2b" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を合成するポリケチドシンターゼ（ＰＫＳ）に存在する、２６ＫＳドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＫＳドメインの境界及び重要な残基（黒で強調表示されている）は、Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997)  による記載に従って選択された。</span>The composite amino acid sequence which compares the 26KS domain (ORF10-18) which exists in the polyketide synthase (PKS) which synthesize | combines the compound 2 (a). The boundary of this KS domain and important residues (highlighted in black) were selected as described by Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997).</span>
      </figref>
      <figref num="2c" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を合成するポリケチドシンターゼ（ＰＫＳ）に存在する、２６ＫＳドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＫＳドメインの境界及び重要な残基（黒で強調表示されている）は、Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997)  による記載に従って選択された。</span>The composite amino acid sequence which compares the 26KS domain (ORF10-18) which exists in the polyketide synthase (PKS) which synthesize | combines the compound 2 (a). The boundary of this KS domain and important residues (highlighted in black) were selected as described by Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997).</span>
      </figref>
      <figref num="2d" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を合成するポリケチドシンターゼ（ＰＫＳ）に存在する、２６ＫＳドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＫＳドメインの境界及び重要な残基（黒で強調表示されている）は、Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997)  による記載に従って選択された。</span>The composite amino acid sequence which compares the 26KS domain (ORF10-18) which exists in the polyketide synthase (PKS) which synthesize | combines the compound 2 (a). The boundary of this KS domain and important residues (highlighted in black) were selected as described by Kakavas et al., J. Bacteriol. 179, 7515-7522 (1997).</span>
      </figref>
      <figref num="3a" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２６ＡＴドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＡＴドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al.による記載に従って選択された。</span>The compound amino acid sequence which compares the 26AT domain (ORF10-18) which exists in PKS of compound 2 (a). The AT domain boundaries and key residues (highlighted in black) were selected as described above by Kakavas et al.</span>
      </figref>
      <figref num="3b" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２６ＡＴドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＡＴドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al. による記載に従って選択された。</span>The compound amino acid sequence which compares the 26AT domain (ORF10-18) which exists in PKS of compound 2 (a). The AT domain boundaries and key residues (highlighted in black) were selected as described by Kakavas et al. Above.</span>
      </figref>
      <figref num="3c" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２６ＡＴドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＡＴドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al. による記載に従って選択された。</span>The compound amino acid sequence which compares the 26AT domain (ORF10-18) which exists in PKS of compound 2 (a). The AT domain boundaries and key residues (highlighted in black) were selected as described by Kakavas et al. Above.</span>
      </figref>
      <figref num="3d" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２６ＡＴドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＡＴドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al. による記載に従って選択された。</span>The compound amino acid sequence which compares the 26AT domain (ORF10-18) which exists in PKS of compound 2 (a). The AT domain boundaries and key residues (highlighted in black) were selected as described by Kakavas et al. Above.</span>
      </figref>
      <figref num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する１５ＤＨドメイン（ＯＲＦ１０、１１、１２、１４、１５、１７及び１８）を比較する複合アミノ酸配列。このＤＨドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al.による記載に従って選択された。不活性ＤＨドメインが、強調表示されている。</span>The compound amino acid sequence which compares 15DH domain (ORF10,11,12,14,15,17 and 18) which exists in PKS of compound 2 (a). The boundary of this DH domain and key residues (highlighted in black) were selected as described above by Kakavas et al. The inactive DH domain is highlighted.</span>
      </figref>
      <figref num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在するＥＲドメイン（ＯＲＦ１７）と、ニスタチン生合成遺伝子座におけるモジュール５〜１５までのＥＲドメインとをBrautaset et al., Chem. Biol., 7, 395-403 (2000) による記載に従って比較するアミノ酸配列。このＥＲドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al.による記載に従って選択された。</span>The ER domain (ORF17) present in the PKS of compound 2 (a) and the ER domains of <figure-callout id="5" label="modules" filenames="2007525148-217.png,2007525148-220.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">modules</a></figure-callout> 5 to 15 at the nystatin biosynthetic locus are represented by Brautaset et al., Chem. Biol., 7, 395-403 (2000 Amino acid sequences to be compared as described by This ER domain boundary and key residues (highlighted in black) were selected as described above by Kakavas et al.</span>
      </figref>
      <figref num="6a" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２６ＫＲドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＫＲドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al.及びFisher et al. Structure Fold Des. 8, 339-347 (2000) による記載に従って選択された。ＯＲＦ１３のモジュール１２に見られる不活性ＫＲドメインが、強調表示されている。</span>The compound amino acid sequence which compares the 26KR domain (ORF10-18) which exists in PKS of compound 2 (a). The KR domain boundaries and key residues (highlighted in black) were selected as described by Kakavas et al. And Fisher et al. Structure Fold Des. 8, 339-347 (2000). The inactive KR domain found in <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 of <figure-callout id="13" label="ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORF</a></figure-callout> 13 is highlighted.</span>
      </figref>
      <figref num="6b" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２６ＫＲドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＫＲドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al.及びFisher et al. Structure Fold Des. 8, 339-347 (2000) による記載に従って選択された。ＯＲＦ１３のモジュール１２に見られる不活性ＫＲドメインが、強調表示されている。</span>The compound amino acid sequence which compares the 26KR domain (ORF10-18) which exists in PKS of compound 2 (a). The KR domain boundaries and key residues (highlighted in black) were selected as described by Kakavas et al. And Fisher et al. Structure Fold Des. 8, 339-347 (2000). The inactive KR domain found in <figure-callout id="12" label="module" filenames="2007525148-203.png,2007525148-206.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 12 of <figure-callout id="13" label="ORF" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ORF</a></figure-callout> 13 is highlighted.</span>
      </figref>
      <figref num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在する２７ＡＣＰドメイン（ＯＲＦ１０〜１８）を比較する複合アミノ酸配列。このＡＣＰドメインの境界及び重要なセリン残基（黒で強調表示されている）は、上記Kakavas et al.による記載に従って選択された。</span>The compound amino acid sequence which compares the 27 ACP domain (ORF10-18) which exists in PKS of compound 2 (a). The boundaries of this ACP domain and important serine residues (highlighted in black) were selected as described by Kakavas et al. Above.</span>
      </figref>
      <figref num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のＰＫＳに存在するＴＥドメイン（ＯＲＦ１８）と、ニスタチン生合成遺伝子座におけるモジュール７のＴＥドメインとを、上記Brautaset et al.による記載に従って比較するアミノ酸配列。このＥＲドメインの境界及び重要な残基（黒で強調表示されている）は、上記Kakavas et al.による記載に従って選択された。各々の配列クラスター（図２〜８）において、配列の下の線は、強く保存されている位置を示すために用いられている。さらに、３つの文字、即ち、＊（アスタリスク）、：（コロン）及び．（ピリオド）が用いられ、「＊」が、単独の完全に保存されている残基を有する位置を示し、「：」が以下のＳＴＡ、ＮＥＱＫ、ＮＨＱＫ、ＮＤＥＱ、ＱＨＲＫ、ＭＩＬＶ、ＭＩＬＦ、ＨＹ及びＦＹＷの強い基のうちの１つが完全に保存されていることを示し、「.」が、 以下のＣＳＡ、ＡＴＶ、ＳＡＧ、ＳＴＮＫ、ＳＴＰＡ、ＳＧＮＤ、ＳＮＤＥＱＫ、ＮＤＥＱＨＫ、ＮＥＱＨＲＫ、ＦＶＬＩＭ及びＨＦＹのより弱い基のうちの１つが完全に保存されていることを示している。</span>Amino acid sequence comparing the TE domain (ORF18) present in the PKS of compound 2 (a) with the TE domain of <figure-callout id="7" label="module" filenames="2007525148-216.png,2007525148-226.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">module</a></figure-callout> 7 at the nystatin biosynthetic locus as described by Brautaset et al. Above. This ER domain boundary and key residues (highlighted in black) were selected as described above by Kakavas et al. In each sequence cluster (FIGS. 2-8), the bottom line of the sequence is used to indicate a strongly conserved position. In addition, there are three characters: * (asterisk),: (colon) and. (Period) is used, “*” indicates a position with a single fully conserved residue, “:” indicates the following STA, NEQK, NHQK, NDEQ, QHRK, MILV, MILF, HY and Indicates that one of the strong groups of FYW is completely conserved, and "." Is weaker than the following CSA, ATV, SAG, STNK, STPA, SGND, SNDEQK, NDEQHK, NEQHRK, FVLIM and HFY One of the groups is shown to be fully conserved.</span>
      </figref>
      <figref num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ニスタチンＰＫＳシステムのモジュール３及び１１に各々に存在するマロニル特異的及びメチルマロニル特異的ＡＴドメインを伴った、化合物２（ａ）のＰＫＳに存在する２６ＡＴドメイン（ＯＲＦ１０〜１８）の、上記Brautaset et al.による記載に従った系統分析。</span>The above Brautaset et al. Of the 26AT domain (ORF 10-18) present in the PKS of compound 2 (a) with the malonyl-specific and methylmalonyl-specific AT domains present in <figure-callout id="3" label="modules" filenames="2007525148-211.png,2007525148-212.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="11" label="modules" filenames="2007525148-203.png,2007525148-219.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">modules</a></figure-callout></a></figure-callout> 3 and 11 of the nystatin PKS system, respectively. Phylogenetic analysis as described by.</span>
      </figref>
      <figref num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のポリケチドのコア構造の生合成経路。</span>Biosynthetic pathway of the core structure of polyketide of compound 2 (a).</span>
      </figref>
      <figref num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）のアミノヒドロキシシクロペンテノン（ａ）及びデオキシ糖（ｂ）成分の生合成経路。</span>Biosynthetic pathway of the aminohydroxycyclopentenone (a) and deoxy sugar (b) components of compound 2 (a).</span>
      </figref>
      <figref num="12a-b" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を機能的に修飾する変異体を提供するため、化合物２（ａ）の遺伝子座を遺伝的に修飾する方法の概要。</span>Summary of methods for genetically modifying the locus of compound 2 (a) to provide variants that functionally modify compound 2 (a).</span>
      </figref>
      <figref num="12c-d" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を機能的に修飾する変異体を提供するため、化合物２（ａ）の遺伝子座を遺伝的に修飾する方法の概要。</span>Summary of methods for genetically modifying the locus of compound 2 (a) to provide variants that functionally modify compound 2 (a).</span>
      </figref>
      <figref num="12e-f" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を機能的に修飾する変異体を提供するため、化合物２（ａ）の遺伝子座を遺伝的に修飾する方法の概要。</span>Summary of methods for genetically modifying the locus of compound 2 (a) to provide variants that functionally modify compound 2 (a).</span>
      </figref>
      <figref num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">エレクトロスプレー質量分析法によって得られた化合物２（ａ）の合成データを示している。</span>The synthesis data of compound 2 (a) obtained by electrospray mass spectrometry are shown.</span>
      </figref>
      <figref num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＵＶl<sub class="style-scope patent-text">max-  </sub>によって得られた化合物２（ａ）の合成データを示している。</span>The synthesis data of compound 2 (a) obtained by UVl <sub class="style-scope patent-text">max-</sub> are shown.</span>
      </figref>
      <figref num="15a" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を、陽子を含むｄ<sub class="style-scope patent-text">３</sub>−ＭｅＯＨ溶液に溶解し、５００ＭＨｚでＮＭＲ分析して得られた合成データを示している。</span>Compound 2 (a), dissolved in <sub class="style-scope patent-text">d</sub> 3 -MeOH solution containing protons shows combined data obtained by NMR analysis at 500 MHz.</span>
      </figref>
      <figref num="15b" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">化合物２（ａ）を、炭素を含むｄ<sub class="style-scope patent-text">３</sub>−ＭｅＯＨ溶液に溶解し、５００ＭＨｚでＮＭＲ分析して得られた合成データを示している。</span>The synthetic data obtained by dissolving Compound 2 (a) in a d <sub class="style-scope patent-text">3</sub> -MeOH solution containing carbon and performing NMR analysis at 500 MHz are shown.</span>
      </figref>
      <figref num="15c" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ｇＤＱＣＯＳＹの多次元パルスシーケンス実験から得られた、化合物２（ａ）の合成データを示している。</span>The synthetic data of compound 2 (a) obtained from the multidimensional pulse sequence experiment of gDQCOSY are shown.</span>
      </figref>
      <figref num="15d" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ｇＨＳＱＣの多次元パルスシーケンス実験から得られた、化合物２（ａ）の合成データを示している。</span>The synthetic data of the compound 2 (a) obtained from the multidimensional pulse sequence experiment of gHSQC are shown.</span>
      </figref>
      <figref num="15e" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ｇＨＭＢＣの多次元パルスシーケンス実験から得られた、化合物２（ａ）の合成データを示している。</span>The synthetic data of compound 2 (a) obtained from the multidimensional pulse sequence experiment of gHMBC are shown.</span>
      </figref>
      <figref num="15f" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＴＯＣＳＹの多次元パルスシーケンス実験から得られた、化合物２（ａ）の合成データを示している。</span>The synthetic data of the compound 2 (a) obtained from the multidimensional pulse sequence experiment of TOCSY are shown.</span>
      </figref>
      <figref num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">実施例５に記載のモデルマウスにおいて、カンジダ・アルビカンスに対する化合物２（ａ）の抗真菌活性を評価する研究から得られたデータの図。図１６は、化合物２（ａ）（３ｍｇ／ｋｇ）、化合物２（ａ）（１ｍｇ／ｋｇ）、ファンギゾン（０．２５ｍｇ／ｋｇ）及びファンギゾン（０．５０ｍｇ／ｋｇ）の、植菌後の生存率対日数を示している。</span>FIG. 6 is a diagram of data obtained from a study evaluating the antifungal activity of Compound 2 (a) against Candida albicans in the model mice described in Example 5. FIG. 16 shows survival after inoculation of compound 2 (a) (3 mg / kg), compound 2 (a) (1 mg / kg), fungizone (0.25 mg / kg) and fungizone (0.50 mg / kg). Shows rate versus days.</span>
      </figref>
      <figref num="17a-b" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">実施例３で論じられている、化合物２（ａ）の陽子−ＮＭＲ（図１７ａ）、１３Ｃ−ＮＭＲ（図１７ｂ）のスペクトルの割り当て。</span>Assignment of proton-NMR (FIG. 17a), 13C-NMR (FIG. 17b) spectra of compound 2 (a), discussed in Example 3.</span>
      </figref>
    </p>
  </description-of-drawings>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(29)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM15204822" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式Ｉで表される化合物又はその薬学的に許容される塩。<br class="style-scope patent-text">
<chemistry id="" num="1" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000152" he="68" wi="144" file="2007525148.tif" img-format="tif" img-content="drawing" width="576" height="272" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
    式Ｉ<br class="style-scope patent-text">
式中、Ａは−ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>、―Ｎ＝ＣＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>、<br class="style-scope patent-text">
<chemistry id="" num="2" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000153" he="24" wi="47" file="2007525148.tif" img-format="tif" img-content="drawing" width="188" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
及び    <br class="style-scope patent-text">
<chemistry id="" num="3" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000154" he="24" wi="39" file="2007525148.tif" img-format="tif" img-content="drawing" width="156" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
からなる群から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１</sup>、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>は、それぞれ独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、Ｃ<sub class="style-scope patent-text">３−６</sub>シクロアルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>ヘテロシクロアルキル、アリール、ヘテロアリール及びアミノ酸からなる群から選択され、該アルキル、アルケニル、アリール及びヘテロアリール基は、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>、ＮＨ<sub class="style-scope patent-text">２</sub>又はアリールから選択される基で置換されていてもよく、該アリールは、さらにハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>又はＮＨ<sub class="style-scope patent-text">２</sub>から独立して選択される１又は２以上の基で置換されてもよい；<br class="style-scope patent-text">
Ｂは、エテン−１，２−ジイル又は<br class="style-scope patent-text">
<chemistry id="" num="4" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000155" he="24" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
から選択され、<br class="style-scope patent-text">
式中Ｒ<sup class="style-scope patent-text">１０</sup>は、オキソ又はＯＲ<sup class="style-scope patent-text">１１</sup>であり、Ｒ<sup class="style-scope patent-text">１１</sup>は、Ｈ又はヘテロシクロアルキルであり、該ヘテロシクロアルキルは、ＯＸ、Ｃ<sub class="style-scope patent-text">１−３</sub>アルキル及び−Ｏ−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択される１〜４個の置換基で置換されていてもよく、ＸがＨであるか、又は、ＯＸである隣接する置換基が少なくとも２個ある場合に、Ｘは該２つの隣接する酸素基が式：<br class="style-scope patent-text">
<chemistry id="" num="5" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000156" he="25" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
のアセタール５員環を形成する結合であってもよく、<br class="style-scope patent-text">
式中、Ｒ<sup class="style-scope patent-text">５</sup>及びＲ<sup class="style-scope patent-text">６</sup>は、それぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル及びＣ<sub class="style-scope patent-text">２−７</sub>アルケニルからなる群より選択され；<br class="style-scope patent-text">
Ｄは、<br class="style-scope patent-text">
<chemistry id="" num="6" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000157" he="34" wi="37" file="2007525148.tif" img-format="tif" img-content="drawing" width="148" height="136" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
−ＮＲ<sup class="style-scope patent-text">１２ａ</sup>Ｒ<sup class="style-scope patent-text">１２ａ</sup>及びＯＲ<sup class="style-scope patent-text">１２  </sup>から選択され、Ｒ<sup class="style-scope patent-text">１２</sup>は、Ｈ、１〜２個のフェニル基で置換されてもよいＣ<sub class="style-scope patent-text">１−６</sub>アルキルから選択され、該フェニル基は、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル又はハロで置換されていてもよい；<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１２ａ</sup>及びＲ<sup class="style-scope patent-text">１２ａ</sup>は、それぞれ独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニル、Ｃ<sub class="style-scope patent-text">３−６</sub>シクロアルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>ヘテロシクロアルキル、アリール、ヘテロアリール及びアミノ酸から選択され、該アルキル、アルケニル、アリール及びヘテロアリールは、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>、ＮＨ<sub class="style-scope patent-text">２</sub>又はアリールから選択される基で置換されていてもよく、該アリールはさらに、ハロゲン、ＯＨ、ＮＯ<sub class="style-scope patent-text">２</sub>又はＮＨ<sub class="style-scope patent-text">２</sub>から独立して選択される１又は２以上の基で置換されていてもよい。<br class="style-scope patent-text">
Ｗ<sup class="style-scope patent-text">１</sup>は、<br class="style-scope patent-text">
<chemistry id="" num="7" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000158" he="18" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であり、<br class="style-scope patent-text">
Ｗ<sup class="style-scope patent-text">２</sup>は、<br class="style-scope patent-text">
<chemistry id="" num="8" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000159" he="18" wi="35" file="2007525148.tif" img-format="tif" img-content="drawing" width="140" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であり、<br class="style-scope patent-text">
Ｗ<sup class="style-scope patent-text">３</sup>は、<br class="style-scope patent-text">
<chemistry id="" num="9" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000160" he="15" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であり、<br class="style-scope patent-text">
Ｗ<sup class="style-scope patent-text">５</sup>は、<br class="style-scope patent-text">
<chemistry id="" num="10" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000161" he="19" wi="26" file="2007525148.tif" img-format="tif" img-content="drawing" width="104" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であり、<br class="style-scope patent-text">
Ｘ<sup class="style-scope patent-text">１</sup>、Ｘ<sup class="style-scope patent-text">２</sup>、Ｘ<sup class="style-scope patent-text">３</sup>、Ｘ<sup class="style-scope patent-text">４</sup>、Ｘ<sup class="style-scope patent-text">５</sup>、Ｘ<sup class="style-scope patent-text">６</sup>、Ｘ<sup class="style-scope patent-text">７</sup>、Ｘ<sup class="style-scope patent-text">８</sup>、Ｘ<sup class="style-scope patent-text">９</sup>、Ｘ<sup class="style-scope patent-text">１２</sup>及びＸ<sup class="style-scope patent-text">１３</sup>はそれぞれ独立してＨ、−Ｃ（Ｏ）−Ｒ<sup class="style-scope patent-text">７</sup>並びにＸ<sup class="style-scope patent-text">１</sup>、Ｘ<sup class="style-scope patent-text">２</sup>、Ｘ<sup class="style-scope patent-text">３</sup>、Ｘ<sup class="style-scope patent-text">４</sup>、Ｘ<sup class="style-scope patent-text">５</sup>、Ｘ<sup class="style-scope patent-text">６</sup>、Ｘ<sup class="style-scope patent-text">７</sup>、Ｘ<sup class="style-scope patent-text">８</sup>、Ｘ<sup class="style-scope patent-text">９</sup>、Ｘ<sup class="style-scope patent-text">１２</sup>及びＸ<sup class="style-scope patent-text">１３</sup>の隣接する２つが結合である場合に、該２つの隣接する酸素原子と、それらに付着する炭素原子とが式：<br class="style-scope patent-text">
<chemistry id="" num="11" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000162" he="24" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
のアセタール６員環を形成する結合から選択され、<br class="style-scope patent-text">
式中、Ｒ<sup class="style-scope patent-text">５</sup>、Ｒ<sup class="style-scope patent-text">6</sup>及びＲ<sup class="style-scope patent-text">7</sup>はそれぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルケニルから選択され、<br class="style-scope patent-text">
Ｙ<sup class="style-scope patent-text">１</sup>、Ｙ<sup class="style-scope patent-text">２</sup>、Ｙ<sup class="style-scope patent-text">３</sup>、Ｙ<sup class="style-scope patent-text">４</sup>、Ｙ<sup class="style-scope patent-text">５</sup>、Ｙ<sup class="style-scope patent-text">６</sup>、Ｙ<sup class="style-scope patent-text">７</sup>、Ｙ<sup class="style-scope patent-text">９</sup>、Ｙ<sup class="style-scope patent-text">１０</sup>、Ｙ<sup class="style-scope patent-text">１１</sup>、Ｙ<sup class="style-scope patent-text">１２</sup>、Ｙ<sup class="style-scope patent-text">１３</sup>及びＹ<sup class="style-scope patent-text">１５</sup>は、それぞれ独立してエテン−１,２−ジイル、エタン−１,２−ジイル及び<br class="style-scope patent-text">
<chemistry id="" num="12" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000163" he="19" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
から選択され、式中、該エテン−１,２−ジイル基及びエタン−１,２−ジイル基は、メチル基で置換されていてもよい。<br class="style-scope patent-text">
  ＺはＯＨ、ＮＨＲ<sup class="style-scope patent-text">８</sup>及び<br class="style-scope patent-text">
<chemistry id="" num="13" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000164" he="27" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
から選択され、点線が結合を示す場合には、Ｚはオキソ又はＮＲ<sup class="style-scope patent-text">９</sup>であり、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">８</sup>は、独立して、Ｈ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケニルから選択され、<br class="style-scope patent-text">
 Ｒ<sup class="style-scope patent-text">９</sup>は、アリールで置換されていてもよいＣ<sub class="style-scope patent-text">１−６</sub>アルキルである。
</span>A compound represented by formula I or a pharmaceutically acceptable salt thereof. <br class="style-scope patent-text"> <chemistry id="" num="1" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000152" he="68" wi="144" file="2007525148.tif" img-format="tif" img-content="drawing" width="576" height="272" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Formula I <br class="style-scope patent-text"> In the formula, A represents —NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> , —N═CR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> , <br class="style-scope patent-text"> <chemistry id="" num="2" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000153" he="24" wi="47" file="2007525148.tif" img-format="tif" img-content="drawing" width="188" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> as well as <br class="style-scope patent-text"> <chemistry id="" num="3" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000154" he="24" wi="39" file="2007525148.tif" img-format="tif" img-content="drawing" width="156" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of <br class="style-scope patent-text"> R <sup class="style-scope patent-text">1</sup> , R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each independently H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, C <sub class="style-scope patent-text">3-6</sub> cycloalkyl, C <sub class="style-scope patent-text">2-6</sub> heterocycloalkyl, aryl, hetero Selected from the group consisting of aryl and amino acids, wherein the alkyl, alkenyl, aryl and heteroaryl groups may be substituted with a group selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> , NH <sub class="style-scope patent-text">2</sub> or aryl, And may be further substituted with one or more groups independently selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> or NH <sub class="style-scope patent-text">2</sub> ; <br class="style-scope patent-text"> B is ethene-1,2-diyl or <br class="style-scope patent-text"> <chemistry id="" num="4" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000155" he="24" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from <br class="style-scope patent-text"> Wherein R <sup class="style-scope patent-text">10</sup> is oxo or OR <sup class="style-scope patent-text">11</sup> , R <sup class="style-scope patent-text">11</sup> is H or heterocycloalkyl, the heterocycloalkyl selected from OX, C <sub class="style-scope patent-text">1-3</sub> alkyl and —O—C (O) R <sup class="style-scope patent-text">1</sup> Optionally substituted with 1 to 4 substituents, and when X is H or there are at least two adjacent substituents that are OX, X is the two adjacent oxygen groups Is the formula: <br class="style-scope patent-text"> <chemistry id="" num="5" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000156" he="25" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> A bond that forms an acetal 5-membered ring of <br class="style-scope patent-text"> Wherein R <sup class="style-scope patent-text">5</sup> and R <sup class="style-scope patent-text">6</sup> are each independently selected from the group consisting of H, C <sub class="style-scope patent-text">1-6</sub> alkyl and C <sub class="style-scope patent-text">2-7</sub> alkenyl; <br class="style-scope patent-text"> D is <br class="style-scope patent-text"> <chemistry id="" num="6" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000157" he="34" wi="37" file="2007525148.tif" img-format="tif" img-content="drawing" width="148" height="136" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> -NR <sup class="style-scope patent-text">12a</sup> selected from R <sup class="style-scope patent-text">12a</sup> and OR <sup class="style-scope patent-text">12</sup> , wherein R <sup class="style-scope patent-text">12</sup> is selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl optionally substituted with 1-2 phenyl groups, wherein the phenyl group is C <sub class="style-scope patent-text">1-6</sub> alkyl Or optionally substituted with halo; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">12a</sup> and <sup class="style-scope patent-text">R 12a</sup> are each independently, <sub class="style-scope patent-text">H, C 1-6</sub> <sub class="style-scope patent-text">alkyl, C 2-6</sub> <sub class="style-scope patent-text">alkenyl, C 3-6</sub> <sub class="style-scope patent-text">cycloalkyl, C 2-6</sub> heterocycloalkyl, aryl, heteroaryl and amino acid , The alkyl, alkenyl, aryl and heteroaryl may be substituted with a group selected from halogen, OH, NO <sub class="style-scope patent-text">2</sub> , NH <sub class="style-scope patent-text">2</sub> or aryl, wherein the aryl is further halogen, OH, NO <sub class="style-scope patent-text">2</sub> or NH <sub class="style-scope patent-text">2</sub> May be substituted with one or more groups independently selected from <br class="style-scope patent-text"> W <sup class="style-scope patent-text">1</sup> is <br class="style-scope patent-text"> <chemistry id="" num="7" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000158" he="18" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">2</sup> is <br class="style-scope patent-text"> <chemistry id="" num="8" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000159" he="18" wi="35" file="2007525148.tif" img-format="tif" img-content="drawing" width="140" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">3</sup> is, <br class="style-scope patent-text"> <chemistry id="" num="9" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000160" he="15" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="60" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> W <sup class="style-scope patent-text">5</sup> is, <br class="style-scope patent-text"> <chemistry id="" num="10" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000161" he="19" wi="26" file="2007525148.tif" img-format="tif" img-content="drawing" width="104" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> And <br class="style-scope patent-text"> X <sup class="style-scope patent-text">1</sup> , X <sup class="style-scope patent-text">2</sup> , X <sup class="style-scope patent-text">3</sup> , X <sup class="style-scope patent-text">4</sup> , X <sup class="style-scope patent-text">5</sup> , X <sup class="style-scope patent-text">6</sup> , X <sup class="style-scope patent-text">7</sup> , X <sup class="style-scope patent-text">8</sup> , X <sup class="style-scope patent-text">9</sup> , X <sup class="style-scope patent-text">12</sup> and X <sup class="style-scope patent-text">13</sup> are each independently H, —C (O) —R <sup class="style-scope patent-text">7 and</sup> X <sup class="style-scope patent-text">1.</sup> , X <sup class="style-scope patent-text">2</sup> , X <sup class="style-scope patent-text">3</sup> , X <sup class="style-scope patent-text">4</sup> , X <sup class="style-scope patent-text">5</sup> , X <sup class="style-scope patent-text">6</sup> , X <sup class="style-scope patent-text">7</sup> , X <sup class="style-scope patent-text">8</sup> , X <sup class="style-scope patent-text">9</sup> , X <sup class="style-scope patent-text">12</sup> and X <sup class="style-scope patent-text">13</sup> are a bond, the two adjacent oxygen atoms, The carbon atom attached to them is the formula: <br class="style-scope patent-text"> <chemistry id="" num="11" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000162" he="24" wi="23" file="2007525148.tif" img-format="tif" img-content="drawing" width="92" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from bonds that form an acetal 6-membered ring of <br class="style-scope patent-text"> Wherein R <sup class="style-scope patent-text">5</sup> , R <sup class="style-scope patent-text">6</sup> and R <sup class="style-scope patent-text">7</sup> are each independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkenyl, <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">1</sup> , Y <sup class="style-scope patent-text">2</sup> , Y <sup class="style-scope patent-text">3</sup> , Y <sup class="style-scope patent-text">4</sup> , Y <sup class="style-scope patent-text">5</sup> , Y <sup class="style-scope patent-text">6</sup> , Y <sup class="style-scope patent-text">7</sup> , Y <sup class="style-scope patent-text">9</sup> , Y <sup class="style-scope patent-text">10</sup> , Y <sup class="style-scope patent-text">11</sup> , Y <sup class="style-scope patent-text">12</sup> , Y <sup class="style-scope patent-text">13</sup> and Y <sup class="style-scope patent-text">15</sup> are each independently ethene-1,2- Diyl, ethane-1,2-diyl and <br class="style-scope patent-text"> <chemistry id="" num="12" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000163" he="19" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Wherein the ethene-1,2-diyl group and ethane-1,2-diyl group may be substituted with a methyl group. <br class="style-scope patent-text"> Z is OH, NHR <sup class="style-scope patent-text">8</sup> and <br class="style-scope patent-text"> <chemistry id="" num="13" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000164" he="27" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Z is oxo or NR <sup class="style-scope patent-text">9</sup> when the dotted line indicates a bond <br class="style-scope patent-text"> R <sup class="style-scope patent-text">8</sup> is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkenyl, <br class="style-scope patent-text"> R <sup class="style-scope patent-text">9</sup> is C <sub class="style-scope patent-text">1-6</sub> alkyl <sub class="style-scope patent-text">optionally</sub> substituted with aryl.</span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
Ｚがオキソであることを特徴とする、請求項１記載の化合物又はその薬学的に許容される塩。
</span>
The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein Z is oxo.
</span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
    Ｄが、<br class="style-scope patent-text">
<chemistry id="" num="14" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000165" he="25" wi="25" file="2007525148.tif" img-format="tif" img-content="drawing" width="100" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であることを特徴とする、請求項１又は２記載の化合物又はその薬学的に許容される塩。
</span>D is <br class="style-scope patent-text"> <chemistry id="" num="14" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000165" he="25" wi="25" file="2007525148.tif" img-format="tif" img-content="drawing" width="100" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> The compound according to claim 1 or 2, or a pharmaceutically acceptable salt thereof.</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ｂが、<br class="style-scope patent-text">
<chemistry id="" num="15" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000166" he="25" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であることを特徴とする、請求項１、２又は３記載の化合物又はその薬学的に許容される塩。
</span>B <br class="style-scope patent-text"> <chemistry id="" num="15" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000166" he="25" wi="32" file="2007525148.tif" img-format="tif" img-content="drawing" width="128" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> The compound according to claim 1, 2, or 3, or a pharmaceutically acceptable salt thereof.</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ａが-ＮＲ<sup class="style-scope patent-text">１</sup>Ｒ<sup class="style-scope patent-text">２</sup>であることを特徴とする、請求項１〜４のいずれか記載の化合物又はその薬学的に許容される塩。
</span>The compound or pharmaceutically acceptable salt thereof according to any one of claims 1 to 4, wherein A is -NR <sup class="style-scope patent-text">1</sup> R <sup class="style-scope patent-text">2</sup> .</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ａが<br class="style-scope patent-text">
<chemistry id="" num="16" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000167" he="19" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であることを特徴とする、請求項４記載の化合物又はその薬学的に許容される塩。
</span>A is <br class="style-scope patent-text"> <chemistry id="" num="16" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000167" he="19" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> The compound according to claim 4 or a pharmaceutically acceptable salt thereof, wherein</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ｄが、<br class="style-scope patent-text">
<chemistry id="" num="17" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000168" he="25" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
であることを特徴とする請求項１、２、４、５又は６のいずれか記載の化合物又はその薬学的に許容される塩。
</span>D is <br class="style-scope patent-text"> <chemistry id="" num="17" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000168" he="25" wi="28" file="2007525148.tif" img-format="tif" img-content="drawing" width="112" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> The compound according to any one of claims 1, 2, 4, 5 and 6, or a pharmaceutically acceptable salt thereof.</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="18" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000169" he="25" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ａ）<br class="style-scope patent-text">
で表される化合物。
</span> <chemistry id="" num="18" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000169" he="25" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (a) <br class="style-scope patent-text"> A compound represented by</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式IIで表される化合物又はその薬学的に許容される塩。<br class="style-scope patent-text">
<chemistry id="" num="19" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000170" he="21" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
                          式II<br class="style-scope patent-text">
式中、Ａ<sup class="style-scope patent-text">１</sup>が−ＮＨ<sub class="style-scope patent-text">２</sub>、−Ｎ＝ＣＨ−Ｒ<sup class="style-scope patent-text">１３</sup>、アミノ酸又は−ＮＨ−Ｒ<sup class="style-scope patent-text">１４</sup>であり、Ｒ<sup class="style-scope patent-text">１３</sup>は水素又はフェニルであり、Ｒ<sup class="style-scope patent-text">１４</sup>は、イソプロピル、１−（４-ニトロフェニル）メチル、シクロヘキシルからなる群から選択され、該アミノ酸はその窒素原子により付着し；<br class="style-scope patent-text">
<chemistry id="" num="20" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000171" he="27" wi="95" file="2007525148.tif" img-format="tif" img-content="drawing" width="380" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
式中、Ｒ<sup class="style-scope patent-text">１５</sup>はメチル、イソプロピル、フェニル、４−ニトロフェニル、１−アミノエチル、１-アミノ−１−（４-ヒドロキシフェニル）メチル、１−アミノ−２−（４−ヒドロキシフェニル）エチル、１−アミノ−２−メチルプロピル、２−ピロリジニル及び１−アミノ−２−ヒドロキシエチルからなる群から選択され、<br class="style-scope patent-text">
Ｙ<sup class="style-scope patent-text">２０</sup>はエテン−１，２−ジイル及び<br class="style-scope patent-text">
<chemistry id="" num="21" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000172" he="18" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
からなる群から選択され；<br class="style-scope patent-text">
Ｚ<sup class="style-scope patent-text">１</sup>は<br class="style-scope patent-text">
<chemistry id="" num="22" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000173" he="56" wi="147" file="2007525148.tif" img-format="tif" img-content="drawing" width="588" height="224" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
からなる群から選択され；<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">２０</sup>は水素及び<br class="style-scope patent-text">
<chemistry id="" num="23" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000174" he="33" wi="53" file="2007525148.tif" img-format="tif" img-content="drawing" width="212" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
からなる群から選択され；<br class="style-scope patent-text">
Ｙ<sup class="style-scope patent-text">３０</sup>はエテン−1,２−ジイル又はエタン−１,２−ジイルであり；<br class="style-scope patent-text">
Ｄ<sup class="style-scope patent-text">１</sup>はヒドロキシ、メトキシ又は<br class="style-scope patent-text">
<chemistry id="" num="24" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000175" he="33" wi="40" file="2007525148.tif" img-format="tif" img-content="drawing" width="160" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
である。
</span>A compound represented by formula II or a pharmaceutically acceptable salt thereof. <br class="style-scope patent-text"> <chemistry id="" num="19" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000170" he="21" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Formula II <br class="style-scope patent-text"> Wherein A <sup class="style-scope patent-text">1</sup> is —NH <sub class="style-scope patent-text">2</sub> , —N═CH—R <sup class="style-scope patent-text">13</sup> , an amino acid or —NH—R <sup class="style-scope patent-text">14</sup> , R <sup class="style-scope patent-text">13</sup> is hydrogen or phenyl, R <sup class="style-scope patent-text">14</sup> is isopropyl, 1- (4-nitrophenyl) ) Selected from the group consisting of methyl, cyclohexyl, the amino acid being attached by its nitrogen atom; <br class="style-scope patent-text"> <chemistry id="" num="20" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000171" he="27" wi="95" file="2007525148.tif" img-format="tif" img-content="drawing" width="380" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> In which R <sup class="style-scope patent-text">15</sup> is methyl, isopropyl, phenyl, 4-nitrophenyl, 1-aminoethyl, 1-amino-1- (4-hydroxyphenyl) methyl, 1-amino-2- (4-hydroxyphenyl) ethyl, Selected from the group consisting of 1-amino-2-methylpropyl, 2-pyrrolidinyl and 1-amino-2-hydroxyethyl; <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">20</sup> is ethene-1,2-diyl and <br class="style-scope patent-text"> <chemistry id="" num="21" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000172" he="18" wi="30" file="2007525148.tif" img-format="tif" img-content="drawing" width="120" height="72" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of: <br class="style-scope patent-text"> Z <sup class="style-scope patent-text">1</sup> is <br class="style-scope patent-text"> <chemistry id="" num="22" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000173" he="56" wi="147" file="2007525148.tif" img-format="tif" img-content="drawing" width="588" height="224" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of: <br class="style-scope patent-text"> R <sup class="style-scope patent-text">20</sup> is hydrogen and <br class="style-scope patent-text"> <chemistry id="" num="23" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000174" he="33" wi="53" file="2007525148.tif" img-format="tif" img-content="drawing" width="212" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Selected from the group consisting of: <br class="style-scope patent-text"> Y <sup class="style-scope patent-text">30</sup> is ethene-1,2-diyl or ethane-1,2-diyl; <br class="style-scope patent-text"> D <sup class="style-scope patent-text">1</sup> is hydroxy, methoxy or <br class="style-scope patent-text"> <chemistry id="" num="24" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000175" he="33" wi="40" file="2007525148.tif" img-format="tif" img-content="drawing" width="160" height="132" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> It is.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  以下からなる群から選択される化合物：<br class="style-scope patent-text">
<chemistry id="" num="25" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000176" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｂ）<br class="style-scope patent-text">
<chemistry id="" num="26" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000177" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｃ）<br class="style-scope patent-text">
<chemistry id="" num="27" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000178" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｄ）<br class="style-scope patent-text">
<chemistry id="" num="28" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000179" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｅ）<br class="style-scope patent-text">
<chemistry id="" num="29" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000180" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｆ）<br class="style-scope patent-text">
<chemistry id="" num="30" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000181" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｇ）<br class="style-scope patent-text">
<chemistry id="" num="31" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000182" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｈ）<br class="style-scope patent-text">
<chemistry id="" num="32" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000183" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｉ）<br class="style-scope patent-text">
<chemistry id="" num="33" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000184" he="19" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｊ）<br class="style-scope patent-text">
<chemistry id="" num="34" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000185" he="23" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｋ）<br class="style-scope patent-text">
<chemistry id="" num="35" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000186" he="26" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｌ）<br class="style-scope patent-text">
<chemistry id="" num="36" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000187" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｍ）<br class="style-scope patent-text">
<chemistry id="" num="37" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000188" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｎ）<br class="style-scope patent-text">
<chemistry id="" num="38" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000189" he="22" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="88" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｏ）<br class="style-scope patent-text">
<chemistry id="" num="39" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000190" he="24" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｐ）<br class="style-scope patent-text">
<chemistry id="" num="40" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000191" he="26" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｑ）<br class="style-scope patent-text">
<chemistry id="" num="41" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000192" he="25" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｒ）<br class="style-scope patent-text">
<chemistry id="" num="42" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000193" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｓ）<br class="style-scope patent-text">
<chemistry id="" num="43" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000194" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｔ）<br class="style-scope patent-text">
<chemistry id="" num="44" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000195" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｕ）<br class="style-scope patent-text">
<chemistry id="" num="45" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000196" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｖ）<br class="style-scope patent-text">
<chemistry id="" num="46" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000197" he="25" wi="158" file="2007525148.tif" img-format="tif" img-content="drawing" width="632" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｗ）<br class="style-scope patent-text">
<chemistry id="" num="47" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000198" he="26" wi="158" file="2007525148.tif" img-format="tif" img-content="drawing" width="632" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｘ）<br class="style-scope patent-text">
<chemistry id="" num="48" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000199" he="27" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｙ）<br class="style-scope patent-text">
<chemistry id="" num="49" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000200" he="26" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ｚ）<br class="style-scope patent-text">
<chemistry id="" num="50" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000201" he="24" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ａａ）<br class="style-scope patent-text">
<chemistry id="" num="51" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000202" he="21" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry>
化合物２（ａｂ）
</span>A compound selected from the group consisting of: <br class="style-scope patent-text"> <chemistry id="" num="25" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000176" he="27" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (b) <br class="style-scope patent-text"> <chemistry id="" num="26" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000177" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (c) <br class="style-scope patent-text"> <chemistry id="" num="27" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000178" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (d) <br class="style-scope patent-text"> <chemistry id="" num="28" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000179" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (e) <br class="style-scope patent-text"> <chemistry id="" num="29" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000180" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (f) <br class="style-scope patent-text"> <chemistry id="" num="30" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000181" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (g) <br class="style-scope patent-text"> <chemistry id="" num="31" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000182" he="26" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (h) <br class="style-scope patent-text"> <chemistry id="" num="32" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000183" he="25" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (i) <br class="style-scope patent-text"> <chemistry id="" num="33" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000184" he="19" wi="164" file="2007525148.tif" img-format="tif" img-content="drawing" width="656" height="76" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (j) <br class="style-scope patent-text"> <chemistry id="" num="34" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000185" he="23" wi="163" file="2007525148.tif" img-format="tif" img-content="drawing" width="652" height="92" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (k) <br class="style-scope patent-text"> <chemistry id="" num="35" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000186" he="26" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (l) <br class="style-scope patent-text"> <chemistry id="" num="36" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000187" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (m) <br class="style-scope patent-text"> <chemistry id="" num="37" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000188" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (n) <br class="style-scope patent-text"> <chemistry id="" num="38" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000189" he="22" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="88" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (o) <br class="style-scope patent-text"> <chemistry id="" num="39" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000190" he="24" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (p) <br class="style-scope patent-text"> <chemistry id="" num="40" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000191" he="26" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (q) <br class="style-scope patent-text"> <chemistry id="" num="41" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000192" he="25" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (r) <br class="style-scope patent-text"> <chemistry id="" num="42" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000193" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (s) <br class="style-scope patent-text"> <chemistry id="" num="43" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000194" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (t) <br class="style-scope patent-text"> <chemistry id="" num="44" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000195" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (u) <br class="style-scope patent-text"> <chemistry id="" num="45" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000196" he="25" wi="160" file="2007525148.tif" img-format="tif" img-content="drawing" width="640" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (v) <br class="style-scope patent-text"> <chemistry id="" num="46" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000197" he="25" wi="158" file="2007525148.tif" img-format="tif" img-content="drawing" width="632" height="100" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (w) <br class="style-scope patent-text"> <chemistry id="" num="47" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000198" he="26" wi="158" file="2007525148.tif" img-format="tif" img-content="drawing" width="632" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (x) <br class="style-scope patent-text"> <chemistry id="" num="48" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000199" he="27" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="108" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (y) <br class="style-scope patent-text"> <chemistry id="" num="49" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000200" he="26" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="104" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (z) <br class="style-scope patent-text"> <chemistry id="" num="50" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000201" he="24" wi="166" file="2007525148.tif" img-format="tif" img-content="drawing" width="664" height="96" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (aa) <br class="style-scope patent-text"> <chemistry id="" num="51" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png" class="style-scope patent-text"><img id="000202" he="21" wi="165" file="2007525148.tif" img-format="tif" img-content="drawing" width="660" height="84" alt="Figure 2007525148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/df/31/1472840d0c8347/2007525148-99.png"></a></div> </chemistry> Compound 2 (ab)</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ストレプトミセス・アイズネンシス株に由来する細胞を培養するステップ、該培養された細胞を請求項８の化合物の生成に必要な時間、成長培地内で好気的にインキュベートするステップと、該培地を溶媒で抽出し、粗抽出物から請求項８の化合物を精製するステップとを含む、請求項８記載の化合物の生成方法。
</span>
Culturing cells derived from a Streptomyces isenensis strain, aerobically incubating the cultured cells in a growth medium for a time required to produce the compound of claim 8, and And a step of purifying the compound of claim 8 from the crude extract.
</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトミセス・アイズネンシス株が、ＮＲＲＬ  Ｂ−１１２７７又はその変異体であることを特徴とする、請求項１１記載の方法。
</span>
&nbsp;&nbsp;The method according to claim 11, wherein the Streptomyces isenensis strain is NRRL B-11277 or a variant thereof.
</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記変異体が、［Ｃ０３］０２３株（寄託アクセッション番号ＩＤＡＣ０７０８０３−１）又は［Ｃ０３Ｕ０３］０２３株（寄託アクセッション番号ＩＤＡＣ２３１２０３−０２）であることを特徴とする、請求項１２記載の方法。  
</span>
&nbsp;&nbsp;13. The method according to claim 12, characterized in that the mutant is [C03] 023 strain (deposited accession number IDAC070803-1) or [C03U03] 023 strain (deposited accession number IDAC231003-02).
</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  寄託アクセッション番号ＩＤＡＣ０７０８０３−１によって特定されるストレプトミセス・アイズネンシスの株。
</span>
&nbsp;&nbsp;A strain of Streptomyces isenensis identified by the deposit accession number IDAC070803-1.
</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  寄託アクセッション番号ＩＤＡＣ２３１２０３−０２によって特定されるストレプトミセス・アイズネンシスの株。
</span>
&nbsp;&nbsp;A strain of Streptomyces isenensis identified by the deposit accession number IDAC231203-02.
</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  治療上有効な量の請求項１〜１０のいずれか記載の化合物及びその薬学的に許容される担体を含む薬学的組成物。
</span>
&nbsp;&nbsp;A pharmaceutical composition comprising a therapeutically effective amount of a compound according to any of claims 1 to 10 and a pharmaceutically acceptable carrier thereof.
</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  治療上有効な量の請求項８記載の化合物及びその薬学的に許容される担体を含む薬学的組成物。
</span>
&nbsp;&nbsp;9. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 8 and a pharmaceutically acceptable carrier thereof.
</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  治療上有効な量の請求項９記載の化合物及びその薬学的に許容される担体を含む薬学的組成物。
</span>
&nbsp;&nbsp;A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 9 and a pharmaceutically acceptable carrier thereof.
</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  哺乳類の真菌症の治療方法で、該感染を罹患している該哺乳類に請求項１〜１０のいずれか記載の化合物の治療上有効な量を投与することを含む方法。
</span>
&nbsp;&nbsp;11. A method of treating a mycosis in a mammal comprising administering to the mammal suffering from the infection a therapeutically effective amount of a compound according to any of claims 1-10.
</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記真菌感染がカンジダ・アルビカンスに起因することを特徴とする、請求項１９記載の方法。
</span>
&nbsp;&nbsp;20. The method according to claim 19, characterized in that the fungal infection is caused by Candida albicans.
</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  真菌感染がカンジダ種に起因し、該カンジダ種が、カンジダ・グラブラタ、カンジダ・ルシタニエ、カンジダ・パラプシロシス、カンジダ・クルセイ及びカンジダ・トロピカリスからなる群から選択されることを特徴とする、請求項１９の方法。
</span>
&nbsp;&nbsp;The fungal infection is caused by a Candida species, wherein the Candida species is selected from the group consisting of Candida glabrata, Candida lucitanie, Candida parapsilos, Candida crusei and Candida tropicalis. the method of.
</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記真菌感染が、アスペルギルス種に起因し、該アスペルギルス種が、アスペルギルス・フミガーツス、アスペルギルス・ニガー、アスペルギルス・テレウス及びアスペルギルス・フラーブスから選択されることを特徴とする、請求項１９記載の方法。
</span>
&nbsp;&nbsp;20. The method according to claim 19, characterized in that the fungal infection is caused by an Aspergillus species and the Aspergillus species is selected from Aspergillus fumigatus, Aspergillus niger, Aspergillus tereus and Aspergillus flavus.
</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  該真菌感染症が、フサリウム種、セドスポリウム種、クリプトコッカス種、ケカビ種、ヒストプラスマ種、トリコスポロン種、ブラストミセス種又はサッカロマイシス・セレヴィシエに起因することを特徴とする請求項１９記載の方法。
</span>
&nbsp;&nbsp;The method according to claim 19, characterized in that the fungal infection is caused by Fusarium species, Sedsporium species, Cryptococcus species, Moldabia species, Histoplasma species, Trichosporon species, Blast myces species or Saccharomyces cerevisiae.
</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  被検体における真菌感染症の治療方法で、該感染を罹患している被検体に、請求項１〜１０のいずれか記載の化合物の治療上有効な量を投与することを含む方法。
</span>
&nbsp;&nbsp;11. A method of treating a fungal infection in a subject comprising administering to a subject suffering from said infection a therapeutically effective amount of a compound according to any of claims 1-10.
</span>
    </claim-text>
  </claim>
  <claim num="25" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記真菌感染症が、カンジダ・アルビカンス、カンジダ種、アスペルギルス種、フサリウム種、セドスポリウム種、クリプトコッカス種、ケカビ種、ヒストプラスマ種、トリコスポロン種、ブラストミセス種及びサッカロマイシス・セレヴィシエからなる群から選択される真菌に起因することを特徴とする、請求項２４記載の方法。
</span>
&nbsp;&nbsp;The fungal infection is selected from the group consisting of Candida albicans, Candida species, Aspergillus species, Fusarium species, Sedsporium species, Cryptococcus species, Quercus species, Histoplasma species, Trichosporon species, Blast myces species and Saccharomyces cerevisiae 25. The method according to claim 24, characterized by being caused by a fungus.
</span>
    </claim-text>
  </claim>
  <claim num="26" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記カンジダ種が、カンジダ・グラブラタ、カンジダ・ルシタニエ、カンジダ・パラプシロシス、カンジダ・クルセイ及びカンジダ・トロピカリスからなる群から選択されることを特徴とする、請求項２４記載の方法。
</span>
&nbsp;&nbsp;25. The method of claim 24, wherein the Candida species is selected from the group consisting of Candida glabrata, Candida lucitanie, Candida parapsilosis, Candida crusei and Candida tropicalis.
</span>
    </claim-text>
  </claim>
  <claim num="27" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記のアスペルギルス属が、アスペルギルス・フミガーツス、アスペルギルス・ニガー、アスペルギルス・テレウス及びアスペルギルス・フラーブスからなる群から選択されることを特徴とする、請求項２４記載の方法。
</span>
&nbsp;&nbsp;25. The method of claim 24, wherein the Aspergillus genus is selected from the group consisting of Aspergillus fumigatus, Aspergillus niger, Aspergillus tereus and Aspergillus flavus.
</span>
    </claim-text>
  </claim>
  <claim num="28" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  被検体における癌治療方法で、該癌を罹患している被検体に、請求項１〜１０いずれか記載の化合物の治療上有効な量を投与することを含む方法。
</span>
&nbsp;&nbsp;A method for treating cancer in a subject comprising administering to a subject suffering from said cancer a therapeutically effective amount of a compound according to any of claims 1-10.
</span>
    </claim-text>
  </claim>
  <claim num="29" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
    前記癌が、白血病、非小細胞肺細胞癌、大腸癌、中枢神経癌、メラノーマ、卵巣癌、腎臓癌、前立腺癌及び乳癌からなる群から選択されることを特徴とする、請求項２８記載の方法。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;29. The cancer according to claim 28, wherein the cancer is selected from the group consisting of leukemia, non-small cell lung cancer, colon cancer, central nervous cancer, melanoma, ovarian cancer, kidney cancer, prostate cancer and breast cancer. Method.
</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (11)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003062458A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003062458A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-24</span>
                    <span class="td style-scope patent-result">2003-07-31</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">Method, system and knowledge repository for identifying a secondary metabolite from a microorganism 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006528664A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006528664A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-13</span>
                    <span class="td style-scope patent-result">2006-12-21</span>
                    <span class="td style-scope patent-result">エコピア  バイオサイエンシーズ  インク</span>
                    <span class="td style-scope patent-result">
  Polyene polyketides, their preparation and their use as pharmaceuticals
 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3854480A/en"><a id="link" href="#" class="style-scope state-modifier">US3854480A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1969-04-01</span>
                    <span class="td style-scope patent-result">1974-12-17</span>
                    <span class="td style-scope patent-result">Alza Corp</span>
                    <span class="td style-scope patent-result">Drug-delivery system 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS551795B2/en"><a id="link" href="#" class="style-scope state-modifier">JPS551795B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1972-08-08</span>
                    <span class="td style-scope patent-result">1980-01-17</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4452775A/en"><a id="link" href="#" class="style-scope state-modifier">US4452775A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-12-03</span>
                    <span class="td style-scope patent-result">1984-06-05</span>
                    <span class="td style-scope patent-result">Syntex (U.S.A.) Inc.</span>
                    <span class="td style-scope patent-result">Cholesterol matrix delivery system for sustained release of macromolecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4946778A/en"><a id="link" href="#" class="style-scope state-modifier">US4946778A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1987-09-21</span>
                    <span class="td style-scope patent-result">1990-08-07</span>
                    <span class="td style-scope patent-result">Genex Corporation</span>
                    <span class="td style-scope patent-result">Single polypeptide chain binding molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5039660A/en"><a id="link" href="#" class="style-scope state-modifier">US5039660A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-03-02</span>
                    <span class="td style-scope patent-result">1991-08-13</span>
                    <span class="td style-scope patent-result">Endocon, Inc.</span>
                    <span class="td style-scope patent-result">Partially fused peptide pellet 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6117679A/en"><a id="link" href="#" class="style-scope state-modifier">US6117679A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-02-17</span>
                    <span class="td style-scope patent-result">2000-09-12</span>
                    <span class="td style-scope patent-result">Maxygen, Inc.</span>
                    <span class="td style-scope patent-result">Methods for generating polynucleotides having desired characteristics by iterative selection and recombination 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6361974B1/en"><a id="link" href="#" class="style-scope state-modifier">US6361974B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-12-07</span>
                    <span class="td style-scope patent-result">2002-03-26</span>
                    <span class="td style-scope patent-result">Diversa Corporation</span>
                    <span class="td style-scope patent-result">Exonuclease-mediated nucleic acid reassembly in directed evolution 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1244800B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1244800B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-10-29</span>
                    <span class="td style-scope patent-result">2007-03-14</span>
                    <span class="td style-scope patent-result">Kosan Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Rapamycin analogs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2352451C/en"><a id="link" href="#" class="style-scope state-modifier">CA2352451C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-24</span>
                    <span class="td style-scope patent-result">2003-04-08</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">High throughput method for discovery of gene clusters 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (16)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006528664A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006528664A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-13</span>
                    <span class="td style-scope patent-result">2006-12-21</span>
                    <span class="td style-scope patent-result">エコピア  バイオサイエンシーズ  インク</span>
                    <span class="td style-scope patent-result">
  Polyene polyketides, their preparation and their use as pharmaceuticals
 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1477563A3/en"><a id="link" href="#" class="style-scope state-modifier">EP1477563A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-16</span>
                    <span class="td style-scope patent-result">2004-11-24</span>
                    <span class="td style-scope patent-result">Wyeth</span>
                    <span class="td style-scope patent-result">Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005024025A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005024025A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-09-11</span>
                    <span class="td style-scope patent-result">2005-03-17</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">Polyene polyketides and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4441489B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4441489B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">2010-03-31</span>
                    <span class="td style-scope patent-result">メルシャン株式会社</span>
                    <span class="td style-scope patent-result">
  DNA involved in hydroxylation of macrolide compounds
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7507752B2/en"><a id="link" href="#" class="style-scope state-modifier">US7507752B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">2009-03-24</span>
                    <span class="td style-scope patent-result">Wyeth</span>
                    <span class="td style-scope patent-result">Biosynthetic gene cluster for the production of a complex polyketide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN1977046A/en"><a id="link" href="#" class="style-scope state-modifier">CN1977046A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-07-20</span>
                    <span class="td style-scope patent-result">2007-06-06</span>
                    <span class="td style-scope patent-result">卫材R&amp;D管理有限公司</span>
                    <span class="td style-scope patent-result">DNA coding for polypeptide participating in biosynthesis of pladienolide 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2006053313A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2006053313A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-11-12</span>
                    <span class="td style-scope patent-result">2006-05-18</span>
                    <span class="td style-scope patent-result">Wyeth</span>
                    <span class="td style-scope patent-result">Elaiophylin biosynthetic gene cluster 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW200716744A/en"><a id="link" href="#" class="style-scope state-modifier">TW200716744A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-05-26</span>
                    <span class="td style-scope patent-result">2007-05-01</span>
                    <span class="td style-scope patent-result">Eisai R&amp;D Man Co Ltd</span>
                    <span class="td style-scope patent-result">Genetically modified microorganism and process for production of macrolide compound using the microorganism 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CZ299789B6/en"><a id="link" href="#" class="style-scope state-modifier">CZ299789B6</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-05-10</span>
                    <span class="td style-scope patent-result">2008-11-26</span>
                    <span class="td style-scope patent-result">Mikrobiologický ústav AV CR, v.v.i.</span>
                    <span class="td style-scope patent-result">Method of detecting microorganisms producing metabolites comprising C5N unit 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2316937B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2316937B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-04</span>
                    <span class="td style-scope patent-result">2012-12-05</span>
                    <span class="td style-scope patent-result">Eisai R&amp;D Management Co., Ltd.</span>
                    <span class="td style-scope patent-result">Dna encoding polypeptide involved in biosynthesis of herboxidiene 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8288131B2/en"><a id="link" href="#" class="style-scope state-modifier">US8288131B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-08-27</span>
                    <span class="td style-scope patent-result">2012-10-16</span>
                    <span class="td style-scope patent-result">Codexis, Inc.</span>
                    <span class="td style-scope patent-result">Ketoreductase polypeptides and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2010111466A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2010111466A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-03-27</span>
                    <span class="td style-scope patent-result">2010-09-30</span>
                    <span class="td style-scope patent-result">The Trustees Of Columbia University In The City Of New York</span>
                    <span class="td style-scope patent-result">Aptamer-mediated drug release 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ598524A/en"><a id="link" href="#" class="style-scope state-modifier">NZ598524A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-08-29</span>
                    <span class="td style-scope patent-result">2014-06-27</span>
                    <span class="td style-scope patent-result">Abbvie Inc</span>
                    <span class="td style-scope patent-result">Therapeutic dll4 binding proteins 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105037543B/en"><a id="link" href="#" class="style-scope state-modifier">CN105037543B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-02</span>
                    <span class="td style-scope patent-result">2020-11-03</span>
                    <span class="td style-scope patent-result">Abbvie 公司</span>
                    <span class="td style-scope patent-result">Therapeutic DLL4 binding proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8865761B1/en"><a id="link" href="#" class="style-scope state-modifier">US8865761B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-08-07</span>
                    <span class="td style-scope patent-result">2014-10-21</span>
                    <span class="td style-scope patent-result">The University Of Notre Dame Du Lac</span>
                    <span class="td style-scope patent-result">Regulation of cholesterol homeostasis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10227622B2/en"><a id="link" href="#" class="style-scope state-modifier">US10227622B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-04-14</span>
                    <span class="td style-scope patent-result">2019-03-12</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Host cell modified to produce 2-pyrrolidone 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2007525148A/en"><a id="link" href="#" class="style-scope state-modifier">JP2007525148A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-09-06</span>
                    <span class="td style-scope patent-result">
  Polyene polyketides, methods for their production and use as pharmaceuticals [Related Applications] This application is based on US Provisional Application No. 60 / 441,123, filed Jan. 21, 2003, and US Provisional Application No. 60 / 441,2003. Claims priority to 60 / 494,568, US provisional application 60 / 469,810 filed May 13, 2003 and US provisional application 60 / 491,516 filed August 1, 2003 Is.
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7521222B2/en"><a id="link" href="#" class="style-scope state-modifier">US7521222B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-04-21</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinone and processes for its production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7300921B2/en"><a id="link" href="#" class="style-scope state-modifier">US7300921B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-27</span>
                    <span class="td style-scope patent-result">Polyene polyketides and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090069396A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090069396A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-03-12</span>
                    <span class="td style-scope patent-result">Polyene Oxazoles and Processes for Their Preparation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN111278985B/en"><a id="link" href="#" class="style-scope state-modifier">CN111278985B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-09-08</span>
                    <span class="td style-scope patent-result">Novel compound having therapeutic activity against mycobacterium avium complex infection disease and method for producing same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1409686B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1409686B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-03-22</span>
                    <span class="td style-scope patent-result">Genes and proteins for the biosynthesis of rosaramicin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2467249C/en"><a id="link" href="#" class="style-scope state-modifier">CA2467249C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-03-22</span>
                    <span class="td style-scope patent-result">Polyene polyketides, processes for their production and their use as pharmaceuticals 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20010086006A/en"><a id="link" href="#" class="style-scope state-modifier">KR20010086006A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-07</span>
                    <span class="td style-scope patent-result">Vancoresmycin, a process for its production and its use as a pharmaceutical 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NO853567L/en"><a id="link" href="#" class="style-scope state-modifier">NO853567L</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-03-18</span>
                    <span class="td style-scope patent-result">
  NEW ANTIBIOTICS, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5636179B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5636179B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-12-03</span>
                    <span class="td style-scope patent-result">
  Novel compound walkmycin, process for its production and use thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2538147A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2538147A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-08-09</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006213703A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006213703A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-08-17</span>
                    <span class="td style-scope patent-result">New fermentation product 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (5)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US44112303P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US46981003P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-05-13</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US49151603P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-08-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US49456803P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-08-13</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065401A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/CA2004/000068</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2004-01-21</span>
                    <span class="td style-scope patent-result">Polyene polyketides, processes for their production and their use as a pharmaceutical 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-07-30</span>
                    <span class="td nowrap style-scope patent-result">A711</span>
                    <span class="td nowrap style-scope patent-result">Notification of change in applicant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A712</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20090729</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-02-23</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100222</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-05-12</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100511</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-05-19</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100518</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-06-10</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100609</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-06-17</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100616</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-10</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100709</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-20</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100716</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-10-19</span>
                    <span class="td nowrap style-scope patent-result">A02</span>
                    <span class="td nowrap style-scope patent-result">Decision of refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A02</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20101018</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu">·</span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1430989474" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1430989474" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=1909402732" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>